15.09.2014 Views

Annual Report and Accounts 2012/13 - Hillingdon Hospital NHS Trust

Annual Report and Accounts 2012/13 - Hillingdon Hospital NHS Trust

Annual Report and Accounts 2012/13 - Hillingdon Hospital NHS Trust

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> <strong>2012</strong>/<strong>13</strong>


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> <strong>2012</strong>/<strong>13</strong><br />

Presented to Parliament pursuant to Schedule 7,<br />

paragraph 25(4)(a) of the National Health Service Act 2006


CONTENTS<br />

Page<br />

Introduction from the Chair <strong>and</strong> Chief Executive<br />

2<br />

Directors’ report 1<br />

4<br />

Governance report 2<br />

34<br />

Remuneration report<br />

52<br />

Quality report<br />

59<br />

Statement of Accounting Officer’s responsibilities<br />

97<br />

Statement of Directors’ responsibilities in respect<br />

of the accounts<br />

98<br />

<strong>Annual</strong> governance statement<br />

99<br />

Independent Auditor’s report<br />

110<br />

<strong>Annual</strong> accounts <strong>2012</strong>/<strong>13</strong><br />

112<br />

1 Including management commentary, staff survey, regulatory ratings, <strong>and</strong> public interest disclosures<br />

2 Including disclosures set out in the <strong>NHS</strong> Foundation <strong>Trust</strong> Code of Governance<br />

1


INTRODUCTION FROM THE CHAIR AND CHIEF EXECUTIVE<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> has strong links with the local<br />

community, with around 80% of our patients<br />

being drawn from within the Borough of<br />

<strong>Hillingdon</strong>.<br />

During the last year the <strong>Trust</strong>’s clinical<br />

performance remained strong despite the<br />

prolonged <strong>and</strong> extremely busy winter. Our<br />

clinical <strong>and</strong> non-clinical staff performed<br />

admirably under the most severe pressures<br />

<strong>and</strong> we remained compliant against all<br />

Monitor targets for each quarter, including<br />

the challenging Accident & Emergency<br />

(A&E) access target <strong>and</strong> infection control<br />

targets. We managed to deliver these, whilst<br />

delivering our financial plan <strong>and</strong> retaining<br />

our financial risk rating at an acceptable<br />

level.<br />

The annual report <strong>and</strong> accounts outline some<br />

of the successes <strong>and</strong> achievements over the<br />

last year. These achievements would not<br />

have been possible without the hard work<br />

of our staff who are the lifeblood of this<br />

organisation. The <strong>Trust</strong> also benefits from<br />

the support of our Governors who have<br />

an increasingly important role at the <strong>Trust</strong>,<br />

<strong>and</strong> our volunteers <strong>and</strong> charity workers<br />

who play an important role in fundraising<br />

<strong>and</strong> supporting patients <strong>and</strong> staff on the<br />

<strong>Hillingdon</strong> <strong>and</strong> Mount Vernon <strong>Hospital</strong> sites.<br />

It is thanks to the dedication of all of these<br />

people that the lives of many thous<strong>and</strong>s of<br />

patients are saved <strong>and</strong> services maintained<br />

<strong>and</strong> improved each year.<br />

The commitment, skill, care, <strong>and</strong> hard work<br />

exhibited by all our staff is all the more<br />

impressive given the massive challenges<br />

currently facing the <strong>NHS</strong>.<br />

The <strong>NHS</strong> has just completed one of the<br />

biggest reorganisations in recent years.<br />

Under the strategic umbrella of a new<br />

national organisation, <strong>NHS</strong> Engl<strong>and</strong>, from<br />

1st April 20<strong>13</strong> the day-to-day responsibility<br />

for the bulk of healthcare commissioning<br />

has been delegated to local Clinical<br />

Commissioning Groups (CCGs) comprising of<br />

local GPs. <strong>Hillingdon</strong> CCG wishes to reduce<br />

the money that they spend at the hospital,<br />

in addition to the nationally set reductions<br />

in the ‘tariff’ that determines the income the<br />

<strong>Trust</strong> receives for each instance of patient<br />

treatment. This means that we must continue<br />

to balance tight control over finance with<br />

rising dem<strong>and</strong> <strong>and</strong> increasing political <strong>and</strong><br />

patient expectations on quality.<br />

To help balance these issues, the <strong>Trust</strong> is<br />

working in partnership with GPs to redesign<br />

clinical pathways, help to integrate care<br />

across community <strong>and</strong> hospital boundaries,<br />

<strong>and</strong> work more in the community to improve<br />

patient care <strong>and</strong> to make best use of scarce<br />

resources.<br />

Further significant changes affecting the<br />

<strong>Trust</strong>’s future development are outlined<br />

in the North West London clinical strategy<br />

‘Shaping a Healthier Future’. The proposals,<br />

approved in February 20<strong>13</strong>, set out the<br />

direction for the reshaping of health services<br />

in North West London to improve quality,<br />

cope with rising dem<strong>and</strong>, <strong>and</strong> ensure health<br />

services are affordable. They aim to reshape<br />

health services by increasing investment in<br />

community services <strong>and</strong> diverting activity<br />

out of the hospital environment. If successful<br />

the plan will reduce the number of major<br />

hospitals in this part of London. It is to the<br />

credit of our staff that <strong>Hillingdon</strong> <strong>Hospital</strong><br />

has been identified as a major acute hospital<br />

<strong>and</strong> a fixed point in the overall plans <strong>and</strong><br />

we anticipate the greater use of <strong>Hillingdon</strong><br />

<strong>Hospital</strong> by Ealing GPs <strong>and</strong> residents.<br />

Against this massive programme of change<br />

we will continue to focus on our prime<br />

purpose of delivering high quality patient<br />

care <strong>and</strong> improving the patient experience.<br />

We have recieved over £12m Public Dividend<br />

Captial from the Department of Health<br />

to invest in our emergency care services<br />

<strong>and</strong> over £0.7m to refurbish the birthing<br />

environment in our maternity unit. Much of<br />

this work will be undertaken during 20<strong>13</strong>/14<br />

2<br />

Introduction


<strong>and</strong> represents significant investment in our<br />

services.<br />

The national concerns over poor patient<br />

care, exemplified in the Public Inquiry on<br />

Mid Staffordshire <strong>NHS</strong> <strong>Trust</strong> are a salutary<br />

reminder to all hospitals that clinical quality,<br />

patient safety <strong>and</strong> patient experience are<br />

of paramount importance <strong>and</strong> must never<br />

be placed secondary to achieving financial<br />

balance. The <strong>Trust</strong>’s CARES values launched in<br />

May <strong>2012</strong>, were designed by staff <strong>and</strong> go to<br />

the heart of everything we do.<br />

By embedding CARES throughout the<br />

organisation we will ensure that the needs<br />

of our patients always come first <strong>and</strong> that<br />

staff can work in a culture that encourages<br />

openness <strong>and</strong> transparency. The Board<br />

<strong>and</strong> Governors are clear that we as an<br />

organisation will continue to put patient care<br />

at the very top of our agenda. We are clear<br />

that the <strong>Trust</strong> must not compromise clinical<br />

quality <strong>and</strong> safety despite the financial<br />

pressures facing the <strong>NHS</strong> nationally <strong>and</strong><br />

locally.<br />

Introduction<br />

3


DIRECTORS’ REPORT<br />

About us<br />

• 24,633 admissions were made for planned<br />

the <strong>Trust</strong> (25,267 in 2011/12) 3 operations <strong>and</strong> day surgery (23,385 in<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

2011/12).<br />

<strong>Trust</strong> was established on 1st April 2011 when<br />

Monitor authorised The <strong>Hillingdon</strong> <strong>Hospital</strong><br />

<strong>NHS</strong> <strong>Trust</strong> to be an <strong>NHS</strong> Foundation <strong>Trust</strong>.<br />

The <strong>Trust</strong> provides health services at two<br />

hospitals in North West London: <strong>Hillingdon</strong><br />

<strong>and</strong> Mount Vernon. <strong>Hillingdon</strong> <strong>Hospital</strong> is the<br />

only general hospital in the London Borough<br />

of <strong>Hillingdon</strong> <strong>and</strong> offers a wide range of<br />

services including accident <strong>and</strong> emergency,<br />

inpatient care, day surgery, outpatient clinics<br />

<strong>and</strong> maternity services. The <strong>Trust</strong>’s services<br />

at Mount Vernon <strong>Hospital</strong> include routine<br />

In recent years our vision has been ‘to be<br />

the best general hospital in the country’.<br />

Given the significant amount of changes<br />

underway in the environment in which we<br />

operate, the Board agreed that there was a<br />

need to update the <strong>Trust</strong>’s vision. Following<br />

consultation with staff, in May 20<strong>13</strong> the<br />

Board agreed a new vision for the <strong>Trust</strong> that<br />

will inform the 20<strong>13</strong>/14 business planning: ‘To<br />

put compassionate care, safety <strong>and</strong> quality at<br />

the heart of everything we do’.<br />

day surgery at a modern treatment centre,<br />

a minor injuries unit, <strong>and</strong> outpatient clinics.<br />

The <strong>Trust</strong> also acts as a l<strong>and</strong>lord to a number<br />

of other organisations that<br />

provide health services at Mount Vernon,<br />

including East & North Hertfordshire <strong>NHS</strong><br />

<strong>Trust</strong>’s Cancer Centre.<br />

The <strong>Trust</strong>’s turnover in <strong>2012</strong>/<strong>13</strong> was over<br />

£190m <strong>and</strong> we employ over 2,500 staff.<br />

The majority of our patients live in the<br />

London Borough of <strong>Hillingdon</strong> but we<br />

also provide healthcare to people living in<br />

the surrounding areas of Ealing, Harrow,<br />

Buckinghamshire <strong>and</strong> Hertfordshire, giving<br />

us a total catchment population of over<br />

350,000 people.<br />

In <strong>2012</strong>/<strong>13</strong>:<br />

• 110,354 attendances were made to our<br />

accident & emergency department <strong>and</strong><br />

minor injuries unit (108,719 in 2011/12)<br />

• 4,205 babies were born in our maternity<br />

unit (4,218 in 2011/12)<br />

• 289,041 attendances were made as<br />

outpatients (296,606 in 2011/12)<br />

• 24,271 admissions were made for<br />

emergency treatment across all parts of<br />

3 This figure reflects all emergency admissions to the <strong>Trust</strong>; emergency admissions to inpatient wards increased (see page 7<br />

for further information)<br />

4 Directors’ report


Our performance against key targets<br />

The following table summarises the <strong>Trust</strong>’s performance in <strong>2012</strong>/<strong>13</strong> against the targets used<br />

by Monitor to calculate the governance risk rating 4 :<br />

Indicator Target Performance Achieved<br />

Clostridium difficile 24 (maximum) 23 <br />

MRSA 3 (maximum) 1 <br />

All cancers: 31 days for second or subsequent<br />

94% 100% <br />

treatment (surgery)<br />

All cancers: 31 days for second or subsequent<br />

98% 100% <br />

treatment (anti-cancer drug treatments)<br />

All cancers: 62 days for first treatment from<br />

85% 93.3% <br />

urgent GP referral for suspected cancer<br />

All cancers: 62 days for first treatment from <strong>NHS</strong> 90% 93.9% <br />

Cancer Screening Service referral<br />

Maximum time of 18 weeks from point of referral 90% 97.5% <br />

to treatment – admitted<br />

Maximum time of 18 weeks from point of referral 95% 98.8% <br />

to treatment – non admitted<br />

Maximum time of 18 weeks from point of<br />

92% 97.3% <br />

referral to treatment – patients on an incomplete<br />

pathway<br />

All cancers: 31 days diagnosis to first treatment 96% 99.2% <br />

Cancer: two week wait from referral to date first 93% 97.9% <br />

seen for all urgent referrals (cancer suspected)<br />

Cancer: two week wait from referral to date first 93% 98.0% <br />

seen for symptomatic breast patients (cancer not<br />

initially suspected)<br />

A&E: Total time in A&E less than 4 hours (Accident 95% 96.7% <br />

& Emergency, Minor Injuries Unit, Urgent Care<br />

Centre)<br />

Self-certification against compliance with<br />

Fully Compliant Fully Compliant <br />

requirements regards access to healthcare for<br />

people with a learning disability<br />

Moderate Care Quality Commission (CQC)<br />

No declared risk No declared risk <br />

concerns regarding the safety of healthcare<br />

provision<br />

Major CQC concerns regarding the safety of No declared risk No declared risk <br />

healthcare provision<br />

Failure to rectify a compliance or restrictive No declared risk No declared risk <br />

condition(s) by the date set by CQC within the<br />

condition(s) (or as subsequently amended with<br />

the CQC’s agreement)<br />

Published <strong>NHS</strong>LA & CNST Maternity level Level 1 or higher 1 <br />

4<br />

Definitions for the indicators are included in Monitor’s ‘Compliance Framework’ (available on<br />

www.monitor-<strong>NHS</strong>ft.gov.uk)<br />

Directors’ report<br />

5


Infection control<br />

The <strong>Trust</strong> continued to drive forward the<br />

infection prevention <strong>and</strong> control agenda<br />

<strong>and</strong> met the performance targets for both<br />

MRSA <strong>and</strong> Clostridium difficile (C-diff) in<br />

<strong>2012</strong>/<strong>13</strong>. One MRSA bloodstream infection<br />

was reported against a threshold of three,<br />

which is a significant improvement from<br />

the previous year’s performance when we<br />

finished with four reported cases of MRSA.<br />

The <strong>Trust</strong> reported 23 cases against a<br />

threshold of 24 for C-diff infections. Whilst<br />

this meant we met the target, the <strong>Trust</strong> saw<br />

an increase in reported cases from quarter<br />

three resulting in the <strong>Trust</strong> remaining close<br />

to the target.<br />

All C-diff patients had detailed multidisciplinary<br />

root cause analysis (RCA)<br />

undertaken involving the Microbiologists,<br />

the patient’s clinical team (Consultant <strong>and</strong><br />

nursing staff), the infection control team <strong>and</strong><br />

other members of the multi-disciplinary team<br />

(MDT) as required. Key learning from RCAs<br />

undertaken for <strong>2012</strong>/<strong>13</strong> cases included:<br />

• Antimicrobial prescribing: clinical<br />

indication must be documented <strong>and</strong><br />

the antimicrobials reviewed at every<br />

ward round.<br />

• Documentation (both nursing &<br />

medical) needs to be thorough <strong>and</strong><br />

contemporaneous.<br />

• There is a need for improved<br />

communication between teams,<br />

especially when the patient is an<br />

outlier with regard to specialty.<br />

• Specimen results are checked as soon<br />

as possible by ward staff after sending<br />

to the laboratory.<br />

• There should be senior clinical<br />

decision-making in sending samples.<br />

• Patients with diarrhoea on admission<br />

require specimens <strong>and</strong> isolation at the<br />

earliest opportunity.<br />

These themes were shared widely across the<br />

organisation to ensure that the key learning<br />

was shared <strong>and</strong> used to shape future<br />

practice.<br />

The <strong>Trust</strong> faces an increased challenge for<br />

the new financial year with a target of zero<br />

for MRSA <strong>and</strong> 14 for C-diff. We do however<br />

believe that the learning from the root cause<br />

analysis <strong>and</strong> the continued work around<br />

education <strong>and</strong> close monitoring will enable<br />

the <strong>Trust</strong> to meet these more stringent<br />

targets.<br />

Cancer<br />

A comprehensive action plan was<br />

implemented in 2011/12 to strengthen<br />

management arrangements within the<br />

cancer services. As a result of which, the <strong>Trust</strong><br />

delivered strong performance on all cancer<br />

targets in <strong>2012</strong>/<strong>13</strong>.<br />

Referral to Treatment waiting times<br />

All 18 week targets for both admitted <strong>and</strong><br />

non-admitted patients were achieved <strong>and</strong><br />

exceeded. The strong performance across<br />

elective (planned treatment) waiting time<br />

st<strong>and</strong>ards continues to ensure that the <strong>Trust</strong><br />

remains one of the top performing hospitals<br />

in North West London on these targets which<br />

seek to minimise patients’ waiting time for<br />

treatment.<br />

Accident <strong>and</strong> Emergency (A&E)<br />

waiting times<br />

The <strong>Trust</strong> achieved the target for 95% (all<br />

types) of patients to have a total time in<br />

A&E of less than four hours, with a mean<br />

performance throughout the year of 96.6%.<br />

A majority of <strong>Trust</strong>s in London have been<br />

challenged in delivering the A&E st<strong>and</strong>ard<br />

throughout the last quarter of the year.<br />

Unprecedented numbers of ambulance<br />

arrivals <strong>and</strong> increased acuity of patients<br />

made delivery of the target particularly<br />

challenging. Ambulance arrivals increased<br />

6 Directors’ report


400<br />

TRUST TOTAL - ADMISSIONS<br />

Non-Elective Admissions<br />

Excluding: Observation, Specialist, Maternity, Paediatrics & Daniels Wards<br />

Avg 10/11: 256<br />

Avg 11/12: 273<br />

Avg 12/<strong>13</strong>: 287<br />

2010/2011<br />

2011/<strong>2012</strong><br />

<strong>2012</strong>/20<strong>13</strong><br />

350<br />

300<br />

250<br />

Count of Admissions<br />

200<br />

150<br />

100<br />

50<br />

0<br />

1 2 3 4 5 6 7 8 9 10 11 12 <strong>13</strong> 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52<br />

APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR<br />

Week Number<br />

by 3.9% between January <strong>and</strong> March 20<strong>13</strong>,<br />

which resulted in more acutely unwell<br />

patients attending the hospital <strong>and</strong> receiving<br />

care in the resuscitation unit. Patients<br />

admitted to the resuscitation unit are acutely<br />

unwell <strong>and</strong> require a medical team to meet<br />

their clinical needs. This can deplete staff<br />

in the ‘minors’ area, <strong>and</strong> as a consequence,<br />

performance was affected. The <strong>Trust</strong> did<br />

however still manage to deliver the 95%<br />

st<strong>and</strong>ard during January to March which was<br />

our busiest time.<br />

The chart above tracks the increased level of<br />

emergency admissions to our adult inpatient<br />

wards.<br />

Additional funds were made available<br />

by the Department of Health to support<br />

<strong>Trust</strong>s over the winter period. Furthermore,<br />

the <strong>Trust</strong> invested significant funds to<br />

ensure patients continued to be seen <strong>and</strong><br />

treated in a timely manner <strong>and</strong> to restore<br />

performance by increasing the number of<br />

medical, nursing <strong>and</strong> clinical support staff in<br />

the A&E department. An additional Senior<br />

Sister was allocated to every shift to organise<br />

<strong>and</strong> co-ordinate patient flows through the<br />

department.<br />

Extra medical staff were also allocated to<br />

the Emergency Admission Unit (EAU), which<br />

significantly improved flows through the<br />

A&E department by ensuring there were<br />

sufficient beds available in the <strong>Trust</strong> to meet<br />

surges in activity.<br />

The chart on the next page demonstrates<br />

a substantial increase in the number of<br />

patients that were discharged from the EAU<br />

rather than admitted to one of our inpatient<br />

wards.<br />

Access to healthcare for people with<br />

learning disabilities<br />

The <strong>Trust</strong> continues to fully comply with the<br />

requirements regarding access to healthcare<br />

for people with a learning disability.<br />

CQUIN delivery<br />

Commissioning for Quality <strong>and</strong> Innovation<br />

(CQUIN) is a national framework for locally<br />

agreed quality improvement schemes. It links<br />

a proportion of healthcare income to the<br />

achievement of local quality improvement<br />

goals. The financial value of the available<br />

CQUINs for <strong>2012</strong>/<strong>13</strong> was 2.5% of the <strong>Trust</strong>’s<br />

clinical activity income.<br />

CQUINs are divided between those that<br />

are set nationally for all hospitals, those<br />

which are set regionally, <strong>and</strong> those are<br />

agreed locally between the <strong>Trust</strong> <strong>and</strong><br />

Directors’ report<br />

7


120<br />

Emergency Assessment Unit (EAU)<br />

SHORT STAY ADMISSIONS<br />

The number of admissions to EAU, who are also discharged from EAU<br />

2010/2011<br />

2011/<strong>2012</strong><br />

<strong>2012</strong>/20<strong>13</strong><br />

100<br />

80<br />

No of Admissions<br />

60<br />

40<br />

20<br />

0<br />

1 2 3 4 5 6 7 8 9 10 11 12 <strong>13</strong> 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52<br />

APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR<br />

Week No<br />

commissioner. The table below outlines the<br />

overall achievement of the CQUINs across the<br />

year. The variation across the year reflects<br />

that the regional <strong>and</strong> local CQUINs become<br />

progressively more challenging as the year<br />

progresses.<br />

Q1: Achieved<br />

100%<br />

The anticipated final outcome is 76%<br />

achievement.<br />

Further detail on the individual CQUINs is<br />

outlined below:<br />

National<br />

Q2: Achieved<br />

100%<br />

Q3: Achieved<br />

93%<br />

Q4: 52%<br />

(anticipated)<br />

• VTE<br />

The <strong>Trust</strong> exceeded the 90% st<strong>and</strong>ard<br />

on assessment for risk of venous<br />

thromboembolism (VTE) every month in<br />

<strong>2012</strong>/<strong>13</strong>.<br />

• Patient experience<br />

The <strong>Trust</strong> achieved 20% of the patient<br />

experience CQUIN which focuses on<br />

improving response rates in the national<br />

patient experience survey. The <strong>Trust</strong><br />

improved on all of the survey questions<br />

measured for this CQUIN with the<br />

exception of ‘did a member of staff<br />

explain the potential side effects of<br />

your medication’. A review on how staff<br />

explain side effects to patients is being<br />

undertaken <strong>and</strong> further training will be<br />

provided if necessary.<br />

• <strong>NHS</strong> Safety Thermometer<br />

The <strong>Trust</strong> achieved 100% of the <strong>NHS</strong><br />

Safety Thermometer CQUIN which focused<br />

this year on collection <strong>and</strong> return of data.<br />

The intention of this CQUIN for <strong>2012</strong>/<strong>13</strong><br />

was to create systems to monitor staff<br />

training <strong>and</strong> to collect data to establish<br />

baselines to set trajectories for 20<strong>13</strong>/14. In<br />

20<strong>13</strong>/14 the CQUIN will focus on pressure<br />

ulcers <strong>and</strong> will measure performance of all<br />

health <strong>and</strong> social care providers.<br />

• Dementia screening<br />

The <strong>Trust</strong> made considerable progress<br />

in implementing systems to ensure that<br />

patients received the necessary dementia<br />

screening assessment. However, due to<br />

the difficulties with the IT system it was<br />

not possible to provide the necessary data.<br />

As a consequence, the <strong>Trust</strong> did not meet<br />

the required st<strong>and</strong>ards for this CQUIN.<br />

Regional<br />

• North West Formulary<br />

The <strong>Trust</strong> achieved 100% of the North<br />

West London Formulary CQUIN, which<br />

focuses on implementing a st<strong>and</strong>ard<br />

formulary for the prescribing of drugs.<br />

The purpose of the formulary is to<br />

8 Directors’ report


educe the risk of drug errors by ensuring<br />

clinicians <strong>and</strong> pharmacists are familiar<br />

with the medicines they prescribe <strong>and</strong><br />

dispense.<br />

• Real time<br />

The <strong>Trust</strong> anticipates that it will achieve<br />

81% of the ‘Real Time’ CQUIN. The<br />

purpose of this CQUIN was to promote<br />

the use of an electronic process to speed<br />

up communication between primary <strong>and</strong><br />

secondary care, including the sending<br />

of outpatient letters <strong>and</strong> discharge<br />

summaries following a hospital visit or<br />

admission.<br />

Local<br />

• Consultant assessment<br />

Considerable investments were made to<br />

achieve 50% of the 12 hour Consultant<br />

assessment CQUIN. There was a significant<br />

investment in paediatrics where two<br />

additional Consultants have been<br />

appointed. The <strong>Trust</strong> also appointed an<br />

additional Consultant to the Emergency<br />

Admissions Unit to ensure more patients<br />

received senior review within 12 hours<br />

of an emergency admission. The <strong>Trust</strong><br />

is committed to fully achieving the<br />

st<strong>and</strong>ards set out in this CQUIN which also<br />

supports the emerging Emergency Care<br />

Clinical Quality St<strong>and</strong>ards for London.<br />

• Diabetes care<br />

The <strong>Trust</strong> achieved 100% of the Diabetes<br />

Care CQUIN by significantly increasing<br />

specialist care given to patients with<br />

diabetes.<br />

• End of life care<br />

The <strong>Trust</strong> achieved 87% of the End of Life<br />

Care CQUIN. This was an important new<br />

CQUIN developed between the <strong>Trust</strong> <strong>and</strong><br />

local commissioners. The purpose of the<br />

CQUIN was to establish a database <strong>and</strong><br />

a better underst<strong>and</strong>ing of the needs of<br />

patients who require care at this time of<br />

their lives. The information gathered will<br />

help the commissioners <strong>and</strong> the <strong>Trust</strong> to<br />

better design <strong>and</strong> co-ordinate services<br />

more aligned to patients’ needs.<br />

Our finances<br />

Overview of financial performance<br />

The organisation’s second year as a st<strong>and</strong>alone<br />

Foundation <strong>Trust</strong> regulated by Monitor<br />

was, without doubt, even tougher than its<br />

first. The solid financial foundations laid<br />

down over the last ten years were therefore<br />

required more than ever as both the national<br />

economic context <strong>and</strong> more pertinently<br />

the local commissioning financial context<br />

impacted on the <strong>Trust</strong> to an even greater<br />

extent than in the past. Faced with this<br />

context, in May <strong>2012</strong> the Board reluctantly<br />

approved an annual forward financial plan<br />

of a £1.9m income <strong>and</strong> expenditure deficit<br />

for the financial year <strong>2012</strong>/<strong>13</strong>. However, the<br />

<strong>Trust</strong> had just enough financial headroom<br />

that it was able to maintain a financial risk<br />

rating of 3 in each quarter of the <strong>2012</strong>/<strong>13</strong><br />

financial year. The <strong>Trust</strong> achieved its financial<br />

plan for the year <strong>and</strong> although clearly<br />

disappointing, the deficit represented only<br />

1% of total turnover. This performance<br />

though must be viewed within the context<br />

of increased patient expectation, higher<br />

clinical st<strong>and</strong>ards <strong>and</strong> service dem<strong>and</strong>s,<br />

<strong>and</strong> the economic pressures facing the<br />

organisation. When added to the severe local<br />

commissioning financial restrictions, the fact<br />

more healthcare was delivered to a high<br />

st<strong>and</strong>ard was a notable achievement.<br />

Overall surplus for the year<br />

The £1.9m deficit included two significant<br />

non-recurrent transactions. These were<br />

charges for fixed asset impairments of<br />

£0.5m that are not included in Monitor’s<br />

financial risk rating metrics <strong>and</strong> a gain on the<br />

revaluation of its investment properties of<br />

£1.7m. 5<br />

5 Investment properties are those held by the <strong>Trust</strong> to earn rentals <strong>and</strong>/or capital appreciation rather than used to provide<br />

healthcare<br />

Directors’ report<br />

9


Clinical activity levels, which were higher<br />

than contracted by healthcare commissioners,<br />

increased overall <strong>Trust</strong> operating revenue by<br />

2.2% for the year. This drove operating costs<br />

higher for the year by 0.8%. In addition, the<br />

<strong>Trust</strong> underachieved on its efficiency savings<br />

target of £7m by £0.7m – a delivery rate of<br />

90%.<br />

The <strong>Trust</strong>’s Earnings Before Interest, Tax,<br />

Depreciation, <strong>and</strong> Amortisation (EBITDA)<br />

were boosted by bringing catering <strong>and</strong><br />

cleaning services back into direct <strong>Trust</strong><br />

management, <strong>and</strong> the award to the<br />

<strong>Trust</strong>, after a competitive exercise, of the<br />

contract to run pathology services for GPs in<br />

Hounslow.<br />

Cash flow<br />

The <strong>Trust</strong> generated £12.8m cash from<br />

operating as a healthcare provider for the<br />

year. From this £6.3m was used to purchase<br />

new assets <strong>and</strong> a further £3.3m was required<br />

to service the outst<strong>and</strong>ing debt <strong>and</strong> interest<br />

from loans <strong>and</strong> leases. A net £1.2m of<br />

Public Dividend Capital was repaid to the<br />

Department of Health. This resulted in the<br />

<strong>Trust</strong> increasing its cash levels at the yearend<br />

by £2m when the plan at the start of<br />

the year had been to reduce them by £1.5m.<br />

This meant that against the plan of £0.4m it<br />

ended the year with £3.9m cash.<br />

This increase in cash will serve two important<br />

objectives. First, it will allow £1.8m to be<br />

used to finance committed capital schemes<br />

that did not complete as planned by the end<br />

of the current financial year <strong>and</strong> second, it<br />

will provide some additional cash headroom<br />

for the <strong>Trust</strong> going forward.<br />

Capital investment<br />

The <strong>Trust</strong>’s own cash resources to invest<br />

were supplemented by £12.4m of new Public<br />

Dividend Capital received from DH in respect<br />

of a successful business case to upgrade <strong>and</strong><br />

better integrate emergency care facilities on<br />

the <strong>Hillingdon</strong> <strong>Hospital</strong> site. This project will<br />

continue throughout the 20<strong>13</strong>/14 financial<br />

year <strong>and</strong> will form a major element of the<br />

estate investment programme in 20<strong>13</strong>/14 (see<br />

the later section on capital developments).<br />

Apart from major development projects, the<br />

largest area of investment during the year<br />

was again the estate. This centred on the<br />

<strong>Trust</strong>’s plan to prioritise investment to keep<br />

operational buildings safe, fit for purpose,<br />

<strong>and</strong> compliant with statutory legislation.<br />

Given the nature of the <strong>Trust</strong>’s estate this<br />

will inevitably be a long-term process, <strong>and</strong><br />

there is a programme in place to continue<br />

with this investment for the foreseeable<br />

future focused on the highest risk areas.<br />

Other significant projects included the<br />

refurbishment of one of the <strong>Trust</strong>’s busiest<br />

emergency wards <strong>and</strong> the start of a public<br />

toilets upgrade programme.<br />

In addition to investing in the physical<br />

infrastructure of the organisation, the <strong>Trust</strong><br />

also continued to invest in updating its<br />

medical equipment across a range of clinical<br />

services.<br />

Investment in information technology<br />

infrastructure <strong>and</strong> capability also remained a<br />

priority with system upgrades in Maternity,<br />

Pharmacy <strong>and</strong> Pathology. Another important<br />

project saw the <strong>Trust</strong> implement new<br />

hardware <strong>and</strong> software with enhanced<br />

capabilities to better integrate patient<br />

information between hospital systems. Other<br />

investment focused on improving network<br />

infrastructure.<br />

Looking to the future<br />

The <strong>Trust</strong>’s 20<strong>13</strong>/14 Forward Plan will again<br />

be set in the context of a UK economy that<br />

looks like it will remain suppressed for the<br />

foreseeable future. This is having a direct <strong>and</strong><br />

ever increasingly tough financial impact on<br />

all UK public services.<br />

The <strong>NHS</strong> in Engl<strong>and</strong> is no different <strong>and</strong><br />

reductions in the prices providers can charge<br />

commissioners for services under the national<br />

10 Directors’ report


tariff look set to remain. After two years<br />

of general restraint, pay levels for all staff<br />

look set to increase by 1% in the coming<br />

financial year adding further pressure to<br />

<strong>Trust</strong> finances.<br />

The national tariff (which determines how<br />

much <strong>Trust</strong>s receive for providing specific<br />

treatments) seems likely to continue to set<br />

providers the challenge of achieving at least<br />

a 4% efficiency saving in effect to ‘st<strong>and</strong>still’.<br />

Other pressures on acute providers brought<br />

about by restrictions on payment of<br />

emergency admissions <strong>and</strong> readmissions<br />

together with tough penalties for failing to<br />

meet national st<strong>and</strong>ards is expected to add<br />

at least a further 1% to the total efficiency<br />

savings required to be achieved in 20<strong>13</strong>/14.<br />

With the formal abolition of Primary Care<br />

<strong>Trust</strong>s, Clinical Commissioning Groups (CCG)<br />

are taking on the roles <strong>and</strong> responsibilities<br />

<strong>and</strong> forming new organisations with GPs<br />

taking a front seat. Locally, <strong>Hillingdon</strong><br />

Clinical Commissioning Group (HCCG) was<br />

authorised <strong>and</strong> will operate within a cluster<br />

of four adjoining outer North West London<br />

CCGs in Brent, Harrow <strong>and</strong> Ealing.<br />

As <strong>Hillingdon</strong> Primary Care <strong>Trust</strong> ended the<br />

<strong>2012</strong>/<strong>13</strong> financial year requiring significant<br />

external financial support to break-even,<br />

<strong>Hillingdon</strong> CCG is implementing an ambitious<br />

three-year financial recovery plan. This is<br />

aligned to their out of hospital strategy <strong>and</strong><br />

will reduce the amount of work this <strong>Trust</strong><br />

will undertake for them as more healthcare<br />

provision is moved to alternative local<br />

settings.<br />

The impact of this could be as high as 10%<br />

in 20<strong>13</strong>/14, <strong>and</strong> over the three year recovery<br />

plan period could see the <strong>Trust</strong>’s clinical<br />

revenue reduced by up to £30m. This is in<br />

addition to the efficiency savings already<br />

required by the national tariff <strong>and</strong> will<br />

undoubtedly put margins under the severest<br />

strain. Conversely, should the commissioners’<br />

out of hospital strategy not be as successful<br />

at reducing activity as planned, then<br />

potentially the <strong>Trust</strong> will have to treat<br />

patients <strong>and</strong> not be fully paid. As highlighted<br />

elsewhere in the report, this is one of the<br />

key risks facing the <strong>Trust</strong>. To help mitigate<br />

this risk, the <strong>Trust</strong> <strong>and</strong> CCG are working<br />

with PricewaterhouseCoopers to review the<br />

sustainability of the local health economy.<br />

As outlined earlier in the report, the level<br />

of payment linked to delivering specific<br />

demonstrable quality improvement (CQUINs)<br />

will remain at 2.5% of the <strong>Trust</strong> healthcare<br />

contract revenue for the coming year. This<br />

amounts to around £4.3m of income that will<br />

be at risk especially as it is likely to require<br />

the <strong>Trust</strong> to make significant targeted<br />

investment to meet the improvement in<br />

st<strong>and</strong>ards required. To ensure the <strong>Trust</strong><br />

achieves the most it can from the payments,<br />

CQUINs will remain a key focus for clinicians<br />

<strong>and</strong> managers.<br />

These increased financial risks <strong>and</strong> efficiency<br />

saving requirements together with a very<br />

financially challenged local commissioner<br />

will continue to mean improvements in<br />

productivity <strong>and</strong> efficiency will remain<br />

a significant point of focus for the<br />

management team. Clearly, this will have<br />

to be achieved whilst national <strong>and</strong> local<br />

quality st<strong>and</strong>ards are at the very least<br />

maintained <strong>and</strong> increasingly will require the<br />

complete transformation of <strong>Trust</strong> services.<br />

The continued rigorous assessment of the<br />

clinical impact of all significant <strong>Trust</strong> plans<br />

will therefore remain a crucial focus for<br />

management.<br />

The <strong>Trust</strong> is embarking on a comprehensive<br />

transformation programme that will alter<br />

the way we provide almost all services within<br />

the hospital. The focus is on improving the<br />

quality of the services we provide, which will<br />

in turn improve both the patient experience<br />

<strong>and</strong> delivery of the required efficiencies.<br />

Some of the proposed changes will affect<br />

inpatient pathways. Quality initiatives, such<br />

as earlier Consultant review <strong>and</strong> better<br />

discharge planning, will improve the patient<br />

experience <strong>and</strong> reduce the length of time<br />

Directors’ report<br />

11


patients spend in hospital, which will in<br />

turn mean the <strong>Trust</strong> will need less beds.<br />

Critical to this will be the way we work with<br />

our local health, social <strong>and</strong> voluntary care<br />

partners to deliver an integrated system of<br />

care. Improvements to the way we schedule<br />

our theatres will reduce the number of<br />

operations cancelled <strong>and</strong> consequently make<br />

significant savings. The scale of savings <strong>and</strong><br />

transformation required means that the<br />

coming year will be extremely challenging,<br />

but one where we are fully committed to<br />

improving both the quality <strong>and</strong> experience of<br />

the services we provide.<br />

In this challenging external context the<br />

Board of Directors will remain focused<br />

on the considerable challenge of how<br />

the organisation can continue to meet its<br />

continuity of services licence condition, which<br />

requires the <strong>Trust</strong> to ensure it remains a<br />

going concern. In particular, work will focus<br />

on finding alignment between the <strong>Trust</strong>’s<br />

activity plans <strong>and</strong> <strong>Hillingdon</strong> CCG’s QIPP <strong>and</strong><br />

identifying opportunities for the <strong>Trust</strong> to<br />

re-provide services planned to be moved to<br />

an out of hospital setting. The Board will<br />

also further strengthen the <strong>Trust</strong>’s project<br />

management of efficiency savings <strong>and</strong> review<br />

options to reinforce its cash headroom.<br />

Work will also concentrate on how best<br />

to secure sufficient capital investment so<br />

<strong>Trust</strong> facilities remain fit-for-purpose <strong>and</strong><br />

the organisation can gain from the clinical<br />

<strong>and</strong> operational efficiencies technology can<br />

deliver within both medical equipment <strong>and</strong><br />

information technology.<br />

Non-<strong>NHS</strong> income<br />

Section 43(2A) of the <strong>NHS</strong> Act 2006 (as<br />

amended by the Health <strong>and</strong> Social Care Act<br />

<strong>2012</strong>) requires that the <strong>Trust</strong>’s income from<br />

the provision of goods <strong>and</strong> services for the<br />

purposes of the health service in Engl<strong>and</strong><br />

must be greater than its income from the<br />

provision of goods <strong>and</strong> services for any<br />

other purposes. In <strong>2012</strong>/<strong>13</strong>, the <strong>Trust</strong> met<br />

this requirement, with 97% (£188.7m) of the<br />

<strong>Trust</strong>’s income generated by activities for the<br />

purpose of the health service in Engl<strong>and</strong>.<br />

As the vast majority of <strong>Trust</strong> income is<br />

categorised as generated by activities for the<br />

purpose of the health service in Engl<strong>and</strong>, it is<br />

the Board’s view that other income does not<br />

detract from <strong>NHS</strong> provision to any material<br />

extent. Where other income is generated it<br />

supports the <strong>Trust</strong> to make optimum use of<br />

all its assets <strong>and</strong> is used to directly support<br />

principal patient care activities.<br />

Comparative financial performance<br />

The table below outlines how the <strong>Trust</strong><br />

compared to the Foundation <strong>Trust</strong> sector<br />

on a range of key financial performance<br />

indicators. 6<br />

The <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> FT<br />

All Foundation <strong>Trust</strong>s<br />

Average<br />

Financial risk rating 7 – Acute <strong>Trust</strong>s 2.8 3.0<br />

Financial risk rating – Small acute <strong>Trust</strong>s<br />

2.8 2.8<br />

(total turnover less than £200m)<br />

EBITDA 8 margin 5.7% 6.0%<br />

Cost improvement plans delivery 92.2% 83.8%<br />

Capital spend to turnover 3% 4%<br />

Cash balances £3.2m £27.0m<br />

6 The above comparative performance table is based on the Regulator, Monitor’s most recent available review of the<br />

Foundation <strong>Trust</strong> sector, of which 81 were acute, as at quarter 3 <strong>2012</strong>/<strong>13</strong>. To enable a direct comparison, the THH figures<br />

reflect performance as at end of quarter 3 <strong>2012</strong>/<strong>13</strong>.<br />

7 See ‘Regulatory ratings’ for further information on the financial risk rating<br />

8 Earnings Before Interest, Taxes, Depreciation, <strong>and</strong> Amortisation<br />

12 Directors’ report


Regulatory ratings<br />

Monitor, the independent Regulator of<br />

Foundation <strong>Trust</strong>s, assigns Foundation <strong>Trust</strong>s<br />

two risk ratings each quarter:<br />

• A financial risk rating (rated 1-5, where<br />

1 represents the highest risk <strong>and</strong> 5 the<br />

lowest); <strong>and</strong><br />

• A governance risk rating (rated red<br />

(highest risk), amber-red, ambergreen<br />

or green (lowest risk)).<br />

The financial risk rating is based on a range<br />

of metrics across four areas: achievement<br />

of plan, underlying performance, financial<br />

efficiency, <strong>and</strong> liquidity. The governance<br />

risk rating is based on a combination of:<br />

service performance (measured on the<br />

<strong>Trust</strong>’s performance against key performance<br />

indicators selected by Monitor from<br />

the Department of Health’s Operating<br />

Framework); the views of third parties such<br />

as the Care Quality Commission <strong>and</strong> <strong>NHS</strong><br />

Litigation Authority; the provision of the<br />

m<strong>and</strong>atory services that Foundation <strong>Trust</strong>s<br />

must provide; <strong>and</strong> other instances where the<br />

Board may fail to accurately certify on their<br />

performance or governance. In addition,<br />

Monitor retains the discretion to amend the<br />

governance risk rating should a Foundation<br />

<strong>Trust</strong> fail to meet the statutory requirements<br />

of other bodies.<br />

The <strong>Trust</strong>’s risk ratings for 2011/12 <strong>and</strong><br />

<strong>2012</strong>/<strong>13</strong> are presented below.<br />

The <strong>Trust</strong> had planned for a risk rating of<br />

four for the 2011/12 financial year. However,<br />

the rating of three for each quarter of the<br />

year was due to two of the four financial<br />

criteria being one rating below the planned<br />

level. These were in respect of achievement<br />

of plan <strong>and</strong> financial efficiency. The<br />

reason the actual rating in these cases was<br />

below plan was the <strong>Trust</strong> only made a surplus<br />

before impairments of £262k when the<br />

plan was for a surplus of £2.542m. This was<br />

primarily due to three factors: (a) a shortfall<br />

on the <strong>Trust</strong>’s planned efficiency savings; (b)<br />

the <strong>Trust</strong> undertook an amount of activity<br />

that under the terms of its contracts with<br />

commissioners it was not going to be paid<br />

for either in part or full 10 ; <strong>and</strong> (c) price<br />

inflation on goods <strong>and</strong> services required by<br />

the <strong>Trust</strong> had a greater impact on operating<br />

costs than originally planned. Monitor<br />

therefore requested that the <strong>Trust</strong> reforecast<br />

its financial position <strong>and</strong> capital programme.<br />

<strong>Annual</strong> Plan<br />

2011/12<br />

Q1 2011/12 Q2 2011/12 Q3 2011/12 Q4 2011/12<br />

Financial risk rating 4 3 3 3 3<br />

Governance risk rating Green Amber-red Amber-green Green Green<br />

<strong>Annual</strong> Plan<br />

<strong>2012</strong>/<strong>13</strong><br />

Q1 <strong>2012</strong>/<strong>13</strong> Q2 <strong>2012</strong>/<strong>13</strong> Q3 <strong>2012</strong>/<strong>13</strong> Q4 <strong>2012</strong>/<strong>13</strong> 9<br />

Financial risk rating 3 3 3 3 3<br />

Governance risk rating Green Green Green Green Green<br />

9 The Q4 risk ratings are based on the <strong>Trust</strong>’s submission to Monitor at the end of April 20<strong>13</strong>: the <strong>Trust</strong> does not have<br />

Monitor’s confirmed Q4 ratings at the time of finalisation of the report (May 20<strong>13</strong>).<br />

10 These included in areas such as emergency activity, readmitted patients, follow-up outpatient appointments, <strong>and</strong><br />

Consultant to Consultant referrals.<br />

Directors’ report<br />

<strong>13</strong>


At the start of the 2011/12 year, the <strong>Trust</strong><br />

had a governance risk rating of green based<br />

on its risk assessment when submitting the<br />

annual plan to Monitor. The amber-red<br />

rating in Q1 was due to the <strong>Trust</strong> failing<br />

to meet the 62 day cancer target 11 for the<br />

quarter <strong>and</strong> that the <strong>Trust</strong> declared a risk of<br />

failing the annual C-diff target. The <strong>Trust</strong>’s<br />

risk rating improved to amber-green in Q2:<br />

whilst the C-diff performance improved, the<br />

<strong>Trust</strong> again failed to meet the 62 day cancer<br />

target for the quarter. The <strong>Trust</strong>’s rating for<br />

Q3 improved to green as the <strong>Trust</strong> met all<br />

healthcare targets for the quarter, as it did in<br />

Q4.<br />

The <strong>Trust</strong> planned for a risk rating of 3 for<br />

the <strong>2012</strong>/<strong>13</strong> year, which included a planned<br />

financial deficit. The <strong>Trust</strong> maintained this<br />

risk rating throughout the year, but was<br />

requested by Monitor to reforecast the<br />

capital expenditure given the variance to<br />

plan. Based on the performance that was<br />

being sustained from the second half of<br />

2011/12, the <strong>Trust</strong> declared a risk rating of<br />

green for governance for the <strong>2012</strong>/<strong>13</strong> year.<br />

This was maintained for each quarter of the<br />

year, with the <strong>Trust</strong> meeting the required<br />

targets (as outlined in the table at the start<br />

of the report).<br />

Following the submission of the <strong>Trust</strong>’s<br />

<strong>2012</strong>/<strong>13</strong> annual plan, Monitor commissioned<br />

a ‘stage 2 review’ of the <strong>Trust</strong>’s annual<br />

plan. The review, undertaken by<br />

PricewaterhouseCoopers (PwC) sought<br />

to examine the risks around the <strong>Trust</strong>’s<br />

financial stability. The review confirmed the<br />

challenging <strong>and</strong> delicate nature of the <strong>Trust</strong>’s<br />

financial position, particularly in respect of<br />

its cash position, <strong>and</strong> recommended that<br />

the <strong>Trust</strong>’s programme management office<br />

arrangements be substantially strengthened<br />

in light of the level of savings required. The<br />

<strong>Trust</strong> developed an action plan in response<br />

to the report’s recommendations, which<br />

included a significant strengthening of<br />

the arrangements for the delivery of the<br />

efficiency savings programme, <strong>and</strong> increased<br />

Board reporting on cash flow <strong>and</strong> liquidity.<br />

In addition, the Board continues to explore<br />

longer-term options for further increasing<br />

the <strong>Trust</strong>’s liquidity <strong>and</strong> ensuring the <strong>Trust</strong>’s<br />

future sustainability.<br />

There have been no formal interventions by<br />

Monitor at the <strong>Trust</strong>.<br />

Environmental performance:<br />

Sustainability<br />

Sustainable development management<br />

plan<br />

The Sustainability Steering Group has been<br />

created for the purpose of ensuring a whole<br />

<strong>Trust</strong> approach to meeting the organisation’s<br />

sustainability obligations. Sustainability is<br />

now used in procurement specifications <strong>and</strong><br />

is accounted for as an evaluation scoring<br />

element in all new capital, estates, food,<br />

transport, energy <strong>and</strong> waste contracts.<br />

During 20<strong>13</strong> the <strong>Trust</strong> plans to trial a<br />

‘sustainable ward’ with a focus on waste<br />

reduction, energy management, recycling<br />

<strong>and</strong> procurement. The trial will seek to<br />

quantify the reduction in carbon footprint<br />

<strong>and</strong> identify the highest impact schemes<br />

which can be extended across other wards at<br />

the <strong>Trust</strong>.<br />

Reducing our energy use<br />

Another key element of the action plan is<br />

to reduce the <strong>Trust</strong>’s energy use. The Carbon<br />

Reduction Commitment Energy Efficiency<br />

Scheme (often referred to as simply ‘the CRC’)<br />

is a m<strong>and</strong>atory scheme aimed at improving<br />

energy efficiency <strong>and</strong> cutting emissions in<br />

large public <strong>and</strong> private sector organisations.<br />

The scheme features a range of reputational,<br />

behavioural <strong>and</strong> financial drivers, which<br />

aim to encourage organisations to develop<br />

energy management strategies that promote<br />

a better underst<strong>and</strong>ing of energy usage.<br />

11 Percentage of patients receiving first definitive treatment within 62 days of referral from an <strong>NHS</strong> Cancer Screening Service<br />

14 Directors’ report


The table below summarises the <strong>Trust</strong>’s energy use in Gigajoules (GJ):<br />

2008/09 2009/10 2010/11 2011/12 <strong>2012</strong>/<strong>13</strong><br />

Electricity 59,548 61,173 59,851 58,518 56,703<br />

Gas 121,241 89,369 89,327 66,806 87,551<br />

Steam (incinerator) 75,923 79,990 79,991 79,991 69,990<br />

Oil 0 0 0 0 0<br />

Total 256,712 230,532 229,169 205,315 214,244<br />

The <strong>Trust</strong> is on track for an absolute carbon<br />

reduction target of 10% by 2015 against a<br />

2007 baseline assessment.<br />

During 2011/12 the <strong>Trust</strong> reduced the total<br />

energy use by 23,854 Gigajoules (GJ) from<br />

the previous year. This was attributed<br />

to good incinerator reliability providing<br />

steam for the <strong>Hillingdon</strong> <strong>Hospital</strong> site <strong>and</strong><br />

a relatively mild winter. The level of gas<br />

consumption in <strong>2012</strong>/<strong>13</strong> increased from the<br />

previous year due to the extent <strong>and</strong> length of<br />

the winter weather conditions, <strong>and</strong> essential<br />

repair works to the incinerator which led<br />

to heavier use of the back up gas boiler in<br />

March 20<strong>13</strong>.<br />

From 1 st January 20<strong>13</strong> the <strong>Trust</strong> successfully<br />

secured a new five year contract with SRCL<br />

to operate the incinerator based on the<br />

<strong>Hillingdon</strong> <strong>Hospital</strong> site. This arrangement<br />

ensures our clinical waste travels a minimum<br />

distance before entering the incinerator<br />

process; it is also highly sustainable in that<br />

the steam created from burning clinical<br />

waste is used to provide 70% of the energy<br />

needed to heat the radiators <strong>and</strong> provide hot<br />

water at <strong>Hillingdon</strong> <strong>Hospital</strong>.<br />

Waste reduction <strong>and</strong> minimisation<br />

The <strong>Trust</strong>’s Waste Group has met on a<br />

regular basis during the year. Part of its role<br />

is to ensure waste is segregated, managed,<br />

recycled <strong>and</strong> disposed of effectively in line<br />

with the Department of Health publication<br />

‘Safe Management of Healthcare Waste’.<br />

There has been a significant focus on<br />

improving waste signage, ensuring<br />

appropriate waste storage areas are in place,<br />

<strong>and</strong> the correct segregation is followed.<br />

Of the 1,363 tonnes of waste generated at<br />

<strong>Hillingdon</strong> <strong>and</strong> Mount Vernon <strong>Hospital</strong>s in<br />

<strong>2012</strong>/<strong>13</strong>, 351 tonnes (26% of the total) was<br />

recycled. 545 tonnes (40%) of the total was<br />

clinical waste, which was incinerated <strong>and</strong><br />

generated steam to provide heating <strong>and</strong> hot<br />

water at the <strong>Hillingdon</strong> site. The remaining<br />

467 tonnes (34%) was sent for l<strong>and</strong>fill.<br />

Green travel<br />

The <strong>Trust</strong> has continued to promote green<br />

travel for staff <strong>and</strong> service users. Events took<br />

place at both hospital sites giving staff the<br />

opportunity to learn about changing to<br />

greener travel alternatives such as car sharing<br />

<strong>and</strong> cycling to work. The well attended<br />

events were sponsored by Transport for<br />

London <strong>and</strong> will be repeated again this year.<br />

The <strong>Trust</strong> is intending to update its Travel<br />

Survey looking at how people travel to<br />

hospital <strong>and</strong> will be supporting a wide range<br />

of initiatives in the year ahead including<br />

‘Bikewise’ events <strong>and</strong> ‘Walk to Work Week’<br />

<strong>and</strong> will work with Transport for London <strong>and</strong><br />

the local authority to promote better public<br />

transport services to the <strong>Trust</strong>’s hospitals.<br />

Developing our services<br />

Service developments<br />

The <strong>Trust</strong> has undertaken a number of service<br />

developments over the last year, some of<br />

which are outlined below.<br />

Directors’ report<br />

15


Musculoskeletal (MSK) services<br />

The <strong>Trust</strong> has been working with<br />

commissioners to implement a redesigned<br />

Orthopaedic, Rheumatology <strong>and</strong> Pain Service<br />

model from April 20<strong>13</strong> with implementation<br />

of jointly agreed pathways. These pathways<br />

will involve the provision of more integrated<br />

care across primary <strong>and</strong> secondary care<br />

settings with the development of a Clinical<br />

Assessment <strong>and</strong> Treatment service (CATs) to<br />

triage referrals <strong>and</strong> streamline patients down<br />

the most appropriate care pathway. This<br />

large scale programme of work will continue<br />

to develop <strong>and</strong> evolve throughout 20<strong>13</strong>.<br />

Integrated care pilot<br />

The <strong>Trust</strong> has participated in the<br />

development of the outer North West<br />

London Integrated Care Pilot (ICP). The<br />

vision is to improve outcomes for patients<br />

by creating access to more integrated<br />

care outside of hospital. The overarching<br />

aim of this ambitious <strong>and</strong> transformative<br />

programme is to improve health <strong>and</strong><br />

social care support for some of our most<br />

vulnerable residents. Patient pathways will<br />

be redesigned by ICP partners, with an initial<br />

focus on care of the elderly (those over 75<br />

years of age) <strong>and</strong> adults with diabetes.<br />

This integrated approach is expected to<br />

deliver improved outcomes for patients<br />

by averting hospital attendances <strong>and</strong><br />

admissions, reducing length of stay for<br />

those patients who are admitted to hospital,<br />

improving patients’ experience of discharge<br />

from hospital, <strong>and</strong> preventing readmissions.<br />

As a result, a number of pilot schemes have<br />

begun locally in <strong>Hillingdon</strong> including a falls<br />

prevention management service.<br />

Pathology<br />

The <strong>Trust</strong> successfully won the tender for<br />

the provision of Hounslow GP pathology<br />

work. This was a significant result for the<br />

organisation given the very competitive<br />

environment that Pathology services operate<br />

in.<br />

A large scale strategic piece of work has<br />

also begun to explore the long term future<br />

strategy for Pathology services. Pathology is a<br />

rapidly evolving field; modalities of diagnosis<br />

are exp<strong>and</strong>ing <strong>and</strong> the necessity to perform<br />

multiple investigations on a sample is ever<br />

increasing.<br />

In response to these changes, in May <strong>2012</strong><br />

the <strong>Trust</strong> joined with five other <strong>Trust</strong>s in<br />

North West London to carry out a high<br />

level options analysis that would assist us in<br />

determining the most efficient operating<br />

model for the delivery of Pathology, whilst<br />

improving the quality of the service <strong>and</strong><br />

increasing opportunities for training <strong>and</strong><br />

research. Whilst the first phase of this project<br />

suggested a model with a single consolidated<br />

<strong>NHS</strong> hub along with local core laboratories<br />

at each <strong>Trust</strong> site, the next phase of the<br />

project will look to develop <strong>and</strong> review this<br />

option further, including a more detailed<br />

operational model covering all aspects of<br />

Pathology. It will also consider variations<br />

to this option as required by the <strong>Trust</strong>s,<br />

which may have particular needs or areas of<br />

specialist focus. The <strong>Trust</strong> Board is anticipated<br />

to consider the long term strategic options in<br />

late spring 20<strong>13</strong>.<br />

Capital developments<br />

As outlined earlier in the report, we<br />

have continued to invest in improving<br />

our hospitals. Three key developments<br />

in particular will improve the patient<br />

experience <strong>and</strong> the quality of the services<br />

provided by the <strong>Trust</strong>.<br />

Emergency <strong>and</strong> urgent care development<br />

A significant amount of work is currently<br />

taking place to redesign both the estate<br />

infrastructure <strong>and</strong> clinical model of care<br />

for emergency care services. Following<br />

the award of £12.4m of Public Dividend<br />

Capital from the Department of Health, <strong>and</strong><br />

approval of the full business case by the <strong>Trust</strong><br />

Board in March 20<strong>13</strong>, the <strong>Trust</strong> appointed a<br />

contractor to undertake the construction of a<br />

16 Directors’ report


new building. This will accommodate a new<br />

46-bed Acute Medical Unit (AMU) adjacent<br />

to the existing Emergency Department (ED),<br />

a new Rapid Assessment <strong>and</strong> Triage area to<br />

facilitate a quicker clinical assessment, <strong>and</strong> a<br />

new Urgent Care Centre (UCC) to integrate<br />

with community, social & mental health<br />

service providers.<br />

The aim is to provide improved high quality,<br />

safe, urgent <strong>and</strong> emergency care services<br />

for the local population. This will support<br />

achievement of the new A&E indicators,<br />

reduced length of stay, <strong>and</strong> provide an<br />

environment that will encourage integrated<br />

care with other healthcare providers,<br />

including the 111 telephone service. In<br />

addition to redesigning the A&E department<br />

<strong>and</strong> ambulatory emergency care pathways,<br />

the <strong>Trust</strong> plans to develop its workforce to<br />

meet the changing needs of patients that<br />

arrive in the emergency department.<br />

Improvements to the birthing room<br />

environment<br />

The <strong>Trust</strong> has been awarded over £700,000<br />

of Public Dividend Capital to improve the<br />

birthing room environment, within the<br />

Maternity Unit. This will entail refurbishing<br />

all ten rooms on the labour ward <strong>and</strong> include<br />

ensuring that all rooms are en-suite.<br />

Development of endoscopy services<br />

The <strong>Trust</strong> is undertaking an extensive<br />

programme of redevelopment of its<br />

endoscopy services at both Mount Vernon<br />

<strong>and</strong> <strong>Hillingdon</strong> sites. This will entail the<br />

reprovision of endoscopy services at Mount<br />

Vernon <strong>Hospital</strong> from the current location<br />

in the Main Building to the surgical floor in<br />

the Treatment Centre. Endoscopy services<br />

will also be redeveloped as part of the<br />

emergency care changes at the <strong>Hillingdon</strong><br />

site. This will require the current unit to be<br />

relocated to the new facility under the new<br />

AMU building. The endoscopy department<br />

will be equipped with two fully developed<br />

endoscopy suites.<br />

The redevelopment will support accreditation<br />

of both units by the Joint Advisory Group<br />

on Gastrointestinal Endoscopy Services.<br />

The relocation will also mean that patients<br />

will enjoy a significant improvement to the<br />

current environment.<br />

Service changes <strong>and</strong> challenges in<br />

the year ahead<br />

As highlighted in the introduction to the<br />

report, the environment in which the <strong>Trust</strong><br />

operates continues to significantly change.<br />

Several of the key strategic issues affecting<br />

the <strong>Trust</strong> in the coming year are outlined<br />

further below.<br />

Changes in the commissioning of services<br />

From 1st April 20<strong>13</strong>, <strong>NHS</strong> <strong>Hillingdon</strong> Clinical<br />

Commissioning Group is the statutory body<br />

for designing <strong>and</strong> commissioning local health<br />

services in <strong>Hillingdon</strong>, <strong>and</strong> therefore controls<br />

the majority of the <strong>Trust</strong>’s income. Their<br />

focus will be on securing better health care<br />

outcomes <strong>and</strong> responding to the needs <strong>and</strong><br />

wishes of our patients.<br />

They will do this by commissioning/buying<br />

the health <strong>and</strong> care services for the local<br />

population including:<br />

• Elective/planned hospital care<br />

• Rehabilitation care<br />

• Urgent <strong>and</strong> emergency care<br />

• Community health services<br />

• Mental health services.<br />

Other specialist services (for example<br />

neonatal care) will be commissioned by the<br />

National Commissioning Board.<br />

<strong>Hillingdon</strong> CCG covers the same geographical<br />

area as the London Borough of <strong>Hillingdon</strong><br />

<strong>and</strong> consists of all GP practices in the<br />

borough. The Governing Body consists of<br />

local GPs, a secondary care doctor, a senior<br />

nurse, lay members, a Chief Officer, <strong>and</strong> a<br />

Chief Financial Officer.<br />

Directors’ report<br />

17


<strong>Hillingdon</strong> CCG is working with all the CCGs<br />

in North West London to implement the<br />

health care strategy for NW London ‘Shaping<br />

a Healthier Future’. The CCG fully supports<br />

the strategy <strong>and</strong> they are actively developing<br />

an out of hospital strategy, working<br />

closely with The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong>.<br />

The key priorities for the CCG in 20<strong>13</strong>/14 are<br />

to:<br />

• Enable people to die at their preferred<br />

place of death.<br />

• Reduce emergency admissions from<br />

care homes by 10 per cent.<br />

• Reduce by 10 per cent the number of<br />

days of the average length of stay for<br />

people aged 65 or over admitted as a<br />

result of a fall.<br />

North West London reconfiguration<br />

The <strong>Trust</strong> will continue to input into the<br />

reconfiguration proposals set out in the<br />

‘Shaping a Healthier Future’ programme.<br />

The purpose of this review is to improve the<br />

continued provision of high quality, safe<br />

elective, urgent <strong>and</strong> emergency care services<br />

to our local population.<br />

The <strong>Trust</strong> will work with its healthcare<br />

partners <strong>and</strong> other stakeholders to develop<br />

strategic plans to accommodate anticipated<br />

work flows as a result of proposed service<br />

changes.<br />

Urgent Care Centre (UCC)<br />

The <strong>Trust</strong> will be submitting a joint bid with<br />

an external partner for the UCC service which<br />

is being tendered by the CCG. As part of this<br />

bid, clinical pathways will be developed to<br />

identify numbers <strong>and</strong> types of patients to<br />

be treated in the UCC rather than A&E. It is<br />

anticipated that this will hopefully form part<br />

of a fully integrated emergency care model.<br />

Out of hospital care<br />

As healthcare moves out of hospitals<br />

into community settings, the <strong>Trust</strong> will<br />

continue to work with the commissioners<br />

to develop an integrated model of care for<br />

musculoskeletal (MSK) services. As outlined<br />

earlier in the report, this will include<br />

implementation of a Clinical Assessment <strong>and</strong><br />

Triage service (CATs) which ensures provision<br />

of clinically appropriate pathways to the<br />

local population.<br />

The <strong>Trust</strong> is also working in collaboration<br />

with other health <strong>and</strong> social care colleagues<br />

on sector wide Integrated Care Pathways.<br />

As part of this programme, £177k has been<br />

awarded for an assisted discharge pilot,<br />

which will be delivered in collaboration<br />

with Central & North West London <strong>NHS</strong><br />

Foundation <strong>Trust</strong> (CNWL). This is expected to<br />

reduce both length of stay <strong>and</strong> readmissions<br />

for patients in this programme by assisting<br />

them in their transition from acute to<br />

community care. A further £60k has also<br />

been awarded from the ICP innovation fund<br />

for the delivery of a diabetic educational<br />

programme for nursing home staff.<br />

The <strong>Trust</strong> fully anticipates working on a<br />

number of further out of hospital schemes,<br />

particularly as it relates to planned care, with<br />

new pathways developed in conjunction with<br />

our CCG colleagues.<br />

Development of dermatology services<br />

The <strong>Trust</strong> plans to provide an integrated skin<br />

centre at Mount Vernon <strong>Hospital</strong>, which will<br />

include the development of a tertiary service.<br />

The <strong>Trust</strong> will also be developing bids for<br />

dermatology community services as they are<br />

tendered in a number of localities.<br />

Partnership working<br />

The <strong>Trust</strong> has continued to develop<br />

<strong>and</strong> enhance its relationships with local<br />

health <strong>and</strong> social care partners. The <strong>Trust</strong><br />

has formally entered into a number of<br />

regional programmes of work, including<br />

the Integrated Care Pilot for outer North<br />

West London, a joint review of Pathology<br />

modernisation across the sector as well as<br />

formally being a member of the Imperial<br />

18 Directors’ report


College Health Partners Academic Health<br />

Science Partnership. The partnership brings<br />

together health providers in North West<br />

London with Imperial College with the aim<br />

of improving health outcomes by sharing<br />

research.<br />

Locally in <strong>Hillingdon</strong> we have looked to<br />

redesign pathways of care with the CCG<br />

through the redesign of MSK services which<br />

also includes CNWL as our local community<br />

service provider. The <strong>Trust</strong> is a member of<br />

the <strong>Hillingdon</strong> Health Economy Recovery<br />

Board which brings together health <strong>and</strong><br />

social care partners in <strong>Hillingdon</strong> to ensure<br />

there is a financially sustainable local health<br />

economy. The <strong>Trust</strong> is also a member of the<br />

<strong>Hillingdon</strong> Health & Wellbeing Board which<br />

comprises a wider range of health <strong>and</strong> social<br />

care organisations to underst<strong>and</strong> local needs<br />

<strong>and</strong> agree priorities for improving health <strong>and</strong><br />

reducing health inequalities.<br />

Risks <strong>and</strong> uncertainties<br />

The Board has identified a number of<br />

key risks to the organisation which, if not<br />

managed, will impact on the <strong>Trust</strong>’s ability<br />

to deliver its mission <strong>and</strong> objectives. In the<br />

current <strong>and</strong> forecast operating context the<br />

key risks relate to:<br />

• The unprecedented size of the efficiency<br />

savings required in the next five years <strong>and</strong><br />

the <strong>Trust</strong> not receiving payment for the<br />

activity it undertakes, both of which have<br />

the clear potential to impact on the <strong>Trust</strong>’s<br />

financial viability <strong>and</strong> financial capacity to<br />

invest in its services <strong>and</strong> infrastructure.<br />

• The risk that the strategies to deliver<br />

care out of the hospital setting do not<br />

achieve the necessary goals <strong>and</strong> thereby<br />

cause an impact on the <strong>Trust</strong>’s operational<br />

efficiency <strong>and</strong> quality.<br />

• The risk of uncertainty caused by the<br />

reconfiguration of services in North West<br />

London (‘Shaping a Healthier Future’) not<br />

occurring at the rate anticipated.<br />

The <strong>Annual</strong> Governance Statement contains<br />

further information on the risks facing the<br />

<strong>Trust</strong> <strong>and</strong> the approach to managing these.<br />

Quality reporting<br />

The Quality <strong>Report</strong> contains a comprehensive<br />

review of the quality of the <strong>Trust</strong>’s services,<br />

<strong>and</strong> the priorities for quality improvement.<br />

The following summary outlines some key<br />

points of note.<br />

At the heart of the <strong>Trust</strong>’s commitment to<br />

quality is a clearly defined clinical quality<br />

strategy, a system of quality performance<br />

management, <strong>and</strong> as outlined in the<br />

<strong>Annual</strong> Governance Statement, a clear risk<br />

management process. A key part of the<br />

Board’s assurance on quality <strong>and</strong> safety is<br />

the Quality & Risk Committee (QRC). The<br />

Committee was formed in October <strong>2012</strong><br />

following the annual review of the Board<br />

<strong>and</strong> Committees, <strong>and</strong> brought together the<br />

Integrated Risk Management Committee <strong>and</strong><br />

the Clinical Quality & St<strong>and</strong>ards Committee<br />

in order to ensure that quality <strong>and</strong> risk are<br />

considered in an integrated way. The Board<br />

monitors quality through the monthly quality<br />

<strong>and</strong> operational performance report <strong>and</strong> a<br />

more detailed quarterly quality report. The<br />

QRC reviews a further set of quality metrics<br />

<strong>and</strong> high <strong>and</strong> medium risks. High risks are<br />

reviewed by the Board, together with Serious<br />

Incidents <strong>and</strong> the actions taken in response<br />

to the investigation of such incidents.<br />

The <strong>Trust</strong> has a comprehensive clinical audit<br />

work plan covering both national <strong>and</strong> local<br />

audits. Information <strong>and</strong> progress on clinical<br />

audit is reported to the QRC <strong>and</strong> the Audit &<br />

Assurance Committee.<br />

The Board has reviewed itself against the<br />

Monitor Quality Governance Framework <strong>and</strong><br />

considers itself to meet the requirements<br />

in the Framework. In reviewing the<br />

<strong>Trust</strong>’s position against the Framework in<br />

December <strong>2012</strong>, the Board highlighted the<br />

importance of refreshing the <strong>Trust</strong>’s clinical<br />

strategy in light of the Mid Staffordshire<br />

Directors’ report<br />

19


<strong>NHS</strong> Foundation <strong>Trust</strong> Public Inquiry <strong>and</strong><br />

the information available to the Board on<br />

the quality of the <strong>Trust</strong>’s services. The Board<br />

noted the importance of ensuring quality<br />

governance is premised on behaviours,<br />

culture, <strong>and</strong> processes.<br />

Work is therefore currently underway to<br />

refresh the Board’s quality strategy. Priorities<br />

identified by the Board for this work include<br />

ensuring robust mechanisms are in place to<br />

ensure information flows from the ward to<br />

the Board; ensuring the Board receives both<br />

qualitative <strong>and</strong> quantitative information;<br />

<strong>and</strong> an ongoing focus on nursing st<strong>and</strong>ards,<br />

mortality levels, <strong>and</strong> patient safety. Following<br />

issues identified on an unannounced ward<br />

visit by members of the Board, a priority is<br />

to ensure that the Board is assured on the<br />

consistency of care across the <strong>Trust</strong>’s wards.<br />

The Care Quality Commission (CQC)<br />

undertook an unannounced visit in<br />

December <strong>2012</strong> as part of their planned<br />

review of the <strong>Trust</strong>. The report issued<br />

from this visit found the <strong>Trust</strong> to be fully<br />

compliant with the CQC’s Essential St<strong>and</strong>ards<br />

of Quality & Safety. The report made no<br />

recommendations, but highlighted comments<br />

made by patients <strong>and</strong> staff in relation to<br />

communication, the ward environment, <strong>and</strong><br />

staffing levels. An action plan was developed<br />

in response <strong>and</strong> reported through the Quality<br />

& Risk Committee.<br />

There have been no inconsistencies<br />

between the <strong>Annual</strong> Governance Statement<br />

(presented later in the report), the annual<br />

<strong>and</strong> quarterly Board statements submitted<br />

to Monitor as required by the Compliance<br />

Framework, the Quality <strong>Report</strong> (presented<br />

later in the report) <strong>and</strong> reports arising from<br />

the Care Quality Commission planned <strong>and</strong><br />

responsive reviews of the <strong>Trust</strong>.<br />

Further information on the quality of the<br />

<strong>Trust</strong>’s services <strong>and</strong> the Board’s priorities for<br />

improving clinical quality is presented in the<br />

Quality <strong>Report</strong>.<br />

Public, patient, <strong>and</strong> stakeholder<br />

engagement <strong>and</strong> experience<br />

Improvements following patient<br />

feedback<br />

The <strong>Trust</strong> continues to remain committed<br />

to using patient feedback to improve<br />

the services provided by the <strong>Trust</strong>. As<br />

part of this, the <strong>Trust</strong> has reviewed its<br />

approach to monitoring patient experience<br />

<strong>and</strong> established a new Experience <strong>and</strong><br />

Engagement Group which is chaired by<br />

a Non-Executive Director, <strong>and</strong> includes<br />

Executive Directors, divisional nursing leads,<br />

Public Governors, <strong>and</strong> a Staff Governor. The<br />

group meets bi-monthly <strong>and</strong> oversees the<br />

delivery of ‘Putting People First’ our patient<br />

<strong>and</strong> staff experience <strong>and</strong> engagement<br />

strategy. The strategy sets out a variety<br />

of methods that the <strong>Trust</strong> uses to gather<br />

feedback from patients. During <strong>2012</strong>/<strong>13</strong><br />

approximately 11,700 patients have given<br />

feedback using our real time survey system.<br />

The comments from these surveys along with<br />

feedback gained from patients who were<br />

asked what matters most to them were used<br />

to help the <strong>Trust</strong> to identify how we should<br />

prioritise improvements.<br />

In November <strong>2012</strong> the <strong>Trust</strong> implemented<br />

the Friends <strong>and</strong> Family Test (FFT); this is a<br />

st<strong>and</strong>ardised question that will be used<br />

across the <strong>NHS</strong> from April 20<strong>13</strong>. Under the<br />

FFT when patients receive care or treatment<br />

as an inpatient or in an Accident <strong>and</strong><br />

Emergency (A&E) department they are given<br />

the opportunity to state whether or not<br />

they would recommend the ward or A&E<br />

department to friends <strong>and</strong> family if they<br />

needed similar care or treatment. Patients<br />

can respond from one of six options ranging<br />

from ‘extremely likely’ to ‘don’t know’, <strong>and</strong><br />

they are also invited to provide comments<br />

relating to the score that they have given.<br />

The comments help staff to gain an insight<br />

on what patients value <strong>and</strong> the factors that<br />

influence a poor experience of care.<br />

20 Directors’ report


The results from the Friends <strong>and</strong> Family<br />

Test are analysed to determine if any action<br />

is required. An overall score is calculated<br />

by using the proportion of patients<br />

who ‘strongly recommend’ minus those<br />

who would not recommend, or who are<br />

indifferent; this score will be published<br />

on the <strong>NHS</strong> Choices website <strong>and</strong> be made<br />

available publicly by the <strong>Trust</strong> from July 20<strong>13</strong>.<br />

This year we have also refreshed the process<br />

for monitoring feedback that patients leave<br />

on the <strong>NHS</strong> Choices <strong>and</strong> Patient Opinion<br />

websites. All comments are responded to <strong>and</strong><br />

acknowledged by the <strong>Trust</strong>.<br />

Examples of action undertaken or underway<br />

in response to feedback are outlined below.<br />

• Building on work last year to implement<br />

a Visitors Charter, we are introducing<br />

a visitor’s card. The small card contains<br />

some key points from the Visitors Charter<br />

<strong>and</strong> ward telephone numbers. The<br />

cards can be modified at a ward level to<br />

include the Matrons’ contact details <strong>and</strong><br />

ward visiting times.<br />

• A nurse call bell st<strong>and</strong>ard was introduced<br />

in October <strong>2012</strong>. The st<strong>and</strong>ard sets our<br />

aim to respond to call bells within two<br />

minutes <strong>and</strong> never any longer than five<br />

minutes. We are able to monitor our<br />

progress in maintaining this st<strong>and</strong>ard<br />

through our inpatient survey. Our results<br />

from October <strong>2012</strong> to March 20<strong>13</strong> show<br />

that 95% of patients who have used the<br />

nurse call bell reported that their call bell<br />

was answered within the st<strong>and</strong>ard, with<br />

79% of patients reporting that it was<br />

answered within two minutes.<br />

• On 1st February 20<strong>13</strong> the Phlebotomy<br />

service at the Mount Vernon site brought<br />

forward its opening time to 7.30am in<br />

response to patient feedback.<br />

Complaints<br />

Complaints are an important source of<br />

patient feedback.<br />

In <strong>2012</strong>/<strong>13</strong> the <strong>Trust</strong> received 495 complaints,<br />

compared to 386 in 2011/12, a rise of 28%.<br />

The response rate for the year was 76.1%<br />

which means that 383 of the 495 complaints<br />

were answered within the timescale agreed<br />

with the complainant. The chart below<br />

shows the subjects involved. Each complaint<br />

often refers to more than one subject <strong>and</strong><br />

therefore the total on the chart adds up to<br />

more than the total number of complaints.<br />

Under the current complaints regulations,<br />

Complaints by subject categories<br />

Clinical Care<br />

Medical Staff<br />

Communication/<br />

Information to<br />

Patients<br />

Clinical Care<br />

Nursing Staff<br />

Appointments<br />

(OPD & A&E)<br />

Attitude<br />

(Medical Staff)<br />

Attitude<br />

(Nursing Staff)<br />

Hotel Services<br />

Number<br />

Subject<br />

Discharge<br />

Transport<br />

Attitude (Other<br />

Support Staff)<br />

Directors’ report<br />

21


the emphasis is on resolving complaints<br />

locally <strong>and</strong> this has been achieved in 456<br />

(92%) of complaints, with the majority<br />

of these resolved through the <strong>Trust</strong>’s first<br />

response. 27 (5.5%) of complaints were<br />

resolved through further local resolution,<br />

either by writing again to the complainants,<br />

or by meeting with them.<br />

12 of our complainants (2.4%) were not<br />

happy with our local responses <strong>and</strong> referred<br />

their complaint to the Parliamentary<br />

<strong>and</strong> Health Service Ombudsman for an<br />

independent review. The Ombudsman<br />

decided to investigate one complaint <strong>and</strong><br />

that is ongoing. Two complaints were<br />

rejected by the Ombudsman as properly<br />

resolved by the <strong>Trust</strong>. The <strong>Trust</strong> was asked to<br />

undertake further work locally to resolve the<br />

complaint in four cases, three of which have<br />

now been completed <strong>and</strong> closed, <strong>and</strong> one<br />

remains open. In five cases the papers have<br />

been supplied to the Ombudsman <strong>and</strong> we<br />

are awaiting their decision.<br />

The <strong>Trust</strong> has continued to work with<br />

complainants <strong>and</strong> use complaints as drivers<br />

for improvements to the services we<br />

provide. Once again this year changes <strong>and</strong><br />

improvements have been embedded in<br />

clinical areas as a result of complaints.<br />

A particular area of focus has been on<br />

ensuring that test results are followed up<br />

appropriately, <strong>and</strong> new systems have been<br />

put in place in the Clinical Support Services<br />

Division <strong>and</strong> in the Women’s <strong>and</strong> Children’s<br />

Division following a complaint in each<br />

Division that results had been overlooked.<br />

In the Division of Surgery, the Urology<br />

Department has been looking at catheter<br />

care, <strong>and</strong> staff have been working very<br />

closely with a patient who was keen to<br />

be involved in formulating new ideas for<br />

improving the experience <strong>and</strong> underst<strong>and</strong>ing<br />

of patients who have a catheter for a period<br />

of time.<br />

On a simpler level a patient informed us<br />

that after his eye clinic appointments his<br />

eyes were sore <strong>and</strong> it was uncomfortable<br />

to wait for transport in the Outpatient Hall<br />

because the seats were in a draughty area.<br />

The Matron responsible for the Outpatients<br />

Department met with Facilities staff <strong>and</strong> the<br />

seating area has been reconfigured; chairs<br />

have been moved away from the draught<br />

<strong>and</strong> a dedicated waiting area for those<br />

waiting for transport has been arranged,<br />

which is away from draughts. Signage is<br />

being made to identify the area.<br />

Improvements in patient <strong>and</strong> carer<br />

information<br />

Providing high quality <strong>and</strong> clear information<br />

is central to the patient experience.<br />

During <strong>2012</strong>/<strong>13</strong> the Patient Information<br />

Review Group continued to work with staff<br />

across the hospital to develop new patient<br />

<strong>and</strong> carer information <strong>and</strong> to refresh existing<br />

information.<br />

Our Readers Panel, service users, <strong>and</strong> patient<br />

involvement groups support <strong>Trust</strong> staff to<br />

ensure that the information we produce<br />

is clear, jargon free <strong>and</strong> user friendly. For<br />

example, our Fighting Infection Together<br />

(FIT) public involvement group worked with<br />

the <strong>Trust</strong> Infection Control Team to develop<br />

an ‘isolation leaflet’. The leaflet describes<br />

why a patient may be cared for in isolation<br />

<strong>and</strong> what relatives can expect. Input from<br />

patients <strong>and</strong> public has been particularly<br />

helpful in developing leaflets on sensitive<br />

issues. For example, our Readers Panel<br />

supported the production of a Post Mortem<br />

leaflet which is given to relatives soon after<br />

the death of a loved one. The panel ensured<br />

that the leaflet presents the relevant legal<br />

<strong>and</strong> technical information in a sensitive way.<br />

The <strong>Trust</strong> is developing a poster that will<br />

be used in A&E cubicles to illustrate the<br />

typical pathways through the emergency<br />

department explaining the points at which<br />

there may be waiting periods. The poster<br />

22 Directors’ report


is being developed in response to feedback<br />

from patients who are not always sure what<br />

is happening next, <strong>and</strong> why they may be kept<br />

waiting. The poster will support the verbal<br />

updates that are given by the staff in the<br />

department.<br />

Other condition/service specific information<br />

produced in <strong>2012</strong>/<strong>13</strong> included new leaflets in<br />

Radiology; a leaflet to support parents caring<br />

for children with a nasogastric tube; a leaflet<br />

on caring for a surgical wound at home; <strong>and</strong><br />

information on the Liverpool Care Pathway.<br />

During <strong>2012</strong>/<strong>13</strong> the <strong>Trust</strong> developed a Carers’<br />

Strategy <strong>2012</strong>-2015 that outlines the <strong>Trust</strong>’s<br />

commitment to working in partnership with<br />

all carers <strong>and</strong> families by listening, learning<br />

<strong>and</strong> responding to feedback. Our vision is to<br />

provide support <strong>and</strong> information to all carers<br />

ranging from breastfeeding mothers through<br />

to carers’ needs at the end of people’s lives.<br />

Our objectives are to improve a carer’s<br />

experience by:<br />

• Providing appropriate <strong>and</strong> timely<br />

information to support the carer <strong>and</strong> the<br />

person they support.<br />

• Actively involving carers where patient<br />

consent has been granted in decisions<br />

about the care <strong>and</strong> treatment of the<br />

person they care for.<br />

• Involving carers in the planning or<br />

developing of services <strong>and</strong> in monitoring<br />

patient <strong>and</strong> carer experience.<br />

• Providing support for carers who are<br />

caring for people with multiple <strong>and</strong><br />

complex needs e.g. learning disabilities,<br />

physical disabilities <strong>and</strong> dementia.<br />

• Improving staff awareness of the role of a<br />

carer in care delivery.<br />

• Ensuring carers are provided with<br />

sufficient information to enable<br />

safe planning of return to caring<br />

responsibilities.<br />

A Carer’s charter has been developed <strong>and</strong> is<br />

displayed throughout the <strong>Trust</strong>. Information<br />

for Carers is available from our Patient<br />

Advice <strong>and</strong> Liaison Service (PALS) <strong>and</strong> also on<br />

the <strong>Trust</strong> <strong>and</strong> <strong>Hillingdon</strong> Council websites.<br />

A carer survey is available to monitor carers’<br />

experiences.<br />

Consultation <strong>and</strong> engagement<br />

The <strong>Trust</strong> is committed to involving <strong>and</strong><br />

consulting with members, patients <strong>and</strong> the<br />

local community in the planning of service<br />

provision, the development of proposals for<br />

change, <strong>and</strong> decisions about how services<br />

operate. The <strong>Trust</strong> will continue to engage<br />

<strong>and</strong> consult with service users, public <strong>and</strong><br />

the wider local community in decisions<br />

about general service delivery to ensure that<br />

services are designed <strong>and</strong> adapted to better<br />

respond to individual needs.<br />

The Governors <strong>and</strong> members will clearly<br />

have an important role in any consultation<br />

<strong>and</strong> engagement on major service changes.<br />

However the <strong>Trust</strong> will seek to ensure that<br />

such engagement reaches beyond our<br />

membership, particularly where a group that<br />

is under-represented in our membership is<br />

affected.<br />

The <strong>Trust</strong>’s Head of Patient & Public<br />

Engagement proactively engages with the<br />

community <strong>and</strong> voluntary organisations<br />

to identify opportunities for the <strong>Trust</strong> to<br />

engage with their members. For example as<br />

part of this engagement, the <strong>Trust</strong> invited<br />

representatives from the Alzheimer’s Society,<br />

Age UK, <strong>Hillingdon</strong> Carers <strong>and</strong> Disablement<br />

Association <strong>Hillingdon</strong> (DASH) to attend<br />

a focus group to discuss how to improve<br />

services for patients with dementia.<br />

The <strong>Trust</strong> encourages <strong>and</strong> facilitates linkages<br />

between the Council of Governors <strong>and</strong><br />

groups <strong>and</strong> organisations which represent<br />

patients, public <strong>and</strong> the wider community.<br />

During <strong>2012</strong>/<strong>13</strong>, Public Governors attended<br />

Resident Association meetings across the<br />

Borough, ‘Street Champion’ meetings <strong>and</strong><br />

other community events to communicate<br />

with local residents <strong>and</strong> public members.<br />

Governors are encouraged to attend<br />

meetings in the community <strong>and</strong> report<br />

Directors’ report<br />

23


ack to the wider Council of Governors,<br />

to help ensure that the Council of<br />

Governors is aware of public comments <strong>and</strong><br />

concerns which have been raised in these<br />

meetings. The Membership Development &<br />

Engagement Strategy approved by the Board<br />

outlines the <strong>Trust</strong>’s policy on the involvement<br />

of members, patients <strong>and</strong> wider public,<br />

including a statement on the <strong>Trust</strong>’s approach<br />

to consultation, <strong>and</strong> addressing the overlap<br />

<strong>and</strong> interaction between the Governors <strong>and</strong><br />

other consultative <strong>and</strong> representative groups.<br />

The <strong>Trust</strong> did not undertake any formal<br />

consultations in the past year. <strong>NHS</strong> North<br />

West London led a public consultation on<br />

proposals for the reconfiguration of health<br />

services in North West London – entitled<br />

‘Shaping a Healthier Future’ which included<br />

consulting with residents living in the London<br />

Borough of <strong>Hillingdon</strong>.<br />

A selection of examples of public<br />

engagement activities undertaken during the<br />

year are outlined below:<br />

• Members of the Board attended<br />

<strong>Hillingdon</strong> Council’s External Services<br />

Scrutiny Committee on two occasions in<br />

<strong>2012</strong>/<strong>13</strong>. In April <strong>2012</strong> the Medical Director<br />

presented the <strong>Trust</strong>’s Quality Account <strong>and</strong><br />

in September <strong>2012</strong>, the Chief Executive<br />

<strong>and</strong> Medical Director provided an update<br />

on developments at the <strong>Trust</strong>.<br />

• The <strong>Trust</strong> continued to hold bi-monthly<br />

meetings of its ‘People in Partnership’<br />

forum. The forum enables the <strong>Trust</strong> to<br />

listen to the views <strong>and</strong> opinions of the<br />

communities we serve, share information<br />

about what the <strong>Trust</strong> is doing <strong>and</strong> planned<br />

future developments, <strong>and</strong> provides an<br />

opportunity for members to meet <strong>and</strong><br />

communicate with staff, Governors <strong>and</strong><br />

fellow members. The People in Partnership<br />

meetings have been refocused to be<br />

meetings between the members <strong>and</strong><br />

Governors, <strong>and</strong> several of the meetings<br />

are now held in the community during the<br />

day, attracting new members <strong>and</strong> raising a<br />

number of different issues.<br />

• The <strong>Trust</strong> continued an engagement<br />

project that sought to capture experiences,<br />

manage expectations, <strong>and</strong> improve the<br />

maternity experience for women from the<br />

Somali community. At a focus group at<br />

the Sahan Centre in Hayes the <strong>Trust</strong> was<br />

able to provide feedback on action taken<br />

following an earlier session, including<br />

the introduction of awareness sessions on<br />

the maternity department’s m<strong>and</strong>atory<br />

training programme. The maternity<br />

department has recently commenced<br />

a similar engagement process with an<br />

Afghani women’s group to mirror the<br />

success with the Somali women’s group<br />

engagement.<br />

• As outlined earlier in the report, the <strong>Trust</strong><br />

developed ‘Putting People First’ which<br />

sets out the <strong>Trust</strong>’s vision to be a leader<br />

in terms of the patient experience. The<br />

strategy followed a review of feedback<br />

from patients, staff, <strong>and</strong> public, <strong>and</strong> was<br />

widely consulted on with input from<br />

the Local Involvement Network (LINk),<br />

local patient interest groups, <strong>Hillingdon</strong><br />

Council, the Council of Governors, <strong>and</strong><br />

public <strong>and</strong> staff members.<br />

• The <strong>Trust</strong> has continued to work in<br />

close partnership with the <strong>Hillingdon</strong><br />

Local Involvement Network (LINk) <strong>and</strong><br />

appreciates the valuable contribution that<br />

the LINk provides to the organisation.<br />

Representatives from the LINk have<br />

regularly attended focus groups <strong>and</strong><br />

committees <strong>and</strong> are regular attendees<br />

at our People in Partnership meetings.<br />

This year the <strong>Trust</strong> has worked closely<br />

with the LINk on the consultation for the<br />

priorities for the Quality <strong>Report</strong> <strong>and</strong> the<br />

transfer of catering <strong>and</strong> cleaning services<br />

back to in-house management. The <strong>Trust</strong><br />

looks forward to working with the new<br />

Healthwatch which replaces the LINk from<br />

April 20<strong>13</strong>.<br />

24 Directors’ report


Developments in nursing care<br />

Nursing care is central to the patient<br />

experience <strong>and</strong> has been an issue that has<br />

received much attention nationally over the<br />

last year.<br />

The <strong>Trust</strong> has developed a series of essential<br />

nursing <strong>and</strong> midwifery st<strong>and</strong>ards aligned<br />

with our CARES values that underpin<br />

everyday nursing <strong>and</strong> midwifery practice.<br />

We are currently introducing an approach<br />

to ensure that care is consistent <strong>and</strong> reliable<br />

with a focus on responding to fundamental<br />

needs. Our aim is that our patients are<br />

always safe, comfortable, informed, <strong>and</strong><br />

involved whilst receiving care on our wards.<br />

This proactive care approach will help us<br />

to embed our essential st<strong>and</strong>ards into<br />

practice <strong>and</strong> steers nursing staff to use every<br />

scheduled contact with patients, for example<br />

when checking blood pressure <strong>and</strong> at regular<br />

intervals in between, to check on key aspects<br />

of care. These are known as the ‘Ps <strong>and</strong> Qs’.<br />

These include:<br />

• Pain: Does the patient have any pain?<br />

• Position: Is the patient comfortable <strong>and</strong><br />

warm enough, do they need assistance<br />

repositioning?<br />

• Possessions: Does the patient have a<br />

drink <strong>and</strong> all personal possessions such as<br />

tissues <strong>and</strong> spectacles within reach?<br />

• Personal: Does the patient need assistance<br />

to visit the toilet?<br />

• Questions: Does the patient have any<br />

questions about their care?<br />

Every contact with the patient should finish<br />

by asking the patient if there is anything else<br />

that is needed at that time.<br />

The <strong>Report</strong> of the Mid Staffordshire <strong>NHS</strong><br />

Foundation <strong>Trust</strong> Public Inquiry published in<br />

February 20<strong>13</strong> <strong>and</strong> the launch of ‘Compassion<br />

in Practice’, the national Nursing Midwifery<br />

<strong>and</strong> Care Staff Vision <strong>and</strong> Strategy reinforce<br />

the need for care to be based on empathy,<br />

respect <strong>and</strong> dignity. We are confident that<br />

this approach, agreed by our Senior Sisters<br />

<strong>and</strong> Matrons will encourage consistency in<br />

the fundamentals whilst leaving room to<br />

‘tailor’ care around each patient’s individual<br />

needs.<br />

Proactive care is discussed at nurse induction<br />

by the Deputy Director of Nursing <strong>and</strong> is<br />

being led at ward level by the Senior Sister<br />

<strong>and</strong> Matron; it will be supported by posters<br />

<strong>and</strong> a leaflet that will be given to all nurses<br />

in the <strong>Trust</strong>.<br />

Nursing Quality <strong>and</strong> Accreditation<br />

Framework<br />

Measuring the quality of care at a ward level<br />

is not simple or easily quantifiable <strong>and</strong> so<br />

the <strong>Trust</strong> utilises a variety of methods. The<br />

<strong>Trust</strong> has recently developed a new approach<br />

entitled ‘Observations of Care’. This is a<br />

qualitative approach that uses inside <strong>and</strong><br />

outside observers <strong>and</strong> a structured tool,<br />

together with observational prompts that are<br />

used by the Care Quality Commission (CQC)<br />

during their unannounced visits.<br />

Observations of Care are scheduled monthly<br />

<strong>and</strong> enable the <strong>Trust</strong>’s most senior nurses<br />

to spend time on wards increasing the level<br />

of scrutiny <strong>and</strong> vigilance on the quality<br />

of nursing care. The visits assess the ward<br />

environment, attitudes <strong>and</strong> behaviours of<br />

staff, team working <strong>and</strong> specific aspects<br />

of safety. There is also a review of nursing<br />

records to ensure that they reflect clear,<br />

accurate <strong>and</strong> up to date information about<br />

patients’ care <strong>and</strong> treatment. Patients are<br />

also given the opportunity to discuss any<br />

concerns, whilst the observers check that the<br />

patient has a good underst<strong>and</strong>ing of their<br />

care.<br />

Executive <strong>and</strong> Non-Executive Directors are<br />

also invited to join in the observational<br />

visits. The first observation took place in<br />

February 20<strong>13</strong>, when 18 wards were visited.<br />

Verbal feedback is given on the day of<br />

the visit; this is followed up by a written<br />

report highlighting areas of good practice<br />

Directors’ report<br />

25


<strong>and</strong> recommendations for improvement.<br />

Ward staff have stated that they value this<br />

approach <strong>and</strong> that it helps them prepare for<br />

unannounced CQC visits.<br />

Observations of Care provide important<br />

qualitative information that can be used<br />

as part of the <strong>Trust</strong>’s overall assessment of<br />

nursing quality; <strong>and</strong> they are an essential<br />

component of the Nursing Quality <strong>and</strong><br />

Accreditation Framework (NQAF) that the<br />

<strong>Trust</strong> began to develop in February 20<strong>13</strong>.<br />

The NQAF will be based on our aim of<br />

ensuring that patients on our wards are<br />

always safe, comfortable, informed, <strong>and</strong><br />

involved. The NQAF sets out a number of<br />

indicators <strong>and</strong> other quality factors that<br />

will be used to measure <strong>and</strong> demonstrate<br />

sustained improvements in quality. It also<br />

describes the assessment process <strong>and</strong> the<br />

potential rewards for achieving accreditation.<br />

The framework will be shared more widely<br />

<strong>and</strong> approved by senior nurses in the <strong>Trust</strong><br />

prior to its launch later in the first quarter<br />

of 20<strong>13</strong>/14. Our ambition will be for all our<br />

wards to achieve accreditation.<br />

Dementia<br />

In line with the National Dementia Strategy,<br />

improving care for patients with dementia is<br />

listed as a key priority in the <strong>Trust</strong>’s Business<br />

Plan for 20<strong>13</strong>/14. We want to ensure that<br />

older people have timely access to services<br />

that are easy to navigate <strong>and</strong> fit for purpose.<br />

We are driving improvements in both the<br />

organisation <strong>and</strong> delivery of services for<br />

patients <strong>and</strong> carers. These include providing<br />

dementia training to all staff to increase their<br />

knowledge of the condition, ensuring that<br />

care is skilled, compassionate <strong>and</strong> respectful.<br />

We are increasing access to dementia<br />

screening for patients over 75 years, with<br />

forward referral for further assessment as<br />

indicated. We are developing individualised<br />

care <strong>and</strong> treatment plans utilising recognised<br />

tools such as the Alzheimer’s Society’s ‘This Is<br />

Me’ to ensure patient <strong>and</strong> carer involvement.<br />

We are a signatory to the Dementia Action<br />

Alliance’s Declaration <strong>and</strong> are making<br />

changes to our environment to progress our<br />

aspiration of being dementia-friendly.<br />

We will measure achievement of this<br />

objective through a number of monitoring<br />

tools. The <strong>Trust</strong>’s Dementia Strategy work<br />

plan includes ‘SMART’ objectives to deliver<br />

improvements in dementia care. We have<br />

also published an action plan on the<br />

Dementia Action Alliance’s website, which<br />

we will review throughout the year. We will<br />

capture patient <strong>and</strong> carer feedback via direct<br />

questioning <strong>and</strong> review patient surveys,<br />

compliments, complaints <strong>and</strong> incidents<br />

to ensure service changes are resulting in<br />

positive patient <strong>and</strong> carer experience.<br />

Our staff<br />

Staff consultation <strong>and</strong> engagement<br />

The <strong>Trust</strong> has a range of mechanisms for<br />

communicating information on matters<br />

of concern to staff including regular<br />

communication from the Chief Executive,<br />

<strong>and</strong> the Core Brief – an electronic monthly<br />

update. The magazine for staff <strong>and</strong> public<br />

members of the Foundation <strong>Trust</strong>, ‘The<br />

Pulse’, is distributed throughout the <strong>Trust</strong>’s<br />

hospitals.<br />

In <strong>2012</strong>/<strong>13</strong> a weekly General Information<br />

bulletin was introduced to communicate<br />

other information such as upcoming events<br />

or policy changes as a response to requests<br />

for more managed mechanisms around this<br />

type of information.<br />

<strong>Hospital</strong> management <strong>and</strong> Staff in<br />

Partnership representatives meet regularly<br />

at the Joint Negotiating <strong>and</strong> Consultative<br />

Committee to share information <strong>and</strong><br />

discuss a broad range of subjects that may<br />

affect staff. Seven members of the Council<br />

of Governors are elected by staff; <strong>and</strong> a<br />

further Governor is appointed by the Joint<br />

Negotiating & Consultative Committee in<br />

recognition of the importance of partnership<br />

working between the unions <strong>and</strong> <strong>Trust</strong><br />

management.<br />

26 Directors’ report


Staff members are actively informed <strong>and</strong><br />

encouraged to contribute to the <strong>Trust</strong>’s<br />

performance via the above communication<br />

mechanisms <strong>and</strong> specific briefing items. In<br />

<strong>2012</strong>/<strong>13</strong> open briefing sessions with the Chief<br />

Executive were introduced <strong>and</strong> are now<br />

held regularly. At these sessions the Chief<br />

Executive discusses issues relevant to the<br />

<strong>Trust</strong>, including performance <strong>and</strong> financial<br />

matters, <strong>and</strong> responds to questions from<br />

staff. In March 20<strong>13</strong> ‘Listening Sessions’ were<br />

held on both the <strong>Hillingdon</strong> <strong>and</strong> Mount<br />

Vernon sites to discuss what can be learnt<br />

from the Mid Staffordshire <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> Public Inquiry <strong>and</strong> to ask staff for their<br />

thoughts, views <strong>and</strong> concerns about how<br />

every patient can be provided with safe,<br />

quality care which encompasses our CARES<br />

values.<br />

Scores were less positive than other <strong>Trust</strong>s<br />

on team-working, staff working additional<br />

hours, staff receiving job-relevant training,<br />

availability of h<strong>and</strong> washing materials,<br />

incident reporting measures, staff<br />

experiencing violence <strong>and</strong> harassment at<br />

work, staff feeling pressure to attend work<br />

when feeling unwell, staff feeling unable to<br />

contribute towards improvements at work,<br />

equal opportunities for career progression,<br />

<strong>and</strong> staff experiencing discrimination at<br />

work. Tables 2 <strong>and</strong> 3 identify the <strong>Trust</strong>’s top<br />

<strong>and</strong> bottom ranking indicators.<br />

‘Bright ideas’, the <strong>Trust</strong>’s Staff Suggestion<br />

Scheme was launched in 20<strong>13</strong>. This scheme<br />

asks for suggestions from staff on a wide<br />

range of ideas they may have including<br />

ways of saving money, time, or making<br />

improvements in our hospitals.<br />

<strong>NHS</strong> staff survey<br />

Summary of performance<br />

The <strong>NHS</strong> staff survey provides the <strong>Trust</strong><br />

with valuable feedback on the views of our<br />

staff. In <strong>2012</strong>, 44% of staff responded to the<br />

national staff survey compared to 43% in<br />

2011, <strong>and</strong> a national response rate of 50%.<br />

Overall, staff engagement was above (better<br />

than) average when compared to other acute<br />

<strong>Trust</strong>s <strong>and</strong> an improvement on 2011.<br />

In the survey, <strong>Trust</strong> staff members gave<br />

more positive comments compared with<br />

other <strong>Trust</strong>s on a range of issues. These<br />

included staff feeling satisfied with the<br />

quality of work <strong>and</strong> patient care they are<br />

able to deliver, appraisals <strong>and</strong> PDRs (personal<br />

development reviews), good communication,<br />

recommending the <strong>Trust</strong> as a place to work<br />

or receive treatment, <strong>and</strong> staff motivation.<br />

Directors’ report<br />

27


Table 1: <strong>Trust</strong> response rate<br />

2011/<strong>2012</strong> <strong>2012</strong>/<strong>13</strong><br />

<strong>Trust</strong><br />

improvement/<br />

Deterioration<br />

<strong>Trust</strong> National average <strong>Trust</strong> National average<br />

Response rate 43% 54% 44% 50% Increase by 1%<br />

point<br />

Table 2: <strong>Trust</strong>’s top four ranking scores<br />

2011/<strong>2012</strong> <strong>2012</strong>/<strong>13</strong><br />

<strong>Trust</strong><br />

Improvement/<br />

Deterioration<br />

Top four ranking scores <strong>Trust</strong> National average <strong>Trust</strong> National average<br />

KF7 Staff appraised in 90% 81% 94% 84% Increase by 4%<br />

last 12 months<br />

KF8 Staff having well 44% 34% 46% 36% Increase by 2%<br />

structured appraisals in<br />

last 12 months<br />

KF14 Staff reporting 95% 96% 95% 90% No change<br />

errors, near misses or<br />

incidents witnessed in<br />

the last month<br />

KF9 Support from<br />

immediate line managers<br />

3.58 3.61 3.70 3.61 No change<br />

Table 3: <strong>Trust</strong>’s bottom four ranking scores<br />

2011/<strong>2012</strong><br />

<strong>2012</strong>/<strong>13</strong><br />

<strong>Trust</strong><br />

Improvement/<br />

Deterioration<br />

Bottom four ranking<br />

scores<br />

KF17 Staff experiencing<br />

physical violence from<br />

staff in last 12 months<br />

KF6 Staff receiving<br />

job-relevant training,<br />

learning or development<br />

in last 12 months<br />

KF5 Staff working extra<br />

hours<br />

KF10 Staff receiving<br />

health <strong>and</strong> safety<br />

training in last 12<br />

months<br />

<strong>Trust</strong> National average <strong>Trust</strong> National average<br />

1% 1% 4% 3% Increase by 3%<br />

76% 78% 77% 81% Increase by 1%<br />

58% 65% 75% 70% Increase by 17%<br />

81% 81% 65% 74% Decrease by 16%<br />

28 Directors’ report


Action plan<br />

In light of the Francis <strong>Report</strong>, as well as the<br />

outcomes from our own staff survey <strong>and</strong> the<br />

various listening events <strong>and</strong> communication<br />

exercises recently undertaken in the <strong>Trust</strong>, we<br />

are revisiting a range of current action plans<br />

to ensure that our work in response to what<br />

our staff tell us is co-ordinated <strong>and</strong> clear.<br />

We will be specifying what our priorities are<br />

<strong>and</strong> why this is the case, <strong>and</strong> we will also be<br />

linking our work plans closely to the CARES<br />

values that we have adopted. These actions<br />

may include:<br />

• Publicising the staff survey results for<br />

<strong>2012</strong> throughout the <strong>Trust</strong> utilising<br />

various media. As in previous years,<br />

this will be in the style of ‘You Said’,<br />

‘We Will’.<br />

• Promoting an environment that<br />

encourages the management of workrelated<br />

stress using a risk assessment<br />

approach.<br />

• Promoting the National<br />

Whistleblowing help-line.<br />

• Promoting the availability of statutory<br />

<strong>and</strong> m<strong>and</strong>atory training <strong>and</strong> exp<strong>and</strong><br />

options for its delivery.<br />

• Promoting the Dignity at Work policy,<br />

exploring options for providing a<br />

mediation service.<br />

We will communicate the outcome of this<br />

work to all staff as soon as possible.<br />

Future priorities<br />

CARES<br />

In 2011, following a number of focus groups<br />

<strong>and</strong> a period of voting, staff chose CARES<br />

(Communication; Attitude; Responsibility;<br />

Equity; <strong>and</strong> Safety) as the acronym to reflect<br />

the culture <strong>and</strong> values of the <strong>Trust</strong> along with<br />

some underpinning behaviours expected of<br />

all staff.<br />

In <strong>2012</strong>/<strong>13</strong> the CARES Champions group<br />

focused on raising awareness of our culture<br />

<strong>and</strong> values <strong>and</strong> role modelling behaviours<br />

<strong>and</strong> attitudes that CARES promotes. This<br />

has been done in a range of ways including<br />

the Champions talking about CARES to<br />

colleagues <strong>and</strong> patients across the <strong>Trust</strong>. In<br />

<strong>2012</strong> the <strong>Trust</strong> included specific questions on<br />

CARES in the staff survey. This indicated that<br />

84% of staff understood what CARES is.<br />

A CARES rating scale has been included in the<br />

PDR paperwork for this year, st<strong>and</strong>ardised<br />

questions have been developed for use<br />

during selection processes, <strong>and</strong> we have<br />

begun to integrate CARES into key policies<br />

<strong>and</strong> procedural documents. Future priorities<br />

will include further embedding of CARES <strong>and</strong><br />

developing the role of the CARES Champions<br />

into Ambassadors to elevate the status of the<br />

role <strong>and</strong> provide more structure.<br />

Putting People First (PPF) programme<br />

The Putting People First Programme<br />

was established in 2011 with the aim of<br />

improving both the patient experience <strong>and</strong><br />

staff experience <strong>and</strong> to increase patient <strong>and</strong><br />

staff engagement. The programme consists<br />

of work streams to embed <strong>and</strong> integrate<br />

Putting People First in our key processes.<br />

Progress to embed CARES <strong>and</strong> the impact<br />

on the <strong>Trust</strong> will be monitored via the<br />

Putting People First Steering Group using<br />

responses from patients <strong>and</strong> staff to specific<br />

questions in the patient <strong>and</strong> staff surveys.<br />

The group will also monitor the number<br />

of complaints received relating to staff<br />

attitude, communication <strong>and</strong> information<br />

to patients, <strong>and</strong> discrimination. Progress will<br />

be communicated to staff using a variety of<br />

methods, including ‘The Pulse’ <strong>and</strong> other<br />

appropriate newsletters.<br />

Policies in relation to disabled<br />

employees <strong>and</strong> equal opportunities<br />

The <strong>Trust</strong> has an Equality <strong>and</strong> Human Rights<br />

Policy <strong>and</strong> a single equality scheme which<br />

set out very clearly for our staff, patients<br />

<strong>and</strong> the community that we are committed<br />

to delivering an equality <strong>and</strong> human rightsbased<br />

approach to healthcare. The policy<br />

Directors’ report<br />

29


outlines how we will provide equality <strong>and</strong><br />

fairness for all those in our employment <strong>and</strong><br />

not discriminate on grounds of any of the<br />

legally designated protected characteristics<br />

(gender reassignment, marriage <strong>and</strong> civil<br />

partnership, pregnancy <strong>and</strong> maternity, race,<br />

religion <strong>and</strong> belief, sex, sexual orientation,<br />

disability, <strong>and</strong> age).<br />

The <strong>Trust</strong>’s policy is implemented in<br />

accordance with all current legislation<br />

relating to The Equality Act 2010. The <strong>Trust</strong> is<br />

accredited with the ‘two-ticks’ symbol which<br />

is awarded by Job Centre Plus to employers<br />

who have made commitments to employ,<br />

keep, <strong>and</strong> develop the abilities of disabled<br />

staff.<br />

In <strong>2012</strong> the <strong>Trust</strong> published its Equality<br />

Objectives <strong>Report</strong> with specific objectives<br />

around staff culture <strong>and</strong> values, including fair<br />

<strong>and</strong> inclusive recruitment processes. Progress<br />

against this objective is monitored by the<br />

Experience <strong>and</strong> Engagement Group.<br />

Occupational health <strong>and</strong> sickness<br />

absence data<br />

The <strong>Trust</strong> has an Occupational Health<br />

department who provide advice on how<br />

to protect individuals from harm, to help<br />

identify all those aspects of health which<br />

affect employees’ capacity to work efficiently,<br />

<strong>and</strong> improve their quality of life in a safe<br />

working environment. Staff have access to<br />

the Employee Assistance Programme (EAP)<br />

<strong>and</strong> a free confidential helpline that can<br />

provide advice <strong>and</strong> support on a range of<br />

issues such as financial difficulties, workplace<br />

difficulties, <strong>and</strong> health <strong>and</strong> wellbeing.<br />

Information on sickness absence is contained<br />

in note 6.2 to the accounts.<br />

Equality duty<br />

The <strong>Trust</strong> as a public health authority is<br />

‘listed’ under Schedule 19 of the Equality<br />

Act 2010 <strong>and</strong> is therefore required to comply<br />

with the equality duties under Section 149<br />

<strong>and</strong> Regulations 2011.<br />

This means that when staff are delivering<br />

services <strong>and</strong> carrying out the <strong>Trust</strong>’s<br />

functions, they must consciously think about<br />

<strong>and</strong> pay due regard to the three aims of the<br />

general equality duty as an integral part of<br />

the decision making process. Details of the<br />

equality duty aims <strong>and</strong> the <strong>Trust</strong>’s statement,<br />

documenting how the <strong>Trust</strong> is meeting the<br />

duty, have been published on the <strong>Trust</strong>’s<br />

website.<br />

The specific duties require public bodies to:<br />

• Publish relevant, proportionate<br />

information demonstrating their<br />

compliance with the general equality<br />

duty by 31st January 20<strong>13</strong><br />

• Set <strong>and</strong> publish specific, measurable<br />

equality objectives by 6th April 20<strong>13</strong>.<br />

On 31st January 20<strong>13</strong>, the <strong>Trust</strong> published<br />

its Service Equality Compliance <strong>Report</strong> <strong>and</strong><br />

Workforce Equality Compliance <strong>Report</strong><br />

on the <strong>Trust</strong>’s public website. Both reports<br />

include actions <strong>and</strong> initiatives taking place<br />

within the <strong>Trust</strong> to meet the Public Sector<br />

Equality Duty <strong>and</strong> that areas that continue<br />

to need addressing are being addressed via<br />

the four year objectives set in April <strong>2012</strong>. The<br />

<strong>Trust</strong> published an update of its objectives<br />

in April 20<strong>13</strong> <strong>and</strong> will do so thereafter on an<br />

annual basis.<br />

Financial disclosures<br />

The financial statements for the year ended<br />

31st March 20<strong>13</strong> have been prepared on a<br />

going concern basis. After making enquiries,<br />

the Directors have a reasonable expectation<br />

that the <strong>Trust</strong> has adequate resources to<br />

continue in operational existence for the<br />

foreseeable future. For this reason, they<br />

continue to adopt the going concern basis<br />

in preparing the accounts. In making this<br />

declaration the Board is mindful of the<br />

recent financial performance <strong>and</strong> the<br />

extremely challenging financial context<br />

facing the <strong>Trust</strong>, including the requirement<br />

for significant year on year efficiency savings<br />

<strong>and</strong> <strong>Hillingdon</strong> Clinical Commissioning<br />

30 Directors’ report


Group’s (CCG) intention to reduce the level<br />

of activity at the <strong>Trust</strong>. To mitigate these<br />

challenges the Board has invested in an<br />

enhanced programme management office<br />

to support the delivery of the savings, <strong>and</strong> is<br />

also able to draw upon <strong>Hillingdon</strong> <strong>Hospital</strong><br />

being identified as a ‘fixed point’ in the<br />

North West London ‘Shaping a Healthier<br />

Future Strategy’ which the CCG is committed<br />

to supporting.<br />

The <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual states that it is best practice for<br />

<strong>NHS</strong> Foundation <strong>Trust</strong>s to disclose ‘other<br />

income’ when such amounts in the notes<br />

to the accounts are significant. There is<br />

no significant ‘other income’ to report.<br />

As outlined earlier in the report, the vast<br />

majority of the <strong>Trust</strong>’s income is from goods<br />

<strong>and</strong> services related to the Health Service in<br />

Engl<strong>and</strong>.<br />

The <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual states that the annual report<br />

<strong>and</strong> accounts should highlight where any<br />

market values of fixed assets are known<br />

to be significantly different from values<br />

at which those assets are held in the<br />

<strong>Trust</strong>’s financial statements, where it is the<br />

Directors’ view that any such difference<br />

is of such significance that readers of the<br />

accounts should be alerted to this. There<br />

were no significant differences in market<br />

value compared to holding value to report<br />

for the financial year ending 31 March 20<strong>13</strong>.<br />

Investment properties were revalued to<br />

current market value as at 31st March 20<strong>13</strong><br />

from £<strong>13</strong>,124k to £14,816k, resulting in a<br />

gain of £1,692k.<br />

The <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual states that it is best practice for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s to disclose the number of,<br />

<strong>and</strong> average additional pension liabilities for,<br />

individuals who retired early on ill-health<br />

grounds during the year. Four staff retired on<br />

grounds of ill health at a cost to the <strong>Trust</strong> of<br />

£165k (in 2011/12 there were nil retirements<br />

on grounds of ill health).<br />

The <strong>Trust</strong> policy on creditor payment is to<br />

endeavour to adhere to the Better Payment<br />

Practice Code of paying 95% of invoices in<br />

terms of numbers <strong>and</strong> value within 30 days<br />

of receipt, cash flows permitting. Information<br />

on the <strong>Trust</strong>’s payment of creditors <strong>and</strong><br />

compliance with the Better Payment Practice<br />

Code is included in note 7.1 of the accounts.<br />

In relation to the use of financial<br />

instruments, an indication of the financial<br />

risk management objectives <strong>and</strong> policies<br />

of the <strong>Trust</strong> <strong>and</strong> the exposure to price risk,<br />

credit risk, liquidity risk <strong>and</strong> cash flow risk<br />

can be found in note 1.38 of the accounts.<br />

Information on the pension arrangements<br />

<strong>and</strong> other retirement benefits are set out in<br />

note 1.12 of the accounts. Details of senior<br />

employees’ remuneration can be found in<br />

the remuneration report <strong>and</strong> note 6.9 of the<br />

accounts.<br />

Other disclosures<br />

Research <strong>and</strong> development<br />

Clinical teams are encouraged to invite their<br />

patients to participate in high quality multicentre<br />

research studies as part of the <strong>Trust</strong>’s<br />

commitment to improving the quality of<br />

care provided. Participation in research <strong>and</strong><br />

development enables patients to access new<br />

treatments that would not have otherwise<br />

been available <strong>and</strong> supports our clinicians to<br />

stay abreast of the latest treatments.<br />

The majority of the <strong>Trust</strong>’s research <strong>and</strong><br />

development activities are National Institute<br />

for Health Research (NIHR) portfolio adopted<br />

multi-centre studies where the <strong>Trust</strong> acts<br />

as a recruiting site on behalf of the lead<br />

centre. Our research portfolio is a balance of<br />

observational <strong>and</strong> treatment studies across<br />

many clinical areas in the <strong>Trust</strong> including<br />

Cancer, Stroke, Haematology, Paediatrics <strong>and</strong><br />

many of the general medicine <strong>and</strong> surgical<br />

specialities. The <strong>Trust</strong> also supports a small<br />

number of studies undertaken by our own<br />

staff <strong>and</strong> students from the local universities<br />

undertaking PhD <strong>and</strong> Masters courses.<br />

Directors’ report<br />

31


All of our research activity is scrutinised<br />

for quality <strong>and</strong> compliance to acceptable<br />

st<strong>and</strong>ards expected by the Research<br />

Governance Framework. Our research<br />

governance approval metrics comply with the<br />

30 day st<strong>and</strong>ards required by the Department<br />

of Health (NIHR).<br />

Charging for information<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> complies with the cost allocation<br />

<strong>and</strong> charging requirements set out in<br />

HM Treasury <strong>and</strong> Office of Public Sector<br />

Information guidance. There is no additional<br />

charge for material made available to meet<br />

the needs of particular groups of people, e.g.<br />

in Braille or other languages.<br />

Serious incidents involving data loss or<br />

confidentiality breach<br />

The <strong>Trust</strong> takes its responsibility to keep<br />

personal data safe very seriously. New<br />

staff receive information governance<br />

training during induction in their first week<br />

at the <strong>Trust</strong> <strong>and</strong> it is m<strong>and</strong>ated that all<br />

staff undertake information governance<br />

training annually. The <strong>Trust</strong> Board is<br />

required to annually certify against the<br />

<strong>Trust</strong>’s compliance with <strong>NHS</strong> information<br />

governance st<strong>and</strong>ards.<br />

There has been one serious incident relating<br />

to loss of data during <strong>2012</strong>/<strong>13</strong>. In June <strong>2012</strong><br />

the <strong>Trust</strong> misplaced patient records which<br />

attracted media attention. This incident<br />

was investigated as a serious incident by<br />

the <strong>Trust</strong>, <strong>and</strong> reported to the Information<br />

Commissioner’s Office (ICO). The <strong>Trust</strong><br />

is currently assisting the ICO with their<br />

investigation.<br />

The table below contains details of other<br />

reported personal data related incidents as<br />

categorised by the Department of Health.<br />

Policies <strong>and</strong> procedures for countering<br />

fraud <strong>and</strong> corruption<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> will not tolerate any form of fraud,<br />

bribery or corruption by, or of, its employees,<br />

associates, or any person or body acting on<br />

its behalf.<br />

The <strong>Trust</strong> is committed to ensure that the<br />

number of offences is kept to a minimum<br />

<strong>and</strong> that all allegations will be investigated<br />

thoroughly <strong>and</strong> the strongest sanctions<br />

including criminal sanctions will be taken<br />

against anybody found to be or having<br />

committed a fraud, bribery or corruption<br />

offence.<br />

SUMMARY OF PERSONAL DATA RELATED INCIDENTS IN <strong>2012</strong>/<strong>13</strong><br />

Category Nature of incident Total<br />

I Loss/theft of inadequately protected electronic equipment, devices or paper 2<br />

documents from secured <strong>NHS</strong> premises<br />

II Loss/theft of inadequately protected electronic equipment, devices or paper 1<br />

documents from outside secured <strong>NHS</strong> premises.<br />

III Insecure disposal of inadequately protected electronic equipment, devices 0<br />

or paper documents<br />

IV Unauthorised disclosure 3<br />

V Other 0<br />

32 Directors’ report


The <strong>Trust</strong> engages Parkhill as its Local<br />

Counter Fraud Specialist (LCFS) in accordance<br />

with Secretary of State Directions to support<br />

its work in this area.<br />

The <strong>Trust</strong>’s Audit & Assurance Committee<br />

agrees the annual work-plan for the<br />

LCFS <strong>and</strong> receives six-monthly reports on<br />

progress against its delivery. The Committee<br />

has agreed the <strong>Trust</strong>’s Counter Fraud Policy,<br />

which is the <strong>Trust</strong>’s policy for dealing with<br />

suspected fraud, bribery <strong>and</strong> corruption.<br />

Health & safety performance<br />

The <strong>Trust</strong> continues to set the highest<br />

st<strong>and</strong>ards of health <strong>and</strong> safety through our<br />

Health <strong>and</strong> Safety Strategy for all our staff<br />

in the workplace, for members of the public,<br />

patients, <strong>and</strong> others who come in to our<br />

premises.<br />

Health <strong>and</strong> safety governance: The <strong>Trust</strong> has<br />

a management group consisting of clinical<br />

<strong>and</strong> non clinical senior managers from across<br />

the <strong>Trust</strong> whose main purpose is health <strong>and</strong><br />

safety strategy implementation <strong>and</strong> planning<br />

that supports the function of the Health <strong>and</strong><br />

Safety Committee. The Health <strong>and</strong> Safety<br />

Committee has met quarterly throughout<br />

<strong>2012</strong>/<strong>13</strong> <strong>and</strong> the <strong>Trust</strong> Board has received<br />

quarterly reports on health <strong>and</strong> safety issues<br />

<strong>and</strong> performance during the year.<br />

Training: All new members of staff receive<br />

health <strong>and</strong> safety training during their<br />

corporate induction <strong>and</strong> are able to access<br />

refresher training via an e-learning package<br />

<strong>and</strong> face to face courses. The <strong>Trust</strong> has<br />

achieved over 80% compliance with its<br />

health <strong>and</strong> safety training.<br />

<strong>Trust</strong>’s auditors<br />

The Council of Governors has appointed<br />

Deloitte as the <strong>Trust</strong>’s external auditors.<br />

The audit fee is contained in note 4 of the<br />

accounts.<br />

The Board confirms that for each individual<br />

who was a Director at the time that this<br />

report was approved (28th May 20<strong>13</strong>):<br />

• so far as the Director is aware, there is<br />

no relevant audit information of which<br />

the <strong>NHS</strong> Foundation <strong>Trust</strong>’s auditor is<br />

unaware; <strong>and</strong><br />

• the Director has taken all the steps that<br />

they ought to have taken as a Director<br />

in order to make themselves aware of<br />

any relevant audit information <strong>and</strong> to<br />

establish that the <strong>NHS</strong> Foundation <strong>Trust</strong>’s<br />

auditor is aware of that information.<br />

Political <strong>and</strong> charitable donations<br />

During the year, the <strong>Trust</strong> has not made any<br />

political or charitable donations.<br />

Important events affecting the<br />

Foundation <strong>Trust</strong> occurring since the end<br />

of the financial year<br />

The Board confirmed at its meeting on 28th<br />

May 20<strong>13</strong> at which this annual report <strong>and</strong><br />

accounts were approved, that there were no<br />

events that required disclosure.<br />

Performance: During the reporting period<br />

there were a total of 1,936 incidents<br />

reported. 14 of these incidents were<br />

reportable to the Health & Safety Executive<br />

(HSE) under RIDDOR (<strong>Report</strong>ing of Injuries,<br />

Diseases <strong>and</strong> Dangerous Occurrence<br />

Regulations).<br />

Directors’ report<br />

33


GOVERNANCE REPORT<br />

Who does what<br />

The <strong>Trust</strong> is headed by the Board of Directors<br />

(often referred to as ‘the Board’). The Board’s<br />

key responsibilities are to:<br />

• Provide leadership to the Foundation<br />

<strong>Trust</strong> within a framework of processes,<br />

procedures <strong>and</strong> controls which enable risk<br />

to be assessed <strong>and</strong> managed.<br />

• Ensure the Foundation <strong>Trust</strong> complies<br />

with its Terms of Authorisation (<strong>and</strong><br />

from 1st April 20<strong>13</strong> its Licence which<br />

replaces the Terms of Authorisation);<br />

its Constitution; requirements set by<br />

Monitor; <strong>and</strong> relevant statutory <strong>and</strong><br />

contractual obligations.<br />

• Set the Foundation <strong>Trust</strong>’s vision, values<br />

<strong>and</strong> st<strong>and</strong>ards of conduct.<br />

• Set the Foundation <strong>Trust</strong>’s strategic aims<br />

<strong>and</strong> ensure that the necessary human <strong>and</strong><br />

financial resources are in place to deliver<br />

these.<br />

• Ensure the quality <strong>and</strong> safety of the<br />

healthcare services provided by the<br />

Foundation <strong>Trust</strong>.<br />

• Ensure that the Foundation <strong>Trust</strong> exercises<br />

its functions effectively, efficiently <strong>and</strong><br />

economically.<br />

The Board undertakes these responsibilities<br />

through a set business cycle that includes<br />

approving strategic documents such as the<br />

forward plan (also known as the annual<br />

plan) <strong>and</strong> other strategies, <strong>and</strong> receiving<br />

monitoring reports on areas such as key<br />

risks, financial, operational, <strong>and</strong> quality<br />

performance.<br />

The Board has approved a Scheme of<br />

Reservation <strong>and</strong> Delegation which outlines<br />

the decisions that must be taken by the<br />

Board <strong>and</strong> the decisions that are delegated<br />

to the management of the hospital.<br />

For example, contracts or investment<br />

proposals over a certain financial value<br />

must be approved by the Board, whereas<br />

the approval of lower value contracts is<br />

delegated to management.<br />

The Council of Governors is responsible for<br />

representing the interests of the Foundation<br />

<strong>Trust</strong> members <strong>and</strong> partner organisations<br />

in the governance of the Foundation <strong>Trust</strong>.<br />

The Council of Governors is responsible for<br />

providing feedback from the membership<br />

<strong>and</strong> stakeholders on strategic developments<br />

at the <strong>Trust</strong>, including for example on<br />

the annual plan, <strong>and</strong> in turn should keep<br />

members <strong>and</strong> stakeholders informed about<br />

developments at the <strong>Trust</strong>.<br />

At the start of the <strong>2012</strong>/<strong>13</strong> financial year, the<br />

Council of Governors’ statutory powers were<br />

to:<br />

• Appoint, <strong>and</strong> if appropriate, remove the<br />

<strong>Trust</strong> Chairman.<br />

• Appoint, <strong>and</strong> if appropriate, remove the<br />

Non-Executive Directors.<br />

• Decide the remuneration <strong>and</strong> terms <strong>and</strong><br />

conditions of office of the Chairman <strong>and</strong><br />

the Non-Executive Directors.<br />

• Approve the appointment of the Chief<br />

Executive.<br />

• Appoint, <strong>and</strong> if appropriate, remove the<br />

Foundation <strong>Trust</strong>’s external auditor.<br />

• Receive the Foundation <strong>Trust</strong>’s annual<br />

accounts, any report of the auditor on<br />

them, <strong>and</strong> the annual report.<br />

On 1st October <strong>2012</strong>, the ‘private patient cap’<br />

was abolished <strong>and</strong> Foundation <strong>Trust</strong> Councils<br />

of Governors gained new powers in relation<br />

to non-<strong>NHS</strong> income as a result of the Health<br />

& Social Care Act <strong>2012</strong>. If a Foundation <strong>Trust</strong><br />

Board is proposing to generate income from<br />

activities other than for the provision of<br />

goods <strong>and</strong> services for the Health Service in<br />

Engl<strong>and</strong>, then the Council of Governors must<br />

vote on whether it is satisfied that these<br />

activities will not significantly interfere with<br />

the <strong>Trust</strong>’s ability to undertake its principal<br />

purpose (the provision of goods <strong>and</strong> services<br />

34 Governance report


for the Health Service in Engl<strong>and</strong>) or its<br />

other functions. Any proposal by the Board<br />

to increase the proportion of total income<br />

earned from non-principal purpose activities<br />

by five percentage points or more (e.g. from<br />

2% to 7% of the <strong>Trust</strong>’s income) requires<br />

approval by the Council of Governors.<br />

From 1st April 20<strong>13</strong> the Board <strong>and</strong> Council<br />

of Governors gained further new statutory<br />

duties as a result of the Health & Social Care<br />

Act <strong>2012</strong>. These made explicit duties which<br />

were previously implicit in their role.<br />

• The Council of Governors gained<br />

duties to (a) to hold the Non-Executive<br />

Directors individually <strong>and</strong> collectively<br />

to account for the performance of the<br />

Board of Directors; <strong>and</strong> (b) to represent<br />

the interests of the members of the<br />

corporation as a whole <strong>and</strong> the interests<br />

of the public.<br />

• Similar to Directors’ duties under the<br />

Companies Act 2006, Board Directors<br />

collectively <strong>and</strong> individually gained a duty<br />

to promote the success of the <strong>Trust</strong> so as<br />

to maximise the benefits for members <strong>and</strong><br />

for the public; <strong>and</strong> gained duties to avoid<br />

conflict of interests, not to accept any<br />

benefits from third parties <strong>and</strong> declare<br />

interests in any transactions that involve<br />

the <strong>Trust</strong>.<br />

The Council of Governors also gained new<br />

powers to approve ‘significant’ transactions<br />

at the <strong>Trust</strong>.<br />

Whilst the Council of Governors is responsible<br />

for holding the Board, <strong>and</strong> in particular<br />

the Non-Executive Directors, to account<br />

<strong>and</strong> ensuring that it is acting in a way that<br />

means the <strong>Trust</strong> will meet its obligations, it<br />

continues to remain the Board’s responsibility<br />

to oversee the running of the hospital.<br />

Further information on the Board of<br />

Directors <strong>and</strong> Council of Governors is<br />

outlined below.<br />

Board of Directors<br />

As at 31st March 20<strong>13</strong> the Board comprised<br />

seven Non-Executive Directors, a Non-<br />

Executive Chairman <strong>and</strong> seven Executive<br />

Directors 12 . Details of Board members as at<br />

31st March 20<strong>13</strong> are outlined below.<br />

Mike Robinson: Chair<br />

Prior to joining the <strong>Trust</strong> in July 2009, Mike<br />

was Chairman of <strong>NHS</strong> <strong>Hillingdon</strong>, (formerly<br />

<strong>Hillingdon</strong> PCT). He has a BA from Queens<br />

University, Belfast <strong>and</strong> post graduate<br />

qualifications in teaching <strong>and</strong> planning. He<br />

worked for Bristol City Council as Director of<br />

Housing 1984-1991 then as Chief Executive<br />

1991-1994. In March 1994 he was appointed<br />

Deputy Under Secretary at the Ministry<br />

of Defence until June 1995, <strong>and</strong> from<br />

September 1995 until September 2003 he<br />

was Chief Executive of South Gloucestershire<br />

Unitary Council. Mike is also an advisor to a<br />

number of local authorities. Mike chairs the<br />

Board of Directors Nominations Committee<br />

<strong>and</strong> the Transformation Committee. Mike’s<br />

term of office expires on 31st March 2014.<br />

Katey Adderley: Non-Executive Director<br />

Appointed in December 2010, Katey is<br />

a Chartered Management Accountant<br />

with 11 years of investment experience at<br />

Charterhouse Capital Partners where she<br />

was a Director. She has an Economics degree<br />

from Cambridge University <strong>and</strong> a Masters<br />

degree in Economic Evaluation in Healthcare.<br />

As well as bringing up a young family Katey<br />

is active in local voluntary work. Katey is a<br />

member of the <strong>Trust</strong>’s Audit & Assurance<br />

Committee. Katey’s term of office expires on<br />

30th November 2014.<br />

12 Claire Gore, Director of People, was appointed to the Board from 1st March 20<strong>13</strong>, thereby increasing the number of<br />

Executive Directors on the Board to seven (from six). Whilst the Medical Director role has been undertaken as a job-share<br />

from 1st January 20<strong>13</strong>, only one of the job share partners sits on the Board at any time, thereby counting as one Executive<br />

member of the Board.<br />

Governance report<br />

35


Carol Bode: Non-Executive Director<br />

Appointed in April <strong>2012</strong>, Carol is an<br />

Organisational Development Specialist with<br />

30 years in retail, customer services, financial<br />

services, <strong>and</strong> health & education. Previous<br />

roles have included Non-Executive Chairman<br />

of Southern Health <strong>NHS</strong> Foundation <strong>Trust</strong>,<br />

<strong>Trust</strong>ee on the Foundation <strong>Trust</strong> Network<br />

Board, <strong>and</strong> a Corporate Board Director with<br />

a General Motors Company. Carol is an<br />

Associate Consultant with both Foresight<br />

Partnership <strong>and</strong> QGI, <strong>and</strong> a Senior Advisor<br />

to Newton Europe. Carol is also a Magistrate<br />

in North Hampshire, <strong>and</strong> a Director of<br />

The Costello School (an Academy <strong>Trust</strong>) in<br />

Basingstoke. Carol’s term of office expires on<br />

31st March 2015.<br />

Alan McLeod: Non-Executive Director<br />

First appointed in October 2008, Alan<br />

is currently Sales Director of BT UK’s<br />

International Business Unit, <strong>and</strong> has<br />

extensive experience within the international<br />

telecommunications industry from a sales,<br />

marketing <strong>and</strong> technical perspective. Previous<br />

roles have included Managing Director of a<br />

UK Telecoms Company <strong>and</strong> President of an<br />

international joint venture. Alan’s term of<br />

office expires on 30th November 20<strong>13</strong>.<br />

Anthony Palmer: Non-Executive Director<br />

Appointed in April <strong>2012</strong>, Anthony is an<br />

Independent Nursing Consultant <strong>and</strong><br />

Expert Witness providing advice to lawyers,<br />

Coroners, <strong>and</strong> the Crown Prosecution Service.<br />

Anthony was previously Deputy Chief<br />

Executive <strong>and</strong> Director of Nursing for Luton<br />

& Dunstable <strong>Hospital</strong> <strong>NHS</strong> Foundation <strong>Trust</strong>,<br />

<strong>and</strong> held Executive Director Board positions<br />

for over 14 years. Anthony has advised<br />

Public Inquiries, has been involved with Care<br />

Quality Commission reviews as a Clinical<br />

Advisor, <strong>and</strong> was a visiting Professor at the<br />

University of Bedfordshire between 2008 <strong>and</strong><br />

<strong>2012</strong>. Anthony’s term of office expires on<br />

31st March 2015.<br />

Pradip Patel: Non-Executive Director<br />

Appointed in August 2011, Pradip qualified<br />

with a First Class Honours degree in<br />

Pharmacy from the London School of<br />

Pharmacy <strong>and</strong> has an MBA from Nottingham<br />

University. He has worked for Boots for over<br />

34 years, of which the last 18 years have been<br />

at senior <strong>and</strong> Board levels. He was Managing<br />

Director for Boots Opticians <strong>and</strong> Executive<br />

Chairman following its merger with Doll<strong>and</strong><br />

<strong>and</strong> Atchison, <strong>and</strong> is currently Director of<br />

Healthcare Strategy for Alliance Boots. He<br />

is a Fellow of the Chartered Institute of<br />

Management <strong>and</strong> a Member of the Royal<br />

Pharmaceutical Society of Great Britain.<br />

Pradip’s term of office expires on 31st July<br />

2014.<br />

Dr James Reid: Non-Executive Director<br />

<strong>and</strong> Deputy Chair<br />

First appointed in February 2008, James<br />

is a former Chief Executive of a privately<br />

owned oil refining <strong>and</strong> trading company,<br />

with extensive risk management experience<br />

within the oil <strong>and</strong> gas industry. He has a PhD<br />

in Mathematics from Edinburgh University,<br />

<strong>and</strong> worked for Shell for many years holding<br />

senior management positions in Shell’s<br />

trading <strong>and</strong> shipping organisation. James<br />

chairs the Board’s Quality & Risk Committee<br />

<strong>and</strong> the Remuneration Committee <strong>and</strong><br />

is a member of the Audit & Assurance<br />

Committee. James is also a Non-Executive<br />

Director of West Indies Oil Company <strong>and</strong> has<br />

advised various oil companies. James’ term of<br />

office expires on 31st March 2015. In March<br />

<strong>2012</strong> the Council of Governors reappointed<br />

James as Deputy Chairman for a further one<br />

year period to April 20<strong>13</strong>.<br />

Craig Rowl<strong>and</strong>: Non-Executive Director<br />

<strong>and</strong> Senior Independent Director<br />

First appointed in October 2006, Craig<br />

is a qualified accountant <strong>and</strong> former<br />

Managing Director of BT Group’s UK<br />

Business Division. Prior to his career at BT,<br />

Craig worked for Coopers & Lybr<strong>and</strong> (now<br />

36 Governance report


PricewaterhouseCoopers - PwC) where he<br />

qualified as a Chartered Accountant. He<br />

then moved to BT where he performed a<br />

number of Finance Director roles before<br />

moving into general management. Before<br />

leaving BT Craig played a lead role in setting<br />

up BT’s Openreach Division. Craig is also<br />

a Board member of the Christian charity<br />

Tearfund. Craig chairs the <strong>Trust</strong>’s Audit &<br />

Assurance Committee. Craig’s term of office<br />

expires on 30th September 2014. In March<br />

<strong>2012</strong> Craig was reappointed as the <strong>Trust</strong>’s<br />

Senior Independent Director by the Board in<br />

consultation with Council of Governors for a<br />

further one year period to April 20<strong>13</strong>.<br />

Shane DeGaris: Chief Executive (acting<br />

Chief Executive until 22nd May <strong>2012</strong>)<br />

First appointed as the <strong>Trust</strong>’s Deputy Chief<br />

Executive & Chief Operating Officer, in May<br />

<strong>2012</strong> Shane was appointed as the <strong>Trust</strong>’s<br />

substantive Chief Executive following a<br />

period as Acting Chief Executive. Shane is<br />

an experienced <strong>NHS</strong> Director having worked<br />

in a number of London <strong>Trust</strong>s in senior<br />

management roles including as Director of<br />

Operations at Barnet & Chase Farm <strong>Hospital</strong>s<br />

<strong>NHS</strong> <strong>Trust</strong> <strong>and</strong> as Deputy Chief Executive<br />

at Epsom & St Helier University <strong>Hospital</strong>s<br />

<strong>NHS</strong> <strong>Trust</strong>. Australian by birth, he began his<br />

healthcare career in 1990 after training as a<br />

Physiotherapist in Adelaide, South Australia.<br />

Shane has been appointed by the Board<br />

as the <strong>Trust</strong>’s Director of Imperial College<br />

Health Partners, <strong>and</strong> is also a Board member<br />

of the North West London Local Education &<br />

Training Board (a sub committee of Health<br />

Education Engl<strong>and</strong>), which is a Non-Executive<br />

role.<br />

Claire Gore: Director of People<br />

Claire joined the <strong>Trust</strong> in 2010 as Director of<br />

People, <strong>and</strong> was appointed as an Executive<br />

member of the Board by the Board of<br />

Directors Nominations Committee in March<br />

20<strong>13</strong>. Claire is a Fellow of the Chartered<br />

Institute of Personnel <strong>and</strong> Development<br />

(FCIPD) <strong>and</strong> has worked at a senior level<br />

in human resources <strong>and</strong> training <strong>and</strong><br />

development in a number of public sector<br />

organisations including the London Borough<br />

of Brent <strong>and</strong> the Metropolitan Police Service.<br />

Claire has Board level responsibility for<br />

human resources (including recruitment,<br />

employee relations <strong>and</strong> temporary staffing),<br />

occupational health, nurse training,<br />

workforce <strong>and</strong> organisational development.<br />

Dr Richard Grocott-Mason: Medical<br />

Director (job-share)*<br />

Appointed as Medical Director on a jobshare<br />

basis in January 20<strong>13</strong>, Richard Grocott-<br />

Mason is a Consultant in Cardiology <strong>and</strong><br />

General Medicine at THH <strong>and</strong> Harefield<br />

<strong>Hospital</strong>. His clinical work at THH covers<br />

general adult Cardiology <strong>and</strong> acute<br />

medicine cover. At Harefield Richard is<br />

an interventional Cardiologist <strong>and</strong> is on the<br />

rota covering the heart attack centre. Prior<br />

to taking up the position of Medical Director<br />

he was the <strong>Trust</strong>’s Clinical Director for the<br />

Division of Medicine <strong>and</strong> Emergency Care.<br />

Richard has been involved in the Clinical<br />

Expert Panel setting Adult Emergency Care<br />

st<strong>and</strong>ards for <strong>NHS</strong> London <strong>and</strong> part of the<br />

audit team reviewing acute <strong>Trust</strong>s in London.<br />

Richard is the <strong>Trust</strong>’s Responsible Officer for<br />

Revalidation.<br />

* whilst Dr Khakoo <strong>and</strong> Dr Grocott-Mason undertake the role of Medical Director on a job-share basis, the Board member<br />

responsibilities are held by one of the job-share partners at any given time. Dr Khakoo sits on the Board January to June,<br />

with Dr Grocott-Mason holding these responsibilities July to December.<br />

Governance report<br />

37


Dr Abbas Khakoo: Medical Director (jobshare)*<br />

Appointed as Medical Director on a jobshare<br />

basis in January 20<strong>13</strong>, Abbas Khakoo<br />

is a Consultant in Paediatrics <strong>and</strong> the care<br />

of newborn babies. He also runs a children’s<br />

allergy service at <strong>Hillingdon</strong> <strong>Hospital</strong> <strong>and</strong><br />

at St Mary’s <strong>Hospital</strong>, part of Imperial<br />

College Healthcare <strong>NHS</strong> <strong>Trust</strong>. Since October<br />

2010 Abbas has been the Clinical Director<br />

of Paediatrics (Honorary) at <strong>NHS</strong> London,<br />

<strong>and</strong> chairs both the <strong>NHS</strong> London Paediatric<br />

Emergency Clinical Panel <strong>and</strong> the North West<br />

London Paediatric Clinical Implementation<br />

Group. Prior to taking up the position of<br />

Medical Director at THH he was the <strong>Trust</strong>’s<br />

Clinical Director for Quality <strong>and</strong> Safety.<br />

Karl Munslow Ong: Chief Operating<br />

Officer (Acting COO until 11th October<br />

<strong>2012</strong>)<br />

After joining the <strong>Trust</strong> as Director of<br />

Operational Performance, Karl was<br />

appointed as the <strong>Trust</strong>’s substantive Chief<br />

Operating Officer in October <strong>2012</strong> following<br />

a period as Acting Chief Operating Officer.<br />

Karl is an experienced senior manager<br />

who has worked in a number operational<br />

management roles in <strong>Trust</strong>s across London,<br />

having also worked at strategic health<br />

authority level <strong>and</strong> in the private sector<br />

for one of the big four accountancy firms.<br />

Karl holds Board level responsibility for<br />

the management of the clinical divisions,<br />

emergency planning, the QIPP programme<br />

(Quality, Innovation, Productivity <strong>and</strong><br />

Prevention) as well as for ensuring the <strong>Trust</strong><br />

meets <strong>and</strong> exceeds all national <strong>and</strong> local<br />

patient access st<strong>and</strong>ards.<br />

David Searle: Corporate Development<br />

Director<br />

Appointed in 2007, David is a Chartered<br />

Director with senior level experience in<br />

the aerospace <strong>and</strong> defence industries.<br />

David holds Board-level responsibility for<br />

estates <strong>and</strong> facilities, corporate governance<br />

(including risk management <strong>and</strong> information<br />

governance), business development,<br />

communications <strong>and</strong> marketing.<br />

Jacqueline Walker: Acting Executive<br />

Director of the Patient Experience &<br />

Nursing (from 22nd October <strong>2012</strong>)<br />

Appointed as the <strong>Trust</strong>’s Acting Executive<br />

Director of the Patient Experience & Nursing<br />

in October <strong>2012</strong>, Jacqueline joined the<br />

<strong>Trust</strong> in March 2008 as the <strong>Trust</strong>’s Deputy<br />

Director of Nursing. Jacqueline qualified<br />

as a Registered Nurse in 1990 <strong>and</strong> has held<br />

a variety of nursing posts, specialising in<br />

urology <strong>and</strong> renal nursing, <strong>and</strong> in recent<br />

years specialising in senior nurse manager<br />

roles. As Acting Director of the Patient<br />

Experience & Nursing, Jacqueline holds Board<br />

level responsibility for infection prevention<br />

<strong>and</strong> control, safeguarding people, the<br />

patient experience <strong>and</strong> engagement, <strong>and</strong><br />

nursing.<br />

Paul Wratten: Finance Director<br />

Appointed in 2000, Paul is a member of<br />

the Chartered Institute of Public Finance<br />

<strong>and</strong> Accountancy, <strong>and</strong> has spent almost all<br />

his working life within the <strong>NHS</strong>, including<br />

working in performance management for<br />

the <strong>NHS</strong> in London. Paul also holds Boardlevel<br />

responsibility for purchasing <strong>and</strong><br />

supplies; <strong>and</strong> the <strong>Trust</strong>’s information services<br />

<strong>and</strong> information technology functions, which<br />

includes the clinical coding team.<br />

38 Governance report


The Constitution states that the Council<br />

of Governors will appoint one of the Non-<br />

Executive Directors as the Deputy Chairman,<br />

whilst the Board, in consultation with the<br />

Council of Governors appoints the Senior<br />

Independent Director. In March <strong>2012</strong>, James<br />

Reid <strong>and</strong> Craig Rowl<strong>and</strong> were reappointed<br />

for a further one year term as the Deputy<br />

Chairman <strong>and</strong> Senior Independent Director<br />

respectively. In April 20<strong>13</strong> James Reid was<br />

appointed as the Senior Independent<br />

Director <strong>and</strong> Pradip Patel as the Deputy<br />

Chairman; these appointments are not<br />

explicitly time limited <strong>and</strong> therefore run<br />

until the remainder of their term of office,<br />

unless revised by the Board <strong>and</strong> Council of<br />

Governors respectively.<br />

Changes to Board membership<br />

during the year<br />

During <strong>2012</strong>/<strong>13</strong> there were a number of<br />

changes to the Board membership. Patricia<br />

Rushton’s term of office as a Non-Executive<br />

Director expired on 1st April <strong>2012</strong>, with Carol<br />

Bode <strong>and</strong> Anthony Palmer joining the Board<br />

as Non-Executive Directors in April <strong>2012</strong>.<br />

Shane DeGaris <strong>and</strong> Karl MunslowOng were<br />

substantively appointed to the positions of<br />

Chief Executive <strong>and</strong> Chief Operating Officer<br />

respectively, following a period of acting<br />

up to these positions. Dr Susan LaBrooy<br />

retired as the <strong>Trust</strong>’s Medical Director on<br />

31st December <strong>2012</strong>, with Dr Khakoo <strong>and</strong><br />

Dr Grocott-Mason taking up the position<br />

of Medical Director on a job-share basis.<br />

In October <strong>2012</strong> Jacqueline Walker was<br />

appointed as Acting Director of the Patient<br />

Experience & Nursing following Marie Batey’s<br />

secondment to <strong>NHS</strong> London.<br />

Statement on the balance,<br />

completeness <strong>and</strong> appropriateness<br />

of the membership of the Board<br />

The Board of Directors Nominations &<br />

Remuneration Committee is responsible for<br />

reviewing the structure, size <strong>and</strong> composition<br />

of the Board <strong>and</strong> makes recommendations<br />

to the Council of Governors on the skills<br />

required for any upcoming Non-Executive<br />

Director appointments. As outlined above,<br />

the Board comprises individuals with senior<br />

level experience in the public <strong>and</strong> private<br />

sectors, across a range of disciplines including<br />

finance, governance, risk management,<br />

human resources, <strong>and</strong> change management.<br />

Recent Non-Executive appointments with<br />

clinical expertise have further strengthened<br />

the balance of the Board. The Board<br />

therefore confirms that the current<br />

composition is considered to be appropriate.<br />

Taking account of the <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> Code of Governance published by<br />

Monitor, the Board considers the Chairman<br />

<strong>and</strong> all of the Non-Executive Directors to<br />

be ‘independent’. Whilst Craig Rowl<strong>and</strong><br />

was first appointed to the Board of The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong> <strong>NHS</strong> <strong>Trust</strong> more than six<br />

years ago (in October 2006), the Board’s view<br />

is that the Director retains an independent<br />

viewpoint <strong>and</strong> ability to challenge/scrutinise<br />

management.<br />

Board members’ other commitments<br />

<strong>and</strong> Register of Interests<br />

Company Directorships <strong>and</strong> other significant<br />

commitments held by Board members<br />

are outlined above. Board members are<br />

required to enter their relevant interests<br />

in the Register of Directors’ Interests which<br />

is formally reviewed by the Board at least<br />

annually. The full register is available from<br />

the <strong>Trust</strong> Secretary on 01895 279976.<br />

As outlined above, Mike Robinson, the <strong>Trust</strong><br />

Chair, is an advisor to a number of local<br />

authorities. During the course of the year,<br />

Mike ceased to be a Non-Executive Director<br />

of FR Morrison Plc.<br />

Appointment <strong>and</strong> removal of Board<br />

members<br />

In accordance with the requirements of<br />

the <strong>NHS</strong> Act 2006, the Foundation <strong>Trust</strong><br />

Constitution outlines the respective<br />

Governance report<br />

39


esponsibilities of the Directors <strong>and</strong><br />

Governors in appointing <strong>and</strong> removing Board<br />

members.<br />

The Council of Governors is responsible<br />

for appointing, <strong>and</strong> if necessary, removing<br />

the Chairman <strong>and</strong> Non-Executive Directors.<br />

The Council of Governors Nominations<br />

& Remuneration Committee has been<br />

established to make recommendations<br />

to the Council of Governors on the<br />

appointment <strong>and</strong> remuneration of these<br />

positions, including identifying suitably<br />

qualified c<strong>and</strong>idates for appointment. At<br />

the start of the recruitment process the<br />

Board of Directors Nominations Committee<br />

makes recommendations to the Council of<br />

Governors Nominations & Remuneration<br />

Committee on the capabilities required for<br />

these appointments in light of the current<br />

Board composition <strong>and</strong> the challenges facing<br />

the <strong>Trust</strong>.<br />

When considering the appointment <strong>and</strong><br />

remuneration of Non-Executive Directors,<br />

the Council of Governors Nominations<br />

& Remuneration Committee consists<br />

of the <strong>Trust</strong> Chairman (who chairs the<br />

Committee), three Public Governors,<br />

one Staff Governor <strong>and</strong> one Appointed<br />

Governor. When considering the<br />

appointment <strong>and</strong> remuneration of the<br />

Chairman, the Committee consists of three<br />

Public Governors, one Staff Governor, one<br />

Appointed Governor, <strong>and</strong> one Non-Executive<br />

Director (who chairs the Committee on<br />

these occasions - this is currently the Senior<br />

Independent Director). The Chief Executive<br />

<strong>and</strong> Director of People are invited to attend<br />

to provide advice to the Committee.<br />

Should any such circumstances arise, the<br />

Council of Governors Nominations &<br />

Remuneration Committee is responsible for<br />

investigating the grounds for any resolution<br />

to remove the Chairman or a Non-Executive<br />

Director, <strong>and</strong> preparing a report on this issue<br />

with recommendations for the consideration<br />

of the Council of Governors. Removal of<br />

the Chairman or a Non-Executive Director<br />

requires the approval of three-quarters of<br />

the members of the Council of Governors.<br />

The Chief Executive is appointed by the<br />

Board of Directors Nominations Committee<br />

which comprises the Chairman (Committee<br />

chair) <strong>and</strong> all of the Non-Executive Directors.<br />

The appointment must be approved by the<br />

Council of Governors. The Board of Directors<br />

Nominations Committee is responsible for<br />

agreeing the removal of the Chief Executive<br />

should this be required – any such decision<br />

does not require the Council of Governors’<br />

approval.<br />

The Board of Directors Nominations<br />

Committee is responsible for appointing <strong>and</strong><br />

removing the Executive Directors. The Chief<br />

Executive is also a member of the Committee<br />

when it is considering the appointment<br />

<strong>and</strong> removal of the Executive Directors. The<br />

Director of People is invited to attend the<br />

Committee to provide advice as required.<br />

Performance evaluation of the<br />

Board, its Committees, <strong>and</strong> Board<br />

members<br />

The Board reviews its performance annually.<br />

This annual review of the Board draws<br />

upon a self-assessment by each Board<br />

Committee, which includes a review of each<br />

Board Committee’s terms of reference. The<br />

review this year highlighted that there was<br />

a potential for overlap <strong>and</strong> duplication<br />

between the Integrated Risk Management<br />

Committee <strong>and</strong> the Clinical Quality &<br />

St<strong>and</strong>ards Committee, with both Committees<br />

considering issues of clinical risk. The Board<br />

therefore merged these Committees into a<br />

single Committee that focuses on all matters<br />

relating to risk <strong>and</strong> clinical quality, in order<br />

to ensure an alignment of the consideration<br />

of risk <strong>and</strong> issues relating to clinical quality<br />

<strong>and</strong> st<strong>and</strong>ards. The Board also concluded<br />

as part of this review that greater Board<br />

focus <strong>and</strong> scrutiny was required on the<br />

transformation that is essential for the <strong>Trust</strong><br />

to be able to respond to the challenging<br />

financial <strong>and</strong> operating context. The Board<br />

40 Governance report


therefore replaced the Finance & Investment<br />

Committee with a new Committee – the<br />

Transformation Committee – which seeks to<br />

replace a backward review of past financial<br />

statements with a more forward look at<br />

change projects. This new Committee is<br />

part of the Board’s recognition that the<br />

traditional approach of incremental savings<br />

will not be sufficient, which also led to the<br />

investment in an enhanced Programme<br />

Management Office.<br />

The Board agreed not to utilise external<br />

support for this Board evaluation in <strong>2012</strong>/<strong>13</strong><br />

given the significant level of external<br />

review of the <strong>Trust</strong>’s governance during<br />

the Foundation <strong>Trust</strong> application, <strong>and</strong> the<br />

external perspective that could be brought<br />

by recently appointed Board members.<br />

Board members are subject to an annual<br />

individual performance appraisal.<br />

• The Chair’s appraisal is led by the<br />

Senior Independent Director, whilst the<br />

Chairman leads the appraisal of the<br />

Non-Executive Directors. The Council<br />

of Governors, through the Council of<br />

Governors Nominations & Remuneration<br />

Committee, feed in their views to<br />

these appraisals <strong>and</strong> the full Council of<br />

Governors are formally briefed on the<br />

outcomes. The outcomes of the 2011/12<br />

appraisals were considered at the July<br />

<strong>2012</strong> Council of Governors meeting.<br />

• The Chief Executive undertakes the<br />

appraisal of the Executive Directors, <strong>and</strong><br />

the Chair undertakes the appraisal of the<br />

Chief Executive. The Board of Directors<br />

Remuneration Committee oversees the<br />

Chairman’s monitoring <strong>and</strong> evaluation<br />

of the Chief Executive’s performance,<br />

<strong>and</strong> the Chief Executive’s monitoring <strong>and</strong><br />

evaluation of the Executive Directors’<br />

performance. The Committee provides<br />

input into this process midway through<br />

the year <strong>and</strong> at the year-end.<br />

Nominations Committee meetings in<br />

<strong>2012</strong>/<strong>13</strong><br />

Board of Directors Nominations<br />

Committee<br />

The Committee met nine times in <strong>2012</strong>/<strong>13</strong>.<br />

The Committee appointed Shane DeGaris<br />

to the position of substantive Chief<br />

Executive, Karl Munslow Ong to the<br />

position of substantive Chief Operating<br />

Officer, <strong>and</strong> Theresa Murphy to the<br />

position of substantive Director of the<br />

Patient Experience & Nursing <strong>13</strong> following<br />

a thorough recruitment exercise involving<br />

the open advertisement of the positions,<br />

involvement of staff <strong>and</strong> stakeholders,<br />

<strong>and</strong> external assessors. The Committee<br />

appointed Richard Grocott-Mason <strong>and</strong><br />

Abbas Khakoo as Medical Directors on a jobshare<br />

following the advertisement of the<br />

positions internally <strong>and</strong> formal interviews.<br />

The Committee considered the action to<br />

be taken in respect of the Chair, given that<br />

Mike Robinson’s term of office was due to<br />

expire in July 20<strong>13</strong>. The Committee agreed<br />

to recommend to the Council of Governors<br />

that Mike be reappointed for a further short<br />

term (to the end of March 2014) in order<br />

to provide continuity <strong>and</strong> stability during<br />

the introduction of new commissioning<br />

arrangements <strong>and</strong> in light of the recent<br />

changes of Chief Executive <strong>and</strong> senior<br />

management.<br />

In line with its terms of reference,<br />

the Committee also reviewed talent<br />

management <strong>and</strong> succession planning at the<br />

<strong>Trust</strong>, including proposals for the structure of<br />

the Executive team portfolios.<br />

Council of Governors Nominations &<br />

Remuneration Committee<br />

The Committee met twice during <strong>2012</strong>/<strong>13</strong>.<br />

At its meeting in May <strong>2012</strong>, the Committee<br />

provided input on behalf of the Governors<br />

to the Chair’s <strong>and</strong> Non-Executive Directors’<br />

<strong>13</strong> Theresa Murphy is due to start at the <strong>Trust</strong> in May 20<strong>13</strong><br />

Governance report<br />

41


appraisals which were to be undertaken<br />

by the Senior Independent Director <strong>and</strong><br />

Chair respectively. At its meeting in October<br />

<strong>2012</strong>, the Committee considered the<br />

recommendation from the Board of Directors<br />

Nominations Committee on the appointment<br />

of the Chair. The Committee supported<br />

the recommendation that Mike Robinson<br />

be reappointed until the end of March<br />

2014. This recommendation was therefore<br />

presented to, <strong>and</strong> subsequently approved by,<br />

the Council of Governors. Given that this was<br />

a short term reappointment which sought<br />

to provide continuity, the position was not<br />

subject to competition.<br />

Audit & Assurance Committee<br />

The <strong>Trust</strong>’s Audit & Assurance Committee<br />

comprises three Non-Executive Directors, one<br />

of whom has recent <strong>and</strong> relevant financial<br />

experience. The Committee is responsible<br />

for providing an independent <strong>and</strong> objective<br />

review of the <strong>Trust</strong>’s systems of internal<br />

control (both financial <strong>and</strong> non-financial)<br />

<strong>and</strong> the underlying assurance processes in<br />

place at the <strong>Trust</strong>. The Committee is also<br />

responsible for ensuring that the <strong>Trust</strong> has in<br />

place independent <strong>and</strong> effective internal <strong>and</strong><br />

external audit functions. The Committee’s<br />

work in undertaking these responsibilities is<br />

outlined in an annual report to the Board.<br />

Key elements of the Committee’s work<br />

include reviewing the Board Assurance<br />

Framework, <strong>and</strong> reviewing the findings of<br />

the <strong>Trust</strong>’s internal <strong>and</strong> external auditors<br />

<strong>and</strong> Local Counter Fraud Specialist. The<br />

Committee is responsible for reviewing the<br />

annual financial statements, with particular<br />

focus given to major areas of judgement<br />

<strong>and</strong> changes in accounting policies, the basis<br />

of the Board’s determination that the <strong>Trust</strong><br />

remains a going concern, <strong>and</strong> the <strong>Annual</strong><br />

Governance Statement. The Committee<br />

also reviews the assurance available from<br />

the <strong>Trust</strong>’s clinical audit function, <strong>and</strong> has<br />

developed an increasing role in reviewing<br />

the robustness of data quality at the <strong>Trust</strong>. In<br />

addition to its own annual self-evaluation,<br />

the Committee reviews the performance of<br />

internal audit, external audit, <strong>and</strong> the Local<br />

Counter Fraud Specialist each year.<br />

The Committee is usually attended by the<br />

internal <strong>and</strong> external auditors, the Finance<br />

Director <strong>and</strong> the Executive Director of<br />

Corporate Development. The Local Counter<br />

Fraud Specialist attends at least two<br />

meetings a year, <strong>and</strong> other Directors <strong>and</strong><br />

senior managers attend when invited by<br />

the Committee. The <strong>Trust</strong> Secretary is the<br />

Committee Secretary.<br />

The Audit & Assurance Committee (AAC) is<br />

responsible for making recommendations to<br />

the Council of Governors on the appointment<br />

<strong>and</strong> removal of the external auditor. The<br />

Council of Governors has agreed that a full<br />

market testing will be undertaken in time to<br />

enable the Council of Governors to appoint<br />

the external auditor for the 20<strong>13</strong>/14 audit<br />

cycle, as Deloitte would then have provided<br />

external services to the <strong>NHS</strong> <strong>Trust</strong> <strong>and</strong><br />

Foundation <strong>Trust</strong> for five years. This market<br />

testing was in line with the recommendations<br />

of the AAC <strong>and</strong> is consistent with Monitor<br />

guidance.<br />

The Council of Governors has agreed a<br />

process for undertaking this market-testing,<br />

based on recommendations from the AAC.<br />

A working group comprising the AAC <strong>and</strong><br />

representatives of the Council of Governors<br />

will be established to agree the specification<br />

for the tender <strong>and</strong> make recommendations<br />

to the Council of Governors on the<br />

appointment. This process is expected to<br />

conclude with a recommendation to the<br />

Council of Governors in October 20<strong>13</strong> to give<br />

sufficient time for the appointed auditors to<br />

make preparations for the 20<strong>13</strong>/14 audit.<br />

At their meeting in April 2011 the Council<br />

of Governors approved a policy on the<br />

engagement of the external auditors<br />

to undertake additional services, which<br />

had been reviewed <strong>and</strong> recommended<br />

by the Audit & Assurance Committee.<br />

Under the policy, the Council of Governors<br />

42 Governance report


has delegated to the Audit & Assurance<br />

Committee the authority for commissioning<br />

additional services from the external auditor.<br />

Any such work will then be reported to the<br />

Council of Governors. No such additional<br />

work was commissioned in <strong>2012</strong>/<strong>13</strong>.<br />

Other Board committees<br />

As noted above, the Board agreed a revised<br />

Committee structure in <strong>2012</strong>/<strong>13</strong>, which<br />

took effect in January 20<strong>13</strong>. In addition to<br />

the Nominations Committee <strong>and</strong> Audit &<br />

Assurance Committee, the following Board<br />

Committees are in place. Each of these is<br />

chaired by a Non-Executive Director.<br />

• The Transformation Committee was<br />

established this year to assist the<br />

Board with the shaping, review <strong>and</strong><br />

challenge of service transformation,<br />

development <strong>and</strong> redesign, <strong>and</strong> to<br />

provide assurance that the strategy<br />

for the management of human,<br />

financial, estate, <strong>and</strong> IT resources<br />

support such business transformation.<br />

The Committee replaced the Finance<br />

& Investment Committee as the<br />

Board sought to ensure greater Board<br />

scrutiny <strong>and</strong> challenge on service<br />

transformation <strong>and</strong> redesign.<br />

• The Board of Directors Remuneration<br />

Committee, which solely comprises<br />

Non-Executive Directors, is responsible<br />

for agreeing the remuneration <strong>and</strong><br />

terms of service for the Chief Executive<br />

<strong>and</strong> Executive Directors. Further<br />

information on the Committee is<br />

outlined in the Remuneration <strong>Report</strong>.<br />

• The Charitable Funds Committee<br />

assists the <strong>Trust</strong> in its role as corporate<br />

trustee for The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> charity <strong>and</strong> has<br />

been established to make <strong>and</strong> monitor<br />

arrangements for the control <strong>and</strong><br />

management of the <strong>Trust</strong>’s charitable<br />

funds.<br />

• The Quality & Risk Committee was<br />

established this year to provide<br />

assurance <strong>and</strong> make recommendations<br />

in matters relating to clinical quality<br />

<strong>and</strong> st<strong>and</strong>ards, <strong>and</strong> to ensure that risks<br />

to the delivery of the <strong>Trust</strong>’s services<br />

are identified <strong>and</strong> addressed. The<br />

Committee was created out of merger<br />

of the Integrated Risk Management<br />

Committee <strong>and</strong> Clinical Quality &<br />

St<strong>and</strong>ards Committee to ensure that<br />

risk <strong>and</strong> safety are considered in a fully<br />

integrated manner.<br />

Governance report<br />

43


Attendance at Board <strong>and</strong> Board Committee meetings<br />

The following table outlines Board members’ attendance at Board <strong>and</strong> Committee meetings<br />

during <strong>2012</strong>/<strong>13</strong> against the total possible number of meetings for which an individual was a<br />

member. Committee attendance is shown in relation to those Committees of which a Director<br />

was formally a member.<br />

Board of<br />

Directors<br />

(<strong>13</strong> meetings)<br />

Audit &<br />

Assurance<br />

Committee<br />

(5 meetings)<br />

Board<br />

Nominations<br />

Committee<br />

(9 meetings)<br />

Board<br />

Remuneration<br />

Committee<br />

(6 meetings)<br />

Charitable<br />

Funds<br />

Committee<br />

(3 meetings)<br />

Katey Adderley <strong>13</strong> of <strong>13</strong> 5 of 5 8 of 9 6 of 6 3 of 3<br />

Marie Batey 7 of 7 2 of 2<br />

Carol Bode 11 of <strong>13</strong> 4 of 4 5 of 9 4 of 6 3 of 3<br />

Shane DeGaris 12 of <strong>13</strong> 8 of 8<br />

Claire Gore 1 of 1<br />

Abbas Khakoo 3 of 3<br />

Susan LaBrooy 9 of 10<br />

Alan McLeod 12 of <strong>13</strong> 7 of 9 4 of 6<br />

Karl MunslowOng 12 of <strong>13</strong><br />

Anthony Palmer 11 of <strong>13</strong> 5 of 9 3 of 6<br />

Pradip Patel 11 of <strong>13</strong> 8 of 9 6 of 6<br />

James Reid 12 of <strong>13</strong> 5 of 5 8 of 8 6 of 6<br />

Mike Robinson <strong>13</strong> of <strong>13</strong> 9 of 9 6 of 6 3 of 3<br />

Craig Rowl<strong>and</strong> 12 of <strong>13</strong> 5 of 5 7 of 9 6 of 6<br />

David Searle <strong>13</strong> of <strong>13</strong><br />

Jacqueline Walker 6 of 6 1 of 1<br />

Paul Wratten <strong>13</strong> of <strong>13</strong> 3 of 3<br />

Clinical Quality<br />

& St<strong>and</strong>ards<br />

Committee<br />

(3 meetings)<br />

Finance &<br />

Investment<br />

Committee<br />

(4 meetings)<br />

Integrated Risk<br />

Management<br />

Committee<br />

(3 meetings)<br />

Quality & Risk<br />

Committee<br />

(1 meeting)<br />

Transformation<br />

Committee<br />

(3 meetings)<br />

Katey Adderley 4 of 4<br />

Marie Batey 0 of 3 2 of 3<br />

Carol Bode 1 of 1<br />

Shane DeGaris 2 of 3 3 of 3<br />

Claire Gore<br />

Abbas Khakoo 1 of 1 1 of 3<br />

Susan LaBrooy 2 of 3 3 of 3<br />

Alan McLeod 2 of 4 3 of 3 1 of 3<br />

Karl MunslowOng 2 of 3 2 of 3 1 of 1 2 of 3<br />

Anthony Palmer 3 of 3 2 of 3 1 of 1<br />

Pradip Patel 2 of 3 3 of 4 3 of 3<br />

James Reid 3 of 3 3 of 3 1 of 1<br />

Mike Robinson 3 of 3<br />

Craig Rowl<strong>and</strong> 4 of 4 2 of 3<br />

David Searle 4 of 4 3 of 3 1 of 1<br />

Jacqueline Walker 1 of 1 2 of 3<br />

Paul Wratten 4 of 4 3 of 3<br />

44 Governance report


Council of Governors<br />

The role <strong>and</strong> powers of the Council of Governors are outlined earlier in the report. The<br />

composition of the Council of Governors is outlined in the <strong>Trust</strong>’s Constitution.<br />

As at 31st March 20<strong>13</strong> there were 28 members of the Council of Governors: 17 elected to<br />

represent the public members, seven elected to represent the staff members, <strong>and</strong> four<br />

appointed by partner organisations (<strong>Hillingdon</strong> Council, <strong>Hillingdon</strong> Primary Care <strong>Trust</strong>, the<br />

London Ambulance Service, <strong>and</strong> the <strong>Trust</strong>’s Joint Negotiating & Consultative Committee).<br />

However, as at 1st April 20<strong>13</strong>, <strong>Hillingdon</strong> Primary Care <strong>Trust</strong> ceased to exist as a result of the<br />

changes to the commissioning structure in the <strong>NHS</strong> brought about by the Health & Social<br />

Care Act <strong>2012</strong>. Therefore the number of Appointed Governors reduced to three, with the<br />

overall size of the Council of Governors reducing to 27.<br />

The members of the Council of Governors who served during <strong>2012</strong>/<strong>13</strong> are outlined below:<br />

Public Governors<br />

North (5)<br />

Name<br />

Date took office<br />

<strong>and</strong> method (see<br />

key below)<br />

Term of office<br />

expires<br />

David Bishop 01/04/2011 (CE) 31/03/2014<br />

Tony Ellis 01/04/2011 (CE) 31/03/2014<br />

Ahmad Mallick 01/04/2011 (CE) 31/03/2014<br />

Alvan Seth-Smith 12/04/2011 (CE) 31/03/2014*<br />

Pamela Taverner 28/05/<strong>2012</strong> (CE) 31/03/2014*<br />

Rachel Owen<br />

(replaced by Pamela Taverner)<br />

01/04/2011 (CE) Resigned 2/05/<strong>2012</strong><br />

Donald Dakin 01/04/2011 (CE) 31/03/2014<br />

Martin Elliott 17/05/<strong>2012</strong> (CE) 31/03/2014<br />

Central (5)<br />

Neil Fyfe 17/05/<strong>2012</strong> (CE) 31/03/2014<br />

Kerstin Rolfe 01/04/2011 (CE) 31/03/2014<br />

Roger Shipton 01/04/2011 (CE) 31/03/2014<br />

John Coleman 01/04/2011 (CE) 31/03/2014<br />

John Davies 01/04/2011 (CE) 31/03/2014<br />

South (6)<br />

Graham Hawkes 17/05/<strong>2012</strong> (CE) 31/03/2014<br />

Asma Jalal 01/04/2011 (UE) 31/03/2014<br />

Abid Majeed 01/04/2011 (UE) 31/03/2014<br />

Sharda Mohan 01/04/2011 (UE) 31/03/2014<br />

Rest of Engl<strong>and</strong> (1) Stuart Marshall 06/08/<strong>2012</strong> (UE) 31/03/2014<br />

Staff Governors<br />

Doctors & dentists (1) Alvan Pope 17/05/<strong>2012</strong> (CE) 31/03/2014<br />

Bev Hall 01/04/2011 (CE) 31/03/2014<br />

Nurses, midwives,<br />

healthcare assistants (3)<br />

Allied health<br />

professionals (1)<br />

Support staff (2)<br />

Ann Morling<br />

(replaced by Am<strong>and</strong>a O’Brien)<br />

01/04/2011 (CE)<br />

Resigned<br />

11/05/<strong>2012</strong><br />

Am<strong>and</strong>a O’Brien 11/05/<strong>2012</strong> (UE) 31/03/2014<br />

Angela Wilson 01/04/2011 (CE) 31/03/2014<br />

Graham Coombs 01/04/2011 (CE) 31/03/2014<br />

Gay Bineham 01/04/2011 (CE) 31/03/2014<br />

Jennifer Roma 22/11/2011 (CE) 31/03/2014<br />

Governance report<br />

45


Appointed Governors<br />

Post ceased to exist<br />

31/03/20<strong>13</strong><br />

Council changed<br />

Cllr Philip Corthorne<br />

01/04/2011 (A)<br />

appointee<br />

6/11/<strong>2012</strong><br />

Cllr Mary O’Connor 6/11/<strong>2012</strong> (A) 11/05/2014<br />

<strong>Hillingdon</strong> PCT Sarah Cuthbert 20/07/2011 (A)<br />

London Borough of<br />

<strong>Hillingdon</strong> (1)<br />

London Ambulance<br />

Service (1)<br />

Joint Negotiating &<br />

Consultative Committee<br />

(1)<br />

Peter McKenna 01/04/2011 (A) 31/03/2014<br />

Lesley Dixon 01/04/2011 (A) 31/03/2014<br />

Key:<br />

CE – contested election<br />

UE – uncontested election<br />

A – appointed by partner organisation<br />

* The Constitution states that where a vacancy arises for an elected Governor other than by the end of a term of office, the<br />

Council of Governors may invite the next highest polling c<strong>and</strong>idate for that seat at the most recent election, who is willing to<br />

take office, to fill the vacant seat until the next election, at which time the seat will fall vacant <strong>and</strong> be subject to election for<br />

any unexpired period of the term of office. In accordance with these provisions, Alvan Seth-Smith & Pamela Taverner were<br />

invited to take up the positions vacated by Governor resignations. Therefore whilst the term of office is shown as 31st March<br />

2014, should there be an election in the North Public Constituency before this time then the two seats will fall vacant <strong>and</strong> be<br />

subject to election for the period until 31st March 2014.<br />

During <strong>2012</strong>/<strong>13</strong> elections for five constituencies were held. The following table outlines the<br />

turnout <strong>and</strong> number of c<strong>and</strong>idates.<br />

Constituency<br />

Number of<br />

positions<br />

Number of<br />

c<strong>and</strong>idates<br />

Number<br />

of eligible<br />

voters<br />

Turnout<br />

Public: Central 2 6 2,754 24%<br />

Public: South 1 4 2,873 17%<br />

Public: Rest of Engl<strong>and</strong> 1 1 176 N/A<br />

Staff: Doctors & dentists 1 2 433 20%<br />

Staff: Nurses, midwives & healthcare<br />

assistants<br />

1 1 1,321 N/A<br />

Where an election was contested, voting was undertaken by secret postal ballot, using<br />

the single transferable voting system by which members rank the c<strong>and</strong>idates in order of<br />

preference.<br />

46 Governance report


In <strong>2012</strong>/<strong>13</strong> the Council of Governors formally<br />

met four times. Governor attendance at<br />

these meetings is outlined below. Where<br />

a Governor was not in office for all four<br />

meetings, the maximum possible attendance<br />

is shown.<br />

Governor<br />

Meetings<br />

attended<br />

David Bishop (Public) 4 of 4<br />

Tony Ellis (Public) 3 of 4<br />

Ahmad Mallick (Public) 2 of 4<br />

Rachel Owen (Public) 0 of 0<br />

Alvan Seth-Smith (Public) 4 of 4<br />

Pamela Taverner (Public) 2 of 3<br />

Donald Dakin (Public) 2 of 4<br />

Martin Elliott (Public) 3 of 3<br />

Neil Fyfe (Public) 1 of 3<br />

Kerstin Rolfe (Public) 2 of 4<br />

Roger Shipton (Public) 4 of 4<br />

John Coleman (Public) 4 of 4<br />

John Davies (Public) 4 of 4<br />

Graham Hawkes (Public) 3 of 3<br />

Asma Jalal (Public) 2 of 4<br />

Abid Majeed (Public) 2 of 4<br />

Sharda Mohan (Public) 2 of 4<br />

Stuart Marshall (Public) 2 of 2<br />

Alvan Pope (Staff) 3 of 3<br />

Bev Hall (Staff) 3 of 4<br />

Ann Morling (Staff) 0 of 0<br />

Am<strong>and</strong>a O’Brien (Staff) 4 of 4<br />

Angela Wilson (Staff) 4 of 4<br />

Graham Coombs (Staff) 3 of 4<br />

Gay Bineham (Staff) 3 of 4<br />

Jennifer Roma (Staff) 3 of 4<br />

Sarah Cuthbert (Appointed) 0 of 4<br />

Cllr Philip Corthorne (Appointed) 0 of 3<br />

Cllr Mary O’Connor (Appointed) 1 of 1<br />

Peter McKenna (Appointed) 1 of 4<br />

Lesley Dixon (Appointed) 3 of 4<br />

Governors are required to declare any<br />

relevant interests which are then entered<br />

into the publicly available Register of<br />

Governors’ Interests. The Register is formally<br />

reviewed by the Council of Governors<br />

annually <strong>and</strong> is available from the <strong>Trust</strong><br />

Secretary on 01895 279976.<br />

Lead Governor<br />

In line with Monitor’s Code of Governance,<br />

the Council of Governors elects one of the<br />

Public Governors to be the ‘Lead Governor’.<br />

The main duties of the Lead Governor are to:<br />

• Act as a point of contact for Monitor<br />

should the Regulator wish to contact<br />

the Council of Governors on an issue<br />

for which the normal channels of<br />

communication are not appropriate.<br />

• Be the conduit for raising with Monitor<br />

any Governor concerns that the<br />

Foundation <strong>Trust</strong> is at risk of significantly<br />

breaching the Terms of its Authorisation<br />

(now Licence), having made every attempt<br />

to resolve any such concerns locally.<br />

• Chair such parts of meetings of the<br />

Council of Governors which cannot be<br />

chaired by the <strong>Trust</strong> Chair or Deputy Chair<br />

due to a conflict of interest in relation to<br />

the business being discussed.<br />

In April <strong>2012</strong> the Council of Governors<br />

appointed Roger Shipton as the Lead<br />

Governor for the <strong>2012</strong>/<strong>13</strong> financial year.<br />

In April 20<strong>13</strong>, Roger Shipton did not seek<br />

reappointment for the role <strong>and</strong> the Council<br />

of Governors elected John Coleman as Lead<br />

Governor to run until 31st March 2014.<br />

The Board’s liaison with Governors<br />

<strong>and</strong> members<br />

All Board members have a st<strong>and</strong>ing invitation<br />

to attend Council of Governors meetings in<br />

order to ensure they underst<strong>and</strong> the views<br />

of Governors <strong>and</strong> members. The Board <strong>and</strong><br />

Council of Governors meet jointly at least<br />

annually as part of enabling the Governors<br />

to input into the <strong>Trust</strong>’s annual plan <strong>and</strong><br />

also to discuss any other matters of joint<br />

concern. In <strong>2012</strong>/<strong>13</strong> two such meetings were<br />

held: in November <strong>2012</strong> <strong>and</strong> March 20<strong>13</strong>.<br />

Board meetings are held in public <strong>and</strong> there<br />

is an opportunity for members of public <strong>and</strong><br />

Governors to ask questions of the Board<br />

members present. Members of the Board<br />

also attend the <strong>Trust</strong>’s People in Partnership<br />

Governance report<br />

47


meetings <strong>and</strong> <strong>Annual</strong> Members’ Meeting to<br />

liaise with members <strong>and</strong> Governors.<br />

Attendance by Board members at the four<br />

meetings of the Council of Governors <strong>and</strong> the<br />

two joint meetings between the Board <strong>and</strong><br />

Council of Governors in <strong>2012</strong>/<strong>13</strong> is outlined in<br />

the table below.<br />

No of Council of Governor meetings<br />

Board Member<br />

attended in <strong>2012</strong>/<strong>13</strong> (including joint<br />

Board/Governor meetings)<br />

Mike Robinson (Chair) 6 of 6<br />

Katey Adderley (Non-Executive Director) 4 of 6<br />

Marie Batey (Executive Director of Patient<br />

Experience & Nursing)<br />

1 of 2<br />

Carol Bode (Non-Executive Director) 4 of 6<br />

Shane DeGaris (Chief Executive) 5 of 6<br />

Abbas Khakoo (Joint Medical Director) 2 of 2<br />

Susan LaBrooy (Medical Director) 0 of 4<br />

Alan McLeod (Non-Executive Director) 4 of 6<br />

Karl Munslow Ong (Chief Operating Officer) 2 of 6<br />

Anthony Palmer (Non-Executive Director) 3 of 6<br />

Pradip Patel (Non-Executive Director) 4 of 6<br />

James Reid (Deputy Chair & Non-Executive Director) 4 of 6<br />

Craig Rowl<strong>and</strong> (Senior Independent Director & Non-<br />

Executive Director)<br />

4 of 6<br />

David Searle (Executive Director of Corporate<br />

Development)<br />

3 of 6<br />

Jacqueline Walker (Acting Executive Director of the<br />

Patient Experience & Nursing)<br />

3 of 4<br />

Paul Wratten (Finance Director) 4 of 6<br />

48 Governance report


Membership<br />

The Foundation <strong>Trust</strong> membership is divided<br />

into two categories: public membership <strong>and</strong><br />

staff membership.<br />

Staff membership<br />

The staff constituency is a single constituency<br />

divided into the following classes:<br />

• Doctors <strong>and</strong> dentists<br />

• Nurses <strong>and</strong> midwives (including health<br />

care assistants)<br />

• Allied Health Professionals<br />

• Support staff<br />

Staff membership is open to all those<br />

employed by the <strong>Trust</strong> on a permanent basis,<br />

those who have a fixed term contract of at<br />

least 12 months, <strong>and</strong> those who have been<br />

working at the <strong>Trust</strong> for at least 12 months.<br />

These staff are automatically members of<br />

the Staff Constituency unless they ‘opt-out’<br />

from membership. So far no staff have opted<br />

out from being a member of the Foundation<br />

<strong>Trust</strong>. In addition, the following individuals<br />

may become staff members providing they<br />

have exercised these ‘functions’ for a period<br />

of 12 months <strong>and</strong> continue to do so:<br />

Public membership<br />

There are four public constituencies,<br />

which are collectively known as the Public<br />

Constituency. The majority of the public<br />

members are drawn from the three public<br />

constituencies which cover the electoral<br />

wards in <strong>Hillingdon</strong> Borough together<br />

with several neighbouring electoral wards.<br />

The fourth public constituency covers all<br />

other electoral areas in the rest of Engl<strong>and</strong>.<br />

Anyone can become a public member of the<br />

Foundation <strong>Trust</strong> providing they are 16 years<br />

or over, live within the Public Constituency,<br />

<strong>and</strong> are not eligible to be a staff member of<br />

the Foundation <strong>Trust</strong>.<br />

• Volunteers working at the <strong>Trust</strong> (other<br />

than those working for third party<br />

organisations).<br />

• Those working at the <strong>Trust</strong> through the<br />

temporary staffing ‘bank’.<br />

• Those working at the <strong>Trust</strong> through an<br />

independent contractor to provide a<br />

service out-sourced by the <strong>Trust</strong>.<br />

Staff membership will cease at the point that<br />

the member leaves the service of the <strong>Trust</strong>.<br />

Anyone eligible to be a staff member of the<br />

Foundation <strong>Trust</strong> cannot be a public member.<br />

Membership Development <strong>and</strong><br />

Engagement Strategy <strong>2012</strong>-2015<br />

The Board approved a three year<br />

Membership Development <strong>and</strong> Engagement<br />

Strategy in February <strong>2012</strong>. The strategy<br />

describes the <strong>Trust</strong>’s objectives for the<br />

membership <strong>and</strong> the approach we will use<br />

to ensure the <strong>Trust</strong> develops <strong>and</strong> engages<br />

with a representative membership. It<br />

outlines our plans for raising awareness<br />

about membership <strong>and</strong> for the recruitment,<br />

Governance report<br />

49


etention <strong>and</strong> involvement of members. The<br />

strategy was produced with the guidance<br />

<strong>and</strong> input of the Council of Governors <strong>and</strong><br />

builds upon <strong>and</strong> replaces the Membership<br />

Development <strong>and</strong> Public Engagement<br />

Strategy that was approved in 2008 <strong>and</strong><br />

subsequently updated in 2010. A high level<br />

action plan to deliver the Membership<br />

Development <strong>and</strong> Engagement Strategy has<br />

been developed with progress periodically<br />

reported to the Council of Governors <strong>and</strong> the<br />

Board.<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> is committed to recruiting members<br />

from the diverse population served by<br />

the <strong>Trust</strong>. Membership is open to all those<br />

eligible to be a member regardless of gender,<br />

race, disability, ethnicity, religion or any<br />

other groups covered under the Equality Act<br />

<strong>2012</strong>.<br />

The membership base is regularly<br />

reviewed to ensure that the membership<br />

is representative of those eligible to be<br />

members. Specific groups that appear<br />

to be under-represented are targeted in<br />

recruitment campaigns in order to seek to<br />

increase membership representation in these<br />

areas, such as people between the ages of 16<br />

<strong>and</strong> 45.<br />

The Membership Development <strong>and</strong><br />

Engagement Strategy set the following<br />

targets for membership growth:<br />

Target Membership<br />

<strong>2012</strong>/<strong>13</strong> 20<strong>13</strong>/14 2014/15<br />

Public constituency 7,500 7,650 7,750<br />

Staff constituency 3,187* 3,187* 3,187*<br />

Total 10,687 10,837 10,937<br />

* These figures were set based on staffing levels as at<br />

February <strong>2012</strong>, with the recognition that this would depend<br />

on any future changes in staff numbers.<br />

In order to achieve the above targets there is<br />

a need to recruit approximately an additional<br />

500 public members each year to replace<br />

those who cease to be a member by virtue<br />

of moving or passing away. In agreeing the<br />

strategy it was felt that the above targets<br />

should represent a broad indication of our<br />

objective to increase the membership but<br />

the primary focus would be to maintain<br />

the current level of membership, address<br />

areas of under-representation <strong>and</strong> focus on<br />

engagement rather than growth.<br />

Key actions to grow membership are to:<br />

• Utilise existing publications (e.g.<br />

<strong>Hillingdon</strong> People), local groups (e.g.<br />

Street Champion meetings, Resident<br />

Associations <strong>and</strong> Community Voice) <strong>and</strong><br />

local events (May Day Fair <strong>and</strong> summer<br />

carnivals)<br />

• Attend local community <strong>and</strong> voluntary<br />

group meetings i.e. AGMs <strong>and</strong><br />

conferences<br />

• Attend joint public engagement<br />

meetings with <strong>Hillingdon</strong> Clinical<br />

Commissioning Group <strong>and</strong> Central <strong>and</strong><br />

North West London <strong>NHS</strong> Foundation<br />

<strong>Trust</strong><br />

• Attend regular ‘speak-easy’ carer events,<br />

hosted by <strong>Hillingdon</strong> Carers <strong>and</strong> the<br />

Council<br />

• Promote membership at <strong>Trust</strong><br />

engagement events, i.e. armed forces,<br />

BME focus groups <strong>and</strong> patient support<br />

groups<br />

• Organise membership recruitment<br />

events at <strong>Hillingdon</strong> <strong>and</strong> Mount Vernon<br />

<strong>Hospital</strong>s<br />

• Encourage Governors <strong>and</strong> members to<br />

sign up family, friends <strong>and</strong> members of<br />

the public<br />

• Invite ex-staff, their family <strong>and</strong> friends<br />

to become public members<br />

• Utilise existing networks in promoting<br />

membership with staff <strong>and</strong> students at<br />

local universities<br />

• Explore the possibility of holding a<br />

careers event for students attending<br />

local schools <strong>and</strong> colleges<br />

• Make membership forms available in<br />

local libraries <strong>and</strong> shopping centres.<br />

50 Governance report


Membership as at 31st March 20<strong>13</strong><br />

As at 31st March 20<strong>13</strong>, the <strong>Trust</strong> had<br />

7,172 public members. The table below<br />

illustrates the number of public members<br />

for each constituency compared to the total<br />

population.<br />

31 st<br />

March<br />

20<strong>13</strong><br />

% of<br />

membership<br />

Population<br />

base<br />

% of<br />

area<br />

Central 2,704 37.7 177,608 40<br />

North 1,462 20.4 102,842 23.1<br />

South 2,811 39.2 166,500 36.9<br />

Rest of 194 2.7 0 0<br />

Engl<strong>and</strong><br />

Total 7171 100 446,950 0<br />

During <strong>2012</strong>/<strong>13</strong>, the Foundation <strong>Trust</strong><br />

recruited 316 new public members <strong>and</strong> lost<br />

238 public members due to bereavement,<br />

members moving away without providing<br />

a new address or members cancelling their<br />

membership. This has resulted in the <strong>Trust</strong><br />

not meeting the target of 7,500 members.<br />

In April 20<strong>13</strong> the Board agreed a revised<br />

membership target of 7,400 public members<br />

at its Board meeting on 24th April 20<strong>13</strong> to<br />

cover the period April 20<strong>13</strong> to March 2014,<br />

in line with the view that the aim is to focus<br />

on engagement rather than recruitment.<br />

The <strong>Trust</strong> will strive to increase membership<br />

in the coming year to meet this revised<br />

target through a programme of focused<br />

recruitment <strong>and</strong> engagement using the<br />

actions outlined above.<br />

Contacting Directors <strong>and</strong> Governors<br />

Directors <strong>and</strong> Governors can be contacted<br />

through the Foundation <strong>Trust</strong> Office:<br />

• Email: foundation@thh.nhs.uk<br />

• Telephone: 0800 8766953<br />

• Post: Foundation <strong>Trust</strong> Office, <strong>Hillingdon</strong><br />

<strong>Hospital</strong>, Pield Heath Road, Uxbridge, UB8<br />

3NN.<br />

Compliance with the Code of<br />

Governance<br />

The Board considers itself compliant with all<br />

provisions of the <strong>NHS</strong> Foundation <strong>Trust</strong> Code<br />

of Governance <strong>and</strong> has made the required<br />

disclosures in this annual report. The Board<br />

has identified areas where the <strong>Trust</strong>’s<br />

compliance could be strengthened, most<br />

notably in relation to the evolving role of the<br />

Governors, <strong>and</strong> the assurance as to the extent<br />

the Governors consult with the membership.<br />

Work over the coming year will therefore<br />

seek to strengthen the <strong>Trust</strong>’s arrangements<br />

in relation to Governors’ engagement<br />

with the members, Governor engagement<br />

with the Board, <strong>and</strong> Governor training <strong>and</strong><br />

induction, in light of the Health & Social<br />

Care Act <strong>2012</strong> <strong>and</strong> the recommendations of<br />

the Mid Staffordshire <strong>NHS</strong> Foundation <strong>Trust</strong><br />

Public Inquiry.<br />

As at 31st March 20<strong>13</strong> the <strong>Trust</strong> currently had<br />

3,081 staff members. The following table<br />

provides a breakdown by staff group:<br />

Staff Class<br />

Number of members<br />

Doctors <strong>and</strong> Dentists 395<br />

Nurses, Midwives & Healthcare Assistants (including bank staff) 1,222<br />

Allied Health Professionals (including bank staff) 299<br />

Support staff (including bank staff <strong>and</strong> volunteers) 1,165<br />

Total 3,081<br />

Governance report<br />

51


REMUNERATION REPORT<br />

Board of Directors Remuneration<br />

Committee<br />

The Board of Directors Remuneration<br />

Committee comprises all of the Non-<br />

Executive Directors <strong>and</strong> is chaired by the<br />

Deputy Chair. The Chief Executive <strong>and</strong><br />

Director of People are invited to attend<br />

to provide professional advice, except<br />

for when the Committee is considering<br />

these individuals’ remuneration <strong>and</strong>/or<br />

performance. The <strong>Trust</strong> Secretary attends to<br />

take minutes of the Committee’s meetings.<br />

The Committee’s role <strong>and</strong> responsibilities<br />

are primarily two-fold: to agree the<br />

remuneration <strong>and</strong> terms of service for the<br />

Chief Executive <strong>and</strong> the Executive Directors;<br />

<strong>and</strong> to oversee the performance monitoring<br />

of the Chief Executive <strong>and</strong> Executive<br />

Directors. The Committee also reviews at a<br />

high level the remuneration of the <strong>Trust</strong>’s<br />

most senior employees beneath the Board<br />

(i.e. the first line reports to the Executive<br />

Directors <strong>and</strong> the <strong>Trust</strong>’s Consultants) to<br />

ensure this remains appropriate to the<br />

remuneration paid to the Executive Team.<br />

The Committee met six times in <strong>2012</strong>/<strong>13</strong>.<br />

At these meetings the Committee agreed<br />

the remuneration in relation to the<br />

acting <strong>and</strong> substantive Director of Patient<br />

Experience & Nursing positions, <strong>and</strong> for<br />

the Medical Director, Chief Executive, <strong>and</strong><br />

Chief Operating Officer appointments. The<br />

Committee also reviewed the <strong>Trust</strong>’s pay<br />

policy for the Executive Team <strong>and</strong> the case<br />

for any pay awards (see below for further<br />

information), <strong>and</strong> reviewed the remuneration<br />

for the <strong>Trust</strong>’s senior management <strong>and</strong><br />

Consultants. The Committee also reviewed<br />

the Chair <strong>and</strong> Chief Executive’s monitoring of<br />

the Chief Executive’s <strong>and</strong> Executive Directors’<br />

performance at the mid-point of the year<br />

(September <strong>2012</strong>) <strong>and</strong> at the end of the year<br />

(March 20<strong>13</strong>).<br />

At its meeting in May <strong>2012</strong> the Committee<br />

agreed not to award an increase in Executive<br />

Remuneration for <strong>2012</strong>/<strong>13</strong>. This decision was<br />

based on the fact that Agenda for Change<br />

staff <strong>and</strong> those on the medical <strong>and</strong> dentistry<br />

pay scales would not receive a cost of living<br />

increase in <strong>2012</strong>/<strong>13</strong>, <strong>and</strong> the current focus<br />

on efficiency savings <strong>and</strong> reductions in the<br />

<strong>Trust</strong>’s pay spend. The Committee noted<br />

that this meant that no increase had been<br />

awarded for two years, <strong>and</strong> agreed that<br />

external consultants should be commissioned<br />

to report to the March 20<strong>13</strong> meeting on<br />

Executive Remuneration. The Committee<br />

agreed that the report would also assist<br />

the Committee in considering whether its<br />

previous decision not to introduce a formal<br />

performance related element to Executive<br />

Remuneration remains appropriate.<br />

The Committee were mindful of the cost<br />

of commissioning this work <strong>and</strong> therefore<br />

the Chair of the Committee agreed with<br />

the Director of People to purchase an<br />

existing benchmarking report from Capita<br />

on FT remuneration. Hay Group were also<br />

commissioned by the Director of People to<br />

provide a bespoke report to the Committee<br />

on performance related pay.<br />

At the start of <strong>2012</strong>/<strong>13</strong> Capita provided<br />

services to the <strong>Trust</strong> in relation to the<br />

electronic distribution of the <strong>Trust</strong>’s<br />

membership magazine, but had ceased to<br />

provide these services at the time the report<br />

was provided to the Committee. Hay Group<br />

provided no other services to the <strong>Trust</strong> in<br />

<strong>2012</strong>/<strong>13</strong>.<br />

The Committee considered the reports from<br />

Capita <strong>and</strong> Hay at its meeting in March 20<strong>13</strong>.<br />

52 Remuneration report


The Committee confirmed the <strong>Trust</strong>’s<br />

Executive pay policy is to set remuneration at<br />

the median to upper quartile of comparator<br />

<strong>Trust</strong>s, with the following conditions to<br />

be taken into account when determining<br />

individual Executives’ pay:<br />

• Performance<br />

• Experience<br />

• Importance to the organisation<br />

• Marketability <strong>and</strong> likelihood of moving<br />

elsewhere.<br />

The Committee confirmed its previous<br />

decision that Executive Remuneration should<br />

not include provisions for bonus payments<br />

or proportions subject to performance<br />

conditions. The Committee confirmed that<br />

it would continue to consider individual <strong>and</strong><br />

overall <strong>Trust</strong> performance, when determining<br />

Executive remuneration as part of the pay<br />

policy outlined above.<br />

Having considered the pay policy <strong>and</strong> the<br />

benchmarking information provided by<br />

Capita, the Committee agreed that the Chief<br />

Executive <strong>and</strong> Executive Directors would not<br />

receive an increase in remuneration at the<br />

present time.<br />

Neither the Chief Executive nor the Executive<br />

Directors are currently appointed for fixed<br />

term contracts. The Board believes that<br />

such contracts would make it harder to<br />

attract <strong>and</strong> retain high-quality Executives<br />

in a competitive recruitment environment,<br />

<strong>and</strong> can lead to uncertainty affecting service<br />

delivery towards the end of the contract.<br />

The <strong>Trust</strong>’s policy on notice periods <strong>and</strong><br />

termination payments for Executive Directors<br />

is six months, in line with generally accepted<br />

practice at this level in the <strong>NHS</strong>. Any decision<br />

to allow an Executive Director to leave the<br />

<strong>Trust</strong>’s employment without this full notice<br />

period is subject to a risk assessment by the<br />

Board of Directors Nominations Committee,<br />

in line with the Code of Governance.<br />

As outlined earlier in the report, Jacqueline<br />

Walker is currently acting up from her<br />

substantive role as the <strong>Trust</strong>’s Deputy<br />

Director of Nursing to be the Acting<br />

Executive Director of Patient Experience &<br />

Nursing. This is to cover the period until the<br />

<strong>Trust</strong>’s new substantive Executive Director of<br />

Patient Experience & Nursing joins the <strong>Trust</strong><br />

(expected to be at the end of May 20<strong>13</strong>).<br />

Attendance at Remuneration Committee<br />

meetings in <strong>2012</strong>/<strong>13</strong> is outlined earlier in the<br />

‘Governance <strong>Report</strong>’.<br />

Pay policy for wider staff<br />

The Remuneration Committee annually<br />

reviews the pay of the first layer of<br />

management beneath the Board, to ensure<br />

that there is appropriate differential<br />

between the remuneration of the Executive<br />

team <strong>and</strong> their direct reports. As part of this,<br />

the Committee also reviews the structure of<br />

Consultant pay.<br />

Staff beneath the Board are paid according<br />

to nationally defined terms <strong>and</strong> conditions<br />

(i.e. the medical pay-scales or in the case<br />

of non-medical staff, Agenda for Change).<br />

When considering whether to increase<br />

executive remuneration the Remuneration<br />

Committee takes into account whether any<br />

cost of living increases have been awarded<br />

to staff on national terms <strong>and</strong> conditions.<br />

Non-executive remuneration<br />

The Council of Governors is responsible for<br />

agreeing the remuneration of the Chair <strong>and</strong><br />

Non-Executive Directors.<br />

At their meeting in October 2011 the Council<br />

of Governors agreed that the remuneration<br />

for the Chair <strong>and</strong> Non-Executive Directors<br />

should be increased to £45k pa <strong>and</strong> £<strong>13</strong>k<br />

pa respectively to reflect the additional<br />

responsibilities arising from Foundation <strong>Trust</strong><br />

status. In making this decision the Governors<br />

drew upon benchmarking information<br />

<strong>and</strong> independent analysis provided by<br />

Hay Group. In agreeing this increase, the<br />

Council of Governors was mindful of the<br />

wage restraint in the <strong>NHS</strong> <strong>and</strong> agreed that<br />

the increase would not take effect until<br />

1st April <strong>2012</strong> (<strong>and</strong> therefore a year after<br />

Remuneration report<br />

53


authorisation as a Foundation <strong>Trust</strong>) <strong>and</strong><br />

that Non-Executive remuneration would not<br />

be increased for a further two years.<br />

Non-Executive appointments are not within<br />

the jurisdiction of Employment Tribunals <strong>and</strong><br />

there is no entitlement for compensation for<br />

loss of office through employment law.<br />

In making decisions on Non-Executive<br />

Remuneration, the Council of Governors<br />

draws on the recommendations of the<br />

Council of Governors Nominations &<br />

Remuneration Committee. Attendance at<br />

the Committee’s two meetings in <strong>2012</strong>/<strong>13</strong> is<br />

outlined below.<br />

Number of<br />

Name<br />

meetings<br />

attended<br />

Mike Robinson (<strong>Trust</strong> Chair) 1 14 of 2<br />

John Coleman (Public Governor) 2 of 2<br />

Tony Ellis (Public Governor) 2 of 2<br />

Roger Shipton (Public Governor) 2 of 2<br />

Gay Bineham (Staff Governor) 1 of 2<br />

Peter McKenna (Appointed Governor) 2 of 2<br />

Directors’ remuneration in <strong>2012</strong>/<strong>13</strong><br />

For the purposes of the remuneration<br />

report, the Chief Executive has confirmed<br />

that the definition of senior manager covers<br />

the members of the Board, in line with the<br />

definition in Monitor’s <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual that senior managers are ‘those<br />

persons in senior positions having authority<br />

or responsibility for directing or controlling<br />

the major activities of the Foundation <strong>Trust</strong>.’<br />

14 One of the meetings was to discuss Mike Robinson’s appointment <strong>and</strong> therefore this meeting was chaired by Craig<br />

Rowl<strong>and</strong>, the <strong>Trust</strong>’s Senior Independent Director at that time.<br />

54 Remuneration report


Directors’ remuneration (excluding pension contributions) fell within the following<br />

ranges:<br />

Directors' remuneration (excluding pension contributions) fell within the following ranges:<br />

NOTE<br />

NAME AND TITLE<br />

(B<strong>and</strong>s of £5000)<br />

Executive Directors £000s £000s £000s £000s £000s £000s £000s £000s £000s<br />

1 Shane DeGaris, Chief Executive 155-160 90-95 2.5-5 5-7.5 20-25 15-20 272 141 91<br />

Marie Batey, Executive<br />

2 Director of Patient Experience 50-55 90-95 - - 30-35 100-105 574 540 24<br />

<strong>and</strong> Nursing<br />

3 Claire Gore, Director of People 5-10 N/A N/A N/A N/A N/A N/A N/A N/A<br />

4<br />

Richard Grocott-Mason, Joint<br />

Medical Director<br />

40- 45 N/A N/A N/A 40-45 125-<strong>13</strong>0 768 N/A N/A<br />

5<br />

Abbas Khakoo, Joint Medical<br />

Director<br />

40-45 N/A N/A N/A 40-45 120-125 730 N/A N/A<br />

6<br />

Susan LaBrooy, Medical<br />

Director<br />

100-105 175-180 N/A N/A 70-75 215-220 N/A N/A N/A<br />

7<br />

Karl Munslow Ong, Chief<br />

Operating Officer<br />

100-105 5-10 0-2.5 0-2.5 10-15 35-40 <strong>13</strong>0 114 12<br />

David Searle, Executive<br />

Director of Corporate 95-100 95-100 0-2.5 0-2.5 15-20 55-60 380 345 24<br />

Development<br />

Jacqueline Walker, Acting<br />

8 Executive Director of Patient 35-40 N/A N/A N/A 20-25 60-65 N/A N/A N/A<br />

Experience <strong>and</strong> Nursing<br />

Paul Wratten, Finance Director 115-120 115-120 - - 40-45 120-125 709 664 31<br />

Non Executive Directors<br />

Salary<br />

<strong>2012</strong>/<strong>13</strong><br />

(excluding<br />

social<br />

security<br />

costs)<br />

(B<strong>and</strong>s of<br />

£5000)<br />

Salary<br />

2011/12<br />

(excluding<br />

social<br />

security<br />

costs)<br />

(B<strong>and</strong>s of<br />

£5000)<br />

Real<br />

increase in<br />

lump sum<br />

pension at<br />

age 60<br />

(B<strong>and</strong>s of<br />

£2500)<br />

Real<br />

increase in<br />

pension at<br />

age 60<br />

(B<strong>and</strong>s of<br />

£2500)<br />

Total accrued<br />

pension at<br />

age 60 at 31<br />

March 20<strong>13</strong><br />

(B<strong>and</strong>s of<br />

£5000)<br />

Lump sum at<br />

age 60 related<br />

to accrued<br />

pension at 31<br />

March 20<strong>13</strong><br />

Cash<br />

equivalent<br />

transfer value<br />

at 31 March<br />

20<strong>13</strong><br />

Cash<br />

equivalent<br />

transfer value<br />

at 31 March<br />

<strong>2012</strong><br />

Michael Robinson, Chair 35-40 30-35 N/A N/A N/A N/A N/A N/A N/A<br />

Katey Adderley, Non-Executive<br />

10-15<br />

Director<br />

5-10 N/A N/A N/A N/A N/A N/A N/A<br />

9<br />

Carol Bode, Non-Executive<br />

Director<br />

10-15 N/A N/A N/A N/A N/A N/A N/A N/A<br />

Alan McLeod, Non-Executive<br />

Director<br />

10-15 5-10 N/A N/A N/A N/A N/A N/A N/A<br />

9<br />

Anthony Palmer, Non-<br />

Executive Director<br />

10-15 N/A N/A N/A N/A N/A N/A N/A N/A<br />

Pradip Patel, Non-Executive<br />

Director<br />

10-15 0-5 N/A N/A N/A N/A N/A N/A N/A<br />

Craig Rowl<strong>and</strong>, Non-Executive<br />

10-15<br />

Director<br />

5-10 N/A N/A N/A N/A N/A N/A N/A<br />

James Reid, Non-Executive<br />

Director<br />

10-15 5-10 N/A N/A N/A N/A N/A N/A N/A<br />

10<br />

Patricia Rushton, Non-<br />

Executive Director<br />

0-5 5-10 N/A N/A N/A N/A N/A N/A N/A<br />

Real increase<br />

in cash<br />

equivalent<br />

transfer value<br />

<strong>2012</strong>/20<strong>13</strong> 2011/<strong>2012</strong><br />

<strong>2012</strong>/20<strong>13</strong> 2011/<strong>2012</strong><br />

B<strong>and</strong> of B<strong>and</strong> Highest of Highest Paid Paid Director’s Director's Total Total Remuneration Remuneration (£ 000) (£000) 155-160 175-180<br />

Median Total Remuneration<br />

Median Total Remuneration<br />

30,801<br />

30,801<br />

32,237<br />

32,237<br />

Ratio 5.11 5.51<br />

Ratio 5.11 5.51<br />

The HM Treasury Financial <strong>Report</strong>ing Manual (FReM), requires the <strong>Trust</strong> to disclose the median remuneration of the<br />

<strong>Trust</strong> staff <strong>and</strong> the ratio between this <strong>and</strong> the mid-point of the b<strong>and</strong>ed remuneration of the highest paid director. The<br />

calculation is based on full-time equivalent staff of the <strong>Trust</strong> at 31st March 20<strong>13</strong> on an annualised basis.<br />

The HM Treasury Financial <strong>Report</strong>ing Manual (FReM), requires the <strong>Trust</strong> to disclose the<br />

median remuneration of the <strong>Trust</strong> staff <strong>and</strong> the ratio between this <strong>and</strong> the mid-point of<br />

the b<strong>and</strong>ed remuneration of the highest paid director. The calculation is based on full-time<br />

equivalent staff of the <strong>Trust</strong> at 31st March 20<strong>13</strong> on an annualised basis.<br />

Remuneration report<br />

55


Notes<br />

1. (A) Acting Chief Executive until 21/5/<strong>2012</strong>; (B) Chief Executive from 22/5/<strong>2012</strong><br />

(A) Gross Pay 1/4/<strong>2012</strong> to 21/5/<strong>2012</strong> in b<strong>and</strong>s of £5000: £20k - £25k<br />

(B) Gross Pay 22/5/<strong>2012</strong> to 31/3/20<strong>13</strong> in b<strong>and</strong>s of £5000: £<strong>13</strong>5k - 140k<br />

2. To 29/10/<strong>2012</strong><br />

3. In post from 1/3/20<strong>13</strong><br />

4. In post from 1/2/20<strong>13</strong><br />

5. In post from 1/1/20<strong>13</strong>. Clinical work in b<strong>and</strong> of £15k - £20k, Director work in b<strong>and</strong> of £25k to £30k. Recharges out to<br />

Imperial College Healthcare <strong>NHS</strong> <strong>Trust</strong> <strong>and</strong> London Health Programme not included in above.<br />

6. To 31/12/<strong>2012</strong>. Salary was in b<strong>and</strong> of £90k - £95k in respect of executive activities <strong>and</strong> £10k - £15k in respect of clinical<br />

work. Salary is inclusive of a nationally funded excellence award. Time charged relating to a role at the North West<br />

London Cluster (to December <strong>2012</strong>) is excluded.<br />

7. (A) Acting Chief Operating Officer until 10/10/<strong>2012</strong>; (B) Chief Operating Officer from 11/10/<strong>2012</strong>.<br />

(A) Gross Pay 1/4/<strong>2012</strong> to 10/10/<strong>2012</strong> in b<strong>and</strong>s of £5000:£50k - £55k.<br />

During period (A) employed by Homerton <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>and</strong> salary cost fully recharged to <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong>.<br />

(B) Gross Pay 22/5/<strong>2012</strong> to 31/5/20<strong>13</strong> in b<strong>and</strong>s of £5000: £45k - £50k.<br />

8. In post from 22/10/<strong>2012</strong><br />

9. In post from 2/4/<strong>2012</strong><br />

10. In post from 1/4/12 to 2/4/<strong>2012</strong><br />

During <strong>2012</strong>/<strong>13</strong>, no compensation payments have been made to former senior managers,<br />

<strong>and</strong> no payments have been made to third parties for the services of a senior manager. No<br />

Executive Director currently serves as a Non-Executive Director of another organisation. The<br />

Directors received no benefits in kind.<br />

56 Remuneration report


Governor <strong>and</strong> Director expenses<br />

Governors <strong>and</strong> Directors are entitled to claim for certain expenses incurred whilst<br />

undertaking their role at the <strong>Trust</strong>. The rates payable to Governors are outlined in guidelines<br />

approved by the Board of Directors, whilst the rates payable to the Chair <strong>and</strong> Non-Executive<br />

Directors are outlined in guidelines approved by the Council of Governors. These are both<br />

based on the rates payable to the <strong>Trust</strong>’s staff on Agenda for Change Terms <strong>and</strong> Conditions.<br />

The Chief Executive <strong>and</strong> Executive Directors are eligible to claim expenses under the rates<br />

payable to staff employed on the Agenda for Change terms <strong>and</strong> conditions.<br />

The table below outlines the expenses paid to Board members in <strong>2012</strong>/<strong>13</strong> (rounded to<br />

nearest £).<br />

Name<br />

Role<br />

Travel (inc<br />

parking)<br />

Other<br />

Katey Adderley Non-Executive Director £<strong>13</strong>0 £0 £<strong>13</strong>0<br />

Total<br />

£94 £30 £124<br />

Marie Batey Executive Director of Patient Experience &<br />

Nursing 15<br />

Carol Bode Non-Executive Director £586 £0 £586<br />

Shane DeGaris Chief Executive £112 £75 £187<br />

Claire Gore Director of People 16 £0 £0 £0<br />

Richard Grocott- Joint Medical Director 17 £0 £0 £0<br />

Mason<br />

Abbas Khakoo Joint Medical Director 18 £0 £0 £0<br />

Susan LaBrooy Medical Director 19 £0 £0 £0<br />

Alan McLeod Non-Executive Director £0 £0 £0<br />

Karl Munslow Ong Chief Operating Officer £61 £0 £61<br />

Anthony Palmer Non-Executive Director £302 £0 £302<br />

Pradip Patel Non-Executive Director £0 £0 £0<br />

James Reid Non-Executive Director £0 £0 £0<br />

Mike Robinson Chair £0 £0 £0<br />

Craig Rowl<strong>and</strong> Non-Executive Director £0 £0 £0<br />

David Searle Executive Director of Corporate Development £140 £0 £140<br />

£106 £330 £436<br />

Jacqueline Walker Acting Executive Director of Patient<br />

Experience & Nursing 20<br />

Paul Wratten Finance Director £543 £0 £543<br />

No expenses claims were made by members of the Council of Governors in <strong>2012</strong>/<strong>13</strong>.<br />

15 To 29th October <strong>2012</strong><br />

16 From 1st March 20<strong>13</strong><br />

17 From 1st January 20<strong>13</strong><br />

18 From 1st January 20<strong>13</strong><br />

19 To 31st December <strong>2012</strong><br />

20 From 22nd October <strong>2012</strong><br />

Remuneration report<br />

57


<strong>Report</strong>ing related to the review of tax arrangements for public sector appointees<br />

There were three ‘off-payroll engagements’ costing over £58,200 per annum in place as<br />

of 31st January <strong>2012</strong> at the <strong>Trust</strong>. Of these, one has since come onto the <strong>Trust</strong>’s payroll.<br />

Following value for money <strong>and</strong> service considerations, two of the contracts were not<br />

re-engaged or renegotiated to pay via the <strong>Trust</strong>’s payroll or to seek assurance as to the<br />

individual’s tax obligations. However, these are now being reviewed <strong>and</strong>, where relevant,<br />

renegotiated in line with the imminent expiry dates of both of these contracts.<br />

There were no new ‘off-payroll’ engagements between 23rd August <strong>2012</strong> <strong>and</strong> 31st March<br />

20<strong>13</strong> that were for more than £220 per day <strong>and</strong> more than six months in duration.<br />

58 Remuneration report


quality report<br />

Quality <strong>Report</strong> <strong>2012</strong>/20<strong>13</strong><br />

Improving your local hospitals<br />

– our report to you<br />

Quality report<br />

59


Quality report: CONTENTS<br />

Page<br />

About this report<br />

61<br />

Introduction<br />

62<br />

Summary of <strong>2012</strong>/20<strong>13</strong> Quality <strong>Report</strong><br />

63<br />

Looking back<br />

65<br />

Looking forward<br />

77<br />

Statement of assurance from the Board<br />

82<br />

Annexe<br />

90<br />

60 Quality report


ABOUT THIS REPORT<br />

This Quality <strong>Report</strong> confirms the <strong>Trust</strong>’s<br />

commitment to put the patient <strong>and</strong> the<br />

quality of care at the heart of everything<br />

that we do. The report is the result<br />

of consultation with a wide group of<br />

stakeholders, including our Governors,<br />

commissioners, People in Partnership, <strong>and</strong><br />

our Local Involvement Network (LINk – now<br />

known as Health Watch).<br />

Within North West London the “Shaping<br />

a Healthier Future” programme has been<br />

approved by the Joint Committee of Primary<br />

Care <strong>Trust</strong>s. This programme places The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> as<br />

one of the five major hospitals for providing<br />

a full range of 24/7 emergency care in the<br />

region. The programme also places an<br />

emphasis on the provision of a wider range<br />

of out-of-hours primary <strong>and</strong> urgent care,<br />

<strong>and</strong> we are working closely with our GP<br />

commissioners <strong>and</strong> other providers to ensure<br />

that across the healthcare community patient<br />

care is provided in the right place at the right<br />

time.<br />

The project plans for a new Emergency<br />

Care Department, incorporating a rebuilt<br />

Urgent Care Centre, have been approved,<br />

<strong>and</strong> building work on the first phase of the<br />

project (due to be completed in 18 months)<br />

has already commenced. This year we have<br />

also been successful with a Department<br />

of Health capital funding bid for a large<br />

maternity refurbishment, the second highest<br />

amount awarded by the <strong>NHS</strong> in London,<br />

which will improve the birthing environment<br />

for women <strong>and</strong> their partners. We have<br />

also secured <strong>NHS</strong> centrally funded money<br />

for dementia which will provide a better<br />

environment for patients with this condition<br />

during their hospital stay.<br />

steps to a seven day hospital. This forms one<br />

of our main priorities in the “Look Forward”<br />

section of the report.<br />

This year has also seen the publication of<br />

the Francis <strong>Report</strong> which highlights the<br />

failings of a hospital where quality was not<br />

the first priority <strong>and</strong> which did not listen<br />

to its patients or frontline staff. Our care<br />

priorities, which form one part of a range<br />

of measures of patient care, will continue to<br />

be refined <strong>and</strong> extended in the coming year.<br />

Along with using Communication, Attitude,<br />

Responsibility, Equity, Safety (CARES) as<br />

our values we will develop a framework<br />

for providing compassionate care, as well<br />

as monitoring the improvements made in<br />

delivering patient care.<br />

I hope you find this report well presented,<br />

<strong>and</strong> that it gives you useful information<br />

about the <strong>Trust</strong>. I would be very interested<br />

in your views on the style or content of the<br />

report. If you wish to comment please write<br />

to me via the e-mail address below.<br />

Yours sincerely<br />

Shane Degaris<br />

Chief Executive<br />

shane.degaris@thh.nhs.uk<br />

I confirm that to the best of my knowledge<br />

the information in this document is accurate.<br />

This year has seen the publication of<br />

a London-wide set of emergency care<br />

st<strong>and</strong>ards which include more senior decision<br />

making on a seven day a week basis to<br />

reduce weekend mortality <strong>and</strong> take the first<br />

Quality report<br />

61


INTRODUCTION<br />

This Quality <strong>Report</strong>, which looks back at our<br />

achievements in <strong>2012</strong>/<strong>13</strong> <strong>and</strong> summarises our<br />

key quality objectives for the coming year,<br />

will be available on the <strong>NHS</strong> Choices website<br />

<strong>and</strong> our own website – (www.thh.nhs.uk).<br />

Each of the priorities is aligned to the<br />

three domains of quality – safety, clinical<br />

effectiveness <strong>and</strong> patient experience.<br />

they were treated with dignity <strong>and</strong> respect,<br />

or whether they found it easy to access the<br />

service.<br />

What is CQUIN?<br />

CQUIN is a scheme to encourage <strong>NHS</strong> <strong>Trust</strong>s<br />

to improve quality <strong>and</strong> patient safety by<br />

setting targets <strong>and</strong> rewarding achievement<br />

of those targets financially. These targets are<br />

set with local, regional <strong>and</strong> national bodies.<br />

What do we mean when we talk<br />

about patient safety?<br />

“Treating <strong>and</strong> caring for people in a safe<br />

environment <strong>and</strong> protecting them from<br />

avoidable harm”, (National Patient Safety<br />

Agency), for example, ensuring that<br />

medicines are managed safely.<br />

What do we mean when we talk<br />

about clinical effectiveness?<br />

Clinical effectiveness is about whether or not<br />

a patient’s care or treatment was successful.<br />

In other words, did it have the impact that<br />

it was supposed to have? And did it achieve<br />

the best possible result for the patient?<br />

This may include improvement in specific<br />

medical or health conditions, but in the<br />

community we also have a strong focus<br />

on improving quality of life, for example,<br />

independence, mobility, activities of daily<br />

living <strong>and</strong> social participation.<br />

What do we mean when we talk<br />

about patient experience?<br />

Patient experience is about ensuring<br />

patients, relatives <strong>and</strong> carers have as<br />

positive experience as possible at every<br />

stage of the care or treatment that is being<br />

provided. Patient experience refers to the<br />

overall experience throughout the course of<br />

treatment, <strong>and</strong> not just the results that were<br />

achieved at the end.<br />

For example, a patient’s experience could<br />

be strongly influenced by whether they felt<br />

62 Quality report


SUMMARY OF <strong>2012</strong>/20<strong>13</strong><br />

QUALITY REPORT<br />

Looking back at quality<br />

improvement<br />

Our priorities during <strong>2012</strong>/20<strong>13</strong><br />

Priority 1 was the further embedding<br />

of the First Contact Project – Improving<br />

the Outpatient Experience where we<br />

fully achieved two of the four targets;<br />

implementing the Call Management<br />

System (CMS), <strong>and</strong> introducing a document<br />

scanning referral system for all cancer<br />

<strong>and</strong> symptomatic breast referrals. We<br />

partially achieved our plans to centralise<br />

all appointment bookings; the one target<br />

we did not achieve was introducing the<br />

electronic letters from the hospital clinics to<br />

the GP which is currently being piloted in<br />

four specialties.<br />

Priority 2 was about making Changes in<br />

Maternity where we achieved the majority<br />

of our targets (other than breastfeeding);<br />

improving the patient experience by<br />

2% from 86% to 88%; <strong>and</strong> reduced our<br />

caesarean section rates from 30.1% in<br />

2011/<strong>2012</strong> to 26.9% for <strong>2012</strong>/20<strong>13</strong>. Whilst<br />

breast feeding figures have increased to<br />

82.9%, we did not quite meet the target of<br />

85%. We have recruited women from ethnic<br />

minorities to work in clinical <strong>and</strong> non-clinical<br />

public facing roles. We have refurbished<br />

public areas which included a new layout in<br />

maternity triage <strong>and</strong> we were successful in<br />

securing significant funds to modernise the<br />

ten delivery rooms, where work is due to<br />

commence in June 20<strong>13</strong>.<br />

Priority 3 was Care Priorities where we<br />

achieved the target of 90% at year end for<br />

patients having the correct identification<br />

b<strong>and</strong>s <strong>and</strong> staff following the correct<br />

process for confirming identification <strong>and</strong><br />

for hydration/fluid balance. We did not<br />

achieve the 90% target for record keeping;<br />

achieving 79% at year end; although there<br />

was a significant increase of 7% between Q3<br />

<strong>and</strong> Q4 result. We are continuing to focus on<br />

improving nursing record keeping across the<br />

<strong>Trust</strong>.<br />

Priority 4 was The Leaving <strong>Hospital</strong><br />

Project where we have achieved some of<br />

the targets to date such as an increased<br />

positive patient experience for when patients<br />

leave hospital; ensuring patients have the<br />

appropriate discharge documentation <strong>and</strong><br />

keeping the Visual Management System<br />

(our colour coded system for where a<br />

patient is on their pathway) up to date.<br />

Several of the other st<strong>and</strong>ards are close to<br />

their target such as receiving a copy of your<br />

patient journey; 90% of patients are going<br />

home with their medication. We narrowly<br />

missed the 80% target for the proportion<br />

of patients being discharged home before<br />

8pm in the evening. We aim to discharge<br />

patients before 6pm wherever possible,<br />

but they may be discharged later where it<br />

is clinically appropriate <strong>and</strong> safe to do so,<br />

taking the patient’s home circumstances into<br />

consideration. Although we did not achieve<br />

the target of 85% of GPs receiving a copy of<br />

the patient’s discharge summary within 24<br />

hours, there has been an improvement from<br />

the 2011/<strong>2012</strong> baseline figure.<br />

Priority 5 was CQUINs (Commissioning<br />

for Quality <strong>and</strong> Innovation). Of the nine<br />

CQUIN schemes for <strong>2012</strong>/20<strong>13</strong> we have fully<br />

achieved four in Q3: preventing blood clots;<br />

collecting the data for the Patient Safety<br />

Thermometer (a local improvement tool<br />

for measuring, monitoring <strong>and</strong> analysing<br />

patient harm <strong>and</strong> ‘harm free’ care which<br />

includes assessment for blood clots, urinary<br />

catheter related infections, falls <strong>and</strong> pressure<br />

ulcers); using the North West London Drug<br />

Formulary <strong>and</strong> improving the care for<br />

patients with the complications of diabetes.<br />

We partially achieved four remaining CQUINs<br />

in Q3: an improvement of the patient<br />

experience; providing real time information<br />

about our patients for GPs; ensuring we have<br />

Consultant assessments within 12 hours of an<br />

Quality report<br />

63


emergency admission <strong>and</strong> achieving all the<br />

milestones for end of life care. We predict<br />

that we will not achieve our target for the<br />

dementia screening <strong>and</strong> risk assessment<br />

process for this year. Confirmed figures for<br />

the full year will be available in mid June.<br />

Looking forward at quality<br />

improvement<br />

Our priorities for 20<strong>13</strong>/2014<br />

The following five priorities have been<br />

identified for 20<strong>13</strong>/2014:<br />

1. Continuing with the First Contact<br />

Project which will further embed<br />

the way patients are contacted <strong>and</strong><br />

reminded about their appointments<br />

<strong>and</strong> to further centralise bookings. The<br />

Call Management System needs further<br />

development to ensure we are getting<br />

our messages right for patients. There<br />

will be significant resources allocated to<br />

establish an Electronic Document Record<br />

System which will allow easier clinician<br />

access to full healthcare records <strong>and</strong> to<br />

relevant referral forms, enhancing clinical<br />

decision making.<br />

2. Continuing with the Leaving <strong>Hospital</strong><br />

Project to include work with external<br />

experts regarding Improving Inpatient<br />

Care <strong>and</strong> Discharge, to enhance early<br />

assessments for elderly people <strong>and</strong><br />

reduce any unnecessary lengths of stay in<br />

hospital, as well as reducing readmissions.<br />

We will be improving the discharge<br />

process by better co-ordination of teams<br />

<strong>and</strong> working closer together with doctors,<br />

nurses, pharmacists <strong>and</strong> therapists when<br />

reviewing a patient’s needs before they<br />

leave hospital.<br />

on a seven day a week basis to enhance<br />

early senior clinical decision making<br />

<strong>and</strong> eliminate the difference between<br />

weekday <strong>and</strong> weekend mortality.<br />

4. Using CARES as our values. These were<br />

launched in May last year <strong>and</strong> are<br />

supported by a framework that sets out<br />

the st<strong>and</strong>ard in terms of attitude <strong>and</strong><br />

behaviours we expect from our staff.<br />

5. CQUINs (Commissioning for Quality <strong>and</strong><br />

Innovation): we will continue efforts<br />

to prevent blood clots however, we<br />

will be expected to achieve a higher<br />

percentage of patient assessment.<br />

The patient experience CQUIN will be<br />

based on the new “Friends <strong>and</strong> Family<br />

Test”. The dementia risk assessment will<br />

be continued <strong>and</strong> the Patient Safety<br />

Thermometer will be based on reductions<br />

in pressure sores <strong>and</strong> not just on data<br />

submission. Regional CQUINs are not<br />

confirmed but may include supporting<br />

care outside hospital, 12 hour consultant<br />

assessment <strong>and</strong> GP direct access to<br />

diagnostics <strong>and</strong> pathology. Local CQUINs<br />

may include the colorectal cancer<br />

pathway <strong>and</strong> improved communication<br />

between GPs <strong>and</strong> consultants for effective<br />

patient management.<br />

Our priorities will be monitored by the<br />

individual teams, through their Divisional<br />

Reviews <strong>and</strong> quarterly through reports to the<br />

Board or Board Committee <strong>and</strong> the results<br />

will be reported in the 20<strong>13</strong>/2014 <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>.<br />

3. Improving Emergency Care taking into<br />

account the Acute Emergency Care<br />

St<strong>and</strong>ards that have been set across<br />

London <strong>and</strong> an analysis of the <strong>Hospital</strong><br />

St<strong>and</strong>ardised Mortality Ratio (HSMR).<br />

There will be a focus on early consultant<br />

review of patients requiring admission<br />

64 Quality report


LOOKING BACK…<br />

This section starts by looking at key measurements in a dashboard format. These are derived<br />

from some m<strong>and</strong>atory requirements, our consultation with our stakeholders, <strong>and</strong> those of<br />

national importance that patients will want to know about.<br />

Dashboard of key quality measures<br />

Achieved target<br />

Narrowly Missing target<br />

Significantly missing target<br />

Latest data<br />

available to<br />

benchmark<br />

Domain:<br />

Patient Safety (PS)/<br />

Clinical<br />

Effectiveness (CE)/<br />

Patient<br />

Experience (PE)<br />

2011/12<br />

Performance<br />

<strong>2012</strong>/<strong>13</strong><br />

Target<br />

<strong>2012</strong>/<strong>13</strong><br />

Performance<br />

How<br />

London<br />

<strong>Trust</strong>s<br />

Perform<br />

National<br />

Performance<br />

1a: In <strong>Hospital</strong><br />

St<strong>and</strong>ardised<br />

Mortality Ratio<br />

(HSMR)<br />

1b: St<strong>and</strong>ardised<br />

<strong>Hospital</strong><br />

Mortality Index<br />

(SHMI)<br />

1c: the<br />

percentage of<br />

patient deaths<br />

with palliative<br />

care coded at<br />

diagnosis<br />

2a:<br />

Readmissions to<br />

hospital within<br />

28 days<br />

2b: Emergency<br />

readmissions<br />

to hospital<br />

within 28 days<br />

of discharge<br />

from hospital:<br />

0-15 years<br />

(St<strong>and</strong>ardised)<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[Dr Foster]<br />

Jul-2011 to<br />

Jun-<strong>2012</strong><br />

[Dr Foster]<br />

Jul-2011 to<br />

Jun-<strong>2012</strong><br />

[Dr Foster]<br />

Apr-<strong>2012</strong> to<br />

Sep-<strong>2012</strong><br />

[Dr Foster]<br />

Apr-2011 to<br />

Mar-<strong>2012</strong><br />

[HSCIC<br />

Indicator<br />

Portal]<br />

(Local)<br />

PS<br />

PS<br />

PS<br />

CE/PS<br />

107.2<br />

(99.2 - 115.6)<br />

0.8878<br />

(As Expected)<br />

n/a<br />

104.2<br />

(101 - 107.4)<br />


Latest data<br />

available to<br />

benchmark<br />

Domain:<br />

Patient Safety (PS)/<br />

Clinical<br />

Effectiveness (CE)/<br />

Patient<br />

Experience (PE)<br />

2011/12<br />

Performance<br />

<strong>2012</strong>/<strong>13</strong><br />

Target<br />

<strong>2012</strong>/<strong>13</strong><br />

Performance<br />

How<br />

London<br />

<strong>Trust</strong>s<br />

Perform<br />

National<br />

Performance<br />

2c: Emergency<br />

readmissions<br />

to hospital<br />

within 28 days<br />

of discharge<br />

from hospital:<br />

16+ years<br />

(St<strong>and</strong>ardised)<br />

Apr-2011 to<br />

Mar-<strong>2012</strong><br />

[HSCIC<br />

Indicator<br />

Portal]<br />

(Local)<br />

CE/PS 12.09% n/a<br />

[11.86%*]<br />

(7.5%)<br />

[11.95%]<br />

(n/a)<br />

[11.42%]<br />

(n/a)<br />

3: Non clinically<br />

justified<br />

single sex<br />

accommodation<br />

breach, rate per<br />

1,000 finished<br />

consultant<br />

episodes<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

PE 0.11 0 0.06* 0.73 0.21<br />

4: Cancer: Two<br />

week wait from<br />

GP referral<br />

to seeing<br />

a specialist<br />

(suspected<br />

cancer)/(breast<br />

symptoms)<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[OpenExeter/<br />

DH]<br />

CE/PS<br />

Suspected:<br />

98.3%<br />

Breast<br />

Symptom:<br />

96.4%<br />

93%<br />

93%<br />

97.9%”<br />

98.0%”<br />

95.3%<br />

95.1%<br />

95.5%<br />

95.4%<br />

5: Cancer: 31<br />

day maximum<br />

wait from<br />

diagnosis to first<br />

treatment<br />

6: Cancer: 31<br />

day maximum<br />

wait from<br />

diagnosis to<br />

subsequent<br />

treatment, drug<br />

or surgery<br />

7: Cancer: 62-<br />

day maximum<br />

wait from<br />

referral by<br />

GP/screening<br />

service/<br />

consultant<br />

upgrade to<br />

treatment<br />

8: Referral<br />

to treatment<br />

waiting times -<br />

admitted<br />

9: Referral<br />

to treatment<br />

waiting times -<br />

non admitted<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[OpenExeter/<br />

DH]<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[OpenExeter/<br />

DH]<br />

Apr-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[OpenExeter/<br />

DH]<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

CE/PS 97.9% 96% 99.2%” 98.1% 98.4%<br />

CE/PS<br />

CE/PS<br />

Drug: 100.0%<br />

Surgery:<br />

100.0%<br />

GP/GDP:<br />

92.6%<br />

Screening:<br />

68.6%<br />

Upgrade:<br />

98.3%<br />

98%<br />

94%<br />

85%<br />

90%<br />

85%<br />

100.0%”<br />

100.0%”<br />

93.3%”<br />

93.9%”<br />

98.6%”<br />

99.6%<br />

97.2%<br />

86.1%<br />

92.1%<br />

94.2%<br />

99.7%<br />

97.4%<br />

87.5%<br />

95.1%<br />

93.4%<br />

CE/PS 95.9% 90% 96.7%^ 92.4% 93.1%<br />

CE/PS 98.9% 95% 98.6%^ 97.9% 97.7%<br />

66 Quality report


Latest data<br />

available to<br />

benchmark<br />

Domain:<br />

Patient Safety (PS)/<br />

Clinical<br />

Effectiveness (CE)/<br />

Patient<br />

Experience (PE)<br />

2011/12<br />

Performance<br />

<strong>2012</strong>/<strong>13</strong><br />

Target<br />

<strong>2012</strong>/<strong>13</strong><br />

Performance<br />

How<br />

London<br />

<strong>Trust</strong>s<br />

Perform<br />

National<br />

Performance<br />

10: Referral<br />

to treatment<br />

waiting times -<br />

Incomplete1<br />

11: Fractured<br />

neck of femur<br />

emergency<br />

patients in<br />

theatre within<br />

36 hours<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

Apr-2011 to<br />

Mar <strong>2012</strong><br />

NHF Database<br />

CE/PS 96.9% 92% 97.6%^ 93.4% 94.5%<br />

CE/PS 79.1% 90% 90.8% n/a n/a<br />

12: Total time<br />

in A&E: 4 hours<br />

or less<br />

Apr-<strong>2012</strong> to<br />

Jan-20<strong>13</strong><br />

[Unify2/DH]<br />

PE 97.9% 95% 96.7% 96.4% 96.2%<br />

<strong>13</strong>: Percentage<br />

of patients<br />

not treated<br />

within 28 days<br />

of having<br />

operation<br />

cancelled for<br />

non-clinical<br />

reasons<br />

14: Percentage<br />

of women in<br />

the relevant<br />

PCT population<br />

who have seen<br />

a midwife or<br />

a maternity<br />

healthcare<br />

professional,<br />

for health <strong>and</strong><br />

social care<br />

assessment of<br />

needs, risks<br />

<strong>and</strong> choices<br />

by 12 weeks<br />

<strong>and</strong> 6 days of<br />

pregnancy<br />

15: Stroke<br />

patients:<br />

Percentage of<br />

patients that<br />

have spent at<br />

least 90% of<br />

their time on<br />

the stroke unit<br />

16: Stroke<br />

patients:<br />

Percentage of<br />

high risk TIA/<br />

mini stroke<br />

patients who<br />

are treated<br />

within 24 hours<br />

Apr-Dec <strong>2012</strong><br />

[Unify2/DH]<br />

Apr-Dec <strong>2012</strong><br />

[Unify2/DH]<br />

Oct-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

Oct-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

CE/PS 3.4% 0% 6.0% 2.8% 4.6%<br />

PE/CE 90.2% 90%<br />

93.3%<br />

(Excluding<br />

Late Referrals)<br />

80.4% 86.9%<br />

CE 99% 80% 99.6% 93.8% 85.0%<br />

CE 100% 75% 100% 84.6% 75.9%<br />

Quality report<br />

67


17: MRSA<br />

18: Cdiff cases<br />

reported<br />

within the<br />

<strong>Trust</strong> amongst<br />

patients aged 2<br />

<strong>and</strong> over during<br />

the reporting<br />

period<br />

19: Percentage<br />

of patients who<br />

were admitted<br />

to hospital<br />

<strong>and</strong> who were<br />

risk assessed<br />

for Venous<br />

Thrombo<br />

Embolism (VTE)<br />

20a: Patient<br />

<strong>Report</strong>ed<br />

Outcome<br />

Measures<br />

(PROMs) scores<br />

(Health Gain),<br />

Groin Hernia,<br />

EQ-5D Index/<br />

VAS<br />

20b: PROMS<br />

(Health<br />

Gain), Hip<br />

Replacement,<br />

EQ-5D Index/<br />

VAS<br />

20c: PROMS<br />

(Health<br />

Gain), Knee<br />

Replacement,<br />

EQ-5D Index/<br />

VAS<br />

Latest data<br />

available to<br />

benchmark<br />

Apr-2011 to<br />

Mar-<strong>2012</strong><br />

[HPA]<br />

Apr-2011 to<br />

Mar-<strong>2012</strong><br />

[HPA]<br />

Oct-<strong>2012</strong> to<br />

Dec-<strong>2012</strong><br />

[Unify2/DH]<br />

Apr-<strong>2012</strong> to<br />

Sep-<strong>2012</strong><br />

[HES]<br />

Apr-<strong>2012</strong> to<br />

Sep-<strong>2012</strong><br />

[HES]<br />

Apr-<strong>2012</strong> to<br />

Sep-<strong>2012</strong><br />

[HES]<br />

Domain:<br />

Patient Safety (PS)/<br />

Clinical<br />

Effectiveness (CE)/<br />

Patient<br />

Experience (PE)<br />

PS<br />

PS<br />

2011/12<br />

Performance<br />

4 Cases<br />

2.9 Cases per<br />

100,000 bed<br />

days<br />

25 Cases<br />

19.3 Cases per<br />

100,000 bed<br />

days<br />

<strong>2012</strong>/<strong>13</strong><br />

Target<br />

3<br />

24<br />

<strong>2012</strong>/<strong>13</strong><br />

Performance<br />

1 Case<br />

0.77 Cases per<br />

100,000 bed<br />

days<br />

23<br />

16.2 Cases per<br />

100,000 bed<br />

days<br />

How<br />

London<br />

<strong>Trust</strong>s<br />

Perform<br />

114 Cases<br />

2.0 Cases<br />

per<br />

100,000<br />

bed days<br />

1,154<br />

21.1<br />

Cases per<br />

100,000<br />

bed days<br />

PS 87.5% 90% 91.9%+ 93.10%<br />

CE/PS n/a n/a 0.123 / 0.667* n/a<br />

CE/PS n/a n/a 0.4 / 12.105* n/a<br />

National<br />

Performance<br />

471 Cases<br />

1.3 Cases per<br />

100,000 bed<br />

days<br />

7,670<br />

21.8 Cases per<br />

100,000 bed<br />

days<br />

Lowest<br />

Performing<br />

82 Cases,<br />

51.6 Cases<br />

per 100,000<br />

bed days<br />

(Tameside FT)<br />

Highest<br />

Performing<br />

0 Cases<br />

(Birmingham<br />

Women’s)<br />

94.1%<br />

Lowest<br />

Performing<br />

84.6%<br />

(Croydon<br />

Health<br />

Services <strong>NHS</strong><br />

<strong>Trust</strong>)<br />

Highest<br />

Perfoming<br />

100%<br />

(South Essex<br />

Partnership<br />

University FT)<br />

0.091 / -0.603<br />

(i)<br />

0.437 / 10.863<br />

(ii)<br />

CE/PS n/a n/a 0.262 / 18.2* n/a 0.312 / 5 (iii)<br />

21: Inpatient<br />

Experience<br />

Programme<br />

(local survey<br />

results)<br />

88% YTD<br />

[Local Survey]<br />

68 Quality report<br />

PE 87% >87% 88% n/a n/a


Latest data<br />

available to<br />

benchmark<br />

Domain:<br />

Patient Safety (PS)/<br />

Clinical<br />

Effectiveness (CE)/<br />

Patient<br />

Experience (PE)<br />

2011/12<br />

Performance<br />

<strong>2012</strong>/<strong>13</strong><br />

Target<br />

<strong>2012</strong>/<strong>13</strong><br />

Performance<br />

How<br />

London<br />

<strong>Trust</strong>s<br />

Perform<br />

National<br />

Performance<br />

22: Outpatient<br />

Experience<br />

Programme<br />

(local survey<br />

results)<br />

87% YTD<br />

[Local Survey]<br />

PE 86% >86% 87% n/a n/a<br />

23: Maternity<br />

Experience<br />

Programme<br />

(local survey<br />

results)<br />

86%YTD<br />

[Local Survey]<br />

PE 85% >85% 86% n/a n/a<br />

24: Independent<br />

assessment of<br />

cleanliness of<br />

hospital<br />

88% YTD PE 92% >87% 87% n/a n/a<br />

25: Percentage<br />

of complaints<br />

responded to<br />

within agreed<br />

timescale<br />

n/a PE 84% 90% 74.5% n/a n/a<br />

26: <strong>Trust</strong>’s<br />

responsiveness<br />

to personal<br />

needs of our<br />

patients<br />

27: Percentage<br />

of staff<br />

who would<br />

recommend<br />

the <strong>Trust</strong> as a<br />

provider of care<br />

to their family<br />

<strong>and</strong> friends<br />

28: Patient<br />

safety incidents/<br />

percentage<br />

resulted in<br />

severe harm or<br />

death<br />

Apr <strong>2012</strong> to<br />

March 20<strong>13</strong><br />

[National<br />

Patient<br />

Survey]<br />

<strong>2012</strong> Survey<br />

[National<br />

Staff Survey]<br />

Apr <strong>2012</strong> to<br />

March 20<strong>13</strong><br />

[Datix]<br />

PE 62.9% 72% 65% n/a 67.4%<br />

PE 3.53 n/a 3.66 3.70<br />

PS 1% (45)NRLS n/a<br />

0.75% (41)<br />

(0.75 per 100<br />

admissions)<br />

3.57 average<br />

Lowest<br />

Performing<br />

2.90 (North<br />

Cumbria<br />

University<br />

<strong>Hospital</strong>)<br />

Highest<br />

Performing<br />

4.08 (Guy’s &<br />

St Thomas’)<br />

1.3 0.9<br />

Notes: <strong>2012</strong>/20<strong>13</strong> Performance is for Apr-<strong>2012</strong> to Mar-20<strong>13</strong> unless:<br />

* Same as Benchmark Period<br />

+ Apr -<strong>2012</strong> to Jan-20<strong>13</strong><br />

“ Apr-<strong>2012</strong> to Feb-20<strong>13</strong><br />

^ Mar-20<strong>13</strong><br />

Quality report<br />

69


(i) Groin<br />

Lowest<br />

performing<br />

Warrington And<br />

Halton <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong><br />

(-0.062)<br />

EQ-5D Index<br />

Highest<br />

performing<br />

University <strong>Hospital</strong>s<br />

Bristol <strong>NHS</strong><br />

Foundation <strong>Trust</strong><br />

(0.227)<br />

Lowest<br />

performing<br />

The Whittington<br />

<strong>Hospital</strong> <strong>NHS</strong> <strong>Trust</strong><br />

(-10.667)<br />

EQ-5D VAS<br />

Highest<br />

performing<br />

Guy’s And St<br />

Thomas’ <strong>NHS</strong><br />

Foundation <strong>Trust</strong><br />

(11.4)<br />

(ii) Hip<br />

Replacement<br />

Yeovil District <strong>Hospital</strong><br />

<strong>NHS</strong> Foundation <strong>Trust</strong><br />

(0.155)<br />

The Queen Elizabeth<br />

<strong>Hospital</strong>, King’s Lynn,<br />

<strong>NHS</strong> Foundation <strong>Trust</strong><br />

(0.69)<br />

Brighton And<br />

Sussex University<br />

<strong>Hospital</strong>s <strong>NHS</strong> <strong>Trust</strong><br />

(-10.571)<br />

Barts And The<br />

London <strong>NHS</strong> <strong>Trust</strong><br />

(30.6)<br />

(iii) Knee<br />

Replacement<br />

Royal National<br />

Orthopaedic <strong>Hospital</strong><br />

<strong>NHS</strong> <strong>Trust</strong> (0.031)<br />

Mid Cheshire <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong><br />

(0.527)<br />

Imperial College<br />

Healthcare <strong>NHS</strong><br />

<strong>Trust</strong> (-10.667)<br />

Barnsley <strong>Hospital</strong><br />

<strong>NHS</strong> Foundation<br />

<strong>Trust</strong> (24.842)<br />

Supporting information about the<br />

indicators required in accordance with<br />

the Quality Account regulations<br />

Indicator 1b<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this data is as described<br />

for the following reasons - national reporting<br />

shows a stable ratio over the past two years.<br />

The <strong>Trust</strong> is working on improving the<br />

variation between weekdays <strong>and</strong> weekends<br />

<strong>and</strong> will examine any outliers.<br />

Indicator 1c<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this data is as described<br />

for the following reasons – not all patients<br />

who are receiving palliative care are<br />

on the Liverpool Care Pathway. Clearer<br />

identification of these patients will improve<br />

the palliative care coding.<br />

Indicator 2a, 2b <strong>and</strong> 2c<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that these percentages are<br />

as described for the following reasons – the<br />

<strong>Trust</strong> is aware from a variety of data sources<br />

that the figures are higher than expected.<br />

Several initiatives to improve these figures<br />

include strengthening our care pathways <strong>and</strong><br />

the Improving Inpatient Care initiative. Refer<br />

to priority 2 for 20<strong>13</strong>/2014 on page 78.<br />

Indicator 18<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this rate is described for<br />

the following reasons – the <strong>Trust</strong> achieved a<br />

target of 23 out of 24 for <strong>2012</strong>/20<strong>13</strong> <strong>and</strong> has<br />

shown a year on year improvement. The <strong>Trust</strong><br />

will continue with all current initiatives. The<br />

<strong>Trust</strong> hosted a multidisciplinary workshop in<br />

May chaired by a national expert in infection<br />

control which will inform our measures to<br />

improve our targets for 20<strong>13</strong>/2014 of 14 for C<br />

Diff <strong>and</strong> 0 for MRSA.<br />

Indicator 19<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this percentage is as<br />

described for the following reasons – the<br />

<strong>Trust</strong> has shown an improvement over the<br />

last two years. This is a CQUIN for 20<strong>13</strong>/14<br />

<strong>and</strong> work will be taken forward to bring<br />

about further improvement.<br />

Indicator 20a, 20b <strong>and</strong> 20c<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that the outcome scores are<br />

as described for the following reasons – Data<br />

shows that the five domains that this score<br />

refers to are hospital outcome measures (EQ<br />

– 5D index VAS). The <strong>Trust</strong> performs better<br />

70 Quality report


than average for hernias, but worse than<br />

average for hip <strong>and</strong> knee replacements, <strong>and</strong><br />

better than average for all three procedures<br />

from the patient’s perspective (EQ -5 index<br />

VAS).<br />

Indicator 26<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this data is as described<br />

for the following reasons – there has been<br />

a slow improvement but still below target.<br />

Further work is being undertaken to improve<br />

the situation through our customer care<br />

programme, our CARES values initiative <strong>and</strong><br />

the Improving Inpatient Care initiative.<br />

Indicator 27<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this data is as described<br />

for the following reasons – there has been<br />

a steady improvement but further work is<br />

being undertaken through our CARES values<br />

initiative.<br />

Indicator 28<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> considers that this data is as described<br />

for the following reasons - whilst the <strong>Trust</strong><br />

has a lower than average rate of severe<br />

harm / death patient safety incidents, there<br />

is not a nationally established <strong>and</strong> regulated<br />

approach to reporting <strong>and</strong> categorising<br />

patient safety incidents. The approach<br />

taken to determine the classification of each<br />

incident, such as those ‘resulting in severe<br />

harm or death’, will often rely on clinical<br />

judgement. In addition, the classification of<br />

the impact of an incident may be subject to a<br />

potentially lengthy investigation which may<br />

result in the classification being changed.<br />

This change may not be reported externally<br />

<strong>and</strong> the data held by a <strong>Trust</strong> may not be the<br />

same as that held by the NRLS.<br />

Definitions of the two m<strong>and</strong>ated<br />

indicators<br />

Indicator 7<br />

Percentage of patients receiving first<br />

definitive treatment for cancer within 62<br />

days of an urgent GP referral for suspected<br />

cancer.<br />

Indicator 2a<br />

Percentage of emergency admissions to any<br />

hospital in Engl<strong>and</strong> within 28 days of the last<br />

previous discharge from hospital.<br />

Priority 1: The First Contact Project –<br />

improving the outpatient experience<br />

We said:<br />

We would centralise all outpatient<br />

appointment bookings to ensure that calls<br />

are answered more quickly; provide more<br />

telephone lines; patients won’t have to wait<br />

so long to be attended to; the system would<br />

also have an interactive element where<br />

patients will receive a phone call <strong>and</strong> text as<br />

a reminder of their appointment.<br />

We also said we would introduce a document<br />

scanning referral system <strong>and</strong> introduce the<br />

electronic transfer of outpatient clinic letters<br />

from the hospital clinicians to the GP.<br />

The changes would be measured for<br />

impact by reviewing the data from the Call<br />

Management System (CMS) detailing the<br />

average call waiting time <strong>and</strong> ab<strong>and</strong>onment<br />

rate, appointment non-attendance (DNA)<br />

rate <strong>and</strong> the number of complaints.<br />

Quality report<br />

71


We did:<br />

a PARTIALLY ACHIEVED<br />

Booking centralisation<br />

During <strong>2012</strong> staff that make new <strong>and</strong> follow<br />

up appointments have been centralised to<br />

one location. We recognise that this is the<br />

first step towards centralising all bookings<br />

<strong>and</strong> that further work to train staff <strong>and</strong><br />

equip them with the skills to deal with<br />

queries about any outpatient appointment<br />

related query is necessary.<br />

a ACHIEVED<br />

Call Management System (CMS)<br />

The CMS was implemented in June <strong>2012</strong> with<br />

an appointment reminder function going live<br />

in August <strong>2012</strong>.<br />

The CMS has changed the way The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong> deals with telephone<br />

calls from patients about their outpatient<br />

appointments. Now patients are given one<br />

telephone number, they then choose from a<br />

list of options which ensures their call is dealt<br />

with by the correct member of staff (agent).<br />

If all agents are busy the patient is held in<br />

a queue <strong>and</strong> informed that their call will be<br />

answered.<br />

The system provides staff with comprehensive<br />

reports <strong>and</strong> real time information about call<br />

activity, response times, ab<strong>and</strong>onment rates<br />

<strong>and</strong> call resolution. Managers are able to<br />

adjust resources to meet the volume of calls.<br />

There has also been a reduction in Patient<br />

Advice <strong>and</strong> Liaison Services (PALs) concerns<br />

<strong>and</strong> complaints from 129 in 2011/<strong>2012</strong> to 77<br />

in <strong>2012</strong>/20<strong>13</strong>.<br />

The CMS has an optional appointment<br />

reminder functionality (called Remind+)<br />

which contacts patients by telephone seven<br />

days before their appointment to confirm<br />

their attendance. This is then further<br />

supplemented with a text messaging service<br />

which sends a reminder to a mobile number<br />

48 hrs before the appointment.<br />

a ACHIEVED<br />

Introduce a document scanning referral<br />

system<br />

Document scanning has been implemented<br />

for all cancer <strong>and</strong> symptomatic breast<br />

referrals. The new process allows outpatient<br />

appointment centre staff, Multi Disciplinary<br />

Team (MDT) coordinators <strong>and</strong> Health<br />

Care Assistants (HCAs) in outpatients to<br />

access the documents electronically which<br />

eliminates the risk of paper letters getting<br />

lost <strong>and</strong> subsequent delays. GPs are also<br />

increasingly making referrals <strong>and</strong> outpatient<br />

appointments via an electronic system called<br />

Choose <strong>and</strong> Book.<br />

r NOT ACHIEVED<br />

Electronic outpatient letters to GPs<br />

From January 20<strong>13</strong> the <strong>Trust</strong> is piloting the<br />

electronic delivery of outpatient letters to<br />

GPs in <strong>Hillingdon</strong> in the following specialities:<br />

Care of the Elderly, Stroke, Paediatrics <strong>and</strong><br />

breast surgery.<br />

There is much more to do particularly in<br />

relation to the centralisation of booking<br />

appointments <strong>and</strong> implementation of<br />

the electronic document <strong>and</strong> records<br />

management.<br />

Priority 2: Maternity<br />

We said:<br />

As part of our ongoing maternity strategy<br />

for improving quality of care we said that<br />

we would like to see an improvement in our<br />

patient experience survey by at least 1%<br />

<strong>and</strong> respond to shortfalls identified by both<br />

staff <strong>and</strong> comments made within the patient<br />

survey. We look forward to the rich source of<br />

information from the patient diary exercise,<br />

which commenced in November <strong>2012</strong>. As a<br />

response to a survey undertaken by the Local<br />

Involvement Network (LINk) survey we have<br />

engaged more with hard to reach groups<br />

including Somali <strong>and</strong> Afghan support groups.<br />

We also said we would improve the Labour<br />

72 Quality report


Ward environment; reduce caesarean section<br />

rates to 27.6% <strong>and</strong> increase breastfeeding<br />

rates.<br />

We also aimed to increase the number of<br />

non-obstetric deliveries – including an aim to<br />

increase the number of women having their<br />

babies at home.<br />

We also said that we would reconfigure<br />

our community services to improve the<br />

experience.<br />

We did:<br />

a ACHIEVED<br />

Patient experience in maternity is improving.<br />

The patient experience rate is 86% <strong>and</strong> by<br />

Q4 the figure is 88%; an increase so far this<br />

year of 2%. We continue to monitor this on a<br />

monthly basis.<br />

a ACHIEVED<br />

We have now managed to recruit women<br />

from a variety of cultural backgrounds<br />

(representative of the population we<br />

serve) to work in the reception area of the<br />

Maternity main foyer <strong>and</strong> Maternity helpers<br />

(now called maternity mates) on the wards,<br />

depending on language.<br />

Some of these women have a National<br />

Vocational Qualification (NVQ) in health <strong>and</strong><br />

social care <strong>and</strong> are looking to continue their<br />

education into nursing <strong>and</strong> midwifery.<br />

In June we will be meeting with women<br />

from the Afghan community to identify any<br />

specific needs to improve their experience<br />

of our service <strong>and</strong> staff. Key learning points<br />

identified from these informative meetings<br />

are shared with staff through relevant<br />

forums <strong>and</strong> training sessions.<br />

a ACHIEVED<br />

General refurbishment of the maternity unit,<br />

such as painting the stairwell <strong>and</strong> public<br />

areas, <strong>and</strong> the layout of the maternity triage<br />

area have been completed.<br />

The “Improving Birth Environments” bid,<br />

a Department of Health funding project<br />

to improve the physical environment of<br />

Maternity units in Engl<strong>and</strong>, has been<br />

successful <strong>and</strong> will allow us to modernise 10<br />

delivery rooms which will include en-suite<br />

facilities in each room <strong>and</strong> restructure the<br />

Labour Ward reception area. This work is due<br />

to commence in June 20<strong>13</strong>.<br />

a ACHIEVED<br />

The current year to date figure for caesarean<br />

sections is 26.9% for the year compared<br />

with the 2011/<strong>2012</strong> full year figure of 30.1%<br />

showing an improvement to date from last<br />

year.<br />

The multifaceted action plan for caesarean<br />

reduction continues to be monitored <strong>and</strong><br />

implemented to drive forward appropriate<br />

<strong>and</strong> safe changes in practice to allow for<br />

reduction in the overall rates of caesarean<br />

section, both elective <strong>and</strong> emergency.<br />

A three month trial of mixing ante <strong>and</strong><br />

postnatal women on both maternity wards<br />

is currently underway to increase Consultant<br />

presence to each area, to enable more<br />

confident decision making with junior staff.<br />

This will shortly end <strong>and</strong> be audited to<br />

review its impact on care provision.<br />

r NOT ACHIEVED<br />

Breastfeeding initiation rates are improving;<br />

the year to date figure is 82.9% for the<br />

year compared to 81.6% for last year,<br />

however, we did not reach our target of<br />

85%. Breastfeeding initiation stickers have<br />

helped to highlight information sharing <strong>and</strong><br />

training. There is still work to be done on<br />

improving these figures.<br />

With the appointment of a Breastfeeding<br />

Health Visitor, working with public health,<br />

we hope that the restructuring of our<br />

community services will strengthen the joint<br />

education <strong>and</strong> training of all staff with a<br />

view to improving rates further.<br />

Quality report<br />

73


Priority 3: Care priorities<br />

We said we would:<br />

• Ensure every patient is wearing a correctly<br />

labelled identib<strong>and</strong><br />

• Improve record keeping<br />

• Improve hydration <strong>and</strong> fluid balance of<br />

our patients during their stay in hospital.<br />

We did:<br />

a PARTIALLY ACHIEVED<br />

Care priority<br />

Patient<br />

identification<br />

Target<br />

<strong>2012</strong>/20<strong>13</strong><br />

90% 91%<br />

Record keeping 90% 79%<br />

Hydration/ fluid<br />

balance<br />

90% 90%<br />

Result<br />

<strong>2012</strong>/20<strong>13</strong><br />

part of this monthly assessment across all<br />

inpatient wards.<br />

• Matrons <strong>and</strong>/or senior sisters reviewed the<br />

nursing record of all patients on the ward<br />

as part of the monthly Patient Safety<br />

Thermometer survey. This provided an<br />

opportunity for immediate feedback to<br />

staff with clarification of the st<strong>and</strong>ard of<br />

record keeping required.<br />

Priority 4: Leaving hospital –<br />

improving the patient experience<br />

We said we would:<br />

Work to improve the information patients<br />

are given when they leave hospital to<br />

include the purpose <strong>and</strong> side effects of any<br />

medication that they will be taking when<br />

they get home <strong>and</strong> who to contact if they are<br />

worried after leaving hospital.<br />

We have achieved the target of 90% in two<br />

of our care priorities, patient identification<br />

<strong>and</strong> hydration/fluid balance. Record<br />

keeping is short of the target, achieving<br />

79% at year end. We did see a significant<br />

improvement of 8% between Q3 <strong>and</strong> Q4<br />

<strong>and</strong> we will continue to focus our attention<br />

on record keeping throughout 20<strong>13</strong>/2014<br />

to achieve our 90% target even though it is<br />

not included as a priority in the 20<strong>13</strong>/2014<br />

Quality Account. A number of initiatives to<br />

support improved record keeping were put<br />

into place in <strong>2012</strong>/20<strong>13</strong>, these include:<br />

• A Nursing Documentation Working<br />

Group has been set up. This group is<br />

made up of frontline staff <strong>and</strong> has been<br />

working to develop core care plans <strong>and</strong> to<br />

st<strong>and</strong>ardise some of the many charts that<br />

are used across the <strong>Trust</strong>.<br />

• The group will also be developing chart<br />

specific guidance to support accurate <strong>and</strong><br />

effective record keeping.<br />

• A new approach to the regular assessment<br />

<strong>and</strong> assurance of the quality of nursing<br />

care was developed. Peer review of the<br />

nursing documentation is an integral<br />

We did:<br />

St<strong>and</strong>ard<br />

Patient’s experience<br />

of leaving hospital is<br />

positive<br />

Patient receive<br />

a copy of ‘Your<br />

<strong>Hospital</strong> Journey’<br />

Discharge<br />

documentation is<br />

completed as per<br />

policy<br />

Patients underst<strong>and</strong><br />

where they are on<br />

their care pathway<br />

The Visual<br />

Management<br />

System (VMS) is kept<br />

updated<br />

Patient goes<br />

home with their<br />

medication<br />

GP receives copy of<br />

discharge summary<br />

within 24 hrs<br />

Patients discharged<br />

in a timely manner:<br />

Before 12pm<br />

Before 4pm<br />

Before 8pm<br />

Target for<br />

<strong>2012</strong>/20<strong>13</strong><br />

Result<br />

<strong>2012</strong>/20<strong>13</strong><br />

72% 82%<br />

100% 93%<br />

80% 93%<br />

90% 88%<br />

90% 95%<br />

90% 89%<br />

85% 73%<br />

25%<br />

60%<br />

80%<br />

15.8%<br />

42.3%<br />

79.5%<br />

74 Quality report


We saw an improvement in the patient<br />

experience of leaving hospital as measured<br />

by our follow up phone call. Additionally,<br />

many patients have commented that the<br />

follow up call is useful to check out any<br />

concerns that they may have. We continue<br />

to revise our processes so going forward<br />

into 20<strong>13</strong>/2014 our revised <strong>and</strong> simplified<br />

discharge checklist will be integrated into a<br />

new electronic tool that supports safe <strong>and</strong><br />

planned discharges.<br />

Key learning from this project such as the<br />

use of the coloured magnets to display key<br />

steps in the discharge process have now been<br />

incorporated into the electronic whiteboard.<br />

This is part of the Improving Inpatient Care<br />

Project that features in Looking Forward<br />

Priority 2 (see page 78).<br />

Our monthly Observations of Care visits<br />

to wards which began in February include<br />

asking patients key questions about their<br />

underst<strong>and</strong>ing of their care, current<br />

treatment <strong>and</strong> ongoing plans towards<br />

discharge.<br />

We are now looking at integrating<br />

information about who to contact if worried<br />

following discharge with an existing patient<br />

information leaflet.<br />

Quality report<br />

75


Priority 5: CQUINs – Commissioning for quality & innovation (subject to<br />

confirmation)<br />

Looking back:<br />

CQUIN targets for <strong>2012</strong>/20<strong>13</strong><br />

National<br />

Preventing blood clots<br />

Patient experience (patient survey)<br />

Dementia risk assessment (scoring tool to identify clinical risks)<br />

Collection of data for the Patient Safety Thermometer (see page 63<br />

for definition)<br />

Regional schemes<br />

Real time GP information (information for GPs about admission<br />

treatment <strong>and</strong> discharge of patients)<br />

Use of the North West London Formulary (a list of all medicines<br />

that are agreed for use across North West London between hospital<br />

<strong>and</strong> primary care services)<br />

Local schemes<br />

Consultant Assessments within 12 hours of emergency admission<br />

Patients with complications of diabetes<br />

End of life care (a structured pathway to ensure patients receive<br />

high quality patient focused care)<br />

What we did<br />

100% full year result<br />

20% predicted full year result<br />

Not achieved<br />

100% full year result<br />

84% predicted full year result<br />

100% full year result<br />

50% predicted full year result<br />

100% predicted full year result<br />

92% predicted full year result<br />

Exact percentages to be confirmed in mid<br />

June.<br />

Patient experience – The <strong>Trust</strong> achieved<br />

20% of the targets which was a steady<br />

improvement over 2 years.<br />

Dementia risk assessment – This depends<br />

on electronic recording of assessments, the<br />

system required to do this was not available<br />

at the time.<br />

Real time GP information – The IT<br />

system required to achieve this has been<br />

implemented for patients who attend<br />

A&E, <strong>and</strong> patients who are admitted as<br />

an emergency <strong>and</strong> inpatient discharge<br />

summaries. However, an electronic solution<br />

for sending outpatients letters was not<br />

available.<br />

Consultant assessments within 12 hours<br />

of emergency admission – The <strong>Trust</strong> has<br />

successfully achieved 55% of emergency<br />

admitted patients having a consultant<br />

assessment within 12 hours. It will continue<br />

to strive to achieve a higher percentage<br />

during 20<strong>13</strong>/14.<br />

End of life care – The drop in percentage<br />

points is due to a very high level of staff<br />

needing to be trained.<br />

76 Quality report


LOOKING FORWARD…<br />

Our priorities for 20<strong>13</strong>/2014<br />

No. Priority Safety Clinical Patient<br />

effectiveness experience<br />

1<br />

First contact – Continuing to improve the<br />

outpatient experience<br />

ü<br />

ü<br />

2<br />

Continuing with the leaving hospital Project to<br />

include work regarding Improving inpatient care ü ü ü<br />

<strong>and</strong> discharge<br />

3 Emergency care ü ü ü<br />

4 CARES ü<br />

5 CQUINs ü ü ü<br />

In arriving at these priorities, agreed by the<br />

<strong>Trust</strong> Board, we had a systematic process<br />

of stakeholder involvement, as in previous<br />

years. This included our public, in the form<br />

of our People in Partnership (PiP) which<br />

included a series of focus groups, our<br />

Governors, LINKs (which included difficult to<br />

reach groups) <strong>and</strong> our Commissioners. There<br />

was a strong opinion from our stakeholders<br />

that we should continue with projects started<br />

in previous years where further outcomes<br />

needed to be set <strong>and</strong> achieved to fulfil<br />

their potential. Hence the projects relating<br />

to an effective outpatient experience <strong>and</strong><br />

high quality inpatient care with efficient<br />

discharge planning have been retained.<br />

During <strong>2012</strong>/20<strong>13</strong> a review of inpatient care<br />

on one ward showed that the balance of<br />

nurses to healthcare assistants on the ward<br />

was not always at the planned level; multiprofessional<br />

communication was sometimes<br />

fragmented <strong>and</strong> nursing leadership on the<br />

ward needed to improve. We undertook a<br />

number of actions to address these issues<br />

<strong>and</strong> this work continues to inform our<br />

quality priorities, notably through the CARES<br />

<strong>and</strong> Improving Inpatient Care priorities<br />

outlined below. We will also be performing<br />

a detailed review of our ward staffing levels.<br />

During the later stages of the consultation,<br />

the Francis <strong>Report</strong> was released <strong>and</strong> we<br />

have incorporated a number of its key<br />

recommendations in this document. The<br />

“Emergency Care” priority will have targets<br />

related to improving mortality, <strong>and</strong> a full<br />

participation in the “Friends <strong>and</strong> Family” test<br />

which preliminary data from most <strong>Hospital</strong>s<br />

has found to be difficult to implement in<br />

A&E. The priority related to implementing<br />

our CARES framework of staff values goes to<br />

the heart of the Francis report by acting as<br />

the framework for providing patient-focused<br />

high quality, responsive <strong>and</strong> compassionate<br />

care.<br />

PRIORITY 1: First Contact –<br />

continuing to improve the<br />

outpatient experience<br />

Why is this one of our priorities?<br />

We recognise that we have made some<br />

changes to the way patients are contacted<br />

<strong>and</strong> are reminded about their outpatient<br />

appointments <strong>and</strong> these changes have now<br />

been made. Furthermore we have more work<br />

to do to centralise bookings <strong>and</strong> implement<br />

a new electronic document records<br />

management system; this work remains a<br />

priority because the changes have a clear<br />

impact on quality <strong>and</strong> patients’ experience.<br />

Quality report<br />

77


Our aims for 20<strong>13</strong>/2014:<br />

Call Management System (CMS)<br />

Implementation of the CMS has significantly<br />

changed the way we h<strong>and</strong>le calls <strong>and</strong> remind<br />

people about their outpatient appointments.<br />

This year we will set up a focus group to<br />

gain feedback from our patients <strong>and</strong> users<br />

about their experience in navigating the<br />

system so we can establish what further work<br />

is needed <strong>and</strong> take the appropriate action.<br />

Some of the things we will be discussing at<br />

the focus group are the opening times of<br />

the outpatient appointments centre <strong>and</strong><br />

communication with patients about times<br />

when we know the call volume will be high.<br />

We continue to provide staff training on<br />

customer care including telephone h<strong>and</strong>ling<br />

skills which reflects the CARES strategy<br />

(see Priority 4 on page 80). We use r<strong>and</strong>om<br />

call listening to support staff training <strong>and</strong><br />

development. Furthermore staff are being<br />

trained to deal with a variety of patients’<br />

queries with the aim to improve first call<br />

resolution.<br />

Electronic document records management<br />

This year the <strong>Trust</strong> is undertaking a<br />

major change to the way medical records<br />

are accessed <strong>and</strong> stored. The Electronic<br />

Document Records System is being proposed<br />

as a key infrastructure for the <strong>Trust</strong> in<br />

order to enhance the quality <strong>and</strong> efficiency<br />

of healthcare provided to our patients.<br />

The underlying vision for this case is to<br />

ensure that the best <strong>and</strong> most up to date<br />

information should be readily available to<br />

enable professional staff to offer appropriate<br />

care <strong>and</strong> treatment.<br />

It will also increase productivity <strong>and</strong><br />

improve quality of care provided through<br />

the facilitation of electronic forms <strong>and</strong><br />

workflows. Scanned documents e.g. referral<br />

letters will be used in workflow processes,<br />

allowing the conversion of paper formcentric<br />

processes into paperless ones with<br />

electronic forms being stored directly into<br />

patient records to support clinical decision<br />

making <strong>and</strong> administrative functions.<br />

Booking centralisation<br />

During 20<strong>13</strong>/2014 further work will take<br />

place to centralise the booking of new<br />

<strong>and</strong> follow up outpatient appointments<br />

across the <strong>Trust</strong>. We have already achieved<br />

the first stage of centralising where the<br />

Outpatient Appointments Centre now takes<br />

all telephone queries for Mount Vernon<br />

<strong>Hospital</strong> outpatient appointments.<br />

The performance targets we will use to<br />

measure the impact of the changes <strong>and</strong> new<br />

initiatives are:<br />

• Call ab<strong>and</strong>onment rate - we aim to<br />

keep this below 10% (currently 28% for<br />

January-March 20<strong>13</strong>)<br />

• 95% of calls to be answered within 60<br />

seconds<br />

• First contact resolution – aim to resolve<br />

more than 90% of the queries in the first<br />

contact (less than 10% of calls transferred<br />

to other departments)<br />

• Reduction in ‘did not attend’ rates (DNA)<br />

for outpatient appointments (to be<br />

agreed in quarter 1).<br />

PRIORITY 2: Continuing to improve<br />

the Leaving <strong>Hospital</strong> Project –<br />

improving inpatient care<br />

Why is this one of our priorities?<br />

Following the success of implementing our<br />

leaving hospital principles across all of our<br />

wards, we reviewed our goals <strong>and</strong> priorities<br />

<strong>and</strong> re-launched the project as “Improving<br />

Inpatient Care”. The overall objective of<br />

this programme of work is to ensure we<br />

provide high quality of care to all inpatients<br />

by improving the patient journey <strong>and</strong><br />

thereby decreasing length of stay.<br />

78 Quality report


How are we doing so far?<br />

Length of stay for inpatients at <strong>Hillingdon</strong><br />

<strong>Hospital</strong> has been a priority service<br />

improvement goal for a number of years. We<br />

know that the longer patients are in hospital,<br />

the more risks there are to the patient, <strong>and</strong><br />

fundamentally, we know people do not<br />

want to be in hospital. We want to support<br />

our patients to return to their homes <strong>and</strong><br />

be supported in the community as soon as<br />

clinically appropriate. We want to remove all<br />

unnecessary waits in hospital, <strong>and</strong> provide a<br />

better service, particularly for those patients<br />

with greater need, such as those who may<br />

need social care support or ongoing care in<br />

the community.<br />

Successful changes have been made gradually<br />

through individual teams <strong>and</strong> <strong>Trust</strong> wide<br />

initiatives which have enabled more effective<br />

working <strong>and</strong> as a result, more efficient, high<br />

quality care. Almost 50% of our emergency<br />

patients are discharged within 72 hours.<br />

The average length of stay for the <strong>Trust</strong> has<br />

reduced by 0.8 days over the past 12 months;<br />

we are heading in the right direction.<br />

Our aims for 20<strong>13</strong>/2014 are:<br />

The Improving Inpatient Care programme,<br />

initiated in December <strong>2012</strong>, is putting in<br />

place a series of changes across the <strong>Trust</strong> to<br />

continue to reduce the length of stay, by<br />

eliminating delays <strong>and</strong> improving the overall<br />

experience patients receive whilst in hospital.<br />

Examples of this work include:<br />

• Developing an enhanced service for frail<br />

<strong>and</strong> elderly patients who are admitted as<br />

an emergency. The full details are being<br />

developed <strong>and</strong> tested during the early<br />

part of 20<strong>13</strong>, but will aim to involve an<br />

enhanced comprehensive assessment<br />

completed by a specialist Care of the<br />

Elderly Consultant <strong>and</strong> a team of specialist<br />

occupational <strong>and</strong> physiotherapists on<br />

day one of admission. This will then<br />

mean the hospital can start putting in<br />

place everything the patient will need<br />

to get home, as soon as they are better.<br />

For example, for patients who might be<br />

unsteady on their feet, fitting rails in their<br />

home so they can manage stairs without<br />

coming to harm.<br />

• Improving how we set discharge dates,<br />

with better co-ordination of teams<br />

through doctors’ rounds, <strong>and</strong> supporting<br />

nurses, doctors, pharmacists <strong>and</strong><br />

therapists to work together better when<br />

reviewing a patient’s needs.<br />

• Implementing new electronic whiteboards<br />

to provide reminders of all patients’<br />

next steps for all teams who work on the<br />

wards.<br />

• Improving the clarity of information we<br />

provide to nursing <strong>and</strong> residential homes,<br />

in order to support them in looking<br />

after patients when they are discharged<br />

from hospital. This aims to reduce the<br />

likelihood of that person needing to come<br />

back into hospital, as their care teams<br />

will know how to manage their needs<br />

appropriately.<br />

Specific goals for this project are:<br />

• Reduce length of stay to become one of<br />

the top 25% of <strong>Trust</strong>s nationally<br />

• Achieve 40% of all discharges leaving<br />

before 12pm<br />

• Earlier therapy <strong>and</strong> specialist review for<br />

complex elderly patients, supporting up<br />

to an additional 400 patients per year<br />

• Reduce the rate of readmissions aiming to<br />

prevent up to 230 avoidable readmissions<br />

per year<br />

PRIORITY 3: Improving emergency<br />

care<br />

Why is this one of our priorities?<br />

There is national <strong>and</strong> London evidence to<br />

show that there are significant differences<br />

in the mortality rates for patients admitted<br />

as an emergency during the week compared<br />

with patients admitted as an emergency<br />

at the weekend. Reduced service provision<br />

Quality report<br />

79


at weekends has been associated with this<br />

higher mortality rate.<br />

In response to the data, <strong>NHS</strong> London have<br />

developed commissioning st<strong>and</strong>ards for<br />

emergency care with the aim of ensuring<br />

that consultants have early <strong>and</strong> continued<br />

involvement in the care of all patients<br />

admitted as an emergency.<br />

How are we doing so far?<br />

As a <strong>Trust</strong> we are committed to achieving the<br />

emergency care st<strong>and</strong>ards <strong>and</strong> have invested<br />

in additional senior doctor time, out of hours<br />

Monday to Friday <strong>and</strong> also at the weekends.<br />

Notably we have provided Consultant<br />

ward rounds twice a day on our medical<br />

Emergency Assessment Unit. This has ensured<br />

that our patients continue to receive care<br />

from our most senior doctors irrespective of<br />

the day of the week.<br />

We have also ensured that in Medicine,<br />

Surgery <strong>and</strong> Paediatrics, all Consultants<br />

covering A&E are freed from all other clinical<br />

commitments.<br />

Further investment has allowed for an<br />

increase in therapy provision at weekends<br />

which has facilitated patients with complex<br />

needs having access to a multi-disciplinary<br />

team assessment.<br />

In <strong>2012</strong> a detailed review of our hospital<br />

mortality data was carried out, specifically<br />

the measure of mortality known as the<br />

<strong>Hospital</strong> St<strong>and</strong>ardised Mortality Ratio<br />

(HSMR).<br />

This review concluded that the <strong>Trust</strong> had a<br />

lower than average palliative care <strong>and</strong> comorbidity<br />

coding which may falsely elevate<br />

the HSMR, but that some specialties had a<br />

higher than expected HSMR.<br />

In response to the findings of the report a<br />

great deal of work has been undertaken to<br />

improve coding for palliative care <strong>and</strong> comorbidity<br />

which are at a national average<br />

<strong>and</strong> now monitored monthly. Specialties<br />

that were identified to have a higher<br />

than expected HSMR have been or are in<br />

the process of being reviewed through<br />

clinical workshops. These workshops have<br />

provided the opportunity for clinical staff<br />

to come together to identify areas of care<br />

for improvement <strong>and</strong> also to ascertain the<br />

suitability of utilising a care bundle approach<br />

(a group of several clinical interventions).<br />

These approaches together have reduced the<br />

HSMR to 89.8 (up to <strong>and</strong> including January<br />

20<strong>13</strong>) but there is still some weekday versus<br />

weekend variability.<br />

Our aims for 20<strong>13</strong>/2014 are<br />

• To invest in evening <strong>and</strong> weekend<br />

Consultant emergency presence in<br />

Medicine, Surgery, A&E <strong>and</strong> Paediatrics.<br />

• Implement <strong>NHS</strong> London emergency care<br />

st<strong>and</strong>ards in relation to Consultant review<br />

within 12 hours of decision to admit:<br />

number of patients being seen within<br />

target time 20<strong>13</strong>/2014 is 90%, <strong>and</strong> to<br />

ensure that there is no weekday versus<br />

weekend variability.<br />

• To reduce HSMR to London average in<br />

20<strong>13</strong>/2014 <strong>and</strong> ensure no difference in<br />

weekday vs. weekend mortality.<br />

• Seven day access to pharmacy <strong>and</strong> all<br />

therapies (physiotherapy, respiratory, <strong>and</strong><br />

occupational therapy).<br />

• Full participation in the Friends<br />

<strong>and</strong> Family test (more than 15% of<br />

all attending patients) in the A&E<br />

Department where participation so<br />

far has been disappointing, running at<br />

around 5.7% for 2011/<strong>2012</strong>.<br />

PRIORITY 4: CARES<br />

Why is this one of our priorities?<br />

There continues to be an increased focus<br />

nationally on the patient/staff experience<br />

<strong>and</strong> engagement of these groups. It is<br />

essential that we see more significant<br />

changes in attitude <strong>and</strong> behaviour from<br />

our staff to improve the experience of our<br />

patients. Through analysing information<br />

captured from key sources such as the<br />

80 Quality report


National Patient Survey, Inpatient Survey,<br />

National Staff Survey <strong>and</strong> incidents <strong>and</strong><br />

complaints locally, we recognise that we can<br />

make improvements to the experience of our<br />

patients <strong>and</strong> staff.<br />

Our goal is to deliver the best possible<br />

experience to our patients <strong>and</strong> to our<br />

staff. In May <strong>2012</strong> we formally launched<br />

Communication Attitude Responsibility<br />

Equity Safety (CARES), which is our set of<br />

values supported by a framework that sets<br />

out the st<strong>and</strong>ard, in terms of attitude <strong>and</strong><br />

behaviours we expect from our staff. This<br />

will support our staff to deliver care with<br />

compassion as well as ensuring it is also safe<br />

<strong>and</strong> effective.<br />

Our aims for 20<strong>13</strong>/2014 are:<br />

• Complaints – We will ensure that all<br />

complaints are addressed using the CARES<br />

framework. We will make the framework<br />

an integral part of the investigation<br />

process to identify behavioural <strong>and</strong><br />

attitudinal issues as well as the technical<br />

aspects so that we can learn from them.<br />

• Performance <strong>and</strong> Personal Development<br />

Reviews (PDR) – All staff are expected to<br />

undertake a PDR annually with their line<br />

manager so they can ensure individual<br />

performance is linked to the achievement<br />

of <strong>Trust</strong> <strong>and</strong> departmental objectives.<br />

It is also essential to see how they are<br />

progressing in terms of their performance<br />

<strong>and</strong> provides an opportunity to discuss<br />

personal <strong>and</strong> professional development.<br />

We have introduced a CARES behavioural<br />

scale into the PDR paperwork to help<br />

initiate discussions around staff attitude<br />

<strong>and</strong> behaviours so that agreements can be<br />

reached on any developmental areas in an<br />

open manner.<br />

• Customer Care Training – We want all<br />

staff to recognise how their behaviours<br />

<strong>and</strong> attitudes can have a negative or<br />

positive impact on the experience of<br />

patients <strong>and</strong> colleagues. Through the<br />

delivery of a tailored Customer Care<br />

training programme we will support<br />

staff to underst<strong>and</strong> how by adopting the<br />

CARES behaviours they can enhance that<br />

experience.<br />

• CARES plays a large part in the work<br />

programme we are developing in relation<br />

to the Engagement <strong>and</strong> Experience<br />

Strategy.<br />

• Some Key Performance indicators for<br />

20<strong>13</strong>/2014 are presented in the table<br />

above; others are being developed in<br />

quarter 1.<br />

Performance indicator<br />

Communication, involvement <strong>and</strong><br />

information – using the cluster of<br />

questions in the patient survey<br />

Compassionate Care – using<br />

the cluster of questions in the<br />

questionnaire from the Improving<br />

Patient Care initiative.<br />

PRIORITY 5: CQUINs<br />

Target<br />

<strong>2012</strong>/<strong>13</strong><br />

Improve result<br />

by 2%<br />

Achieve 85%<br />

The National CQUINs for the next financial<br />

year will still include the prevention of blood<br />

clots, but we will be expected to achieve a<br />

higher percentage of patient assessment. The<br />

patient experience CQUIN will be based on<br />

the new “Friends <strong>and</strong> Family Test” <strong>and</strong> the<br />

dementia risk assessment will be continued.<br />

The Patient Safety Thermometer will be<br />

based on reductions in pressure sores <strong>and</strong> not<br />

just on data submission.<br />

Regional <strong>and</strong> local CQUINs are still to be<br />

agreed.<br />

Quality report<br />

81


Statements of assurance<br />

from the Board<br />

Information for our regulators<br />

Our regulators need to underst<strong>and</strong> how<br />

we are working to improve quality so the<br />

following pages are specific messages they<br />

have asked us to provide:<br />

Services<br />

During <strong>2012</strong>/20<strong>13</strong> The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> provided medicine,<br />

surgery, clinical support services <strong>and</strong><br />

women’s <strong>and</strong> children’s <strong>NHS</strong> services. The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong><br />

has reviewed all the data available to them<br />

on the quality of care in all of these <strong>NHS</strong><br />

services. The income generated by the <strong>NHS</strong><br />

services reviewed in <strong>2012</strong>/20<strong>13</strong> represents<br />

100% of the total income generated<br />

from the provision of <strong>NHS</strong> services by the<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong><br />

for <strong>2012</strong>/20<strong>13</strong>.<br />

Audit<br />

National audits<br />

During <strong>2012</strong>/20<strong>13</strong>, 38 national clinical audits<br />

<strong>and</strong> two national confidential enquiries<br />

covered <strong>NHS</strong> services that The <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> provides.<br />

During that period The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> participated in 82% of<br />

national clinical audits <strong>and</strong> 100% of national<br />

confidential enquiries for which it was<br />

eligible to participate in. The national clinical<br />

audits <strong>and</strong> national confidential enquiries<br />

that The <strong>Hillingdon</strong> <strong>Hospital</strong> <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> was eligible to participate in during<br />

<strong>2012</strong>/20<strong>13</strong> are listed below alongside the<br />

number of cases submitted to each audit or<br />

enquiry as a percentage of the number of<br />

registered cases required by the terms of that<br />

audit or enquiry.<br />

82 Quality report


Audit Participated Cases submitted<br />

WOMENS AND CHILDRENS HEALTH<br />

Child Health Programme (CHR-UK) Yes 0% (only 1 patient applicable)<br />

Perinatal Mortality (MBRRACE-UK) Yes 100%<br />

Neonatal Intensive <strong>and</strong> Special Care (NNAP) Yes 100%<br />

Paediatric Pneumonia (British Thoracic Society) Yes 100%<br />

Paediatric Asthma (British Thoracic Society) Yes 100%<br />

Paediatric Fever (College of Emergency Medicine) No N/A<br />

Epilepsy 12 Audit (RCPH National Childhood Epilepsy Audit) Yes<br />

Data entry commenced 1 st March 20<strong>13</strong><br />

<strong>and</strong> continues throughout 20<strong>13</strong>/14 –<br />

<strong>Trust</strong> participating<br />

ACUTE CARE<br />

Emergency Use of Oxygen (British Thoracic Society BTS) Yes 100%<br />

Adult Community Acquired Pneumonia (BTS) Yes 100%<br />

Non-invasive Ventilation (BTS) Yes 85%<br />

Renal Colic (College Emergency Medicine) Yes 100%<br />

Hip, Knee <strong>and</strong> Ankle Replacements (National Joint Registry) Yes<br />

<strong>Hillingdon</strong> 71%<br />

Mount Vernon Treatment Centre 93%<br />

Adult Critical Care (ICNARC CMPD) No N/A<br />

Alcohol Related Liver Disease (National Confidential Enquiry<br />

NCEPOD)<br />

Yes 100%<br />

Subarachnoid Haemorrhage (NCEPOD) Yes Data submission ongoing<br />

Severe Trauma (Trauma Audit & Research Network, TARN) Yes 81%<br />

LONG TERM CONDITIONS<br />

Diabetes (National Audit Diabetes Audit) No N/A<br />

Diabetes (RCPH National Paediatric Diabetes Audit) Yes 100%<br />

National Review of Asthma Deaths Yes No applicable cases<br />

Chronic Pain (National Pain Audit) Yes 34.7%<br />

Inflammatory Bowel Disease (IBD)<br />

Yes<br />

Data submission commenced Jan<br />

20<strong>13</strong>, 100% patients included to date<br />

Adult Asthma (BTS) Yes 88%<br />

Adult Bronchiectasis (BTS) No N/A<br />

Paediatric Bronchiectasis (BTS) No N/A<br />

OTHER<br />

Elective Surgery (National PROMS programme)<br />

Yes<br />

Percentages unavailable, numbers are:<br />

Hip replacements: 249; knee<br />

replacements: 312; groin hernia: 167;<br />

varicose veins: 7.<br />

CARDIOVASCULAR DISEASE<br />

Acute Myocardial Infarction & other ACS (MINAP) Yes 100%<br />

Heart Failure (Heart Failure Audit)<br />

Yes<br />

59% due to staff changeover our<br />

participation is lower than previous<br />

years - this has now been resolved<br />

Cardiac Arrest (National Cardiac Arrest Audit)<br />

No<br />

N/A, <strong>Trust</strong> will be submitting data<br />

from July 20<strong>13</strong><br />

CANCER<br />

Head <strong>and</strong> Neck Oncology (DAHNO) Yes 100%<br />

Lung Cancer (National Lung Cancer Audit) Yes Expected 100%<br />

Bowel Cancer (National Bowel Cancer Audit Programme) Yes 100%<br />

Oesophago-gastric Cancer (National O-G Cancer Audit) Yes<br />

Deadline for submission October 20<strong>13</strong><br />

- expected 100%<br />

OLDER PEOPLE<br />

Fractured Neck of Femur (College of Emergency Medicine) Yes 70%<br />

National Audit of Dementia (NAD) Yes 100%<br />

Parkinson’s Disease (National Parkinson’s Audit) No N/A<br />

Sentinel Stroke National Audit Programme (SSNAP) Yes 100%<br />

Hip Fracture (National Hip Fracture Database) Yes 100%<br />

BLOOD <strong>and</strong> TRANSPLANT<br />

Blood Sample Labelling (National Comparative Audit of<br />

Blood Transfusion)<br />

Yes 100%<br />

Potential Donor Audit (<strong>NHS</strong> Blood <strong>and</strong> Transplant) Yes 100%<br />

Medical use of Blood (National Comparative Audit of Blood<br />

Transfusion)<br />

Yes 100% Quality report 83


Taking actions<br />

The reports of <strong>13</strong> national clinical audits were reviewed by the provider in <strong>2012</strong>/20<strong>13</strong> <strong>and</strong> The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> intends to take the following actions to improve<br />

the quality of healthcare provided.<br />

Audit<br />

Neonatal intensive <strong>and</strong> special care (NNAP)<br />

Diabetes (RCPH) national paediatric<br />

diabetes audit<br />

Pain management in children (College of<br />

Emergency Medicine)<br />

Epilepsy 12 audit (rcph national childhood<br />

epilepsy audit)<br />

Paediatric asthma (British Thoracic Society)<br />

Emergency use of oxygen (British Thoracic<br />

Society)<br />

Non-invasive ventilation (British Thoracic<br />

Society)<br />

Severe sepsis & septic shock (College Of<br />

Emergency Medicine)<br />

Cardiac arrest procedures – time to<br />

intervene (NCEPOD)<br />

Inflammatory bowel disease (IBD)<br />

Lung cancer (National Lung Cancer Audit)<br />

Oesophago-gastric cancer (National O-G<br />

Cancer Audit)<br />

Hip fracture (National Hip Fracture<br />

Database)<br />

Actions<br />

The <strong>Trust</strong> performs well in the majority of the st<strong>and</strong>ards for this audit. We<br />

have not been submitting data for whether babies have an encephalopathy<br />

(neurological assessment) to allow us to review clinical practice, this has<br />

now been addressed <strong>and</strong> data will be available within future reports.<br />

The <strong>Trust</strong> now uses the Twinkle database which records all of the<br />

requirements for the national paediatric diabetes audit. Use of this<br />

database prompts awareness of diabetes clinical indicators to team<br />

members, improves the quality of data collection <strong>and</strong> will allow for a more<br />

automated submission to this national audit.<br />

To reduce admissions for diabetic ketoacidosis <strong>and</strong> to raise awareness for<br />

early diagnosis of diabetes, we are using the diabetes UK 4Ts campaign<br />

(toilet, thirsty, tired, thinner) in all our clinic letters sent to GPs <strong>and</strong> schools.<br />

A pain rating scale document is in development. This document can help us<br />

to assess pain severity quickly so we will be able to manage a child’s pain as<br />

soon as possible.<br />

A ‘transitional clinic’ to transfer from paediatric to adult epilepsy care has<br />

been set up. The first clinic ran in July <strong>2012</strong> <strong>and</strong> we plan to run 3 to 4 clinics<br />

per year.<br />

A <strong>Trust</strong> paediatric asthma guideline has been produced <strong>and</strong> was published<br />

for use in the hospital in December <strong>2012</strong>. Two new A&E Paediatric<br />

Consultants started in December <strong>2012</strong>, which will support implementation<br />

of this guideline <strong>and</strong> improve paediatric asthma st<strong>and</strong>ards.<br />

Improvements will be made, relating to documentation of prescribing of<br />

oxygen, as a result of an oxygen prescribing policy being published within<br />

the <strong>Trust</strong>. A new prescription chart is in development for the hospital,<br />

which includes a section on oxygen prescribing.<br />

The lead respiratory Consultants are using existing training sessions to reiterate<br />

the need to document a clear non invasive ventilation (NIV) plan.<br />

A clinical guideline specific to the emergency department is being agreed,<br />

this will be used in conjunction with the sepsis care bundle.<br />

The <strong>Trust</strong> has signed up to join the national cardiac arrest audit <strong>and</strong> will<br />

start submitting data from July 20<strong>13</strong>.<br />

Written information leaflets for surgical inflammatory bowel disease (IBD)<br />

patients now provided. Meetings with x-ray <strong>and</strong> gastroenterology have<br />

been restructured to discuss IBD patients, surgeons are present to discuss to<br />

relevant patients.<br />

The national lung cancer audit has been improved for the <strong>2012</strong> submissions.<br />

The development of closer links with the Royal Brompton <strong>and</strong> Harefield<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> <strong>and</strong> locally between our clinical nurse specialist <strong>and</strong><br />

lung team co-ordinator has greatly facilitated a more streamlined reporting<br />

process.<br />

Patients within this audit are included as part of a review of emergency<br />

admission & re-admission rates of palliative care patients captured at<br />

local level. All patients are identified with a pall alert tag on the patient<br />

administration system. The Co-Ordinate My Care (CMC) system is a recent<br />

strategy to identify patients with their consent to reduce emergency<br />

admissions <strong>and</strong> re-admissions into hospital <strong>and</strong> guide community resources<br />

to them with appropriate care identified in the community.<br />

Following the introduction of the “assessment <strong>and</strong> protocol document<br />

for hip fragility fractures” compliance with hip fracture st<strong>and</strong>ards has<br />

improved, including falls assessment <strong>and</strong> both abbreviated mental tests.<br />

A separate audit of this document is now taking place <strong>and</strong> any identified<br />

improvements will be made.<br />

84 Quality report


Local audits<br />

The reports of 84 local clinical audits were reviewed by the provider in <strong>2012</strong>/<strong>13</strong> <strong>and</strong><br />

examples of The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> actions to improve the quality of<br />

healthcare provided are detailed below.<br />

Audit of inpatient pathways <strong>and</strong> day of<br />

discharge processes<br />

Quality of inpatient care (treatment) plans<br />

Audit of Deep Vein Thrombosis pathway<br />

Re-audit - Staff survey of caring for<br />

vulnerable patients including those with a<br />

learning difficulty<br />

Survey of staff to evaluate the<br />

implementation of the mental capacity act<br />

2005 <strong>and</strong> DOLS - re-audit<br />

Staff taking blood cultures using best practice<br />

Measures of care nursing audits: Falls,<br />

hydration <strong>and</strong> fluid balance, medicines<br />

management, record keeping, privacy <strong>and</strong><br />

dignity, pressure ulcer prevention, food<br />

<strong>and</strong> nutrition, failure to rescue & patient<br />

identification<br />

Audit of children who Do Not Attend (DNA)<br />

Children’s Outpatients (Wendy Ward)<br />

Audit of records of women with safeguarding<br />

concerns in Maternity Department<br />

This audit was part of the improving inpatient care project <strong>and</strong> will<br />

roll out the new PAS+ system which will help streamline processes<br />

on the ward to the introduction of electronic white boards <strong>and</strong> real<br />

time bed management. This should support better discharge planning<br />

<strong>and</strong> recording of estimated dates of discharge.<br />

To improve quality of care plans we are working with each Division<br />

to devise ward round st<strong>and</strong>ards, which will include increased multidisciplinary<br />

input into care planning. We are also looking at ways to set<br />

<strong>and</strong> record estimated discharge dates consistently e.g. prompt stickers on<br />

ward rounds.<br />

Revised Deep Vein Thrombosis Pathway is under development in<br />

consultation with the Clinical Commissioning Group.<br />

This re-audit identified a general positive increase in awareness of caring<br />

for vulnerable patients. The use of the vulnerable adults action card<br />

<strong>and</strong> patient passport is continually re-inforced to staff, for example, at<br />

m<strong>and</strong>atory training <strong>and</strong> induction. The documents are available on the<br />

<strong>Trust</strong> Intranet.<br />

The re-audit identified the need for further training for staff on the<br />

Mental Capacity Act. Local training sessions have been provided within<br />

the <strong>Trust</strong>. In March 20<strong>13</strong> a training session was delivered by Central<br />

North West London <strong>NHS</strong> Foundation <strong>Trust</strong>.<br />

The blood culture audit has demonstrated a significant increase in<br />

blood culture training provided by the <strong>Trust</strong> from 16% in 2009 to 83%<br />

in <strong>2012</strong>. We have st<strong>and</strong>ardised blood culture equipment <strong>and</strong> all new<br />

medical staff receive blood culture theoretical training including a copy<br />

of the blood culture guidelines on induction. The Foundation Year 1 &<br />

2 doctors receive clinical skills & competency checks within 6 weeks of<br />

commencement in the <strong>Trust</strong>.<br />

During <strong>2012</strong>/<strong>13</strong> there has been an overall improvement with some<br />

areas sustaining well above target scores. To achieve this, the Nursing<br />

Performance Unit undertook bespoke teaching, one to one working,<br />

role modelling <strong>and</strong> observation feedback. This together with staff<br />

motivation, commitment, <strong>and</strong> engagement in undertaking audits <strong>and</strong><br />

hard work resulted in improvement.<br />

All clinic staff have been reminded of the need to document, in the<br />

patient notes, the process followed when a child does not attend their<br />

appointment. Each consulting room has a copy of the DNA process<br />

flowchart on the desk for staff to refer to.<br />

A postnatal communication sheet, to aid information sharing, has been<br />

developed <strong>and</strong> introduced. This document identifies the lead midwife,<br />

confirms the health visitor has been contacted <strong>and</strong> specifies the plan of<br />

action for individual safeguarding cases.<br />

Quality report<br />

85


Research<br />

Commitment to research as a driver for<br />

improving the quality of care <strong>and</strong> patient<br />

experience<br />

The number of patients receiving <strong>NHS</strong><br />

services provided by The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong>, that were recruited<br />

during the period to participate in research<br />

approved by a research ethics committee was<br />

547.<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> has a good research track record for<br />

a hospital of its size. We are continuing<br />

with our strategy to broaden our research<br />

portfolio <strong>and</strong> this has enabled us to offer a<br />

greater number of patients, from different<br />

clinical areas the opportunity to participate<br />

in research. This year we invested in a<br />

research nurse to support our Cardiologists<br />

<strong>and</strong> Diabetes Consultants as a means of<br />

increasing commercially funded <strong>and</strong> portfolio<br />

adopted research activity in these areas.<br />

It is projected that within two years the<br />

commercial income generated should sustain<br />

this post thereafter.<br />

Participation in clinical research demonstrates<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong>‘s commitment to improving the<br />

quality of care we offer <strong>and</strong> to making our<br />

contribution to wider health improvement.<br />

This allows our clinical staff to stay abreast<br />

of the latest treatment possibilities <strong>and</strong><br />

active participation in research allows our<br />

patient’s access to new treatments that<br />

they otherwise would not have. With this<br />

in mind we aim to offer our patients the<br />

opportunity to participate in a wide range of<br />

clinical research projects. These studies are<br />

both funded by the pharmaceutical industry<br />

<strong>and</strong> by the Department of Health via the<br />

North West London Comprehensive Research<br />

Network (CLRN); for this work we received<br />

£524,911 from the CLRN.<br />

The money generated from this research<br />

activity funds research nurses <strong>and</strong> data<br />

managers to support the clinicians in this<br />

work. The majority of our studies are<br />

National Institute for Health Research (NIHR)<br />

portfolio adopted multi-centre studies where<br />

we are acting as a recruiting site on behalf<br />

of the lead centre. Our research portfolio is<br />

a balance of observational <strong>and</strong> treatment<br />

studies across many clinical areas in the <strong>Trust</strong><br />

including cancer, stroke, <strong>and</strong> haematology,<br />

many of the general medicine <strong>and</strong> surgical<br />

specialities <strong>and</strong> paediatrics. We also support<br />

PhD <strong>and</strong> Masters students from the local<br />

universities giving them access to our<br />

patients for their projects.<br />

During <strong>2012</strong>/20<strong>13</strong> we had 66 open or followup<br />

studies. We recruited 505 patients into<br />

30 NIHR Portfolio Studies, supported the<br />

repatriation of 20 patients recruited into<br />

treatment studies at other hospitals <strong>and</strong><br />

supported four Masters or PhD student<br />

studies.<br />

Our research management processes reflect<br />

the Research Support Services nationally<br />

<strong>and</strong> have a setup time that meets the NIHR<br />

national targets. On average our research<br />

governance review is undertaken in less than<br />

10 days which is well below the national<br />

target of 30 days.<br />

Summary of lessons learned from serious<br />

incidents<br />

During <strong>2012</strong>/20<strong>13</strong>, the <strong>Trust</strong> reported<br />

nine Serious Incidents where panel<br />

investigations were conducted. There were<br />

two Serious Incidents reported as ‘Never<br />

Events’; one of these was investigated by<br />

a panel. Never Events are serious grade<br />

2, largely preventable patient safety<br />

incidents that should never occur if the<br />

available preventable measures have been<br />

implemented by healthcare providers (NPSA<br />

2010). It is a legal requirement under CQC<br />

regulations to report them. Protecting<br />

patients from avoidable harm is something<br />

to which there is universal agreement <strong>and</strong><br />

the <strong>Trust</strong> has clearly defined processes <strong>and</strong><br />

procedures to follow to help avoid these<br />

events occurring.<br />

86 Quality report


Lessons learnt as a result of the serious incidents include:<br />

Area Division Summary<br />

CT scans<br />

Deteriorating patients<br />

Cancer <strong>and</strong> Clinical<br />

Support Services<br />

(CCSS)<br />

All divisions<br />

The investigation led to the requirement for more radiology<br />

staff.<br />

Training <strong>and</strong> use of an established structured communication<br />

tool (SBAR) for the deteriorating patient.<br />

Record keeping All divisions Training <strong>and</strong> audit programme in place.<br />

Administration of medicine for<br />

patients that are nil by mouth<br />

Review the Deep Vein<br />

Thrombosis (DVT) clinical<br />

pathway<br />

Refresher training for DVT <strong>and</strong><br />

Venous Thrombo Embolysis<br />

(VTE)<br />

Translation for non-English<br />

speaking patients<br />

Maternal sepsis<br />

Recognition <strong>and</strong> management<br />

of diabetes in the sick patient<br />

Sharing the learning from<br />

serious incidents<br />

Skills <strong>and</strong> drills training in the<br />

maternity triage area<br />

Neonatal resuscitation training<br />

Maternity escalation policy<br />

Supernumerary status for the<br />

maternity bleep holder<br />

CTG training <strong>and</strong> CTG ‘buddy’<br />

system<br />

Medicine<br />

Medicine<br />

All medical staff<br />

Maternity<br />

Maternity<br />

Medical staff<br />

Medical staff<br />

Maternity<br />

Paediatrics<br />

Maternity<br />

Maternity<br />

Maternity<br />

Reminder to staff regarding using alternative routes of<br />

medicine administration.<br />

Review undertaken <strong>and</strong> new pathway being implemented.<br />

Refresher training provided <strong>and</strong> access for doctors to the e<br />

learning module for DVT.<br />

Memo sent out to remind all staff to provide the <strong>Trust</strong><br />

translation service when required.<br />

Reminder sent to all staff regarding the use of the centre for<br />

maternal <strong>and</strong> child enquiries (cmace) guidelines <strong>and</strong> inclusion<br />

of giving antibiotics to cover listeria.<br />

Clinical training reviewed <strong>and</strong> updated.<br />

Conducted at the divisional clinical governance forums<br />

Now included in the regular skills <strong>and</strong> drills programme.<br />

(Skills <strong>and</strong> drills are practice clinical scenarios undertaken<br />

both formally, through m<strong>and</strong>atory training <strong>and</strong> informally<br />

through mock assessments (spontaneous <strong>and</strong> unexpected<br />

scenarios, practicing specific emergency situations, usually<br />

led by the practice development team <strong>and</strong> a Consultant).<br />

These are undertaken to ensure that staff are prepared for<br />

all emergency situations, <strong>and</strong> where shortfalls are identified,<br />

then further training implemented).<br />

Refresher training in place using the regular skills <strong>and</strong> drills<br />

programme (as above).<br />

Policy reinforced, ongoing monitoring of compliance being<br />

undertaken.<br />

Under review, all co-ordinators reminded about their<br />

supernumerary status.<br />

Reviewed <strong>and</strong> competencies being monitored, spot audits in<br />

place.<br />

Security of documents in transit Corporate Use of security envelopes across the <strong>Trust</strong>.<br />

Escalation of missing patient<br />

communication<br />

Corporate<br />

Monitored on the incident reporting system.<br />

Scanning cancer referral<br />

documents<br />

CCSS<br />

Scanning now in place.<br />

WHO surgical patient safety<br />

checklist<br />

Safe sedation<br />

Pain procedure lists <strong>and</strong> shifts<br />

Surgical<br />

Surgical<br />

Surgical<br />

Implemented <strong>and</strong> audit being undertaken. Reminder to use<br />

checklist sent out to staff.<br />

Reminder of safe sedation practice sent out to staff <strong>and</strong> audit<br />

being undertaken to ensure compliance.<br />

Review of workload undertaken, number, skill mix <strong>and</strong><br />

duration of lists.<br />

Quality report<br />

87


Goals agreed with commissioners<br />

(CQUINs)<br />

A proportion, 2.5%, of out turn value of<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong>’s income in <strong>2012</strong>/20<strong>13</strong> was conditional<br />

on achieving quality improvement <strong>and</strong><br />

innovation goals agreed between The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>and</strong> any body they entered into a contract,<br />

agreement or arrangement with for the<br />

provision of <strong>NHS</strong> services, through the<br />

Commissioning for Quality <strong>and</strong> Innovation<br />

payment framework. The monetary total for<br />

the associated payments was £3.3 million.<br />

Further details of the agreed goals for<br />

<strong>2012</strong>/20<strong>13</strong> <strong>and</strong> for the following 12 month<br />

period are available on request from the<br />

Financial Planning Department, The Furze,<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong>, Pield Heath Road, Uxbridge, Middlesex.<br />

UB8 3NN or from the <strong>Trust</strong> website www.thh.<br />

nhs.uk.<br />

Care Quality Commission<br />

The <strong>Trust</strong> is required to register with the Care<br />

Quality Commission <strong>and</strong> is registered without<br />

conditions. The CQC paid an unannounced<br />

visit in December <strong>2012</strong> as part of their<br />

planned review of the <strong>Trust</strong>. The report<br />

issued from this visit stated the <strong>Trust</strong> is fully<br />

compliant with the Essential St<strong>and</strong>ards of<br />

Quality <strong>and</strong> Safety.<br />

The <strong>Trust</strong> received notification on 15 th<br />

February 20<strong>13</strong> that it was an outlier for<br />

puerperal sepsis (maternal infection)<br />

following delivery <strong>and</strong> an update was<br />

also requested on maternal emergency<br />

readmission rates. Coding issues <strong>and</strong> clinical<br />

issues mostly relating to urinary catheters<br />

<strong>and</strong> infections were identified <strong>and</strong> a<br />

comprehensive action plan was put in place<br />

which enabled the readmission rate to<br />

reduce to less than 1% bringing us within the<br />

expected range <strong>and</strong> well below the national<br />

average.<br />

Data quality<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> submitted records during April –<br />

January for <strong>2012</strong>/20<strong>13</strong> to the Secondary<br />

User’s Service (SUS) for inclusion in the<br />

<strong>Hospital</strong> Episode Statistics (HES) which<br />

included the patient’s valid <strong>NHS</strong> number (to<br />

month 10:)<br />

• 98.5% for admitted patient care<br />

• 99.8% for outpatients care<br />

• 96.4% for accident <strong>and</strong> emergency care.<br />

The percentage records in the published data<br />

which included the patient’s valid General<br />

Medical Practitioner Code was:<br />

• 100% for admitted patient care<br />

• 100% for outpatient care<br />

• 100% for accident <strong>and</strong> emergency care.<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> will be taking forward the following<br />

actions to improve data quality:<br />

• continue to review <strong>and</strong> action data<br />

quality issues at the <strong>Trust</strong>’s data quality<br />

meetings<br />

• daily data quality reports are published<br />

on the <strong>Trust</strong>’s web based management<br />

information system for action <strong>and</strong><br />

rectification.<br />

Information Governance Toolkit<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong>’s Information Governance Assessment<br />

report overall score for <strong>2012</strong>/20<strong>13</strong> was 81%<br />

<strong>and</strong> termed as unsatisfactory as one of 44<br />

requirements remains at level 1; all the other<br />

scores are at level 2 or 3.<br />

Clinical coding error rate<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> was subject to the Payment by Results<br />

Clinical Coding Audit during the reporting<br />

period by the Audit Commission. However,<br />

the final <strong>2012</strong>/20<strong>13</strong> report is yet to be<br />

published <strong>and</strong> so the latest published report<br />

is from 2011/<strong>2012</strong>.<br />

88 Quality report


The Audit Commission sampled Finished<br />

Consultant Episodes (FCEs) <strong>and</strong> the overall<br />

average Health Resource Group (HRG) error<br />

rate was 6.5% at episode level compared to<br />

a National average of 9.1% in 2009/2010.<br />

The error rates reported in that audit for<br />

diagnoses <strong>and</strong> treatment coding (clinical<br />

coding) was:<br />

• Primary diagnosis incorrect 4.0%<br />

• Secondary diagnosis incorrect 5.1%<br />

• Primary procedure incorrect 3.6%<br />

• Secondary procedure incorrect 16.2%.<br />

The results were not extrapolated further<br />

than the actual sample audited. The sample<br />

covered 100 case notes from Respiratory<br />

Medicine <strong>and</strong> 100 r<strong>and</strong>omly selected case<br />

notes across all specialties.<br />

Quality report<br />

89


ANNEXE<br />

Commissioner statement from<br />

<strong>Hillingdon</strong> Clinical Commissioning<br />

Group (CCG)<br />

<strong>Hillingdon</strong> CCG is pleased to receive The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s Foundation <strong>Trust</strong><br />

<strong>2012</strong>/<strong>13</strong> Quality Account. We note that the<br />

involvement of your patients in identification<br />

of priorities for 20<strong>13</strong>/14 <strong>and</strong> that you have<br />

included reference to the Francis <strong>Report</strong>.<br />

<strong>2012</strong>/<strong>13</strong> priorities<br />

We share the <strong>Trust</strong>’s disappointment that<br />

not all the <strong>2012</strong>/<strong>13</strong> priorities were achieved;<br />

in particular those relating to information<br />

to GPs following discharge <strong>and</strong> discharging<br />

patients early in the day as these support<br />

effective <strong>and</strong> safe discharge from hospital<br />

for patients <strong>and</strong> reduces the likelihood<br />

of readmission. We would hope to see<br />

a strong patient voice in future work to<br />

improve discharge processes. We note<br />

the very positive steps taken as part of<br />

priority 4 Leaving <strong>Hospital</strong> – Improving the<br />

Patient Experience; especially the follow up<br />

telephone call <strong>and</strong> monthly observations of<br />

care visits. Priority 2 – Changes in Maternity<br />

also demonstrated well if not 100%<br />

achievement of targets set. It would be<br />

helpful to see more detail on the steps that<br />

will be taken to increase breast feeding rates.<br />

Quality measures<br />

Quality Measure 4: Independent measure of<br />

cleanliness was 88% <strong>and</strong> rated green. The<br />

National Inpatient Survey (CQC) indicated<br />

that the <strong>Trust</strong> scored below the national<br />

average for cleanliness of the toilets <strong>and</strong><br />

bathrooms as well as the hospital ward.<br />

There is some discrepancy between the<br />

scores.<br />

We notice that many of the performance<br />

achievements have been achieved by the<br />

<strong>Trust</strong>.<br />

20<strong>13</strong>/14 priorities<br />

Broadly speaking the CCG supports the<br />

priorities identified for 20<strong>13</strong>/14. It is<br />

reassuring to see a continued focus on<br />

patient experience through continuation<br />

of the CARES priority. We recognise it is<br />

important enough to be a st<strong>and</strong>-alone<br />

priority but would anticipate that these<br />

values underpin all other priorities.<br />

We were surprised that reference to the<br />

Emergency Care Intensive Support Team<br />

(ECIST) was not made in relation to the<br />

emergency care priority but pleased to see it<br />

identified as an area of focus in 20<strong>13</strong>/14.<br />

Information for regulators<br />

It would be useful in future reports to<br />

have a better underst<strong>and</strong>ing of the impact<br />

of actions where the action has been for<br />

example “reviews” or “memos”.<br />

The overall score for the Information<br />

Governance Toolkit was 81% <strong>and</strong> termed<br />

“unsatisfactory”. It would have been helpful<br />

if actions planned to improve the score had<br />

been included in the Quality Account.<br />

<strong>Hillingdon</strong> CCG can confirm that the review<br />

of the <strong>2012</strong>/<strong>13</strong> performance is consistent<br />

with the SLA monitoring information it has<br />

received in <strong>2012</strong>/<strong>13</strong>.<br />

Linking to our previous comment on<br />

discharge processes, there is a need to<br />

continue focus on reducing admissions.<br />

90 Quality report


<strong>Hillingdon</strong> Health Watch response<br />

to The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong> <strong>Annual</strong> Quality<br />

<strong>Report</strong><br />

Introduction<br />

Although Health Watch <strong>Hillingdon</strong> was only<br />

established under The Health <strong>and</strong> Social Care<br />

Act <strong>2012</strong> on 1st April 20<strong>13</strong>, it feels qualified<br />

to respond to The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> (THH) Quality <strong>Report</strong><br />

<strong>2012</strong>-20<strong>13</strong>, due to the transfer of staff <strong>and</strong><br />

volunteers from <strong>Hillingdon</strong> Link who have<br />

been involved in working with THH in this<br />

<strong>and</strong> the previous year’s quality accounts<br />

programme.<br />

Health Watch <strong>Hillingdon</strong> wishes to thank<br />

THH for the opportunity to comment on the<br />

<strong>Trust</strong>’s Quality <strong>Report</strong> for the year <strong>2012</strong>-20<strong>13</strong>.<br />

We would also like to acknowledge the<br />

<strong>Trust</strong>’s continued commitment to engage<br />

with <strong>Hillingdon</strong> LINk during the last year. This<br />

has seen an open working relationship, in<br />

which the <strong>Trust</strong> has embraced the LINk as a<br />

critical friend, encouraging positive challenge<br />

for the improvement of service quality.<br />

The Chief Executive Officer, Chair <strong>and</strong><br />

Director of Nursing of the <strong>Trust</strong> met regularly<br />

with LINk representatives <strong>and</strong> LINk were<br />

invited to sit on a number of important<br />

groups to monitor patient experience<br />

<strong>and</strong> quality, such as the Experience <strong>and</strong><br />

Engagement Group, the Maternity Liaison<br />

Group, <strong>and</strong> The Leaving <strong>Hospital</strong> Project<br />

Group.<br />

Quality report<br />

Health Watch <strong>Hillingdon</strong> found this year’s<br />

Quality <strong>Report</strong> easy to read, with clear<br />

explanation throughout the document,<br />

making it accessible to the general public.<br />

Written in a similar style to the 2011/12<br />

report, this year’s report is more focused<br />

on quantitative outcomes, <strong>and</strong> although<br />

subjective, we have a preference for the<br />

qualitative touches from last year which<br />

quoted patients feedback.<br />

From the Quality <strong>Report</strong> <strong>and</strong> the work<br />

LINk has been doing with the <strong>Trust</strong> it is<br />

self-evident that the <strong>Trust</strong> is committed to<br />

improving the quality of the services they<br />

provide.<br />

Health Watch <strong>Hillingdon</strong> found the Quality<br />

<strong>Report</strong> to be an honest assessment of the<br />

<strong>Trust</strong>’s performance <strong>and</strong> provided a balanced<br />

report on the quality of their services.<br />

The <strong>Trust</strong> should be congratulated on<br />

achieving many of its targets <strong>and</strong> in making<br />

significant progress in many other areas. It<br />

was especially good to see the recruiting<br />

of women in Maternity reception <strong>and</strong> as<br />

Maternity Mates to meet the diverse cultural<br />

needs of the women in <strong>Hillingdon</strong>.<br />

We are pleased that the <strong>Trust</strong> has been<br />

c<strong>and</strong>id in acknowledging the areas which<br />

require improvement <strong>and</strong> in recognising<br />

shortfalls that the <strong>Trust</strong> has made<br />

commitments to improve in these areas. We<br />

particularly feel that for patients, further<br />

improvements around record keeping, <strong>and</strong><br />

discharge information given to GP’s <strong>and</strong><br />

community health services within 24 hours,<br />

will be specifically beneficial.<br />

We are in agreement with <strong>and</strong> support THH<br />

in their choice of 20<strong>13</strong>/14 quality priorities<br />

which has taken into account the views of<br />

LINk <strong>and</strong> the wider public.<br />

The First Contact Project has now been a<br />

<strong>Trust</strong> priority for four years <strong>and</strong> CARES is a<br />

long term programme. It would be helpful<br />

for the general public, where completion of<br />

a project is planned over a long period of<br />

time, for this to be indicated in the report,<br />

setting out the long term goals in addition<br />

to the short term. If this is not the case <strong>and</strong> a<br />

priority extends due to complexities, it would<br />

be useful if the reasons for this are reported.<br />

The <strong>Trust</strong> has also indicated in its future<br />

priorities for 20<strong>13</strong>/14 that it intends to<br />

Quality report<br />

91


increase those people discharged before<br />

12pm from 15.8% to 40% <strong>and</strong> that the<br />

number of patients being seen by a<br />

consultant within 12 hours of the decision<br />

to admit them will increase from 55% to<br />

90%. We very much welcome these areas as<br />

priorities, with improvements of this scale<br />

<strong>and</strong> the positive affect this will have on the<br />

patient experience. We are cautious of the<br />

effect these targets may have on patient<br />

expectation, especially around discharge.<br />

Health Watch <strong>Hillingdon</strong> look forward to<br />

continuing the relationship THH has had<br />

with LINk <strong>and</strong> working with THH in a joint<br />

commitment to monitor <strong>and</strong> improve quality.<br />

External Services Scrutiny<br />

Committee Statement<br />

Response on behalf of the External Services<br />

Scrutiny Committee at the London Borough<br />

of <strong>Hillingdon</strong><br />

The External Services Scrutiny Committee<br />

welcomes the opportunity to comment on<br />

the <strong>Trust</strong>’s <strong>2012</strong>/20<strong>13</strong> Quality <strong>Report</strong> <strong>and</strong><br />

acknowledges the <strong>Trust</strong>’s commitment to<br />

attend its meetings when requested.<br />

The Committee is pleased to note that the<br />

mortality rate is lower than the national<br />

average expected in hospitals. The <strong>Trust</strong> has<br />

met the year’s targets for infection control.<br />

The Committee has noted that the <strong>Trust</strong> has<br />

had only one incident of MRSA in the last<br />

year; <strong>and</strong> notes the target for next year is<br />

zero. The patient bed days are also below<br />

the national average <strong>and</strong> London average.<br />

The <strong>Trust</strong> has also met the 4 hour average<br />

waiting time at A&E.<br />

The Committee is mindful of the imminent<br />

closure of Ealing <strong>Hospital</strong>’s A & E department<br />

<strong>and</strong> whether this will have a big impact on<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>. The Committee has<br />

noted that in theory rather than the numbers<br />

increasing at <strong>Hillingdon</strong>, people should<br />

be directed to the appropriate care. The<br />

Committee has noted the challenging times<br />

within the <strong>NHS</strong> <strong>and</strong> the planning involved in<br />

this. The <strong>Trust</strong> will be spending £12million<br />

in the next few years to start to gear up for<br />

this change. The Committee would like to be<br />

kept up to date on these changes <strong>and</strong> how<br />

they will affect the residents of <strong>Hillingdon</strong><br />

for better or worse.<br />

The Committee is aware that improving<br />

patient care <strong>and</strong> discharge continues to be<br />

a priority for the <strong>Trust</strong>. Complaints with<br />

regard to discharge have been identified<br />

as a problem that needs to be addressed;<br />

in particular with regard to when patients<br />

receive their medication. It has been<br />

recognised that this is a problem <strong>and</strong> the<br />

aim is to have patient’s papers ready on<br />

discharge. The Committee has noted that<br />

the targets for complaints response had<br />

not been met <strong>and</strong> suggested improvement<br />

in this area. There are some issues with<br />

the turnaround time for complaints which<br />

needed addressing. The Committee has<br />

noted that the <strong>Trust</strong> is still using a paper<br />

based system but there are plans for<br />

improvements to this.<br />

It is noted that the <strong>Trust</strong> has formulated 5<br />

priorities for the forthcoming year which are<br />

broadly similar to last years. These priorities<br />

are: First Contact Project; Improving Inpatient<br />

Care <strong>and</strong> Discharge; Improving Emergency<br />

Care; CARES <strong>and</strong> CQUINs.<br />

Overall, the Committee is pleased with<br />

the continued progress that the <strong>Trust</strong> has<br />

made over the last year but notes that<br />

there are a number of areas where further<br />

improvements still need to be made. We<br />

look forward to being informed of how the<br />

priorities outlined in the Quality <strong>Report</strong> are<br />

implemented over the course of 20<strong>13</strong>/14.<br />

92 Quality report


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong> response to the<br />

consultation<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> thanks all its stakeholders for their<br />

comments about the <strong>2012</strong>-<strong>13</strong> Quality <strong>Report</strong>.<br />

The <strong>Trust</strong> would like to reassure our<br />

Commissioners that there is a clear action<br />

plan to improve Information Governance<br />

training to achieve Level 2. This plan includes<br />

full training to all new staff on induction,<br />

more regular refresher sessions, bespoke<br />

training where needed, an up to date<br />

training record, <strong>and</strong> clear escalation for nonattendance.<br />

There is also a more detailed<br />

action plan to increase breastfeeding rates.<br />

to be articulated rather than just a one year<br />

strategy, <strong>and</strong> we will share these plans in the<br />

coming year.<br />

The External Services Scrutiny Committee<br />

comment on the potential impact of the<br />

implementation of Shaping a Healthier<br />

Future, <strong>and</strong> the <strong>Trust</strong> will involve all<br />

stakeholders, including the residents of<br />

<strong>Hillingdon</strong>, to ensure that a high quality<br />

service will be provided. A merging of the<br />

PALS <strong>and</strong> complaints teams, as well as our<br />

plan to deal with issues as they arise at<br />

the bedside, should lead to a reduction in<br />

complaints <strong>and</strong> a prompter turnaround.<br />

Our Commissioners are right in noting the<br />

importance of the <strong>2012</strong> Emergency Care<br />

Intensive Support Team (ECIST) report<br />

<strong>and</strong> the <strong>NHS</strong> Engl<strong>and</strong>: Improving A&E<br />

Performance report (Gateway reference<br />

00062, released April 20<strong>13</strong>), which both<br />

support our stated aims for improving<br />

emergency care. They also offer other best<br />

practice <strong>and</strong> operational recommendations<br />

many of which have been, or are being,<br />

implemented.<br />

Our Commissioners have rightly pointed out<br />

the difference between our independent<br />

measure of cleanliness (an audit of<br />

cleanliness st<strong>and</strong>ards) being higher than the<br />

National Inpatient Survey for the cleanliness<br />

of toilets <strong>and</strong> bathrooms as well as the<br />

hospital ward (a measure of the patients<br />

perception of cleanliness). The results of the<br />

National Inpatient Survey has historically<br />

been lower <strong>and</strong> is difficult to reconcile<br />

because they are asking different questions<br />

<strong>and</strong> measuring different things.<br />

Health Watch note the need for the <strong>Trust</strong> to<br />

continue to be c<strong>and</strong>id, balanced, <strong>and</strong> honest,<br />

qualities we agree are essential. We agree<br />

that a clear plan for long term project needs<br />

Quality report<br />

93


Independent Auditor’s <strong>Report</strong> to<br />

the Council of Governors of The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> on the Quality <strong>Report</strong><br />

We have been engaged by the Council of<br />

Governors of The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong> to perform an independent<br />

assurance engagement in respect of The<br />

<strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong>’s<br />

Quality <strong>Report</strong> for the year ended 31 March<br />

20<strong>13</strong> (the “Quality <strong>Report</strong>”) <strong>and</strong> certain<br />

performance indicators contained therein.<br />

This report, including the conclusion, has<br />

been prepared solely for the Council of<br />

Governors of The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> as a body, to assist<br />

the Council of Governors in reporting<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong>’s quality agenda, performance <strong>and</strong><br />

activities. We permit the disclosure of this<br />

report within the <strong>Annual</strong> <strong>Report</strong> for the year<br />

ended 31 March 20<strong>13</strong>, to enable the Council<br />

of Governors to demonstrate they have<br />

discharged their governance responsibilities<br />

by commissioning an independent assurance<br />

report in connection with the indicators.<br />

To the fullest extent permitted by law, we<br />

do not accept or assume responsibility to<br />

anyone other than the Council of Governors<br />

as a body <strong>and</strong> The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong><br />

Foundation <strong>Trust</strong> for our work or this report<br />

save where terms are expressly agreed <strong>and</strong><br />

with our prior consent in writing.<br />

Scope <strong>and</strong> subject matter<br />

The indicators for the year ended 31 March<br />

20<strong>13</strong> subject to limited assurance consist of<br />

the national priority indicators as m<strong>and</strong>ated<br />

by Monitor:<br />

• Maximum 62 day waiting time from<br />

urgent GP referral to treatment for all<br />

cancers;<br />

• Emergency readmissions within 28<br />

days of discharge from hospital.<br />

We refer to these national priority indicators<br />

collectively as the “indicators”.<br />

Respective responsibilities of the<br />

Directors <strong>and</strong> auditors<br />

The Directors are responsible for the content<br />

<strong>and</strong> the preparation of the Quality <strong>Report</strong><br />

in accordance with the criteria set out in<br />

the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual issued by Monitor. Our responsibility<br />

is to form a conclusion, based on limited<br />

assurance procedures, on whether anything<br />

has come to our attention that causes us to<br />

believe that:<br />

• the Quality <strong>Report</strong> is not prepared in<br />

all material respects in line with the<br />

criteria set out in the <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing Manual;<br />

• the Quality <strong>Report</strong> is not consistent in<br />

all material respects with the sources<br />

specified in the guidance; <strong>and</strong><br />

• the indicators in the Quality <strong>Report</strong><br />

identified as having been the subject<br />

of limited assurance in the Quality<br />

<strong>Report</strong> are not reasonably stated in<br />

all material respects in accordance<br />

with the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>ing Manual <strong>and</strong> the six<br />

dimensions of data quality set out in<br />

the Detailed Guidance for External<br />

Assurance on Quality <strong>Report</strong>s.<br />

We read the Quality <strong>Report</strong> <strong>and</strong> consider<br />

whether it addresses the content<br />

requirements of the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>ing Manual, <strong>and</strong> consider the<br />

implications for our report if we become<br />

aware of any material omissions.<br />

We read the other information contained in<br />

the Quality <strong>Report</strong> <strong>and</strong> consider whether it is<br />

materially inconsistent with the documents<br />

specified within the detailed guidance. We<br />

consider the implications for our report<br />

if we become aware of any apparent<br />

misstatements or material inconsistencies<br />

with those documents (collectively the<br />

94 Quality report


“documents”). Our responsibilities do not<br />

extend to any other information.<br />

We are in compliance with the applicable<br />

independence <strong>and</strong> competency requirements<br />

of the Institute of Chartered Accountants in<br />

Engl<strong>and</strong> <strong>and</strong> Wales (ICAEW) Code of Ethics.<br />

Our team comprised assurance practitioners<br />

<strong>and</strong> relevant subject matter experts.<br />

Assurance work performed<br />

We conducted this limited assurance<br />

engagement in accordance with<br />

International St<strong>and</strong>ard on Assurance<br />

Engagements 3000 (Revised) – “Assurance<br />

Engagements other than Audits or Reviews<br />

of Historical Financial Information” issued<br />

by the International Auditing <strong>and</strong> Assurance<br />

St<strong>and</strong>ards Board (“ISAE 3000”). Our limited<br />

assurance procedures included:<br />

• Evaluating the design <strong>and</strong><br />

implementation of the key processes<br />

<strong>and</strong> controls for managing <strong>and</strong><br />

reporting the indicators.<br />

• Making enquiries of management.<br />

• Testing key management controls.<br />

• Limited testing, on a selective basis, of<br />

the data used to calculate the indicator<br />

back to supporting documentation.<br />

• Comparing the content requirements<br />

of the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong><br />

<strong>Report</strong>ing Manual to the categories<br />

reported in the Quality <strong>Report</strong>.<br />

• Reading the documents.<br />

A limited assurance engagement is smaller<br />

in scope than a reasonable assurance<br />

engagement. The nature, timing <strong>and</strong> extent<br />

of procedures for gathering sufficient<br />

appropriate evidence are deliberately<br />

limited relative to a reasonable assurance<br />

engagement.<br />

Limitations<br />

Non-financial performance information<br />

is subject to more inherent limitations<br />

than financial information, given the<br />

characteristics of the subject matter <strong>and</strong><br />

the methods used for determining such<br />

information. The absence of a significant<br />

body of established practice on which to<br />

draw allows for the selection of different<br />

but acceptable measurement techniques<br />

which can result in materially different<br />

measurements <strong>and</strong> can impact comparability.<br />

The precision of different measurement<br />

techniques may also vary. Furthermore, the<br />

nature <strong>and</strong> methods used to determine such<br />

information, as well as the measurement<br />

criteria <strong>and</strong> the precision thereof, may<br />

change over time. It is important to read the<br />

Quality <strong>Report</strong> in the context of the criteria<br />

set out in the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong><br />

<strong>Report</strong>ing Manual.<br />

The scope of our assurance work has not<br />

included governance over quality or nonm<strong>and</strong>ated<br />

indicators which have been<br />

determined locally by The <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong>.<br />

Conclusion<br />

Based on the results of our procedures,<br />

nothing has come to our attention that<br />

causes us to believe that, for the year ended<br />

31 March 20<strong>13</strong>:<br />

• the Quality <strong>Report</strong> is not prepared in<br />

all material respects in line with the<br />

criteria set out in the <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing Manual;<br />

• the Quality <strong>Report</strong> is not consistent in<br />

all material respects with the sources<br />

specified in the guidance; <strong>and</strong><br />

• the indicators in the Quality <strong>Report</strong><br />

subject to limited assurance have not<br />

been reasonably stated in all material<br />

respects in accordance with the <strong>NHS</strong><br />

Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual.<br />

Deloitte LLP<br />

Chartered Accountants<br />

St Albans<br />

29 May 20<strong>13</strong><br />

Quality report<br />

95


Statement of Directors’<br />

responsibilities in respect of the<br />

Quality <strong>Report</strong><br />

The Directors are required under the Health<br />

Act 2009 <strong>and</strong> the National Health Service<br />

(Quality <strong>Accounts</strong>) Regulations 2010 as<br />

amended to prepare Quality <strong>Accounts</strong> for<br />

each financial year. Monitor has issued<br />

guidance to <strong>NHS</strong> Foundation <strong>Trust</strong> Boards<br />

on the form <strong>and</strong> content of <strong>Annual</strong> Quality<br />

<strong>Report</strong>s (which incorporate the above legal<br />

requirements) <strong>and</strong> on the arrangements<br />

that Foundation <strong>Trust</strong> Boards should put<br />

in place to support the data quality for the<br />

preparation of the Quality <strong>Report</strong>.<br />

In preparing the Quality <strong>Report</strong>, Directors are<br />

required to take steps to satisfy themselves<br />

that:<br />

• the content of the Quality <strong>Report</strong> meets<br />

the requirements set out in the <strong>NHS</strong><br />

Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual <strong>2012</strong>/20<strong>13</strong>;<br />

• the content of the Quality <strong>Report</strong> is not<br />

inconsistent with internal <strong>and</strong> external<br />

sources of information including:<br />

° Board minutes <strong>and</strong> papers for the<br />

period April <strong>2012</strong> to May 20<strong>13</strong><br />

° Papers relating to quality reported to<br />

the Board over the period April <strong>2012</strong> to<br />

May 20<strong>13</strong><br />

° Feedback from the Commissioners<br />

dated 22/5/20<strong>13</strong><br />

° Feedback from the Governors dated<br />

25/4/20<strong>13</strong><br />

° Feedback from LINks dated 7/5/20<strong>13</strong><br />

° The <strong>Trust</strong>’s Complaints <strong>Report</strong><br />

published under Regulation 18 of the<br />

Local Authority Social Services <strong>and</strong><br />

<strong>NHS</strong> Complaints Regulations 2009,<br />

17/5/20<strong>13</strong>;<br />

° The latest national patient survey<br />

published 16/4/20<strong>13</strong><br />

° The latest national staff survey<br />

28/2/20<strong>13</strong><br />

° The Head of Internal Audit’s annual<br />

opinion over the <strong>Trust</strong>’s control<br />

environment dated 8/5/20<strong>13</strong><br />

° CQC Quality <strong>and</strong> Risk Profiles dated<br />

from 1 April <strong>2012</strong> to 31 March 20<strong>13</strong><br />

• The Quality <strong>Report</strong> presents a balanced<br />

picture of the <strong>NHS</strong> Foundation <strong>Trust</strong>’s<br />

performance over the period covered;<br />

• The performance information reported in<br />

the Quality <strong>Report</strong> is reliable <strong>and</strong> accurate;<br />

• There are proper internal controls over the<br />

collection <strong>and</strong> reporting of the measures<br />

of performance included in the Quality<br />

<strong>Report</strong>, <strong>and</strong> these controls are subject to<br />

review to confirm that they are working<br />

effectively in practice;<br />

• The data underpinning the measures<br />

of performance reported in the Quality<br />

<strong>Report</strong> is robust <strong>and</strong> reliable, conforms<br />

to specified data quality st<strong>and</strong>ards <strong>and</strong><br />

prescribed definitions, is subject to<br />

appropriate scrutiny <strong>and</strong> review; <strong>and</strong><br />

the Quality <strong>Report</strong> has been prepared<br />

in accordance with Monitor’s annual<br />

reporting guidance (which incorporates<br />

the Quality <strong>Accounts</strong> Regulations)<br />

(published at www.monitor-<strong>NHS</strong>ft.gov.<br />

uk/annualreportingmanual) as well as<br />

the st<strong>and</strong>ards to support data quality for<br />

the preparation of the Quality <strong>Report</strong><br />

(available at www.monitor-<strong>NHS</strong>ft.gov.uk/<br />

annualreportingmanual).<br />

The Directors confirm to the best of their<br />

knowledge <strong>and</strong> belief they have complied<br />

with the above requirement in preparing the<br />

Quality <strong>Report</strong>.<br />

96 Quality report


STATEMENT OF THE CHIEF EXECUTIVE’S RESPONSIBILITIES AS<br />

THE ACCOUNTING OFFICER OF THE HILLINGDON HOSPITALS<br />

<strong>NHS</strong> FOUNDATION TRUST<br />

The <strong>NHS</strong> Act 2006 states that the Chief Executive is the Accounting Officer of the <strong>NHS</strong><br />

Foundation <strong>Trust</strong>. The relevant responsibilities of the Accounting Officer, including their<br />

responsibility for the propriety <strong>and</strong> regularity of public finances for which they are<br />

answerable, <strong>and</strong> for the keeping of proper accounts, are set out in the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

Accounting Officer Memor<strong>and</strong>um issued by Monitor.<br />

Under the <strong>NHS</strong> Act 2006, Monitor has directed The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> to prepare for each financial year a statement of accounts in the form <strong>and</strong> on the basis<br />

set out in the <strong>Accounts</strong> Direction. The accounts are prepared on an accruals basis <strong>and</strong> must<br />

give a true <strong>and</strong> fair view of the state of affairs of The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> <strong>and</strong> of its income <strong>and</strong> expenditure, total recognised gains <strong>and</strong> losses <strong>and</strong> cash flows for<br />

the financial year.<br />

In preparing the accounts, the Accounting Officer is required to comply with the<br />

requirements of the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing Manual <strong>and</strong> in particular to:<br />

• observe the <strong>Accounts</strong> Direction issued by Monitor, including the relevant accounting <strong>and</strong><br />

disclosure requirements, <strong>and</strong> apply suitable accounting policies on a consistent basis;<br />

• make judgements <strong>and</strong> estimates on a reasonable basis;<br />

• state whether applicable accounting st<strong>and</strong>ards as set out in the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>ing Manual have been followed, <strong>and</strong> disclose <strong>and</strong> explain any material<br />

departures in the financial statements; <strong>and</strong><br />

• prepare the financial statements on a going concern basis.<br />

The Accounting Officer is responsible for keeping proper accounting records which disclose<br />

with reasonable accuracy at any time the financial position of the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>and</strong><br />

to enable him/her to ensure that the accounts comply with requirements outlined in the<br />

above mentioned Act. The Accounting Officer is also responsible for safeguarding the assets<br />

of the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>and</strong> hence for taking reasonable steps for the prevention <strong>and</strong><br />

detection of fraud <strong>and</strong> other irregularities.<br />

To the best of my knowledge <strong>and</strong> belief, I have properly discharged the responsibilities set<br />

out in Monitor’s <strong>NHS</strong> Foundation <strong>Trust</strong> Accounting Officer Memor<strong>and</strong>um.<br />

Statement<br />

97


STATEMENT OF DIRECTORS’ RESPONSIBILITIES IN RESPECT OF<br />

THE ACCOUNTS<br />

The Directors are required under the National Health Service Act 2006 to prepare accounts<br />

for each financial year. Monitor, with the approval of the Secretary of State, directs that<br />

these accounts give a true <strong>and</strong> fair view of the state of affairs of the <strong>Trust</strong> <strong>and</strong> of the<br />

Statements of Comprehensive Income, Financial Position, Tax Payers Equity, Cash Flow <strong>and</strong> all<br />

disclosure notes in the <strong>Annual</strong> <strong>Accounts</strong>.<br />

In preparing those accounts, Directors are required to:<br />

• apply on a consistent basis accounting policies according to the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>ing Manual <strong>2012</strong>/<strong>13</strong> with the approval of the Secretary of State;<br />

• Make judgements <strong>and</strong> estimates which are reasonable <strong>and</strong> prudent;<br />

• State whether applicable accounting st<strong>and</strong>ards have been followed, subject to any<br />

material departures disclosed <strong>and</strong> explained in the accounts;<br />

• Comply with International Financial <strong>Report</strong>ing St<strong>and</strong>ards.<br />

The Directors are responsible for keeping proper accounting records which disclose with<br />

reasonable accuracy at any time the financial position of the <strong>Trust</strong> <strong>and</strong> to enable them<br />

to ensure that the accounts comply with requirements outlined in the above mentioned<br />

direction of the Secretary of State. They are also responsible for safeguarding the assets of<br />

the <strong>Trust</strong> <strong>and</strong> hence for taking reasonable steps for the prevention <strong>and</strong> detection of fraud<br />

<strong>and</strong> other irregularities.<br />

The Directors confirm to the best of their knowledge <strong>and</strong> belief they have complied with the<br />

above requirements in preparing the accounts.<br />

98


ANNUAL GOVERNANCE STATEMENT <strong>2012</strong>/<strong>13</strong><br />

1. Scope of responsibility<br />

As Accounting Officer, I have responsibility<br />

for maintaining a sound system of internal<br />

control that supports the achievement of the<br />

<strong>NHS</strong> Foundation <strong>Trust</strong>’s policies, aims <strong>and</strong><br />

objectives, whilst safeguarding the public<br />

funds <strong>and</strong> departmental assets for which<br />

I am personally responsible, in accordance<br />

with the responsibilities assigned to me. I am<br />

also responsible for ensuring that the <strong>NHS</strong><br />

Foundation <strong>Trust</strong> is administered prudently<br />

<strong>and</strong> economically <strong>and</strong> that resources are<br />

applied efficiently <strong>and</strong> effectively. I also<br />

acknowledge my responsibilities as set out in<br />

the <strong>NHS</strong> Foundation <strong>Trust</strong> Accounting Officer<br />

Memor<strong>and</strong>um.<br />

2. The purpose of the system of<br />

internal control<br />

The system of internal control is designed<br />

to manage risk to a reasonable level rather<br />

than to eliminate all risk of failure to achieve<br />

policies, aims <strong>and</strong> objectives; it can therefore<br />

only provide reasonable <strong>and</strong> not absolute<br />

assurance of effectiveness. The system of<br />

internal control is based on an on-going<br />

process designed to identify <strong>and</strong> prioritise<br />

the risks to the achievement of the policies,<br />

aims <strong>and</strong> objectives of The <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong>, to evaluate<br />

the likelihood of those risks being realised<br />

<strong>and</strong> the impact should they be realised, <strong>and</strong><br />

to manage them efficiently, effectively <strong>and</strong><br />

economically. The system of internal control<br />

has been in place in The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> for the year ended 31<br />

March 20<strong>13</strong> <strong>and</strong> up to the date of approval<br />

of the annual report <strong>and</strong> accounts.<br />

3. Capacity to h<strong>and</strong>le risk<br />

The Board is responsible for reviewing<br />

the effectiveness of the system of internal<br />

control, including systems <strong>and</strong> resources<br />

for managing all types of risk. The <strong>Trust</strong><br />

Board approved Risk Management<br />

Strategy <strong>and</strong> Policy (including Board<br />

Assurance Framework) ensures that the<br />

<strong>Trust</strong> approaches the control of risk in a<br />

strategic <strong>and</strong> organised manner. It sets out<br />

the responsibilities of Executive Directors<br />

<strong>and</strong> Senior Managers in relation to their<br />

leadership in risk management <strong>and</strong> makes it<br />

clear that all employees have a role to play<br />

in risk management appropriate to their<br />

level within the organisation. The Board has<br />

established a Committee structure to provide<br />

assurance on <strong>and</strong> challenge to the <strong>Trust</strong>’s<br />

risk management process. Each of these<br />

Committees are chaired by a Non-Executive<br />

Director to enhance this challenge, <strong>and</strong> the<br />

Committee chairs report formally to the<br />

Board to escalate issues that require further<br />

Board discussion. An example of this is the<br />

attendance at the Quality & Risk Committee<br />

(QRC) of both the Clinical Director <strong>and</strong> the<br />

Matron for Children’s services to explain<br />

to the committee the complexities of<br />

staffing level risks in A&E <strong>and</strong> a lack of<br />

high dependency unit (HDU) facilities. This<br />

enabled the QRC to recommend to the Board<br />

that both of these risks are high on the risk<br />

register.<br />

The two main Board committees for risk<br />

management are the Audit & Assurance<br />

Committee (AAC) <strong>and</strong> the QRC. The QRC<br />

was formed in-year from an amalgamation<br />

of the former Integrated Risk Management<br />

Committee (IRMC) <strong>and</strong> the Clinical Quality<br />

& St<strong>and</strong>ards Committee (CQSC). The AAC<br />

provides assurance that there is a sound<br />

system of internal control <strong>and</strong> governance.<br />

The QRC ensures that risks to the delivery<br />

of the <strong>Trust</strong>’s services are identified <strong>and</strong><br />

<strong>Annual</strong> governance statement<br />

99


addressed. Corporate risks are reported<br />

from ward to Board/QRC via Divisional<br />

Governance Boards using the online risk<br />

register managed by the <strong>Trust</strong>’s Corporate<br />

Governance department. The QRC also<br />

provides assurance in matters relating to<br />

clinical quality <strong>and</strong> st<strong>and</strong>ards. The Medical<br />

Director <strong>and</strong> Director of Patient Experience<br />

& Nursing together provide leadership<br />

in Clinical Governance, supported by the<br />

Assistant Director of Clinical Governance &<br />

Quality.<br />

The Board Assurance Framework (BAF) is<br />

the key proactive risk identification tool<br />

for the <strong>Trust</strong>. The <strong>Trust</strong>’s Strategy on a<br />

Page which includes critical success factors,<br />

reviewed annually, is mapped into the<br />

BAF. The BAF aims to provide the Board<br />

with assurance that significant threats to<br />

achieving the principal <strong>Trust</strong> objectives have<br />

been identified <strong>and</strong> are being appropriately<br />

controlled, <strong>and</strong> that there is timely <strong>and</strong><br />

reliable assurance in place to evidence<br />

this. Action plans within the BAF address<br />

how assurances will be provided; or, where<br />

assurances have identified inadequate<br />

controls, how controls will be improved.<br />

The BAF provides a structure for the<br />

evidence to support the <strong>Annual</strong> Governance<br />

Statement. Any unacceptable residual levels<br />

of risk remaining are further risk assessed<br />

<strong>and</strong> added to the corporate risk register to<br />

ensure the gaps in control are reduced or<br />

closed as soon as reasonably practicable. The<br />

BAF has cross references from the delivery<br />

of strategic objectives to the corporate<br />

risk register; to regulatory st<strong>and</strong>ards e.g.<br />

<strong>NHS</strong>LA, CQC in order to demonstrate where<br />

a strategic objective links with a regulatory<br />

st<strong>and</strong>ard <strong>and</strong> the risks currently associated<br />

with the delivery of the objective; <strong>and</strong> to the<br />

monthly performance targets where trends<br />

in poor performance are picked up, noted<br />

in the BAF <strong>and</strong> the actions taken to mitigate<br />

the poor performance stated.<br />

The AAC <strong>and</strong> QRC have the opportunity to<br />

review <strong>and</strong> shape the BAF at their quarterly<br />

meetings. The <strong>Trust</strong> Board reviews the BAF<br />

twice a year <strong>and</strong> there is an annual Board<br />

Strategy Session which focuses on refreshing<br />

the BAF to ensure the principal risks have<br />

been identified. No significant gaps in<br />

control have been identified by the Board/<br />

Board Committees this year.<br />

There are structured processes in place<br />

for incident reporting, the investigation<br />

of Serious Incidents <strong>and</strong> following up<br />

outcomes from Board commissioned external<br />

reports. The <strong>Trust</strong> Board, through the Risk<br />

Management Strategy & Policy (including<br />

Board Assurance Framework) <strong>and</strong> the<br />

Incident Policy (including Serious Incident),<br />

promotes open <strong>and</strong> honest reporting of<br />

incidents, risks <strong>and</strong> hazards.<br />

The <strong>Trust</strong> has a positive culture of reporting<br />

incidents enhanced by accessible online<br />

reporting systems available across the <strong>Trust</strong>.<br />

The latest National <strong>Report</strong>ing Learning<br />

System (NRLS) report (March 20<strong>13</strong>) has shown<br />

the <strong>Trust</strong> to be in the 50th percentile for<br />

incident reporting. Clinical <strong>and</strong> non-clinical<br />

events that are assessed using the <strong>Trust</strong><br />

Incident (including Serious Incident) policy<br />

to be a Serious Incident (SI) are forwarded to<br />

the Chief Executive or designated Executive<br />

to confirm if the incident is an SI.<br />

Once declared, SIs are reported on the<br />

Department of Health Strategic Executive<br />

Information System (STEIS); to Monitor on<br />

a quarterly basis <strong>and</strong> a monthly update<br />

to the <strong>Trust</strong> Board on the progress of<br />

investigation/action progress <strong>and</strong> lessons<br />

learnt. Lessons learnt are shared within <strong>and</strong><br />

where appropriate across Divisions. Further<br />

information on the SIs at the <strong>Trust</strong>, <strong>and</strong><br />

the actions taken by the <strong>Trust</strong> as a result of<br />

the learning from these, is included in the<br />

Quality <strong>Report</strong>.<br />

100 <strong>Annual</strong> governance statement


The Board has proactively commissioned<br />

external assurance when the information<br />

reviewed by the Board, such as from Serious<br />

Incidents, mortality data, <strong>and</strong> ward visits<br />

has indicated that there is scope for further<br />

investigation <strong>and</strong> improvement.<br />

Risk management training <strong>and</strong> awareness is<br />

included in the m<strong>and</strong>atory New Employees<br />

Week (NEW) programme for all new<br />

employees. The <strong>Trust</strong>’s Health <strong>and</strong> Safety<br />

team deliver risk management training<br />

appropriate to all levels across the <strong>Trust</strong><br />

including the <strong>Trust</strong> Board. The Nursing<br />

Education Skills Programmes are reviewed<br />

three monthly, <strong>and</strong> updated to ensure the<br />

latest evidence-based/best practices are<br />

incorporated; this would include learning<br />

from for example NPSA alerts.<br />

The Board is committed to a culture of<br />

continual learning <strong>and</strong> quality improvement.<br />

Learning from risk management activities<br />

such as trends in incidents, complaints <strong>and</strong><br />

claims are monitored <strong>and</strong> acted upon at<br />

Divisional level. Where appropriate, Internal<br />

Audit <strong>and</strong> Clinical Audit is used to provide<br />

assurance that changes to practice have<br />

become embedded e.g. the programme of<br />

Infection Prevention <strong>and</strong> Control audit <strong>and</strong><br />

monitoring provides assurance to the Board<br />

<strong>and</strong> has played a pivotal role in the reduction<br />

in Healthcare Associated Infections. Major<br />

reports from Healthcare Regulators are<br />

used to assess what lessons the <strong>Trust</strong> can<br />

learn from significant incidents <strong>and</strong> events<br />

in other healthcare organisations in order<br />

to evaluate <strong>and</strong> improve our practice the<br />

most recent being the Independent Inquiry<br />

into care provided by Mid Staffordshire<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> January 2005 – March<br />

2009 Volume II Robert Francis QC (Francis),<br />

published February 20<strong>13</strong>. Here a public<br />

Board paper was produced in February<br />

20<strong>13</strong> highlighting the key findings <strong>and</strong><br />

immediate actions to be taken by the <strong>Trust</strong>.<br />

Listening events have been held with staff<br />

in March 20<strong>13</strong> on both hospital sites as<br />

recommended by Health Secretary Jeremy<br />

Hunt. In addition, a presentation to the<br />

People in Partnership meeting was delivered;<br />

this provided an outline of the findings of<br />

the Francis Inquiry <strong>and</strong> its recommendations<br />

<strong>and</strong> allowed the <strong>Trust</strong> an opportunity to<br />

engage with its public <strong>and</strong> patients to hear<br />

their concerns <strong>and</strong> views in relation to<br />

the report. Recognising that the CQC will<br />

publish guidance for Governors to make<br />

their role more accountable, a presentation<br />

<strong>and</strong> discussion at a Council of Governors<br />

meeting was also undertaken. The Board<br />

will also consider the implications at a future<br />

Board Strategy session to ensure work that<br />

is to be taken forward is aligned with the<br />

conversations that have already taken place<br />

in relation to a new <strong>and</strong> refreshed clinical<br />

quality strategy.<br />

4. The risk <strong>and</strong> control framework<br />

The system of internal control is based on an<br />

on-going risk management process that is<br />

embedded in the organisation <strong>and</strong> combines<br />

many elements. The aforementioned<br />

comprehensive Risk Management Strategy<br />

& Policy (including BAF) is available to all<br />

staff on the <strong>Trust</strong>’s intranet site. All staff<br />

are responsible for managing risks within<br />

the scope of their role <strong>and</strong> responsibilities<br />

as employees of the <strong>Trust</strong>. The purpose of<br />

this risk management policy is to ensure<br />

that the <strong>Trust</strong> manages risks in all areas<br />

using a systematic <strong>and</strong> consistent approach.<br />

The document describes the <strong>Trust</strong>’s overall<br />

risk management process <strong>and</strong> the <strong>Trust</strong>’s<br />

risk identification, evaluation <strong>and</strong> control<br />

system, which includes the risk matrix used to<br />

evaluate risks. Risks are identified reactively<br />

<strong>and</strong> proactively.<br />

All risks are assessed against one st<strong>and</strong>ard<br />

tool this ensures that a consistent approach<br />

is taken to the evaluation <strong>and</strong> monitoring of<br />

risk in terms of the assessment of likelihood<br />

<strong>and</strong> impact. Risks are monitored through a<br />

formal reporting process where the assessed<br />

level of risk <strong>and</strong> its strategic significance<br />

determines where it will be reviewed <strong>and</strong><br />

<strong>Annual</strong> governance statement<br />

101


monitored. The monitoring of risks <strong>and</strong><br />

action plans have been undertaken by the<br />

<strong>Trust</strong> Board/<strong>Trust</strong> Board committees during<br />

<strong>2012</strong>/<strong>13</strong>.<br />

These committees are supported by<br />

Executive chaired committees/groups <strong>and</strong><br />

Divisional governance structures that channel<br />

information up to <strong>and</strong> down from the Board/<br />

Board committees via the online risk register.<br />

Risk appetite as well as risk tolerance is<br />

covered in the risk strategy. The Board has<br />

not set specific limits for this, but will view<br />

risks <strong>and</strong> the progress of actions designed<br />

to mitigate risk, on an individual risk basis.<br />

The accepted risks are reviewed at least<br />

annually by IRMC/QRC/Divisional Governance<br />

Boards to check that the controls for these<br />

accepted risks still st<strong>and</strong>. The Board’s IRMC/<br />

QRC recommends which corporate risks<br />

may be accepted based on the level of<br />

the required resource; assurance that all<br />

reasonable measures have been put in<br />

place to mitigate any risks; <strong>and</strong> that there is<br />

assurance that these are monitored regularly.<br />

Risk consequences are considered as part<br />

of cost improvement plans, business cases,<br />

capital expenditure projects <strong>and</strong> staffing<br />

<strong>and</strong> workforce priorities regarding vacancy<br />

authorisation. This ensures that the <strong>Trust</strong><br />

is taking account of the key inter-linking<br />

priorities <strong>and</strong> dependencies of finance,<br />

operation <strong>and</strong> service quality risk in order to<br />

deliver the best quality service to patients.<br />

The <strong>Trust</strong> Board reviews all of the high<br />

corporate risks quarterly; the IRMC/QRC<br />

reviews all the medium <strong>and</strong> high corporate<br />

risks quarterly <strong>and</strong> the Divisional Boards<br />

review all relevant risks at all levels quarterly.<br />

The main risks facing the <strong>Trust</strong> are<br />

summarised:<br />

• Significant clinical risks in-year:<br />

shortage of paediatric A&E nurses<br />

<strong>and</strong> lack of commissioned High<br />

Dependency Unit (HDU) facilities<br />

for children (the latter being a pan<br />

London issue). This is mitigated by<br />

adult trained nurses from other<br />

areas of A&E being deployed to the<br />

paediatric A&E as required; a senior<br />

staff nurse has been appointed as<br />

Head of Paediatric nursing to assist<br />

with staff cover including redeploying<br />

paediatric nurses from the ward to<br />

A&E as required. Paediatric HDU cover<br />

is provided by using bank/agency<br />

nursing staff; a dedicated paediatric<br />

clinical transfer bag is available <strong>and</strong><br />

in use <strong>and</strong> a paediatric ventilator<br />

has been procured <strong>and</strong> used prior to<br />

transferring children out of the <strong>Trust</strong><br />

as required this is monitored through<br />

internal incident reporting.<br />

• Financial – financial performance<br />

<strong>and</strong> liquidity. This risk is mitigated<br />

by a revised monthly <strong>and</strong> quarterly<br />

performance management framework,<br />

monthly QIPP Board <strong>and</strong> monthly<br />

<strong>Trust</strong> Board reporting. The <strong>Trust</strong> has a<br />

committed working capital facility <strong>and</strong><br />

written agreements from NW London<br />

Commissioners to support with cash in<br />

<strong>2012</strong>/<strong>13</strong> to maintain current financial<br />

risk rating <strong>and</strong> written agreement<br />

from NW London Commissioners to<br />

pay for valid over performance in<br />

<strong>2012</strong>/<strong>13</strong>.<br />

• Age <strong>and</strong> condition of the Estate poses<br />

both a clinical <strong>and</strong> financial risk with<br />

its extensive <strong>and</strong> old building stock<br />

on both sites; resulting in increasing<br />

frequency <strong>and</strong> severity of fabric failure<br />

<strong>and</strong> interruption of service delivery.<br />

This is managed by a prioritised<br />

five year forward view of high <strong>and</strong><br />

significant backlog maintenance<br />

requirements, risk assessed <strong>and</strong> rated<br />

against available capital.<br />

102 <strong>Annual</strong> governance statement


The main future risks facing the <strong>Trust</strong> are<br />

summarised:<br />

Future clinical risks:<br />

‣ NW London Shaping a Healthier<br />

Future does not develop at the<br />

anticipated rate affecting acute<br />

activity;<br />

‣ the large emergency care project<br />

(ECP) is not managed or delivered as<br />

planned to specific timescales/cost;<br />

<strong>and</strong> during the build the reduction in<br />

A&E treatment space is not efficiently<br />

managed; <strong>and</strong><br />

‣ potential staffing pressure <strong>and</strong> costs<br />

post Francis.<br />

These risks are mitigated by:<br />

‣ working closely with GPs <strong>and</strong> CCG<br />

leads to ensure that the right<br />

incentives <strong>and</strong> contract levers are in<br />

place to influence social care provision<br />

to facilitate timely discharge <strong>and</strong> an<br />

appreciation that shifting work from<br />

the acute hospital is only possible once<br />

the out of hospital strategy is worked<br />

up in the community;<br />

‣ for the ECP early clinical engagement<br />

to improve patient pathway<br />

efficiencies, reduce length of stay <strong>and</strong><br />

ensure adequate communication for<br />

staff, patients <strong>and</strong> visitors; <strong>and</strong><br />

‣ for staffing issues post Francis – the<br />

<strong>Trust</strong> has recently participated in a<br />

pan-London nursing <strong>and</strong> midwifery<br />

productivity benchmarking exercise<br />

which, along with other best practice<br />

guidance will inform our future<br />

staffing requirements; from April 20<strong>13</strong><br />

the <strong>Trust</strong> is implementing m<strong>and</strong>atory<br />

customer care training for all staff; a<br />

leadership strategy has been agreed<br />

by the Board <strong>and</strong> work has begun<br />

in a number of areas; over 30 of the<br />

<strong>Trust</strong>’s nursing leaders have undergone<br />

a three day leadership development<br />

course, in April the <strong>Trust</strong> will extend<br />

its Talent Management Programme to<br />

nearly 500 staff including consultants<br />

which will help identify any gaps in<br />

leadership skills amongst our leaders<br />

as well as identify those with potential<br />

whilst supporting our succession<br />

planning <strong>and</strong> training commissioning;<br />

a review of b<strong>and</strong> 1-4 roles <strong>and</strong><br />

development has also commenced.<br />

Future financial risk:<br />

‣ commissioning risk if activity is not<br />

paid for, potentially leading to clinical<br />

<strong>and</strong> financial viability concerns;<br />

‣ operational <strong>and</strong> investment cash gets<br />

extremely tight <strong>and</strong> starts to impede<br />

on service delivery; <strong>and</strong><br />

‣ unprecedented size of efficiency<br />

savings required in 20<strong>13</strong>/14 <strong>and</strong> for<br />

the next five years <strong>and</strong> its impact on<br />

quality of care provided.<br />

These risks are mitigated by:<br />

‣ regular meetings with the <strong>Hillingdon</strong><br />

Clinical Commissioning Group <strong>and</strong><br />

the North West (NW) London sector<br />

commissioners to identify issues early;<br />

‣ regular internal meetings in relation<br />

to contract management performance<br />

with responsible managers;<br />

‣ agreed robust mitigation plans are<br />

in place to manage the financial<br />

consequences of a reasonable<br />

reduction in revenue as a consequence<br />

of services being decommissioned.<br />

The <strong>Trust</strong> will remain focused on the tension<br />

between quality, safety, financial efficiency,<br />

<strong>and</strong> risk to ensure that patient care remains<br />

uncompromised. The <strong>Trust</strong> will do this by<br />

having regular Board <strong>and</strong> Executive reviews<br />

of progress <strong>and</strong> delivery of agreed plans <strong>and</strong><br />

checking that all schemes are quality impact<br />

assessed.<br />

For data security, the <strong>Trust</strong> has an established<br />

Information Security Management System<br />

(ISMS) similar to that defined within the<br />

<strong>Annual</strong> governance statement<br />

103


International St<strong>and</strong>ard (ISO) 27001. This<br />

entails the identification <strong>and</strong> classification of<br />

information assets, risk assessing those assets<br />

<strong>and</strong> then establishing control frameworks<br />

to keep those assets secure. The <strong>Trust</strong> has<br />

committed to establishing ISMS through its<br />

compliance with the Information Governance<br />

(IG) Toolkit. One key element of our<br />

compliance is having a current Information<br />

Risk Policy. The policy is supported by an<br />

Information Risk Strategy <strong>and</strong> accompanying<br />

procedures. These set out the arrangements<br />

for governing information risk processes,<br />

i.e. the framework of accountability <strong>and</strong><br />

the roles <strong>and</strong> responsibilities of staff,<br />

management <strong>and</strong> committees. Together<br />

these contribute to the organisation meeting<br />

its legislative <strong>and</strong> regulatory requirements,<br />

as well as meeting requirements from the<br />

Department of Health for organisations to<br />

manage the security of their information,<br />

defined within the Connecting for Health<br />

Information Governance Toolkit. Compliance<br />

evidence for version 10 of the Information<br />

Governance Toolkit has been uploaded<br />

to <strong>NHS</strong> Connecting for Health <strong>and</strong> all<br />

requirements are at a level 2 or 3 except for<br />

the requirement to have 95% of staff trained<br />

annually in Information Governance which<br />

is at level 1. IG training compliance will be<br />

driven by a change in <strong>Trust</strong> Statutory <strong>and</strong><br />

M<strong>and</strong>atory Training Policy which provides<br />

monthly reporting of staff compliance to<br />

managers, <strong>and</strong> by the delivery of bespoke<br />

training to specific staff groups.<br />

The key quality performance information is<br />

assessed monthly by the <strong>Trust</strong> Board which<br />

reviews the performance report – both the<br />

targets table <strong>and</strong> the prose which interprets<br />

the numbers, discrepancies <strong>and</strong> any required<br />

actions. The data is further assured by the use<br />

of Data Quality Badges which are described<br />

in each monthly performance report.<br />

Internal Audit reviewed IG arrangements in<br />

the <strong>Trust</strong> <strong>and</strong> gave substantial assurance. This<br />

took into account the one serious incident<br />

regarding data loss which was duly reported<br />

to the Information Commissioner, Monitor<br />

<strong>and</strong> fully investigated <strong>and</strong> managed by<br />

the <strong>Trust</strong>. Lessons learnt have now become<br />

established practice for example internal mail<br />

is now transported in sealed Envopaks rather<br />

than individual envelopes.<br />

Control measures are in place to ensure<br />

that all the organisation’s obligations<br />

under equality, diversity <strong>and</strong> human rights<br />

legislation are complied with.<br />

Equality impact assessments (EIA) are<br />

integrated into core <strong>Trust</strong> business e.g. they<br />

are carried out as st<strong>and</strong>ard procedure for<br />

all <strong>Trust</strong>’s policies. In addition the <strong>Trust</strong> has<br />

published its Service <strong>and</strong> Workforce Equality<br />

Compliance <strong>Report</strong>s on 31st January 20<strong>13</strong><br />

<strong>and</strong> reported on year one of its Equality<br />

Objectives on 6th April 20<strong>13</strong> providing<br />

assurance that the <strong>Trust</strong> is compliant with<br />

Equality legislation.<br />

As an employer with staff entitled to<br />

membership of the <strong>NHS</strong> Pension Scheme,<br />

control measures are in place to ensure<br />

all employer obligations contained within<br />

the Scheme regulations are complied with.<br />

This includes ensuring that deductions<br />

from salary, employer’s contributions <strong>and</strong><br />

payments to the Scheme are in accordance<br />

with the Scheme rules, <strong>and</strong> that member<br />

Pension Scheme records are accurately<br />

updated in accordance with the timescales<br />

detailed in the Regulations.<br />

Care Quality Commission (CQC)<br />

Compliance<br />

Compliance with the CQC essential st<strong>and</strong>ards<br />

of quality <strong>and</strong> safety are one of the elements<br />

of the organisation’s risk management<br />

process.<br />

The <strong>Trust</strong> is registered with the CQC without<br />

conditions. The <strong>Trust</strong> is fully compliant with<br />

the registration requirements of the Care<br />

Quality Commission.<br />

104 <strong>Annual</strong> governance statement


To ensure the <strong>Trust</strong> remains compliant with<br />

the CQC essential st<strong>and</strong>ards of quality <strong>and</strong><br />

safety the following assurance processes are<br />

in place:<br />

• Corporate Governance examines the<br />

Quality & Risk profile <strong>and</strong> produces a<br />

tracker risk profile for review by the<br />

Executive team <strong>and</strong> senior managers<br />

in the <strong>Trust</strong>. This enables any issues to<br />

be raised <strong>and</strong> challenged <strong>and</strong> opens<br />

dialogue with the CQC inspectors<br />

as required. The highest rated risk<br />

this year has been high amber for<br />

complaints; this has now dropped to<br />

low amber. Complaints have been<br />

picked up in the Board performance<br />

reports <strong>and</strong> systems are in place to<br />

increase efficiency with dealing with<br />

complaints.<br />

• CQSC/QRC receives a CQC compliance<br />

report twice yearly <strong>and</strong> AAC<br />

annually. This report is produced<br />

by Corporate Governance <strong>and</strong> is an<br />

outcome review of all the regulated<br />

outcomes. The provider compliance<br />

assessments (PCA) are used to ensure<br />

the <strong>Trust</strong> has due processes in place<br />

to enable compliance. However, the<br />

current <strong>Trust</strong> approach does not<br />

facilitate a granular approach to<br />

compliance monitoring <strong>and</strong> Corporate<br />

Governance are putting forward a<br />

case to install a software package that<br />

enables input of data from varied<br />

sources in order to gauge CQC (<strong>and</strong><br />

<strong>NHS</strong>LA) compliance across each area<br />

of the <strong>Trust</strong>. This will form part of the<br />

evolving Informatics Strategy.<br />

Internal audit reviewed a sample of our<br />

PCA <strong>and</strong> methodology of CQC compliance<br />

monitoring <strong>and</strong> gave substantial assurance in<br />

September <strong>2012</strong>.<br />

The CQC paid an unannounced visit to the<br />

<strong>Hillingdon</strong> <strong>Hospital</strong> site in December <strong>2012</strong>.<br />

The resulting report from the CQC stated full<br />

compliance with the essential st<strong>and</strong>ards of<br />

quality <strong>and</strong> safety. These two recent external<br />

reports, as well as the internal monitoring<br />

of CQC compliance, provide me with good<br />

assurance that the <strong>Trust</strong> continues to be fully<br />

compliant with the CQC essential st<strong>and</strong>ards<br />

of quality <strong>and</strong> safety.<br />

There has been one Internal Audit report<br />

giving Limited Assurance this year <strong>and</strong> this<br />

related to Oversees Visitors <strong>and</strong> the <strong>Trust</strong> not<br />

having robust systems in place to ensure that<br />

appropriate identification, billing, payment<br />

<strong>and</strong> debt collection procedures were in place<br />

<strong>and</strong> operating effectively. Since this report<br />

several improvements have been put in place<br />

at the frontline to ensure higher efficiency.<br />

The <strong>Trust</strong> involves its key public stakeholders<br />

with managing the risks that affect them<br />

through the following mechanisms:<br />

• Engagement with the local Health<br />

Overview <strong>and</strong> Scrutiny Committee<br />

• Engagement with the Local Involvement<br />

Network (Healthwatch from 1st April<br />

20<strong>13</strong>)The Council of Governors are<br />

consulted on key issues <strong>and</strong> risks as part<br />

of the annual plan<br />

• Board approved Membership<br />

Development <strong>and</strong> Engagement<br />

Strategy <strong>2012</strong>-15, which was consulted<br />

on extensively with the Council of<br />

Governors<br />

• Regular People in Partnership Forums<br />

which aim to involve patients <strong>and</strong> the<br />

local community in decision-making on<br />

the acute health services offered<br />

• <strong>Annual</strong> Members Meeting<br />

• Foundation <strong>Trust</strong> Office where members<br />

can raise specific issues with the <strong>Trust</strong><br />

<strong>and</strong>/or relevant Governor<br />

• Engagement with User Groups <strong>and</strong><br />

Support Groups e.g. People Improving<br />

Cancer Services, Fighting Infection<br />

Together, Somalian Maternity focus<br />

group, Disability Action Group, Readers<br />

Panel.<br />

<strong>Annual</strong> governance statement<br />

105


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> has undertaken risk assessments <strong>and</strong><br />

Carbon Reduction Delivery Plans are in place<br />

in accordance with emergency preparedness<br />

<strong>and</strong> civil contingency requirements, as based<br />

on UKCIP 2009 weather projects, to ensure<br />

that this organisation’s obligations under<br />

the Climate Change Act <strong>and</strong> the Adaptation<br />

<strong>Report</strong>ing requirements are complied with.<br />

Adaption reporting uses a risk assessment<br />

approach; coupled with regular detailed<br />

buildings condition survey, in conjunction<br />

with resilience planning, founded on<br />

weather-based risks e.g. heat wave, extreme<br />

cold, drought, <strong>and</strong> flood.<br />

Compliance with the Code of Governance -<br />

The Board considers itself compliant with all<br />

provisions of the <strong>NHS</strong> Foundation <strong>Trust</strong> Code<br />

of Governance. This is following discussion<br />

<strong>and</strong> review at the AAC <strong>and</strong> <strong>Trust</strong> Board. The<br />

Board has made the disclosures required by<br />

the Code in the Governance <strong>Report</strong> section<br />

of this annual report, including attendance<br />

records <strong>and</strong> coverage of work for each Board<br />

committee.<br />

5. Review of economy, efficiency<br />

<strong>and</strong> effectiveness of the use of<br />

resources<br />

The following key processes are in place to<br />

ensure that resources are used economically,<br />

efficiently <strong>and</strong> effectively:<br />

• Scheme of Delegation <strong>and</strong> Reservation<br />

of Powers approved by the Board sets<br />

out the decisions, authorities <strong>and</strong> duties<br />

delegated to officers of the <strong>Trust</strong>.<br />

• St<strong>and</strong>ing Financial Instructions detail<br />

the financial responsibilities, policies<br />

<strong>and</strong> procedures adopted by the <strong>Trust</strong>.<br />

They are designed to ensure that an<br />

organisation’s financial transactions<br />

are carried out in accordance with the<br />

law <strong>and</strong> Government policy in order<br />

to achieve probity, accuracy, economy,<br />

efficiency <strong>and</strong> effectiveness.<br />

• Robust competitive processes used for<br />

procuring non-staff expenditure items.<br />

Above £25k, procurement involves<br />

competitive tendering.<br />

• Cost improvement programmes (CIPs),<br />

which are assessed for their impact on<br />

quality with local clinical ownership <strong>and</strong><br />

accountability<br />

• Use of National <strong>and</strong> London<br />

benchmarking for non-clinical support<br />

functions.<br />

The <strong>Trust</strong> Board has gained assurance<br />

from the former Finance <strong>and</strong> Investment<br />

(F&I) Committee in respect of financial<br />

<strong>and</strong> budgetary management across the<br />

organisation <strong>and</strong> the AAC, which receives<br />

quarterly reports regarding Losses <strong>and</strong><br />

Compensations (with high value approved<br />

by the Board), Write-Off of Bad Debts, Going<br />

Concern <strong>and</strong> Contingent Liabilities. The AAC<br />

has agreed levels of charges for overseas<br />

visitors based on write offs to ensure that<br />

the charges take account of the risk of nonpayment.<br />

For information the F&I Committee has<br />

been disb<strong>and</strong>ed. The newly formed<br />

Transformation Committee (January 20<strong>13</strong>)<br />

was established to assist the Board with the<br />

shaping, review <strong>and</strong> challenge of service<br />

transformation, development <strong>and</strong> redesign,<br />

increasing governance of the CIPs (supported<br />

by a strengthened project management<br />

office established in the light of a Monitor<br />

<strong>Annual</strong> Plan Review recommendation);<br />

<strong>and</strong> to provide assurance that the strategy<br />

for the management of human, financial,<br />

estate, <strong>and</strong> IT resources support such business<br />

transformation. The Committee replaced<br />

the Finance & Investment Committee<br />

as the Board sought to ensure greater<br />

Board scrutiny <strong>and</strong> challenge on service<br />

transformation <strong>and</strong> redesign.<br />

Value for money discussions take place at<br />

Board strategy sessions based on service line<br />

reporting reviewing how much a service<br />

106 <strong>Annual</strong> governance statement


costs to run versus the income it generates<br />

<strong>and</strong> how it is performing both clinically<br />

<strong>and</strong> operationally. This is particularly the<br />

approach used around services where<br />

competition is greatest <strong>and</strong>/or where a<br />

service is out to tender.<br />

Further information with reference to the<br />

<strong>Trust</strong>’s financial future regarding the Going<br />

Concern assessment, is included in the<br />

‘Financial Disclosures’ section in the Directors<br />

<strong>Report</strong> of this <strong>Annual</strong> <strong>Report</strong>. This draws<br />

specific attention to the recent financial<br />

performance, the challenging financial<br />

context facing the <strong>Trust</strong> <strong>and</strong> the programme<br />

the Board is investing in to support the<br />

delivery of the savings identified going<br />

forward.<br />

There are a range of internal <strong>and</strong> external<br />

audits (e.g. Audit Commission external<br />

reviews on payment by results) that provide<br />

further assurance on quality of financial<br />

data, economy, efficiency <strong>and</strong> effectiveness,<br />

including internal audit reports on creditors,<br />

financial reporting <strong>and</strong> budgetary control,<br />

healthcare contracting & payment by results,<br />

cash management, cost improvement<br />

programmes <strong>and</strong> financial <strong>and</strong> activity data<br />

<strong>and</strong> how it is linked including clinical coding.<br />

These are all reported to AAC. All Internal<br />

Audit reports into finance functions have<br />

reported substantial assurance for the past<br />

three financial years.<br />

6. <strong>Annual</strong> Quality <strong>Report</strong><br />

The Directors are required under the Health<br />

Act 2009 <strong>and</strong> the National Health Service<br />

(Quality <strong>Accounts</strong>) Regulations 2010 (as<br />

amended) to prepare Quality <strong>Accounts</strong><br />

for each financial year. Monitor has issued<br />

guidance to <strong>NHS</strong> Foundation <strong>Trust</strong> Boards<br />

on the form <strong>and</strong> content of <strong>Annual</strong> Quality<br />

<strong>Report</strong>s which incorporate the above legal<br />

requirements in the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>Annual</strong> <strong>Report</strong>ing Manual.<br />

The <strong>Trust</strong>’s commitment to quality <strong>and</strong><br />

quality governance is based on a clearly<br />

defined clinical quality strategy, a system<br />

of quality performance management, <strong>and</strong><br />

a clear risk management process. There is a<br />

performance <strong>and</strong> quality report presented<br />

to the Board which allows key threats <strong>and</strong><br />

risks to quality to be identified with more<br />

quality detail including review of incident,<br />

complaints data <strong>and</strong> the like being reviewed<br />

by the Board’s committee, the Clinical Quality<br />

<strong>and</strong> St<strong>and</strong>ards Committee (CQSC)/now the<br />

Quality & Risk Committee (QRC).<br />

The supply of information to the Board,<br />

<strong>and</strong> the management team, <strong>and</strong> oversight<br />

of this, is undertaken by a specialist team in<br />

clinical governance. This is led by a senior<br />

clinical manager <strong>and</strong> supported by specialist<br />

risk facilitators <strong>and</strong> a clinical audit <strong>and</strong><br />

effectiveness manager <strong>and</strong> audit team.<br />

The Board monitors quality through the<br />

following processes:<br />

1) the monthly quality operational report<br />

<strong>and</strong> a quarterly quality report;<br />

2) the reporting of serious incidents <strong>and</strong><br />

learning from them to the monthly<br />

Board meetings;<br />

3) a more in-depth review of quality <strong>and</strong><br />

parameters by the CQSC/QRC.<br />

4) Observations of care – undertaken on<br />

a monthly basis where Board members<br />

accompany senior nurses <strong>and</strong> visit<br />

wards on a rotational basis to review<br />

the quality of care. During the visit, the<br />

environment, attitudes <strong>and</strong> behaviours<br />

of staff, team working <strong>and</strong> specific<br />

aspects of patient experience <strong>and</strong><br />

safety are assessed.<br />

The <strong>Trust</strong> has a comprehensive clinical audit<br />

work plan covering both national <strong>and</strong><br />

local audits. Regular updates on clinical<br />

audit are reported to the CQSC/QRC. Issues<br />

raised via Clinical Audit result in changes in<br />

practice within the <strong>Trust</strong> e.g. as a result of<br />

the National Audit of Dementia the <strong>Trust</strong><br />

has implemented the following: A dementia<br />

<strong>Annual</strong> governance statement<br />

107


training programme that ensures the correct<br />

level of training for staff e.g. specialised<br />

training for staff working closely with<br />

dementia patients <strong>and</strong> ‘This is me’ document,<br />

which helps to find out better information<br />

about dementia patients to help care better<br />

for them <strong>and</strong> meet their individual needs.<br />

A Clinical Assurance Panel (CAP) has been<br />

set up to assess the quality impact of any<br />

changing service brought about for QIPP. This<br />

is a multi-professional clinical panel, chaired<br />

by the Medical Director, which formally<br />

reviews all cross-divisional service changes.<br />

A nursing quality dashboard has been<br />

developed to allow ward to Board reporting;<br />

this includes headline nursing metrics under<br />

the domains of clinical effectiveness, patient<br />

safety <strong>and</strong> patient quality experience.<br />

The dashboard is presented to the QRC<br />

on a quarterly basis <strong>and</strong> reviewed by the<br />

Director of Nursing at divisional performance<br />

meetings with senior nursing staff on a<br />

monthly basis.<br />

A framework exists for the management <strong>and</strong><br />

accountability of data quality, supported<br />

by a comprehensive audit programme <strong>and</strong><br />

the Data Quality Policy, which consist of a<br />

set of quality data groups that run across<br />

the organisation. These groups report to<br />

an Executive Director-led steering group<br />

which feeds quarterly into the AAC. These<br />

quarterly data quality reports to AAC cover<br />

the Monitor compliance data reported to<br />

the Board <strong>and</strong> other key data quality issues<br />

like <strong>NHS</strong> number <strong>and</strong> duplicate records. This,<br />

together with the data audit results, provides<br />

assurance to the Board on data quality<br />

issues <strong>and</strong> strength of internal control.<br />

Three key data areas have been identified<br />

this year where further actions are being<br />

implemented:<br />

1) Duplicate patient records – this involves<br />

the last few remaining <strong>Trust</strong> systems<br />

that have a relatively high number of<br />

duplicate records (above 3%).<br />

2) 18 week patient pathways - to<br />

strengthen controls to ensure these are<br />

always accurately recorded.<br />

3) VTE assessment sheets – to ensure<br />

these are always attached to patient<br />

notes.<br />

The priorities for the <strong>Annual</strong> Quality<br />

<strong>Report</strong> are drawn together <strong>and</strong> shaped<br />

via a structured timeline which engages<br />

our key stakeholders, such as Patients<br />

in Partnership, Governors, Healthwatch;<br />

the Clinical Divisions, Clinical Governance<br />

Committee <strong>and</strong> QRC. These processes <strong>and</strong><br />

the leadership involved ensure the Quality<br />

<strong>Report</strong> represents a balanced view.<br />

7 Review of effectiveness<br />

As Accounting Officer, I have responsibility<br />

for reviewing the effectiveness of the<br />

system of internal control. My review of<br />

the effectiveness of the system of internal<br />

control is informed by the work of the<br />

internal auditors, clinical audit <strong>and</strong> the<br />

executive managers <strong>and</strong> clinical leads<br />

within the <strong>NHS</strong> Foundation <strong>Trust</strong> who<br />

have responsibility for the development<br />

<strong>and</strong> maintenance of the internal control<br />

framework. I have drawn on the content<br />

of the quality report attached to this<br />

<strong>Annual</strong> <strong>Report</strong> <strong>and</strong> other performance<br />

information available to me. My review is<br />

also informed by comments made by the<br />

external auditors in their management<br />

letter <strong>and</strong> other reports. I have been advised<br />

on the implications of the result of my<br />

review of the effectiveness of the system<br />

of internal control by the Board, the Audit<br />

<strong>and</strong> Assurance Committee, Integrated<br />

Risk Management Committee/Quality<br />

& Risk Committee <strong>and</strong> Clinical Quality<br />

<strong>and</strong> St<strong>and</strong>ards committee, <strong>and</strong> a plan to<br />

address weaknesses <strong>and</strong> ensure continuous<br />

improvement of the system is in place.<br />

108 <strong>Annual</strong> governance statement


The process that has been used to maintain<br />

<strong>and</strong> review the effectiveness of the system of<br />

internal control centres on<br />

• the effectiveness of the Board has<br />

been reviewed during the year <strong>and</strong><br />

as a result the Board changed its<br />

committee arrangements to enable<br />

it to work in a more structured way<br />

with regards to service development<br />

<strong>and</strong> transformation, including the role<br />

of the <strong>Trust</strong>’s workforce, estate <strong>and</strong> IT<br />

services<br />

• the Board’s annual review of the<br />

Board Committee structure, their<br />

effectiveness <strong>and</strong> terms of reference<br />

which are reviewed by the Board <strong>and</strong><br />

by each Committee; of note this year<br />

the changes in amalgamating IRMC<br />

<strong>and</strong> CQSC to form the QRC, dissolving<br />

the F&I committee <strong>and</strong> forming the<br />

Transformation Committee;<br />

• development, review <strong>and</strong> challenge<br />

of the BAF which is compiled by<br />

Corporate Governance in conjunction<br />

with the relevant Executive Directors<br />

<strong>and</strong> their senior managers; the BAF<br />

is then scrutinised quarterly at both<br />

the former IRMC/QRC <strong>and</strong> AAC prior<br />

to being reviewed by the Board twice<br />

yearly.<br />

Internal audit have reviewed the BAF <strong>and</strong> the<br />

methodology involved in forming the tool<br />

<strong>and</strong> have given substantial assurance that the<br />

<strong>Trust</strong> has in place adequate <strong>and</strong> appropriate<br />

arrangements for gaining assurances about<br />

the effectiveness of the organisation’s system<br />

of internal control.<br />

Some of the more challenging areas this year<br />

have been the closeness to the Clostridium<br />

difficile target, A&E 4 hour target issues in<br />

the later part of quarters 3 <strong>and</strong> 4 <strong>and</strong> the<br />

cost improvement plan. However, despite<br />

these challenges the <strong>Trust</strong> has managed to<br />

maintain a financial risk rating of 3 <strong>and</strong> a<br />

green governance rating.<br />

On balance, I therefore conclude that that<br />

the Board has conducted a review of the<br />

effectiveness of the <strong>Trust</strong>’s system on internal<br />

controls <strong>and</strong> found them to be sufficient.<br />

Conclusion<br />

My review confirms that The <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> has no<br />

significant internal control issues <strong>and</strong> a<br />

generally sound system of internal control<br />

that supports the achievement of its policies,<br />

aims <strong>and</strong> objectives.<br />

The BAF is reviewed <strong>and</strong> challenged as<br />

described in section 3 above. There is then<br />

an annual examination <strong>and</strong> refreshing of the<br />

principal objectives cited in the BAF, new risks<br />

added if required or risks amended to suit<br />

the current climate.<br />

<strong>Annual</strong> governance statement<br />

109


INDEPENDENT AUDITOR’S REPORT TO THE BOARD OF<br />

GOVERNORS AND BOARD OF DIRECTORS OF THE HILLINGDON<br />

HOSPITALS <strong>NHS</strong> FOUNDATION TRUST<br />

We have audited the financial statements of The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation<br />

for the year ended 31 March 20<strong>13</strong> which comprise the Income Statement, the Statement<br />

of Comprehensive Income, the Balance Sheet, the Cash Flow Statement, the Statement<br />

of Changes in Taxpayers Equity <strong>and</strong> the related notes 1 to 31. The financial reporting<br />

framework that has been applied in their preparation is applicable law <strong>and</strong> the accounting<br />

policies directed by Monitor – Independent Regulator of <strong>NHS</strong> Foundation <strong>Trust</strong>s.<br />

This report is made solely to the Board of Governors <strong>and</strong> Board of Directors (“the Boards”) of<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong>, as a body, in accordance with paragraph 4 of<br />

Schedule 10 of the National Health Service Act 2006. Our audit work has been undertaken<br />

so that we might state to the Boards those matters we are required to state to them in an<br />

auditor’s report <strong>and</strong> for no other purpose. To the fullest extent permitted by law, we do not<br />

accept or assume responsibility to anyone other than the trust <strong>and</strong> the Boards as a body, for<br />

our audit work, for this report, or for the opinions we have formed.<br />

Respective responsibilities of the accounting officer <strong>and</strong> auditor<br />

As explained more fully in the Accounting Officer’s Responsibilities Statement, the<br />

Accounting Officer is responsible for the preparation of the financial statements <strong>and</strong> for<br />

being satisfied that they give a true <strong>and</strong> fair view. Our responsibility is to audit <strong>and</strong> express<br />

an opinion on the financial statements in accordance with applicable law, the Audit Code<br />

of <strong>NHS</strong> Foundation <strong>Trust</strong>s <strong>and</strong> International St<strong>and</strong>ards on Auditing (UK <strong>and</strong> Irel<strong>and</strong>). Those<br />

st<strong>and</strong>ards require us to comply with the Auditing Practices Board’s Ethical St<strong>and</strong>ards for<br />

Auditors.<br />

Scope of the audit of the financial statements<br />

An audit involves obtaining evidence about the amounts <strong>and</strong> disclosures in the financial<br />

statements sufficient to give reasonable assurance that the financial statements are free from<br />

material misstatement, whether caused by fraud or error. This includes an assessment of:<br />

whether the accounting policies are appropriate to the trust’s circumstances <strong>and</strong> have been<br />

consistently applied <strong>and</strong> adequately disclosed; the reasonableness of significant accounting<br />

estimates made by the Accounting Officer; <strong>and</strong> the overall presentation of the financial<br />

statements. In addition, we read all the financial <strong>and</strong> non-financial information in the<br />

annual report to identify material inconsistencies with the audited financial statements <strong>and</strong><br />

to identify any information that is apparently materially incorrect based on, or materially<br />

inconsistent with, the knowledge acquired by us in the course of performing the audit. If we<br />

become aware of any apparent material misstatements or inconsistencies we consider the<br />

implications for our report.<br />

110 Auditor’s report


Opinion on financial statements<br />

In our opinion the financial statements:<br />

• give a true <strong>and</strong> fair view of the state of the trust’s affairs as at 31 March 20<strong>13</strong> <strong>and</strong> of its<br />

income <strong>and</strong> expenditure for the year then ended;<br />

• have been properly prepared in accordance with the accounting policies directed by<br />

Monitor – Independent Regulator of <strong>NHS</strong> Foundation <strong>Trust</strong>s; <strong>and</strong><br />

• have been prepared in accordance with the requirements of the National Health Service<br />

Act 2006.<br />

Opinion on other matter[s] prescribed by the National Health Service Act<br />

2006<br />

In our opinion:<br />

• the part of the Directors’ Remuneration <strong>Report</strong> to be audited has been properly prepared<br />

in accordance with the National Health Service Act 2006; <strong>and</strong><br />

• the information given in the Directors’ <strong>Report</strong> for the financial year for which the<br />

financial statements are prepared is consistent with the financial statements.<br />

Matters on which we are required to report by exception<br />

We have nothing to report in respect of the following matters where the Audit Code for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s requires us to report to you if, in our opinion:<br />

• the <strong>Annual</strong> Governance Statement does not meet the disclosure requirements set out in<br />

the <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing Manual, is misleading or inconsistent with<br />

information of which we are aware from our audit. We are not required to consider, nor<br />

have we considered, whether the <strong>Annual</strong> Governance Statement addresses all risks <strong>and</strong><br />

controls or that risks are satisfactorily addressed by internal controls;<br />

• proper practices have not been observed in the compilation of the financial statements;<br />

or<br />

• the <strong>NHS</strong> foundation trust has not made proper arrangements for securing economy,<br />

efficiency <strong>and</strong> effectiveness in its use of resources.<br />

Certificate<br />

We certify that we have completed the audit of the accounts in accordance with the<br />

requirements of Chapter 5 of Part 2 of the National Health Service Act 2006 <strong>and</strong> the Audit<br />

Code for <strong>NHS</strong> Foundation <strong>Trust</strong>s.<br />

Craig Wisdom (Senior Statutory Auditor)<br />

for <strong>and</strong> on behalf of Deloitte LLP<br />

Chartered Accountants <strong>and</strong> Statutory Auditor<br />

St Albans, United Kingdom<br />

29 May 20<strong>13</strong><br />

Auditor’s report<br />

111


ANNUAL ACCOUNTS <strong>2012</strong>/<strong>13</strong><br />

Foreword to the accounts<br />

The accounts for the year ended 31st March 20<strong>13</strong> have been prepared by the <strong>Hillingdon</strong><br />

<strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> in accordance with paragraphs 24 <strong>and</strong> 25 of Schedule 7 of<br />

the National Health Services Act 2006 in the form which the Independent Regulator of <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s (Monitor) has, with the approval of the Secretary of State, directed.<br />

112 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

STATEMENT OF COMPREHENSIVE INCOME NOTE 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Operating Income 3 194,541 190,291<br />

Operating expenses 4 (192,732) (191,129)<br />

OPERATING SURPLUS / (DEFICIT) 1,810 (838)<br />

NON-OPERATING INCOME<br />

Finance income 8 14 14<br />

Other non-operating Income 9 1,692 2,347<br />

TOTAL NON-OPERATING INCOME 1,706 2,361<br />

NON-OPERATING COSTS<br />

Finance expense - financial liabilities 10 (1,778) (1,688)<br />

Finance expense - unwinding of discount on provisions 25 (63) (47)<br />

PDC Dividends payable (3,533) (3,723)<br />

TOTAL NON-OPERATING COSTS (5,374) (5,458)<br />

SURPLUS/(DEFICIT) FOR THE YEAR (1,858) (3,935)<br />

Other comprehensive income<br />

Impairments 12 (16) (5,062)<br />

Revaluations 12 420 6,212<br />

TOTAL COMPREHENSIVE INCOME / (EXPENSE) FOR THE YEAR (1,454) (2,785)<br />

All income <strong>and</strong> expenditure is derived from continuing operations.<br />

The notes on pages 117 <strong>13</strong>5 to 156 174 form part of these accounts.<br />

<strong>Annual</strong> accounts<br />

1<strong>13</strong>


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

STATEMENT OF FINANCIAL POSITION NOTE 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Non-current assets<br />

Intangible Assets 11 1,948 0<br />

Property, plant <strong>and</strong> equipment 12 114,917 115,771<br />

Investment property 14 14,816 <strong>13</strong>,124<br />

Trade <strong>and</strong> other receivables 18 1,473 1,344<br />

Total non-current assets <strong>13</strong>3,154 <strong>13</strong>0,239<br />

Current assets<br />

Inventories 17 3,042 2,916<br />

Trade <strong>and</strong> other receivables 18 <strong>13</strong>,319 14,509<br />

Cash <strong>and</strong> cash equivalents 19 3,906 1,897<br />

Total current assets 20,267 19,322<br />

Total assets 153,421 149,561<br />

Current liabilities<br />

Trade <strong>and</strong> other payables 20 (20,446) (18,348)<br />

Borrowings 21 (1,353) (1,351)<br />

Provisions 25 (165) (162)<br />

Total Current Liabilities (21,964) (19,861)<br />

Net current assets/(liabilities) (1,697) (539)<br />

Total assets less current liabilities <strong>13</strong>1,457 129,700<br />

Non-current liabilities<br />

Borrowings 21 (21,942) (21,186)<br />

Provisions 25 (1,948) (1,930)<br />

Total assets employed 107,567 106,584<br />

Financed by taxpayers' equity:<br />

Public dividend capital 60,251 57,814<br />

Revaluation reserve 23,090 23,436<br />

Retained earnings 24,226 25,334<br />

Total taxpayers' equity 107,567 106,584<br />

The financial statements on pages <strong>13</strong>1 to <strong>13</strong>4 were approved by the Board on 28th May 20<strong>13</strong> <strong>and</strong> signed on<br />

its behalf by:<br />

The financial statements on pages 1<strong>13</strong> to 116 were approved by the Board on 28th May 20<strong>13</strong> <strong>and</strong><br />

signed on its behalf by:<br />

Signed: …………………………(Chief Executive)<br />

Date: ……………………<br />

114 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

STATEMENT OF CHANGES IN TAXPAYERS' EQUITY<br />

Income <strong>and</strong><br />

STATEMENT OF CHANGES IN TAXPAYERS' EQUITY<br />

Public Dividend Revaluation Income <strong>and</strong> Expenditure<br />

Public Total Dividend Capital Revaluation Reserve Expenditure Reserve<br />

Total<br />

£000<br />

£000 Capital<br />

£000<br />

£000 Reserve<br />

£000<br />

£000 Reserve<br />

£000<br />

£000<br />

Taxpayers' Equity at 1 April <strong>2012</strong> 106,584 57,814 23,436 25,334<br />

Taxpayers'<br />

Surplus/(deficit)<br />

Equity at 1 April<br />

for<br />

<strong>2012</strong><br />

the year<br />

106,584 57,814 23,436 25,334<br />

(1,858) 0 0 (1,858)<br />

Surplus/(deficit)<br />

Transfers<br />

for<br />

between<br />

the year<br />

reserves<br />

(1,858) 0 0 (1,858)<br />

0 0 (750) 750<br />

Transfers<br />

Impairments<br />

between reserves 0<br />

(16)<br />

0<br />

0<br />

(750)<br />

(16)<br />

750<br />

0<br />

Impairments<br />

Revaluations - property, plant <strong>and</strong> equipment<br />

(16)<br />

420<br />

0<br />

0<br />

(16)<br />

420<br />

0<br />

0<br />

Revaluations<br />

Public<br />

- property,<br />

Dividend<br />

plant<br />

Capital<br />

<strong>and</strong><br />

received<br />

equipment 420<br />

2,437<br />

0<br />

2,437<br />

420<br />

0<br />

0<br />

0<br />

Public Dividend<br />

Taxpayers'<br />

Capital<br />

Equity<br />

received<br />

at 31 March 20<strong>13</strong><br />

2,437<br />

107,567<br />

2,437<br />

60,251<br />

0<br />

23,090<br />

0<br />

24,226<br />

Taxpayers' Equity at 31 March 20<strong>13</strong> 107,567 60,251 23,090 24,226<br />

Taxpayers' Equity at 1 April 2011 108,569 57,014 23,262 28,293<br />

Taxpayers' Equity at 1 April 2011 108,569 57,014 23,262 28,293<br />

Surplus/(deficit) for the year (3,935) 0 0 (3,935)<br />

Surplus/(deficit) for the year<br />

Transfers between reserves (3,935) 0 0 (3,935)<br />

0 0 (976) 976<br />

Transfers between reserves<br />

Impairments 0 0 (976) 976<br />

(5,062) 0 (5,062) 0<br />

Impairments<br />

Revaluations - property, plant <strong>and</strong> equipment (5,062) 0 (5,062) 0<br />

6,212 0 6,212 0<br />

Revaluations - property, plant <strong>and</strong> equipment<br />

Public Dividend Capital received 6,212 0 6,212 0<br />

800 800 0 0<br />

Public Dividend Capital received<br />

Taxpayers' Equity at 31 March <strong>2012</strong> 800 106,584 800 57,814 0 23,436 0 25,334<br />

Taxpayers' Equity at 31 March <strong>2012</strong> 106,584 57,814 23,436 25,334<br />

<strong>Annual</strong> accounts<br />

115


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

STATEMENT OF CASH FLOWS NOTE 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Cash flows from operating activities<br />

Operating surplus/(deficit) 1,810 (838)<br />

Non-cash income <strong>and</strong> expense:<br />

Depreciation <strong>and</strong> amortisation 7,619 7,482<br />

Impairments 36 4,197<br />

(Gain)/Loss on disposal 441 0<br />

Receipt of Donated Assets (194) (1,281)<br />

(Increase)/Decrease in Trade <strong>and</strong> Other Receivables 1,126 (1,908)<br />

(Increase)/Decrease in Inventories (126) 78<br />

Increase/(Decrease) in Trade <strong>and</strong> Other Payables 2,159 5,116<br />

Increase/(Decrease) in Trade <strong>and</strong> Other Liabilities (63) 0<br />

Increase/(Decrease) in Provisions 21 (75)<br />

Other Movements in Cash Flow 1 0<br />

Net cash generated from/(used in) Operations 12,830 12,771<br />

Cash flows from investing activities<br />

Interest received 14 14<br />

Sales of property plant <strong>and</strong> equipment 5 0<br />

Purchase of intangible assets (20) 0<br />

Purchase of Property, Plant <strong>and</strong> Equipment (8,578) (5,425)<br />

Net cash generated from/(used in) investing activities (8,579) (5,411)<br />

Cash flows from financing activities<br />

Public dividend capital received 2,437 800<br />

Loans repaid to the Department of Health (390) (390)<br />

Capital element of finance lease rental payments (851) (721)<br />

Capital element of LIFT (257) (241)<br />

Capital Finance through Finance Leases 2,256 0<br />

Interest paid (284) (297)<br />

Late payment of Commercial Debts Interest (8) (3)<br />

Interest Element on Finance Lease (142) (128)<br />

Interest element of LIFT (1,344) (1,260)<br />

PDC Dividend paid (3,659) (3,723)<br />

Net cash generated from/(used in) financing activities (2,242) (5,963)<br />

Increase/(decrease) in cash <strong>and</strong> cash equivalents 2,009 1,397<br />

Cash <strong>and</strong> Cash equivalents at start of period 1,897 500<br />

Cash <strong>and</strong> Cash equivalents at end of period 19 3,906 1,897<br />

116 <strong>Annual</strong> accounts


Note 1 Accounting Policies<br />

1.1. Basis of Preparation<br />

Monitor, the Independent Regulator<br />

of <strong>NHS</strong> Foundation <strong>Trust</strong>s has directed<br />

that the financial statements of <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s shall meet the<br />

accounting requirements of the <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s <strong>Annual</strong> <strong>Report</strong>ing<br />

Manual (FT ARM), as agreed with HM<br />

Treasury. Consequently, the following<br />

financial statements have been<br />

prepared in accordance with the <strong>2012</strong>-<br />

<strong>13</strong> FT ARM. The accounting policies<br />

contained in that manual follow<br />

International Financial <strong>Report</strong>ing<br />

St<strong>and</strong>ards (IFRS) <strong>and</strong> the HM<br />

Treasury's Financial <strong>Report</strong>ing Manual<br />

(FReM) to the extent that they are<br />

meaningful <strong>and</strong> appropriate to <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s. The particular<br />

policies adopted by the <strong>Trust</strong> are<br />

described below. They have been<br />

applied consistently in dealing with<br />

items considered material in relation<br />

to the accounts.<br />

1.2. Accounting judgments <strong>and</strong><br />

key sources of estimation <strong>and</strong><br />

uncertainty<br />

In the application of the <strong>Trust</strong>’s<br />

accounting policies management<br />

is required to make judgments,<br />

estimates, <strong>and</strong> assumptions about<br />

the carrying amount of assets<br />

<strong>and</strong> liabilities that are not readily<br />

apparent from other sources.<br />

The estimates <strong>and</strong> associated<br />

assumptions are based on historical<br />

experience <strong>and</strong> other factors<br />

considered of relevance. Actual results<br />

may differ from those estimates<br />

<strong>and</strong> underlying assumptions are<br />

continually reviewed. Revisions to<br />

estimates are recognised in the period<br />

in which the estimate is revised, if the<br />

revision affects only that period, or<br />

in the period of revision <strong>and</strong> future<br />

periods if the revision affects both<br />

current <strong>and</strong> future periods.<br />

The following are the areas that<br />

critical judgments have been made<br />

in the process of applying accounting<br />

policies at the end of the reporting<br />

period that have a risk of causing a<br />

material adjustment to the carrying<br />

amount of assets <strong>and</strong> liabilities within<br />

the next financial year<br />

• Going Concern<br />

• Asset valuation <strong>and</strong> lives<br />

• Impairments of receivables<br />

• Provisions<br />

• Accruals.<br />

The critical judgements are addressed<br />

in the accounting policies that follow.<br />

1.3. Going concern<br />

After making enquiries, the directors<br />

have a reasonable expectation that<br />

the Foundation <strong>Trust</strong> has adequate<br />

resources to continue in operational<br />

existence for the foreseeable future.<br />

For this reason, they continue to<br />

adopt the going concern basis in<br />

preparing these financial statements.<br />

1.4. Accounting convention<br />

These accounts have been prepared<br />

under the historical cost convention<br />

modified to account for the<br />

revaluation of property, plant<br />

<strong>and</strong> equipment, intangible assets,<br />

inventories <strong>and</strong> certain financial assets<br />

<strong>and</strong> financial liabilities.<br />

1.5. Current / non-current<br />

classification<br />

Assets <strong>and</strong> liabilities are classified as<br />

current if they are expected to be<br />

realised within twelve months from<br />

the Statement of Financial Position<br />

date, the primary purpose of the asset<br />

<strong>and</strong> liability is to be traded, or of<br />

<strong>Annual</strong> accounts<br />

117


loans <strong>and</strong> receivables where they have<br />

a maturity of less than twelve months<br />

from the Statement of Financial<br />

Position date. All other assets <strong>and</strong><br />

liabilities are classified as non-current.<br />

1.6. Consolidation<br />

The <strong>Trust</strong>’s charitable funds would<br />

be considered as a subsidiary entity<br />

in that the <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> are corporate<br />

trustees <strong>and</strong> as such exert control over<br />

the uses of these funds. The <strong>Trust</strong> also<br />

governs the financial <strong>and</strong> operational<br />

policies as homogeneous with those<br />

of the main body. However HM<br />

Treasury has granted a dispensation<br />

from applying IAS 27 for <strong>2012</strong>/<strong>13</strong>.<br />

1.7. Income recognition<br />

Income in respect of services provided<br />

is recognised when, <strong>and</strong> to the extent<br />

that, performance occurs, <strong>and</strong> is<br />

measured at the fair value of the<br />

consideration receivable. The main<br />

source of revenue for the <strong>Trust</strong> is from<br />

<strong>NHS</strong> commissioners for healthcare<br />

services.<br />

Where income is received for a<br />

specific activity that is to be delivered<br />

in the following year, that income is<br />

deferred.<br />

Income from the sales of non-current<br />

assets is recognised only when all<br />

material conditions of sale have been<br />

met, <strong>and</strong> is measured as the sums due<br />

under the sale contract.<br />

1.8. Partially Completed Spells<br />

The Partial Spells accrual relates to<br />

patients who remain undischarged at<br />

31/03/20<strong>13</strong> in relation to income. The<br />

<strong>Trust</strong> reflect income at the point of<br />

discharge in line with the matching<br />

concept. The <strong>Trust</strong> have accrued<br />

income on a per patient basis to<br />

31/03/20<strong>13</strong> based on average tariff<br />

rates for the speciality. Ordinarily<br />

this activity is coded once the patient<br />

has been discharged <strong>and</strong> generated<br />

a Health Resource Grouper code to<br />

which National Tariff rates are applied<br />

to calculate the income. Hence an<br />

average tariff is applied based on<br />

point of delivery <strong>and</strong> length of stay by<br />

speciality.<br />

1.9. Expenditure on employee<br />

benefits<br />

Short-term employee benefits<br />

Salaries, wages <strong>and</strong> employmentrelated<br />

payments are recognised in<br />

the period in which the service is<br />

received from employees.<br />

1.10. Pension costs<br />

Past <strong>and</strong> present employees are<br />

covered by the provisions of the <strong>NHS</strong><br />

Pensions Scheme. The scheme is an<br />

unfunded, defined benefit scheme<br />

that covers <strong>NHS</strong> employers, General<br />

Practices <strong>and</strong> other bodies, allowed<br />

under the direction of the Secretary<br />

of State, in Engl<strong>and</strong> <strong>and</strong> Wales. The<br />

scheme is not designed to be run in<br />

a way that would enable the <strong>NHS</strong><br />

Foundation <strong>Trust</strong> to identify its share<br />

of the underlying scheme assets <strong>and</strong><br />

liabilities. Therefore, the scheme is<br />

accounted for as if it were a defined<br />

contribution scheme: the cost to<br />

the <strong>NHS</strong> body of participating in<br />

the scheme is taken as equal to the<br />

contributions payable to the scheme<br />

for the accounting period.<br />

For early retirements other than<br />

those due to ill health the additional<br />

pension liabilities are not funded<br />

by the scheme. The full amount of<br />

the liability for the additional costs<br />

is charged to expenditure at the<br />

time the <strong>Trust</strong> commits itself to the<br />

retirement, regardless of the method<br />

of payment.<br />

118 <strong>Annual</strong> accounts


Further details of <strong>NHS</strong> Pensions<br />

payable under these provisions<br />

can be found on the <strong>NHS</strong> Pensions<br />

website at www.nhsba.nhs.uk/<br />

pensions.<br />

1.11. Other expenses<br />

Other operating expenses are<br />

recognised when, <strong>and</strong> to the extent<br />

that, the goods or services have<br />

been received. They are measured at<br />

the fair value of the consideration<br />

payable. Expenditure is recognised<br />

in operating expenses except where<br />

it results in the creation of a non<br />

current asset such as property, plant<br />

<strong>and</strong> equipment.<br />

1.12. <strong>NHS</strong> pension scheme<br />

The scheme is subject to a full<br />

actuarial valuation every four years<br />

(until 2004, every five years) <strong>and</strong> an<br />

accounting valuation every year. An<br />

outline of these follows:<br />

a. Full actuarial (funding) valuation<br />

The purpose of this valuation<br />

is to assess the level of liability<br />

in respect of the benefits due<br />

under the scheme (taking into<br />

account its recent demographic<br />

experience), <strong>and</strong> to recommend<br />

the contribution rates to be<br />

paid by employers <strong>and</strong> scheme<br />

members.<br />

The scheme is subject to full<br />

actuarial valuations. The last such<br />

valuation, which determined<br />

current contribution rates was<br />

undertaken as at 31 March 2004<br />

<strong>and</strong> covered the period from 1<br />

April 1999 to that date.<br />

The conclusion from the 2004<br />

valuation was that the scheme<br />

had accumulated a notional<br />

deficit of £3.3 billion against<br />

the notional assets as at 31<br />

March 2004. In order to defray<br />

the costs of benefits, employers<br />

pay contributions at 14% of<br />

pensionable pay <strong>and</strong> most<br />

employees had up to April 2008<br />

paid 6%, with manual staff<br />

paying 5%.<br />

Following the full actuarial review<br />

by the Government Actuary<br />

undertaken as at 31 March<br />

2004, <strong>and</strong> after consideration<br />

of changes to the <strong>NHS</strong> Pension<br />

Scheme taking effect from 1<br />

April 2008, his Valuation report<br />

recommended that employer<br />

contributions could continue<br />

at the existing rate of 14% of<br />

pensionable pay, from 1 April<br />

2008, following the introduction<br />

of employee contributions on<br />

a tiered scale from 5% up to<br />

8.5% of their pensionable pay<br />

depending on total earnings.<br />

On advice from the scheme<br />

actuary, scheme contributions<br />

may be varied from time to time<br />

to reflect changes in the scheme’s<br />

liabilities.<br />

b. Accounting valuation<br />

A valuation of the scheme liability<br />

is carried out annually by the<br />

scheme actuary as at the end of<br />

the reporting period by updating<br />

the results of the full actuarial<br />

valuation.<br />

Between the full actuarial<br />

valuations at a two-year<br />

midpoint, a full <strong>and</strong> detailed<br />

member data-set is provided<br />

to the scheme actuary. At this<br />

point the assumptions regarding<br />

the composition of the scheme<br />

membership are updated to allow<br />

the scheme liability to be valued.<br />

The valuation of the scheme<br />

liability as at 31 March 20<strong>13</strong>, is<br />

<strong>Annual</strong> accounts<br />

119


ased on detailed membership<br />

data as at 31 March 2008 (the<br />

latest midpoint) updated to 31<br />

March 20<strong>13</strong> with summary global<br />

member <strong>and</strong> accounting data.<br />

The latest assessment of the<br />

liabilities of the scheme is<br />

contained in the scheme actuary<br />

report, which forms part of the<br />

annual <strong>NHS</strong> Pension Scheme<br />

(Engl<strong>and</strong> <strong>and</strong> Wales) Resource<br />

Account, published annually.<br />

These accounts can be viewed on<br />

the <strong>NHS</strong> Pensions website. Copies<br />

can also be obtained from The<br />

Stationery Office.<br />

c. Scheme provisions<br />

The <strong>NHS</strong> Pension Scheme provided<br />

defined benefits, which are<br />

summarised below. This list is an<br />

illustrative guide only, <strong>and</strong> is not<br />

intended to detail all the benefits<br />

provided by the Scheme or the<br />

specific conditions that must be<br />

met before these benefits can be<br />

obtained:<br />

The Scheme is a “final salary”<br />

scheme. <strong>Annual</strong> pensions are<br />

normally based on 1/80th for the<br />

1995 section <strong>and</strong> of the best of<br />

the last three years pensionable<br />

pay for each year of service,<br />

<strong>and</strong> 1/60th for the 2008 section<br />

of reckonable pay per year of<br />

membership.<br />

Members who are practitioners<br />

as defined by the Scheme<br />

Regulations have their annual<br />

pensions based upon total<br />

pensionable earnings over the<br />

relevant pensionable service.<br />

With effect from 1 April 2008<br />

members can choose to give up<br />

some of their annual pension<br />

for an additional tax free lump<br />

sum, up to a maximum amount<br />

permitted under HMRC rules.<br />

This new provision is known as<br />

“pension commutation”.<br />

<strong>Annual</strong> increases are applied to<br />

pension payments at rates defined<br />

by the Pensions (Increase) Act<br />

1971, <strong>and</strong> are based on changes in<br />

retail prices in the twelve months<br />

ending 30 September in the<br />

previous calendar year.<br />

Early payment of a pension,<br />

with enhancement, is available<br />

to members of the scheme who<br />

are permanently incapable of<br />

fulfilling their duties effectively<br />

through illness or infirmity. A<br />

death gratuity of twice final<br />

year’s pensionable pay for death<br />

in service, <strong>and</strong> five times their<br />

annual pension for death after<br />

retirement is payable.<br />

For early retirements other<br />

than those due to ill health the<br />

additional pension liabilities are<br />

not funded by the scheme. The<br />

full amount of the liability for<br />

the additional costs is charged to<br />

the statement of comprehensive<br />

income at the time the <strong>Trust</strong><br />

commits itself to the retirement,<br />

regardless of the method of<br />

payment. These costs exclude<br />

voluntary early retirement, as<br />

these costs are borne by the<br />

employee.<br />

Members can purchase additional<br />

service in the <strong>NHS</strong> Scheme <strong>and</strong><br />

contribute to money purchase<br />

AVC’s run by the Scheme’s<br />

approved providers or by<br />

other Free St<strong>and</strong>ing Additional<br />

Voluntary Contributions (FSAVC)<br />

providers.<br />

120 <strong>Annual</strong> accounts


1.<strong>13</strong> Property, plant <strong>and</strong> equipment<br />

recognition<br />

Property, plant <strong>and</strong> equipment is<br />

capitalised if:<br />

• it is held for use in delivering services<br />

or for administrative purposes;<br />

• it is probable that future economic<br />

benefits will flow to, or service<br />

potential will be supplied to, the<br />

<strong>Trust</strong>;<br />

• the cost of the item can be<br />

measured reliably; <strong>and</strong><br />

• the item has cost of at least £5,000;<br />

or<br />

• collectively, a number of items<br />

have a cost of at least £5,000 <strong>and</strong><br />

individually have a cost of more<br />

than £250, where the assets are<br />

functionally interdependent, they<br />

had broadly simultaneous purchase<br />

dates, are anticipated to have<br />

simultaneous disposal dates <strong>and</strong> are<br />

under single managerial control; or<br />

• items form part of the initial<br />

equipping <strong>and</strong> setting-up cost<br />

of a new building, ward or unit,<br />

irrespective of their individual or<br />

collective cost.<br />

The <strong>Trust</strong> is permitted to borrow funds<br />

to the extent that it complies with the<br />

Prudential Borrowing Code for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s. The capital sum is<br />

recognised as a liability <strong>and</strong> interest<br />

incurred is charged to finance expenses<br />

in the Statement of Comprehensive<br />

Income. Total borrowings of the<br />

<strong>Trust</strong> <strong>and</strong> performance against the<br />

Prudential Borrowing Limit is disclosed<br />

in note 29.<br />

Componentisation<br />

Where a large asset, for example<br />

a building, includes a number of<br />

components with significantly different<br />

asset lives e.g. plant <strong>and</strong> equipment,<br />

then these components are treated as<br />

separate assets <strong>and</strong> depreciated over<br />

their own useful economic lives.<br />

Valuation<br />

All property, plant <strong>and</strong> equipment are<br />

measured initially at cost, representing<br />

the cost directly attributable to<br />

acquiring or constructing the asset<br />

<strong>and</strong> bringing it to the location <strong>and</strong><br />

condition necessary for it to be capable<br />

of operating in the manner intended<br />

by management. All assets are<br />

measured subsequently at fair value.<br />

L<strong>and</strong> <strong>and</strong> buildings used for the<br />

<strong>Trust</strong>’s services or for administrative<br />

purposes are stated in the Statement<br />

of Financial Position at their revalued<br />

amounts, being the fair value at the<br />

date of revaluation less any subsequent<br />

accumulated depreciation <strong>and</strong><br />

impairment losses. Revaluations are<br />

performed with sufficient regularity to<br />

ensure that carrying amounts are not<br />

materially different from those that<br />

would be determined at the end of<br />

the reporting period. Fair values are<br />

determined as follows:<br />

• L<strong>and</strong> <strong>and</strong> non-specialised buildings –<br />

market value for existing use<br />

• Investment Properties - market value<br />

<strong>and</strong> or net rental income stream<br />

• Specialised buildings – depreciated<br />

replacement cost.<br />

HM Treasury has adopted a st<strong>and</strong>ard<br />

approach to depreciated replacement<br />

cost valuations based on modern<br />

equivalent assets <strong>and</strong>, where it would<br />

meet the location requirements of the<br />

service being provided, an alternative<br />

site can be valued.<br />

Properties in the course of construction<br />

for service or administration purposes<br />

are carried at cost, less any impairment<br />

loss. Cost includes professional fees<br />

but not borrowing costs, which are<br />

recognised as expenses immediately, as<br />

allowed by IAS 23 for assets held at fair<br />

<strong>Annual</strong> accounts<br />

121


value. Assets depreciation commences<br />

when they are brought into use.<br />

A full revaluation exercise took place in<br />

the 20011/12 financial year. In line with<br />

Treasury guidance, where appropriate<br />

the revaluation was based on a<br />

Modern Equivalent Assets replacement<br />

basis. The valuation was carried out in<br />

accordance with the Royal Institute of<br />

Chartered Surveyors (RICS) Appraisal<br />

<strong>and</strong> Valuation Manual insofar as these<br />

terms are consistent with the agreed<br />

requirements of the Department of<br />

Health <strong>and</strong> HM Treasury. The Surveyors<br />

were Gerald Eve.<br />

The <strong>Trust</strong> carries out a full revaluation<br />

exercise at least every five years<br />

unless the <strong>Trust</strong> considers there has<br />

been significant market movement In<br />

the intervening years. The <strong>Trust</strong> has<br />

taken advice from Gerald Eve who<br />

have advised that there have been no<br />

significant market movements relating<br />

to the <strong>Trust</strong>'s l<strong>and</strong> <strong>and</strong> buildings for<br />

<strong>2012</strong>/<strong>13</strong> financial year.<br />

New fixtures <strong>and</strong> equipment are<br />

carried at depreciated historic cost as<br />

this is not considered to be materially<br />

different from fair value.<br />

Subsequent expenditure<br />

Subsequent expenditure relating to an<br />

item of property, plant <strong>and</strong> equipment<br />

is recognised as an increase in the<br />

carrying amount of the asset when<br />

it is probable that additional future<br />

economic benefits or service potential<br />

deriving from the cost incurred to<br />

replace a component of such item will<br />

flow to the enterprise <strong>and</strong> the cost of<br />

the item can be determined reliably.<br />

Where a component of an asset is<br />

replaced, the cost of the replacement<br />

is capitalised if it meets the criteria<br />

for recognition above. The carrying<br />

amount of the part replaced is<br />

de-recognised. Other expenditure that<br />

does not generate additional future<br />

economic benefits or service potential,<br />

such as repairs <strong>and</strong> maintenance,<br />

is charged to the Statement of<br />

Comprehensive Income in the period in<br />

which it is incurred.<br />

Depreciation, amortisation <strong>and</strong><br />

impairments<br />

Freehold l<strong>and</strong>, properties under<br />

construction, <strong>and</strong> assets held for<br />

sale are not depreciated. Otherwise,<br />

depreciation <strong>and</strong> amortisation are<br />

charged to write off the costs or<br />

valuation of property, plant <strong>and</strong><br />

equipment <strong>and</strong> intangible noncurrent<br />

assets, less any residual<br />

value, over their estimated useful<br />

lives, in a manner that reflects the<br />

consumption of economic benefits<br />

or service potential of the assets.<br />

The estimated useful life of an asset<br />

is the period over which the <strong>Trust</strong><br />

expects to obtain economic benefits<br />

or service potential from the asset.<br />

This is specific to the <strong>Trust</strong> <strong>and</strong> may be<br />

shorter than the physical life of the<br />

asset itself. Estimated useful lives <strong>and</strong><br />

residual values are reviewed each year<br />

end, with the effect of any changes<br />

recognised on a prospective basis.<br />

Assets held under finance leases are<br />

depreciated over the lease period.<br />

In accordance with the Foundation<br />

<strong>Trust</strong> <strong>Annual</strong> <strong>Report</strong>ing Manual (FT<br />

ARM), impairments that are due to a<br />

loss of economic benefits or service<br />

potential in the asset are charged to<br />

operating expenses. A compensating<br />

transfer is made from the revaluation<br />

reserve to the income <strong>and</strong> expenditure<br />

reserve of an amount equal to the<br />

lower of (i) the impairment charged<br />

to operating expenses; <strong>and</strong> (ii) the<br />

balance in the revaluation reserve<br />

attributable to that asset before the<br />

impairment.<br />

122 <strong>Annual</strong> accounts


Other impairments are treated as<br />

revaluation losses. Reversals of other<br />

impairments are treated as revaluation<br />

gains.<br />

An impairment arising from a loss of<br />

economic benefit or service potential<br />

is reversed when, <strong>and</strong> to the extent<br />

that, the circumstances that gave rise<br />

to the loss is reversed. Reversals are<br />

recognised in operating income to<br />

the extent that the asset is restored<br />

to the carrying amount it would have<br />

had if the impairment had never been<br />

recognised. Any remaining reversal is<br />

recognised in the revaluation reserve.<br />

Where, at the time of the original<br />

impairment, a transfer was made from<br />

the revaluation reserve to the income<br />

<strong>and</strong> expenditure reserve, an amount<br />

is transferred back to the revaluation<br />

reserve when the impairment reversal<br />

is recognised.<br />

Revaluation gains, losses <strong>and</strong><br />

de-recognition<br />

Revaluation gains are recognised<br />

in the revaluation reserve, except<br />

where, <strong>and</strong> to the extent that, they<br />

reverse a revaluation decrease that<br />

has previously been recognised in<br />

operating expenses, in which case they<br />

are recognised in operating income.<br />

Revaluation losses are charged to the<br />

revaluation reserve to the extent that<br />

there is an available balance for the<br />

asset concerned, <strong>and</strong> thereafter are<br />

charged to operating expenses.<br />

Gains <strong>and</strong> losses recognised in the<br />

revaluation reserve are reported in the<br />

Statement of Comprehensive Income<br />

as an item of ‘other comprehensive<br />

income’.<br />

De-recognition<br />

Assets intended for disposal are<br />

reclassified as ‘Held for Sale’ once all<br />

of the following criteria are met: 1) the<br />

asset is available for immediate sale<br />

in its present condition subject only to<br />

terms which are usual <strong>and</strong> customary<br />

for such sales; 2) the sale must be<br />

highly probable i.e. management are<br />

committed to a plan to sell the asset;<br />

or an active programme has begun to<br />

find a buyer <strong>and</strong> complete the sale; 3)<br />

the asset is being actively marketed<br />

at a reasonable price; 4) the sale is<br />

expected to be completed within 12<br />

months of the date of classification as<br />

‘Held for Sale’; <strong>and</strong> the actions needed<br />

to complete the plan indicate it is<br />

unlikely that the plan will be dropped<br />

or significant changes made to it.<br />

Following reclassification, the assets<br />

are measured at the lower of their<br />

existing carrying amount <strong>and</strong> their ‘fair<br />

value less costs to sell’. Depreciation<br />

ceases to be charged. Assets are derecognised<br />

when all material sale<br />

contract conditions have been met.<br />

Property, plant <strong>and</strong> equipment which<br />

is to be scrapped or demolished does<br />

not qualify for recognition as ‘Held<br />

for Sale’ <strong>and</strong> instead is retained as<br />

an operational asset <strong>and</strong> the asset’s<br />

economic life is adjusted. The asset<br />

is de-recognised when scrapping or<br />

demolition occurs.<br />

1.14. Investment property<br />

Investment property is property<br />

held to earn rentals or for capital<br />

appreciation or both. A key factor<br />

in determining classification would<br />

be whether property was saleable<br />

separately. In considering whether<br />

l<strong>and</strong> meets this criteria the <strong>Trust</strong> would<br />

consider whether property had direct<br />

public access.<br />

<strong>Annual</strong> accounts<br />

123


Investment property is accounted for<br />

under the fair value model. A gain<br />

or loss arising from a change in the<br />

fair value of investment property is<br />

recognised in profit or loss for the<br />

period in which it arises.<br />

1.15. Donated assets<br />

Donated property, plant <strong>and</strong><br />

equipment assets are capitalised<br />

at their fair value on receipt. The<br />

donation is credited to income at<br />

the same time, unless the donor has<br />

imposed a condition that the future<br />

economic benefits embodied in the<br />

donation are to be consumed in a<br />

manner specified by the donor, in<br />

which case, the donation is deferred<br />

within liabilities <strong>and</strong> is carried forward<br />

to future financial years to the extent<br />

that the condition has not yet been<br />

met.<br />

The donated assets are subsequently<br />

accounted for in the same manner<br />

as other items of property, plant <strong>and</strong><br />

equipment.<br />

1.16. Intangible assets<br />

Recognition<br />

Intangible assets are non-monetary<br />

assets without physical substance which<br />

are capable of being sold separately<br />

from the rest of the <strong>Trust</strong>s business<br />

or which arise from contractual or<br />

other legal rights. They are recognised<br />

only where it is probable that future<br />

economic benefits will flow to, or<br />

service potential be provided to, the<br />

Foundation <strong>Trust</strong> <strong>and</strong> where the cost of<br />

the asset can be measured reliably.<br />

• The project is technically feasible<br />

to the point of completion <strong>and</strong> will<br />

result in an intangible asset for sale<br />

or use;<br />

• The Foundation <strong>Trust</strong> (FT) intends to<br />

complete the asset <strong>and</strong> sell or use it;<br />

• The FT has the ability to sell or use<br />

the asset;<br />

• How the asset will generate<br />

probable future economic benefits<br />

e.g. the presence of a market for its<br />

output or where it is to be used for<br />

internal use, the usefulness of the<br />

asset;<br />

• Adequate financial, technical, <strong>and</strong><br />

other resources are available to the<br />

FT to complete the development<br />

<strong>and</strong> sell or use the asset during<br />

development.<br />

Internally generated intangible<br />

assets<br />

Internally generated goodwill,<br />

br<strong>and</strong>s, mastheads, publishing titles,<br />

customer lists, <strong>and</strong> similar items are not<br />

capitalised as intangible assets, neither<br />

is expenditure on research.<br />

Impairments<br />

Assets that are subject to amortisation<br />

are reviewed for impairment whenever<br />

events or changes in circumstances<br />

indicate that the carrying amount may<br />

not be recoverable. Any impairment<br />

loss is recognised in the Statement of<br />

Comprehensive Income to reduce the<br />

carrying amount to the recoverable<br />

amount.<br />

Expenditure on research is not<br />

capitalised.<br />

The <strong>Trust</strong> is permitted to borrow funds<br />

to the extent that it complies with the<br />

Prudential Borrowing Code for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s. The capital sum is<br />

recognised as a liability <strong>and</strong> interest<br />

incurred is charged to finance expenses<br />

in the Statement of Comprehensive<br />

Income. Total borrowings of the<br />

<strong>Trust</strong> <strong>and</strong> performance against the<br />

Prudential Borrowing Limit is disclosed<br />

in note.<br />

124 <strong>Annual</strong> accounts


Software<br />

Software which is integral to the<br />

operation of hardware e.g. an<br />

operating system, is capitalised as part<br />

of the relevant item of property, plant<br />

<strong>and</strong> equipment. Software which is not<br />

integral to the operation of hardware<br />

e.g. application software is capitalised<br />

as an intangible asset.<br />

Measurement<br />

Intangible assets are recognised<br />

initially at cost, comprising of all<br />

directly attributable costs needed<br />

to create, produce <strong>and</strong> prepare the<br />

asset to the point that it is capable of<br />

operating in the manner intended by<br />

management. Subsequently intangible<br />

assets are measured at fair value.<br />

Revaluation gains <strong>and</strong> losses <strong>and</strong><br />

impairments are treated in the same<br />

manner as for property, plant <strong>and</strong><br />

equipment. comprising of all directly<br />

attributable costs needed to create,<br />

produce <strong>and</strong> prepare the asset to the<br />

point that it is capable of operating in<br />

the manner intended by management.<br />

Subsequently intangible assets are<br />

measured at fair value. Revaluation<br />

gains <strong>and</strong> losses <strong>and</strong> impairments<br />

are treated in the same manner as<br />

for property, plant <strong>and</strong> equipment.<br />

Intangible assets held for sale are<br />

measured at the lower of their carrying<br />

amount or ‘fair value less costs to sell.<br />

Amortisation<br />

Intangible assets are amortised over<br />

their expected useful economic lives<br />

in a manner consistent with the<br />

consumption of economic or service<br />

delivery benefits.<br />

• Development expenditure up to 5<br />

years<br />

• Software up to 5 years.<br />

1.17. Leases<br />

The <strong>Trust</strong> as lessee<br />

Finance leases<br />

Where substantially all risks <strong>and</strong><br />

rewards of ownership of a leased asset<br />

are borne by the <strong>NHS</strong> Foundation <strong>Trust</strong>,<br />

the asset is recorded as property, plant<br />

<strong>and</strong> equipment <strong>and</strong> a corresponding<br />

liability is recorded. The value at which<br />

both are recognised is the lower of the<br />

fair value of the asset or the present<br />

value of the minimum lease payments,<br />

discounted using the interest rate<br />

implicit in the lease. The implicit<br />

interest rate is that which produces a<br />

constant periodic rate of interest on<br />

the outst<strong>and</strong>ing liability.<br />

The asset <strong>and</strong> liability are recognised<br />

at the commencement of the lease.<br />

Thereafter, the asset is accounted<br />

for as an item of property plant <strong>and</strong><br />

equipment.<br />

The annual rental is split between the<br />

repayment of the liability <strong>and</strong> a finance<br />

cost so as to achieve a constant rate<br />

of finance over the life of the lease.<br />

The annual finance cost is charged<br />

to finance costs in the Statement of<br />

Comprehensive Income. The lease<br />

liability, is de-recognised when the<br />

liability is discharged, cancelled or<br />

expires.<br />

Operating leases<br />

Other leases are regarded as operating<br />

leases <strong>and</strong> the rentals are charged<br />

to operating expenses on a straightline<br />

basis over the term of the lease.<br />

Operating lease incentives received are<br />

added to the lease rentals <strong>and</strong> charged<br />

to operating expenses over the life of<br />

the lease.<br />

Leases of l<strong>and</strong> <strong>and</strong> buildings<br />

Where a lease is for l<strong>and</strong> <strong>and</strong> buildings,<br />

the l<strong>and</strong> component is separated<br />

from the building component <strong>and</strong><br />

<strong>Annual</strong> accounts<br />

125


the classification for each is assessed<br />

separately.<br />

The <strong>Trust</strong> as Lessor<br />

Rental income from operating leases is<br />

recognised on a straight-line basis over<br />

the term of the lease. Initial direct costs<br />

incurred in negotiating <strong>and</strong> arranging<br />

an operating lease are added to the<br />

carrying amount of the leased asset<br />

<strong>and</strong> recognised on a straight-line basis<br />

over the lease term.<br />

1.18. Local Improvement Finance<br />

<strong>Trust</strong> (LIFT) transactions<br />

HM Treasury has determined that<br />

government bodies shall account for<br />

infrastructure LIFT schemes where the<br />

government body controls the use of<br />

the infrastructure <strong>and</strong> the residual<br />

interest in the infrastructure at the<br />

end of the arrangement as service<br />

concession arrangements, following<br />

the principles of the requirements of<br />

IFRIC 12. The <strong>Trust</strong> therefore recognises<br />

the LIFT asset as an item of property,<br />

plant <strong>and</strong> equipment together with<br />

a liability to pay for it. The services<br />

received under the contract are<br />

recorded as operating expenses.<br />

The annual lease plus payment<br />

is separated into the following<br />

component parts, using appropriate<br />

estimation techniques where necessary:<br />

a. Payment for the fair value of<br />

services received;<br />

b. Payment for the LIFT asset, including<br />

finance costs;<br />

The <strong>Trust</strong> is currently party to a 25-year<br />

LIFT lease plus contract.<br />

Services received<br />

The fair value of services received<br />

in the year is recorded under the<br />

relevant expenditure headings within<br />

‘operating expenses’.<br />

LIFT Asset<br />

The LIFT assets are recognised as<br />

property, plant <strong>and</strong> equipment,<br />

when they come into use. The assets<br />

are measured initially at fair value<br />

in accordance with the principles of<br />

IAS 17. Subsequently, the assets are<br />

measured at fair value, which is kept<br />

up to date in accordance with the<br />

<strong>Trust</strong>’s approach for each relevant<br />

class of asset in accordance with the<br />

principles of IAS 16.<br />

LIFT liability<br />

A LIFT liability is recognised at the<br />

same time as the LIFT assets are<br />

recognised. It is measured initially at<br />

the same amount as the fair value of<br />

the LIFT assets <strong>and</strong> is subsequently<br />

measured as a finance lease liability in<br />

accordance with IAS 17.<br />

An annual finance cost is calculated by<br />

applying the implicit interest rate in<br />

the lease to the opening lease liability<br />

for the period, <strong>and</strong> is charged to<br />

‘Finance Costs’ within the Statement of<br />

Comprehensive Income.<br />

The element of the lease plus payment<br />

that is allocated as a finance lease<br />

rental is applied to meet the annual<br />

finance cost <strong>and</strong> to repay the lease<br />

liability over the contract term.<br />

An element of the lease plus payment<br />

increase due to cumulative indexation<br />

is allocated to the finance lease. In<br />

accordance with IAS 17, this amount<br />

is not included in the minimum lease<br />

payments, but is instead treated as<br />

contingent rent <strong>and</strong> is expensed as<br />

incurred. In substance, this amount<br />

is a finance cost in respect of the<br />

liability <strong>and</strong> the expense is presented<br />

as a contingent finance cost in the<br />

Statement of Comprehensive Income.<br />

126 <strong>Annual</strong> accounts


1.19. Inventories<br />

Inventories are valued on a FIFO basis<br />

(First In First Out).<br />

1.20. Cash <strong>and</strong> cash equivalents<br />

Cash is cash in h<strong>and</strong> <strong>and</strong> deposits with<br />

any financial institution repayable<br />

without penalty on notice of not more<br />

than 24 hours. Cash equivalents are<br />

investments that mature in 3 months<br />

or less from the date of acquisition <strong>and</strong><br />

that are readily convertible to known<br />

amounts of cash with insignificant risk<br />

of change in value.<br />

In the Statement of Cash Flows, cash<br />

<strong>and</strong> cash equivalents are shown net of<br />

bank overdrafts that are repayable on<br />

dem<strong>and</strong> <strong>and</strong> that form an integral part<br />

of the <strong>Trust</strong>’s cash management.<br />

1.21. Provisions<br />

The amount recognised as a provision<br />

is the best estimate of the expenditure<br />

required to settle the obligation<br />

at the end of the reporting period,<br />

taking into account the risks <strong>and</strong><br />

uncertainties. Injury Benefits <strong>and</strong><br />

Early Retirement: Where a provision<br />

is measured using the cash flows<br />

estimated to settle the obligation, its<br />

carrying amount is the present value of<br />

those cash flows using HM Treasury’s<br />

discount rates.<br />

From <strong>2012</strong>/<strong>13</strong> The Treasury publishes<br />

three discount rates that are to be<br />

employed. These are short term less<br />

than 5 years. Medium term 5 to 10<br />

years <strong>and</strong> long term over 10 years.<br />

Where cash flows are expected to fall<br />

into into more than one on these time<br />

frames, then multiple discount rates<br />

will need to be used when calculating<br />

the carrying value of the provision.<br />

In discussion with the <strong>Trust</strong> Auditors,<br />

it has been agreed that the <strong>Trust</strong> will<br />

continue using its long term rate of<br />

3% as there is no material effect in<br />

changing the rate used.<br />

The period over which future cash<br />

flows will be paid is estimated using<br />

the Engl<strong>and</strong> life expense tables as<br />

published by the Office of National<br />

Statistics.<br />

1.22. Clinical negligence costs<br />

The <strong>NHS</strong> Litigation Authority (<strong>NHS</strong>LA)<br />

operates a risk pooling scheme under<br />

which the <strong>Trust</strong> pays an annual<br />

contribution to the <strong>NHS</strong>LA which in<br />

return settles all clinical negligence<br />

claims. The contribution is charged<br />

to expenditure. Although the <strong>NHS</strong>LA<br />

is administratively responsible for<br />

all clinical negligence cases the legal<br />

liability remains with the <strong>Trust</strong>.<br />

1.23. Non-clinical risk pooling<br />

The <strong>Trust</strong> participates in the Property<br />

Expenses Scheme <strong>and</strong> the Liabilities<br />

to Third Parties Scheme. Both are risk<br />

pooling schemes under which the <strong>Trust</strong><br />

pays an annual contribution to the <strong>NHS</strong><br />

Litigation Authority <strong>and</strong>, in return,<br />

receives assistance with the costs of<br />

claims arising. The annual membership<br />

contributions, <strong>and</strong> any excesses<br />

payable in respect of particular claims<br />

are charged to operating expenses as<br />

<strong>and</strong> when they become due.<br />

1.24. Contingencies<br />

A contingent liability is a possible<br />

obligation that arises from past<br />

events <strong>and</strong> whose existence will be<br />

confirmed only by the occurrence<br />

or non-occurrence of one or more<br />

uncertain future events not wholly<br />

within the control of the <strong>Trust</strong>, or<br />

a present obligation that is not<br />

recognised because it is not probable<br />

that a payment will be required to<br />

settle the obligation or the amount<br />

of the obligation cannot be measured<br />

sufficiently reliably. A contingent<br />

liability is not recognised but is<br />

<strong>Annual</strong> accounts<br />

127


disclosed unless the possibility of a<br />

payment is remote.<br />

A contingent asset is a possible asset<br />

that arises from past events <strong>and</strong> whose<br />

existence will be confirmed by the<br />

occurrence or non-occurrence of one<br />

or more uncertain future events not<br />

wholly within the control of the <strong>Trust</strong>.<br />

A contingent asset is not recognised<br />

but is disclosed where an inflow of<br />

economic benefits is probable.<br />

Where the time value of money is<br />

material, contingencies are disclosed at<br />

their present value.<br />

1.25. Public Dividend Capital (PDC)<br />

<strong>and</strong> PDC dividend<br />

Public dividend capital (PDC) is a type<br />

of public sector equity finance based<br />

on the excess of assets over liabilities<br />

at the time of establishment of the<br />

predecessor <strong>NHS</strong> <strong>Trust</strong>. HM Treasury has<br />

determined that PDC is not a financial<br />

instrument within the meaning of IAS<br />

32.<br />

A charge, reflecting the cost of capital<br />

utilised by the <strong>NHS</strong> Foundation <strong>Trust</strong>,<br />

is payable as public dividend capital<br />

dividend. The charge is calculated at<br />

the rate set by HM Treasury (currently<br />

3.5%) on the average relevant net<br />

assets of the <strong>NHS</strong> Foundation <strong>Trust</strong><br />

during the financial year. Relevant net<br />

assets are calculated as the value of all<br />

assets less the value of all liabilities,<br />

except for (i) donated assets (including<br />

lottery funded assets), (ii) net cash<br />

balances held with the Government<br />

Banking Services (GBS), excluding cash<br />

balances held in GBS accounts that<br />

relate to a short-term working capital<br />

facility, <strong>and</strong> (iii) any PDC dividend<br />

balance receivable or payable. In<br />

accordance with the requirements laid<br />

down by the Department of Health<br />

(as the issuer of PDC), the dividend for<br />

the year is calculated on the actual<br />

average relevant net assets as set out<br />

in the ‘pre-audit’ version of the annual<br />

accounts. The dividend thus calculated<br />

is not revised should any adjustment to<br />

net assets occur as a result of the audit<br />

of the annual accounts.<br />

1.26. Value Added Tax<br />

Most of the activities of the <strong>Trust</strong><br />

are outside the scope of VAT <strong>and</strong>, in<br />

general, output tax does not apply<br />

<strong>and</strong> input tax on purchases is not<br />

recoverable. Irrecoverable VAT is<br />

charged to the relevant expenditure<br />

category or included in the capitalised<br />

purchase cost of fixed assets. Where<br />

output tax is charged or input VAT is<br />

recoverable, the amounts are stated<br />

net of VAT.<br />

The <strong>Trust</strong> makes both taxable <strong>and</strong><br />

exempt supplies <strong>and</strong> incurs input tax<br />

that relates to both kinds of supply.<br />

The <strong>Trust</strong> is therefore classified<br />

as 'partly exempt'. Partly exempt<br />

businesses must undertake calculations<br />

which work out how much input tax<br />

they may recover. The percentage<br />

relating to partially exempt supplies<br />

is currently 1.25% which reduces the<br />

<strong>Trust</strong>'s VAT recovery. This percentage is<br />

reviewed annually.<br />

1.27. Corporation tax<br />

The <strong>Trust</strong> is a Health Service body<br />

within the meaning of s519A ICTA 1988<br />

<strong>and</strong> accordingly in relation to specified<br />

activities of a Foundation <strong>Trust</strong> (s519A<br />

(3) to (8) ICTA 1988).<br />

None of the <strong>Trust</strong>'s activities in the<br />

period are subject to a corporation tax<br />

liability.<br />

1.28. Third party assets<br />

Assets belonging to third parties (such<br />

as money held on behalf of patients)<br />

are not recognised in the accounts<br />

since the <strong>Trust</strong> has no beneficial<br />

interest in them.<br />

128 <strong>Annual</strong> accounts


1.29. Losses <strong>and</strong> special payments<br />

Losses <strong>and</strong> special payments are<br />

items that Parliament would not<br />

have contemplated when it agreed<br />

funds for the health service or passed<br />

legislation. By their nature they are<br />

items that ideally should not arise.<br />

They are therefore subject to special<br />

control procedures compared with<br />

the generality of payments. They are<br />

divided into different categories, which<br />

govern the way that individual cases<br />

are h<strong>and</strong>led.<br />

Losses <strong>and</strong> special payments are<br />

charged to the relevant functional<br />

headings in expenditure on an accruals<br />

basis.<br />

1.30. Financial instruments <strong>and</strong><br />

financial liabilities<br />

Recognition<br />

Financial assets <strong>and</strong> financial liabilities<br />

which arise from contracts to the<br />

purchase or sale of non-financial items<br />

(such as goods or services), which are<br />

entered into in accordance with the<br />

Foundation <strong>Trust</strong>'s normal purchase,<br />

sale or usage requirements, are<br />

recognised when, <strong>and</strong> to the extent<br />

which, performance occurs i.e. when<br />

receipt or delivery of the goods or<br />

services is made.<br />

Financial assets or financial liabilities<br />

in respect of assets required or<br />

disposed of through finance leases<br />

are recognised <strong>and</strong> measured in<br />

accordance with the accounting policy<br />

for leases described below.<br />

De-recognition<br />

All financial assets are de-recognised<br />

when the rights to receive cash flows<br />

from the assets have expired or the<br />

<strong>Trust</strong> has transferred substantially all<br />

of the risks <strong>and</strong> rewards of ownership.<br />

Financial liabilities are de-recognised<br />

when the obligation is discharged,<br />

cancelled or expires.<br />

Classification <strong>and</strong> Measurement<br />

Financial assets are categorised as loans<br />

<strong>and</strong> receivables or available for sale as<br />

financial assets. Financial liabilities are<br />

classified as other financial liabilities.<br />

1.31. Loans <strong>and</strong> receivables<br />

Loans <strong>and</strong> receivables are nonderivative<br />

financial assets with fixed or<br />

determinable payments which are not<br />

quoted in an active market. They are<br />

included in current assets if receivable<br />

in the current reporting period, or<br />

in non current assets if outside the<br />

current reporting period.<br />

The <strong>Trust</strong>'s loans <strong>and</strong> receivables<br />

comprise cash <strong>and</strong> cash equivalents,<br />

<strong>NHS</strong> debtors, accrued income <strong>and</strong><br />

other debtors.<br />

Loans <strong>and</strong> receivables are recognised<br />

initially at fair value, net of transaction<br />

costs, <strong>and</strong> are measured subsequently<br />

at amortised cost, using the effective<br />

interest method. The effective interest<br />

rate is the rate that discounts exactly<br />

estimated future cash receipts through<br />

the expected life of the financial asset<br />

or, when appropriate, a shorter period,<br />

to the net carrying amount of the<br />

financial asset.<br />

Interest on loans <strong>and</strong> receivables is<br />

calculated using the effective interest<br />

method <strong>and</strong> credited to the Statement<br />

of Comprehensive Income.<br />

1.32. Other financial liabilities<br />

All other financial liabilities are<br />

recognised initially at fair value, net<br />

of transaction costs incurred, <strong>and</strong><br />

measured subsequently at amortised<br />

cost using the effective interest<br />

method. The effective interest rate<br />

is the rate that discounts exactly<br />

estimated future cash payments<br />

through the expected life of the<br />

financial liability or, when appropriate,<br />

<strong>Annual</strong> accounts<br />

129


a shorter period, to the net carrying<br />

amount of the financial liability.<br />

They are included in current liabilities<br />

except for amounts payable more<br />

than 12 months after the reporting<br />

period, which reclassified as long-term<br />

liabilities.<br />

Interest on financial liabilities carried<br />

at amortised cost is calculated using<br />

the effective interest method <strong>and</strong><br />

charged to finance costs. Interest on<br />

financial liabilities taken out to finance<br />

property, plant <strong>and</strong> equipment or<br />

intangible assets is not capitalised as<br />

part of the cost of those assets.<br />

1.33. Impairment of financial assets<br />

At the end of the reporting period, the<br />

<strong>Trust</strong> assesses whether any financial<br />

assets, other than those held at ‘fair<br />

value through profit <strong>and</strong> loss’ are<br />

impaired. Financial assets are impaired<br />

<strong>and</strong> impairment losses recognised<br />

if there is objective evidence of<br />

impairment as a result of one or more<br />

events which occurred after the initial<br />

recognition of the asset <strong>and</strong> which has<br />

an impact on the estimated future cash<br />

flows of the asset.<br />

For financial assets carried at amortised<br />

cost, the amount of the impairment<br />

loss is measured as the difference<br />

between the asset’s carrying amount<br />

<strong>and</strong> the present value of the revised<br />

future cash flows discounted at the<br />

asset’s original effective interest rate.<br />

The loss is recognised in the Statement<br />

of Comprehensive Income <strong>and</strong> the<br />

carrying amount of the asset is reduced<br />

directly or through the use of a bad<br />

debt provision.<br />

1.34. Foreign currencies<br />

The <strong>Trust</strong>'s functional currency <strong>and</strong><br />

presentational currency is sterling.<br />

Transactions denominated in a foreign<br />

currency are translated into sterling at<br />

the exchange rate ruling on the dates<br />

of the transactions. Resulting exchange<br />

gains <strong>and</strong> losses are recognised in the<br />

<strong>Trust</strong>’s surplus/deficit in the period in<br />

which they arise.<br />

1.35. Prudential borrowing regime<br />

The <strong>Trust</strong> is permitted to borrow funds<br />

to the extent that it complies with the<br />

Prudential Borrowing Code for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s. The capital sum is<br />

recognised as a liability <strong>and</strong> interest<br />

incurred is charged to finance expenses<br />

in the Statement of Comprehensive<br />

Income.<br />

1.36. Government grants<br />

Government grants are grants from<br />

Government bodies other than income<br />

from primary care trusts or <strong>NHS</strong> trusts<br />

for the provision of services. Where<br />

a grant is used to fund revenue or<br />

capital expenditure it is taken to<br />

the Statement of Comprehensive<br />

Income to match that expenditure.<br />

The exception to this is where specific<br />

grant conditions apply regarding the<br />

recognition of income.<br />

1.37. Private patient income<br />

The statutory limitation on private<br />

patient income in section 44 of the<br />

2006 Act was repealed on 1 October<br />

<strong>2012</strong> by the Health <strong>and</strong> Social Care<br />

Act <strong>2012</strong>. The financial statements<br />

disclosures that were provided<br />

previously are no longer required.<br />

1.38. Financial risk management<br />

International Financial reporting<br />

st<strong>and</strong>ard IFRS 7 requires disclosure<br />

of the role that financial instruments<br />

have had during the period in creating<br />

or changing the risks a body faces<br />

in undertaking its activities. Because<br />

of the continuing service provider<br />

relationship that the <strong>NHS</strong> Foundation<br />

<strong>Trust</strong> has with primary care trusts <strong>and</strong><br />

the way those primary care trusts are<br />

financed, the <strong>NHS</strong> Foundation <strong>Trust</strong> is<br />

<strong>13</strong>0 <strong>Annual</strong> accounts


not exposed to the degree of financial<br />

risk faced by business entities. Also<br />

financial instruments play a much<br />

more limited role in creating or<br />

changing risk than would be typical<br />

of listed companies, to which the<br />

financial reporting st<strong>and</strong>ards mainly<br />

apply. The <strong>NHS</strong> Foundation <strong>Trust</strong> has<br />

limited powers to borrow or invest<br />

surplus funds <strong>and</strong> financial assets <strong>and</strong><br />

liabilities are generated by day-to-day<br />

operational activities rather than being<br />

held to change the risks facing the <strong>NHS</strong><br />

Foundation <strong>Trust</strong> in undertaking its<br />

activities.<br />

The <strong>Trust</strong>’s treasury management<br />

operations are carried out by the<br />

finance department, within parameters<br />

defined formally within the <strong>Trust</strong>’s<br />

st<strong>and</strong>ing financial instructions <strong>and</strong><br />

policies agreed by the board of<br />

directors. <strong>Trust</strong> treasury activity is<br />

subject to review by the <strong>Trust</strong>’s internal<br />

auditors.<br />

Currency risk<br />

The <strong>Trust</strong> is principally a domestic<br />

organisation with the great majority of<br />

transactions, assets <strong>and</strong> liabilities being<br />

in the UK <strong>and</strong> sterling based. The <strong>Trust</strong><br />

has no overseas operations. The <strong>Trust</strong><br />

therefore has low exposure to currency<br />

rate fluctuations.<br />

Interest rate risk<br />

To date, the <strong>Trust</strong> has only borrowed<br />

from UK Government for capital<br />

expenditure. The borrowings were for<br />

1 - 25 years, in line with the life of the<br />

associated assets, <strong>and</strong> interest charged<br />

at the National Loans Fund rate, fixed<br />

for the life of the loan. The <strong>Trust</strong><br />

therefore has low exposure to interest<br />

rate fluctuations.<br />

Credit risk<br />

Because the majority of the <strong>Trust</strong>’s<br />

income comes from contracts with<br />

other public sector bodies, the <strong>Trust</strong><br />

has low exposure to credit risk. The<br />

maximum exposures as at 31 March<br />

20<strong>13</strong> are in receivables from customers,<br />

as disclosed in the trade <strong>and</strong> other<br />

receivables note.<br />

Liquidity risk<br />

The majority of the <strong>Trust</strong>’s operating<br />

costs are incurred under contracts with<br />

Primary Care <strong>Trust</strong>s, which are financed<br />

from resources voted annually by<br />

Parliament. The <strong>Trust</strong> funds its capital<br />

expenditure from funds obtained<br />

within its prudential borrowing limit.<br />

The <strong>Trust</strong> is not, therefore, exposed to<br />

significant liquidity risks.<br />

1.39. Events after the reporting<br />

period<br />

There are no post balance sheet events<br />

to report.<br />

1.40. Research <strong>and</strong> development<br />

Research <strong>and</strong> development expenditure<br />

is charged against income in the year<br />

in which it is incurred, except insofar as<br />

development expenditure relates to a<br />

clearly defined project <strong>and</strong> the benefits<br />

of it can reasonably be regarded as<br />

assured. Expenditure so deferred is<br />

limited to the value of future benefits<br />

expected <strong>and</strong> is amortised through<br />

the Operating Cost Statement on<br />

a systematic basis over the period<br />

expected to benefit from the project.<br />

It should be revalued on the basis<br />

of current cost. The amortisation<br />

is calculated on the same basis as<br />

depreciation, on a quarterly basis.<br />

1.41. Significant accounting<br />

assumptions<br />

The <strong>Trust</strong> view is there is no material<br />

credit risk within its financial assets<br />

<strong>and</strong> liabilities. All significant potential<br />

suppliers are credit risk assessed before<br />

the <strong>Trust</strong> enters into a contract.<br />

The <strong>Trust</strong> is permitted to borrow funds<br />

<strong>Annual</strong> accounts<br />

<strong>13</strong>1


to the extent that it complies with the<br />

Prudential Borrowing Code for <strong>NHS</strong><br />

Foundation <strong>Trust</strong>s. The capital sum is<br />

recognised as a liability <strong>and</strong> interest<br />

incurred is charged to fiannce expenses<br />

in the Statement of Comprehensive<br />

Income. Total borrowings of the<br />

<strong>Trust</strong> <strong>and</strong> performance against the<br />

Prudential Borrowing Limit is disclosed<br />

in note 29.<br />

1.42. New st<strong>and</strong>ards <strong>and</strong><br />

interpretations<br />

IAS 1 Presentation of financial<br />

statements (Other Comprehensive<br />

Income) - subject to consultation<br />

IAS 12 Income Taxes amendment -<br />

subject to consultation<br />

IAS 19 Post - employment benefits<br />

(pensions) - subject to consultation<br />

IAS 27 Separate Financial<br />

Statements - subject to consultation<br />

IAS 28 Investments in Associates<br />

<strong>and</strong> Joint Ventures - subject to<br />

consultation<br />

IFRS 7 - Financial Instruments:<br />

Disclosures -amendments - subject to<br />

consultation<br />

IFRS 9 Financial Instruments - subject<br />

to consultation<br />

IFRS 10 Consolidated Financial<br />

Statements - subject to consultation<br />

IFRS 11 Joint Arrangements - subject<br />

to consultation<br />

IFRS 12 Disclosure of Interests<br />

in Other Entities - subject to<br />

consultation<br />

IFRS <strong>13</strong> Fair Value Measurement -<br />

subject to consultation<br />

IPSAS 32 - Service Concession<br />

Arrangement - subject to consultation<br />

<strong>13</strong>2 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

Note 2<br />

Operating segments<br />

Note 2<br />

Surgical<br />

Medical Operating Women & segments Clinical Support Corporate<br />

Total<br />

Division<br />

Division Children's<br />

Services<br />

Division<br />

Surgical<br />

Medical Women & Clinical Support Corporate<br />

Total<br />

Division<br />

Division<br />

Division Children's<br />

Services<br />

Division<br />

31st March 20<strong>13</strong> ### 31st March 20<strong>13</strong> ### 31st March 20<strong>13</strong> ### 31st March 20<strong>13</strong> ### 31st March 20<strong>13</strong> ### 31st March 20<strong>13</strong><br />

Division<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

<strong>NHS</strong> Clinical Income<br />

(£'000)<br />

58,535<br />

(£'000)<br />

64,436<br />

(£'000)<br />

31,556<br />

(£'000)<br />

14,791<br />

(£'000)<br />

-<br />

(£'000)<br />

169,317<br />

Non<br />

<strong>NHS</strong><br />

<strong>NHS</strong><br />

Clinical<br />

Clinical<br />

Income<br />

Income<br />

58,535<br />

306<br />

64,436<br />

256<br />

31,556<br />

236<br />

14,791<br />

118 1,341<br />

- 169,317<br />

2,256<br />

Other<br />

Non <strong>NHS</strong><br />

Income<br />

Clinical Income<br />

2,306<br />

306<br />

1,911<br />

256<br />

1,217<br />

236<br />

2,389<br />

118<br />

10,421<br />

1,341<br />

18,244<br />

2,256<br />

Unallocated<br />

Other Income<br />

Income<br />

2,306<br />

-<br />

1,911<br />

-<br />

1,217<br />

-<br />

2,389<br />

-<br />

10,421<br />

-<br />

18,244<br />

4,724<br />

Total<br />

Unallocated<br />

Operating<br />

Income<br />

Revenue 61,147<br />

-<br />

66,603<br />

-<br />

33,009<br />

-<br />

17,298<br />

-<br />

11,762<br />

-<br />

194,541<br />

4,724<br />

Total Operating Revenue<br />

Pay<br />

61,147<br />

(29,730)<br />

66,603<br />

(31,144)<br />

33,009<br />

(17,893)<br />

17,298<br />

(23,773)<br />

11,762<br />

(19,572)<br />

194,541<br />

(122,1<strong>13</strong>)<br />

Non<br />

Pay<br />

Pay (14,036)<br />

(29,730)<br />

(10,942)<br />

(31,144) (17,893)<br />

(2,292) (10,089)<br />

(23,773)<br />

(24,570)<br />

(19,572) (122,1<strong>13</strong>)<br />

(61,929)<br />

Internal<br />

Non Pay<br />

Recharges<br />

(14,036)<br />

(2,351)<br />

(10,942)<br />

(2,045)<br />

(2,292)<br />

(844)<br />

(10,089)<br />

5,249<br />

(24,570)<br />

(10)<br />

(61,929)<br />

0<br />

Unallocated<br />

Internal Recharges<br />

Expenses<br />

(2,351)<br />

-<br />

(2,045)<br />

-<br />

(844)<br />

-<br />

5,249<br />

-<br />

(10)<br />

- (593)<br />

0<br />

Total Unallocated Operating Expenses Expenditure<br />

- - - - - (593)<br />

before Depreciation,Impairments<br />

Total Operating Expenditure<br />

<strong>and</strong> Interest<br />

before Depreciation,Impairments<br />

(46,117) (44,<strong>13</strong>1) (21,029) (28,6<strong>13</strong>) (44,152) (184,635)<br />

<strong>and</strong> Interest<br />

(46,117) (44,<strong>13</strong>1) (21,029) (28,6<strong>13</strong>) (44,152) (184,635)<br />

Earnings before Interest, Taxation,<br />

Depreciation, <strong>and</strong> Amortisation<br />

Earnings before Interest, Taxation,<br />

15,030 22,472 11,980 (11,315) (32,390) 9,906<br />

Depreciation, <strong>and</strong> Amortisation<br />

15,030 22,472 11,980 (11,315) (32,390) 9,906<br />

Unallocated Depreciation &<br />

Amortisation<br />

(7,619)<br />

Unallocated Depreciation &<br />

Unallocated<br />

Amortisation<br />

Impairments<br />

(7,619) (477)<br />

Operating<br />

Unallocated<br />

Surplus/(Deficit)<br />

Impairments<br />

15,030 22,472 11,980 (11,315) (32,390) 1,810<br />

(477)<br />

Operating Surplus/(Deficit) 15,030 22,472 11,980 (11,315) (32,390) 1,810<br />

Surgical Division<br />

Medical Women & Clinical Support Corporate<br />

Total<br />

Division Children's<br />

Services<br />

Division<br />

Surgical Division<br />

Medical Women & Clinical Support Corporate<br />

Total<br />

Division<br />

31st March <strong>2012</strong> ### 31st March Division <strong>2012</strong> ### 31st March Children's <strong>2012</strong> ### 31st March Services <strong>2012</strong> ### 31st March Division <strong>2012</strong> ### 31st March <strong>2012</strong> ###<br />

Division<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

(£'000)<br />

###<br />

<strong>NHS</strong> Clinical Income<br />

(£'000)<br />

58,067<br />

(£'000)<br />

61,301<br />

(£'000)<br />

32,<strong>13</strong>8<br />

(£'000)<br />

<strong>13</strong>,494<br />

(£'000)<br />

-<br />

(£'000)<br />

165,000<br />

Non<br />

<strong>NHS</strong><br />

<strong>NHS</strong><br />

Clinical<br />

Clinical<br />

Income<br />

Income<br />

58,067<br />

263<br />

61,301<br />

310<br />

32,<strong>13</strong>8<br />

106<br />

<strong>13</strong>,494<br />

<strong>13</strong>9 1,151<br />

- 165,000<br />

1,969<br />

Other<br />

Non <strong>NHS</strong><br />

Income<br />

Clinical Income<br />

2,270<br />

263<br />

1,947<br />

310<br />

1,334<br />

106<br />

2,415<br />

<strong>13</strong>9<br />

7,720<br />

1,151<br />

15,686<br />

1,969<br />

Unallocated<br />

Other Income<br />

Income<br />

2,270 1,947<br />

-<br />

1,334<br />

-<br />

2,415<br />

-<br />

7,720<br />

-<br />

15,686<br />

7,636<br />

Total<br />

Unallocated<br />

Operating<br />

Income<br />

Revenue 60,600 63,558<br />

-<br />

33,578<br />

-<br />

16,048<br />

-<br />

8,871<br />

-<br />

190,291<br />

7,636<br />

Total Operating Revenue<br />

Pay<br />

60,600<br />

(29,663)<br />

63,558<br />

(30,298)<br />

33,578<br />

(17,879)<br />

16,048<br />

(23,406)<br />

8,871<br />

(17,511)<br />

190,291<br />

(118,757)<br />

Non<br />

Pay<br />

Pay (14,670)<br />

(29,663) (30,298)<br />

(9,321)<br />

(17,879)<br />

(2,256) (10,060)<br />

(23,406)<br />

(23,773)<br />

(17,511) (118,757)<br />

(60,080)<br />

Internal<br />

Non Pay<br />

Recharges<br />

(14,670)<br />

(2,302) (2,028)<br />

(9,321) (2,256)<br />

(865)<br />

(10,060)<br />

5,200<br />

(23,773)<br />

(5)<br />

(60,080)<br />

0<br />

Unallocated<br />

Internal Recharges<br />

Expenses<br />

(2,302)<br />

-<br />

(2,028)<br />

-<br />

(865)<br />

-<br />

5,200<br />

-<br />

(5)<br />

(6<strong>13</strong>)<br />

0<br />

Total Operating Expenditure before<br />

Unallocated Expenses - - - - (6<strong>13</strong>)<br />

Depreciation,Impairments <strong>and</strong><br />

Total Operating Expenditure before<br />

Interest<br />

(46,635) (41,647) (21,000) (28,266) (41,289) (179,450)<br />

Depreciation,Impairments <strong>and</strong><br />

Interest<br />

(46,635) (41,647) (21,000) (28,266) (41,289) (179,450)<br />

Earnings before Interest, Taxation,<br />

Depreciation, <strong>and</strong> Amortisation<br />

Earnings before Interest, Taxation,<br />

<strong>13</strong>,965 21,911 12,578 (12,218) (32,418) 10,841<br />

Depreciation, <strong>and</strong> Amortisation<br />

<strong>13</strong>,965 21,911 12,578 (12,218) (32,418) 10,841<br />

Unallocated Depreciation &<br />

Amortisation<br />

Unallocated Depreciation &<br />

(7,482)<br />

Unallocated AmortisationImpairments (4,197) (7,482)<br />

Operating<br />

Unallocated<br />

Surplus/(Deficit)<br />

Impairments<br />

<strong>13</strong>,965 21,911 12,578 (12,218) (32,418) (838)<br />

(4,197)<br />

Operating Surplus/(Deficit) <strong>13</strong>,965 21,911 12,578 (12,218) (32,418) (838)<br />

The only activity of the <strong>NHS</strong> Foundation <strong>Trust</strong> is Healthcare <strong>and</strong> its primary customers are<br />

Primary Care <strong>Trust</strong>s (PCTs). However, segmental information has been included on the basis<br />

The only The<br />

the<br />

activity only activity<br />

following<br />

of of<br />

information the <strong>NHS</strong> Foundation<br />

is reported <strong>Trust</strong> is Healthcare<br />

regularly to<br />

<strong>Trust</strong><br />

the Chief<br />

is <strong>and</strong> Healthcare, its primary customers<br />

Executive for the purpose<br />

<strong>and</strong> its are<br />

of<br />

primary customers are Primary Care <strong>Trust</strong><br />

Primary Care <strong>Trust</strong>s (PCTs). However, segmental information has been included on the basis<br />

(PCTs). However, allocating resources to that segment <strong>and</strong> assessing its performance. Transactions between<br />

the following segmental information is reported information regularly to has the Chief been Executive included for the purpose of basis the following information is reported<br />

divisions would reflect the re-allocation of shared costs. All services relating to transactions<br />

regularly<br />

allocating<br />

shown to the<br />

resources<br />

below Chief<br />

to<br />

were provided Executive<br />

that segment<br />

to external for<br />

<strong>and</strong> assessing<br />

customers the purpose<br />

its performance.<br />

of the <strong>Trust</strong>. of allocating<br />

Transactions<br />

resources<br />

between<br />

to that segment <strong>and</strong> assessing its<br />

divisions would reflect the re-allocation of shared costs. All services relating to transactions<br />

performance. Segmental shown below Transactions net were assets provided are not between recorded to external as customers part divisions of the of internal the would <strong>Trust</strong>. reporting reflect process the <strong>and</strong> re-allocation as such are not disclosed. of shared costs. All services relating<br />

to transactions The Segmental reportable net shown assets segments are below not are recorded different were as operational provided part of the divisions internal to external within reporting the <strong>Trust</strong>, process customers which <strong>and</strong> as provide such of are the not <strong>Trust</strong>. disclosed.<br />

different groups of service. They are managed separately as they involve different medical<br />

The reportable segments are different operational divisions within the <strong>Trust</strong>, which provide<br />

Segmental<br />

disciplines<br />

net<br />

<strong>and</strong><br />

assets<br />

patient<br />

are<br />

groups.<br />

not<br />

Segments<br />

recorded<br />

have<br />

as<br />

not<br />

part<br />

been aggregated<br />

different groups of service. They are managed separately of as they involve internal different reporting medical process <strong>and</strong> as such are not disclosed.<br />

disciplines <strong>and</strong> patient groups. Segments have not been aggregated<br />

The major external customer is <strong>NHS</strong> <strong>Hillingdon</strong> which accounted for revenue of £<strong>13</strong>1,997k <strong>and</strong> features in all segments.<br />

The reportable segments are different operational divisions within the <strong>Trust</strong>, which provide different groups of<br />

No other<br />

major<br />

customer<br />

external<br />

accounted<br />

customer is<br />

for<br />

<strong>NHS</strong><br />

more<br />

<strong>Hillingdon</strong><br />

than 10%<br />

which<br />

of revenue.<br />

accounted for revenue of £<strong>13</strong>1,997k <strong>and</strong> features in all segments.<br />

service.<br />

No<br />

They<br />

other<br />

are<br />

customer<br />

managed<br />

accounted<br />

separately<br />

for more than 10%<br />

as they<br />

of revenue.<br />

involve different medical disciplines <strong>and</strong> patient groups. Segments<br />

have not been aggregated.<br />

The major external customer is <strong>NHS</strong> <strong>Hillingdon</strong> which accounted for revenue of £<strong>13</strong>1,997k <strong>and</strong> features in all<br />

segments. No other customer accounted for more than 10% of revenue.<br />

<strong>Annual</strong> accounts<br />

<strong>13</strong>3


Page 22<br />

Note 3.1 Operating income (by classification) 31 March 20<strong>13</strong> 31 March 20<strong>13</strong> 31 March 20<strong>13</strong><br />

Total Total Total<br />

£000 £000 £000<br />

<strong>NHS</strong> Clinical Income<br />

Elective income 31,434 31,434<br />

M<strong>and</strong>atory Non M<strong>and</strong>atory<br />

Income<br />

Income<br />

Non elective income 53,837 53,837<br />

Outpatient income 41,216 41,216<br />

A & E income 11,397 11,397<br />

Other <strong>NHS</strong> clinical income 31,433 31,433<br />

Non-<strong>NHS</strong> Clinical Income<br />

Private patient income 253 253<br />

Other non-protected clinical income 2,031 2,031<br />

Total income from activities 171,601 169,317 2,284<br />

Other operating income<br />

Research <strong>and</strong> development 998 998<br />

Education <strong>and</strong> training 7,323 7,018 305<br />

Receipts from donated assets 194 194<br />

Non-patient care services to other bodies 8,176 8,176<br />

Other 4,204 4,204<br />

Rental revenue from operating leases 1,981 1,981<br />

Income in respect of staff costs where accounted on gross basis<br />

64 64<br />

Total other operating income 22,940 7,018 15,922<br />

Total Operating Income 194,541 176,335 18,206<br />

31 March <strong>2012</strong> 31 March <strong>2012</strong> 31 March <strong>2012</strong><br />

Total Total Total<br />

£000 £000 £000<br />

<strong>NHS</strong> Clinical Income<br />

Elective income 30,110 30,110<br />

M<strong>and</strong>atory Non M<strong>and</strong>atory<br />

Income<br />

Income<br />

Non elective income 52,444 52,444<br />

Outpatient income 39,755 39,755<br />

A & E income 10,831 10,831<br />

Other <strong>NHS</strong> clinical income 31,860 31,860<br />

Non-<strong>NHS</strong> Clinical Income<br />

Private patient income 243 243<br />

Other non-protected clinical income 1,902 1,902<br />

Total income from activities 167,145 165,000 2,145<br />

Other operating income<br />

Research <strong>and</strong> development 954 954<br />

Education <strong>and</strong> training 7,470 7,077 393<br />

Charitable <strong>and</strong> other contributions to expenditure 1,281 1,281<br />

Non-patient care services to other bodies 8,304 8,304<br />

Other 3,467 3,467<br />

Rental revenue from operating leases 1,626 1,626<br />

Income in respect of staff costs where accounted on gross basis<br />

44 44<br />

Total other operating income 23,146 7,077 16,069<br />

Total Operating Income 190,291 172,077 18,214<br />

M<strong>and</strong>atory income relates to the treatment of <strong>NHS</strong> patients <strong>and</strong> for the training <strong>and</strong> education for clinical<br />

healthcare M<strong>and</strong>atory Income staff. relates to the treatment of <strong>NHS</strong> patients <strong>and</strong> for the training <strong>and</strong> education for<br />

clinical healthcare staff.<br />

<strong>13</strong>4 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

Note 3.2 Operating income by entity 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

<strong>NHS</strong> Foundation <strong>Trust</strong>s 1,926 524<br />

<strong>NHS</strong> <strong>Trust</strong>s 7,228 7,726<br />

Department of Health 189 0<br />

Strategic Health Authorities 6,975 7,063<br />

Primary Care <strong>Trust</strong>s 172,586 167,028<br />

Local Authorities 41 54<br />

Non Government Bodies 5,596 7,896<br />

Total operating income 194,541 190,291<br />

Non Operating income 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Finance Income (Interest on Bank <strong>Accounts</strong>) 14 14<br />

Valuation Gain on Investment Properties 1,692 2,347<br />

Total non operating income 1,706 2,361<br />

Note 3.3 Operating lease income 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Operating Lease Income<br />

Rents recognised as income in the period 1,519 1,017<br />

Contingent rents recognised as income in the period 462 609<br />

TOTAL 1,981 1,626<br />

Future minimum lease payments due<br />

on leases of L<strong>and</strong> expiring<br />

- not later than one year; 1,150 659<br />

- later than one year <strong>and</strong> not later than five years; 4,600 2,637<br />

- later than five years. 82,800 48,075<br />

sub total 88,550 51,371<br />

on leases of Buildings expiring<br />

- not later than one year; 200 322<br />

- later than one year <strong>and</strong> not later than five years; 776 846<br />

- later than five years. 356 1,742<br />

sub total 1,332 2,910<br />

TOTAL 89,882 54,281<br />

Leasing arrangements relate significantly to l<strong>and</strong> rental on both the <strong>Hillingdon</strong> <strong>and</strong> Mount Vernon site.<br />

Most substantially, the <strong>Trust</strong> is party to a lease with BMI for l<strong>and</strong> rental on the Mount Vernon site. This is a<br />

99 year lease which commenced in March 1991. At the beginning of <strong>2012</strong>/<strong>13</strong> a revision of the lease<br />

agreement was signed by both parties, the end period for the lease remained the same, but one change<br />

was to update the contracted rental value written within the contract to 2011/12 price levels. As a result,<br />

rent previously reported as contingent rent, is now reflected within rents recognised as income. In<br />

addition, the future minimum lease payments, based upon the length of the lease <strong>and</strong> the rental value<br />

written within the lease, have increased substantially.<br />

<strong>Annual</strong> accounts<br />

<strong>13</strong>5


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

Note 4. Operating expenses (by type) 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Services from <strong>NHS</strong> Foundation <strong>Trust</strong>s 983 835<br />

Services from <strong>NHS</strong> <strong>Trust</strong>s 30 256<br />

Services from PCTs<br />

0 31<br />

Employee Expenses - Executive directors 889 918<br />

Employee Expenses - Non-executive directors <strong>13</strong>9 71<br />

Employee Expenses - Staff 121,231 117,774<br />

Supplies <strong>and</strong> services - clinical (excluding drug costs) 20,898 20,430<br />

Supplies <strong>and</strong> services - general 5,977 7,963<br />

Establishment 3,917 3,776<br />

Transport 1,335 1,270<br />

Premises 7,487 6,246<br />

Increase/(decrease) in provision for impairment of receivables 524 335<br />

Increase in other provisions 122 88<br />

Drugs 12,028 11,546<br />

Other impairment of financial assets 0 0<br />

Rentals under operating leases - minimum lease receipts 547 540<br />

Rentals under operating leases - contingent rent 63 38<br />

Depreciation on property, plant <strong>and</strong> equipment 7,108 7,482<br />

Amortisation on intangible assets 511 0<br />

Impairments of property, plant <strong>and</strong> equipment 36 4,197<br />

Audit services- statutory audit* 115 100<br />

Clinical negligence 5,155 4,574<br />

Loss on disposal of other property, plant <strong>and</strong> equipment 441 0<br />

Legal fees 98 <strong>13</strong>7<br />

Consultancy costs 40 8<br />

Training, courses <strong>and</strong> conferences 465 367<br />

Patient travel 5 6<br />

Car parking & Security 109 <strong>13</strong>6<br />

Redundancy - (Included in employee expenses) 51 112<br />

<strong>Hospital</strong>ity 16 25<br />

Insurance 231 267<br />

Other services, e.g. external payroll 2,030 1,168<br />

Losses, ex gratia & special payments- (Not included in employee expenses)<br />

53 49<br />

Other 98 384<br />

TOTAL OPERATING EXPENSES 192,732 191,129<br />

*The <strong>Trust</strong>s auditors Deloitte LLP have not limited their auditor's liability under their contract with the <strong>Trust</strong>.<br />

* The <strong>Trust</strong>’s auditors Deloitte LLP have not limited their auditor’s liability under their contract with the <strong>Trust</strong>.<br />

<strong>13</strong>6 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

5. Operating lease Expenditure<br />

Payments recognised as an expense 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Minimum lease payments 547 540<br />

Contingent rents 63 38<br />

610 578<br />

Total future minimum lease payments 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Payable:<br />

Not later than one year 362 603<br />

Between one <strong>and</strong> five years 0 352<br />

Total 362 955<br />

The <strong>Trust</strong> is is party to to a a five five year year lease lease agreement for for a Module a Module Healthcare Healthcare Complex Complex building building on the on the<br />

<strong>Hillingdon</strong> <strong>Hospital</strong> site.<br />

All future minimum lease payments relate to a single lease with a cessation date end October 20<strong>13</strong>.<br />

All future minimum lease payments relate to a single lease with a cassation date end October 20<strong>13</strong><br />

<strong>Annual</strong> accounts<br />

<strong>13</strong>7


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

6. Employee costs <strong>and</strong> numbers<br />

6.1 Directors aggregate remuneration 31 March 20<strong>13</strong> 31 March 20<strong>13</strong> 31 March <strong>2012</strong> 31 March <strong>2012</strong><br />

Remuneration Number of Remuneration Number of<br />

£000 Directors ** £000 Directors<br />

Executive Directors (Details of Directors can be found in<br />

<strong>Annual</strong> <strong>Report</strong>)<br />

889 10 918 8<br />

Non Executive Directors* <strong>13</strong>9 9 71 7<br />

Total** 1,028 19 989 15<br />

**Analysis of Directors Remuneration (£000)<br />

Gross pay 849 799<br />

Employer Pension Contributions 96 97<br />

Employer National Insurance Contributions 83 93<br />

Total 1,028 989<br />

*Non Executive Directors are not members of the <strong>NHS</strong><br />

pension scheme.<br />

** The number of directors denotes the number of<br />

individuals employed in a director position at some point<br />

during the financial year, not the number of directors<br />

simultaneously employed.<br />

6.2 Staff sickness absence 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Number Number<br />

Days lost (long term) 18,020 17,176<br />

Days lost (short term) 12,327 11,815<br />

Total days lost 30,347 28,991<br />

Total staff years* 2,610 2,4<strong>13</strong><br />

Average working days lost 12 12<br />

Total staff employed in period (headcount) 2,904 2,701<br />

Total staff employed in period with no absence (headcount) 1,037 997<br />

Percentage staff with no sick leave 35.71% 36.91%<br />

*Staff years is a calculation based on the number of<br />

working days of full time <strong>and</strong> part time staff employed by<br />

the <strong>Trust</strong> converted into composite staff years.<br />

6.3 Early Retirements due to ill health 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Number Number<br />

No of early retirements on the grounds of ill-health 4 0<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Value of early retirements on the grounds of ill-health 165 0<br />

<strong>13</strong>8 <strong>Annual</strong> accounts<br />

Page 26


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

The<br />

6. Employee<br />

<strong>Hillingdon</strong><br />

costs<br />

<strong>Hospital</strong>s<br />

<strong>and</strong> numbers<br />

<strong>NHS</strong> Foundation<br />

(continued)<br />

<strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

6.<br />

6.4<br />

Employee<br />

Employee costs<br />

costs <strong>and</strong> numbers (continued)<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Total Permanently Other Total Permanently Other<br />

6.4 Employee costs 31 March employed 20<strong>13</strong> 31 March employed <strong>2012</strong><br />

Total Permanently Other Total Permanently Other<br />

£000 employed £000 £000 £000 employed £000 £000<br />

Salaries <strong>and</strong> wages 102,261 £000 97,661 £000 4,600 £000 99,612 £000 94,850 £000 4,762 £000<br />

Social security costs 9,079 8,777 302 8,919 8,583 336<br />

Salaries<br />

Employer<br />

<strong>and</strong><br />

contributions<br />

wages<br />

to <strong>NHS</strong> Pension scheme<br />

102,261 11,046 97,661 10,874 4,600 171 99,612 10,865 94,850 10,707 4,762 158<br />

Social Termination security benefits costs 9,079 51 8,777 51 3020 8,919 124 8,583 124 3360<br />

Employer Agency/contract contributions staff to <strong>NHS</strong> Pension scheme 11,046 2,140 10,8740 2,140 171 10,865 1,446 10,7070 1,446 158<br />

Termination Less Salary Costs benefits Recharged to Other Organisations (1,487) 51 (1,487) 51 0 (1,361) 124 (1,361) 124 0<br />

Agency/contract Less Termination staff Costs Recharged to Other Organisations 2,1400 0 2,1400 1,446 (12) (12) 0 1,4460<br />

Less Salary Costs Recharged to Other Organisations (1,487) (1,487) 0 (1,361) (1,361) 0<br />

Less Termination Costs Recharged to Other Organisations 0 0 0 (12) (12) 0<br />

Employee benefits expense 123,090 115,877 7,2<strong>13</strong> 119,593 112,891 6,702<br />

Of Employee the total benefits above: expense 123,090 115,877 7,2<strong>13</strong> 119,593 112,891 6,702<br />

Charged to capital 919 898 21 789 789 0<br />

Charged Of the total revenue above:<br />

Charged to capital<br />

122,171<br />

123,090 919<br />

114,979<br />

115,877 898<br />

7,192<br />

7,2<strong>13</strong> 118,804<br />

119,593 789<br />

112,102<br />

112,891 789<br />

6,702<br />

6,7020<br />

Charged to revenue 122,171 114,979 7,192 118,804 112,102 6,702<br />

6.5 Average number of people employed<br />

123,090 115,877<br />

31 March 20<strong>13</strong><br />

7,2<strong>13</strong> 119,593 112,891<br />

31 March <strong>2012</strong><br />

6,702<br />

6.5 Average number of people employed<br />

Total Permanently Other Total Permanently Other<br />

31 March employed 20<strong>13</strong> 31 March employed <strong>2012</strong><br />

Total Permanently Other Total Permanently Other<br />

Number employed Number Number Number employed Number Number<br />

Medical <strong>and</strong> dental Number 403 Number 398 Number 5 Number 399 Number 394 Number 5<br />

Administration <strong>and</strong> estates 702 665 37 709 660 49<br />

Medical Healthcare <strong>and</strong> assistants dental <strong>and</strong> other support staff 403 392 398 319 74 5 399 308 394 259 49 5<br />

Administration Nursing, midwifery <strong>and</strong> <strong>and</strong> estates health visiting staff 702 793 665 725 37 68 709 816 660 745 49 71<br />

Healthcare Scientific, therapeutic assistants <strong>and</strong> <strong>and</strong> other technical support staff staff 392 368 319 355 74 <strong>13</strong> 308 365 259 356 499<br />

Nursing, midwifery <strong>and</strong> health visiting staff 793 725 68 816 745 71<br />

Scientific,<br />

Total<br />

therapeutic <strong>and</strong> technical staff<br />

2,658 368 2,461 355 197 <strong>13</strong> 2,597 365 2,414 356 183 9<br />

Total Of the above:<br />

2,658 2,461 197 2,597 2,414 183<br />

Of Number the above: of whole time equivalent staff engaged on capital projects 15 15 0 12 12 0<br />

Number of whole time equivalent staff engaged on capital projects 15 15 0 12 12 0<br />

6.6 Exit Packages 31 March 20<strong>13</strong><br />

Exit package cost b<strong>and</strong> (including any special payment element)<br />

Total<br />

6.6 Exit Packages 31 March 20<strong>13</strong><br />

*Number of<br />

*Cost of<br />

number of Total cost of<br />

Exit package cost b<strong>and</strong> (including any special payment element) compulsory compulsory<br />

Total exit exit<br />

redundancies<br />

*Number of redundancies *Cost of<br />

number packages of Total packages cost of<br />

compulsory Number compulsory £000s Number exit £000s exit<br />

£200,001 0 0 0 0<br />

Total 2 51 2 51<br />

6.6 Exit Packages 31 March <strong>2012</strong><br />

Exit package cost b<strong>and</strong> (including any special payment element)<br />

Total<br />

6.6 Exit Packages *Number of<br />

*Cost 31 of March <strong>2012</strong> number of Total cost of<br />

Exit package cost b<strong>and</strong> (including any special payment element) compulsory compulsory<br />

Total exit exit<br />

redundancies<br />

*Number of redundancies *Cost of<br />

number packages of Total packages cost of<br />

compulsory Number compulsory £000s Number exit £000s exit<br />

£200,001 0 0 0 0<br />

Total 5 112 5 112<br />

<strong>Annual</strong> accounts<br />

<strong>13</strong>9<br />

Page 27


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> -- <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

7 Better Payment Practice Code<br />

7.1 Better Payment Practice Code -- measure of<br />

compliance<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Number £000 Number £000<br />

Total Non-<strong>NHS</strong> trade invoices paid in the year 56,422 68,300 48,339 59,804<br />

Total Non <strong>NHS</strong> trade invoices paid within target <strong>13</strong>,849 23,206 9,058 19,232<br />

Percentage of Non-<strong>NHS</strong> trade invoices paid within target 25% 34% 19% 32%<br />

Total <strong>NHS</strong> trade invoices paid in the year 2,418 14,085 2,579 <strong>13</strong>,934<br />

Total <strong>NHS</strong> trade invoices paid within target 453 5,516 442 4,719<br />

Percentage of <strong>NHS</strong> trade invoices paid within target 19% 39% 17% 34%<br />

The<br />

The Better<br />

Better Payment<br />

Payment Practice Practice<br />

Code Code<br />

requires requires<br />

the the<br />

<strong>Trust</strong> <strong>Trust</strong><br />

to to<br />

aim aim<br />

to to<br />

pay pay<br />

all all<br />

undisputed undisputed<br />

invoices invoices<br />

by the<br />

by the due date or within 30<br />

due days date of receipt or within of goods 30 days or of a receipt valid invoice, of goods whichever or a valid is invoice, later. whichever is is later.<br />

7.2 The Late Payment of Commercial Debts (Interest) Act 1998 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Amounts included in finance costs from claims made under this legislation 8 3<br />

8 Finance income 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Interest on bank accounts 14 14<br />

9 Other non -operating income 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Change in fair value of investment property 1,692 2,347<br />

Total 1,692 2,347<br />

10 Finance expenses 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Interest expense:<br />

Finance leases 142 128<br />

Interest on late payment of commercial debt 8 3<br />

Interest on Loans from the Department of Health 284 297<br />

Interest on LIFT contract 1,344 1,260<br />

Total 1,778 1,688<br />

140 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

Page 29<br />

11 Intangible Assets 31 March 20<strong>13</strong><br />

£000<br />

Cost brought forward at 1st April <strong>2012</strong> 0<br />

Reclassification from Property, Plant <strong>and</strong> Equipment 3,933<br />

Additions - purchased 20<br />

Cost at 31 March 20<strong>13</strong><br />

3,953<br />

Amortisation Brought Forward at 1st April <strong>2012</strong> 0<br />

Reclassification from Property, Plant <strong>and</strong> Equipment 1,494<br />

Amortisation provided in Year 511<br />

Amortisation at at 31 31 March March 20<strong>13</strong> 20<strong>13</strong><br />

2,005<br />

Net Book Value at 31 March 20<strong>13</strong><br />

1,948<br />

Intangible Assets consists of Software Licences<br />

Intangible assets consists of software licences.<br />

During the year Management identified that assets included in<br />

Property, Plant <strong>and</strong> Equipment within the heading Information<br />

Technology, would be more accurately disclosed as intangible<br />

During the year, management identified that assets included in Property, Plant <strong>and</strong><br />

assets.<br />

Equipment within the heading information Technology, would be more accurately disclosed<br />

as intangible assets.<br />

<strong>Annual</strong> accounts<br />

141


* The Prior Period Adjustment relates to the reversal of accumulated depreciation as at 31st March <strong>2012</strong> following a<br />

revaluation exercise of the <strong>Trust</strong>’s operational l<strong>and</strong> <strong>and</strong> buildings.<br />

** Protected assets are assets which are used in the <strong>Trust</strong>’s primary purpose for treating Page <strong>NHS</strong> 30 patients.<br />

* The Prior Period Adjustment relates to the reversal of accumulated depreciation as at 31 March <strong>2012</strong> following a revaluation exercise of the <strong>Trust</strong>'s operational l<strong>and</strong> <strong>and</strong> buildings.<br />

Protected Assets* 71,147 17,276 53,871 0 0 0 0 0 0<br />

Unprotected Assets 43,770 15,193 8,142 653 4,106 9,014 0 6,609 53<br />

Total 31 March 20<strong>13</strong> 114,917 32,469 62,0<strong>13</strong> 653 4,106 9,014 0 6,609 53<br />

Ownership Analysed as follows:-<br />

Net book value<br />

Owned 98,326 32,119 48,932 653 4,106 6,927 0 5,536 53<br />

Finance leased 2,256 0 0 0 0 1,183 0 1,073 0<br />

LIFT 10,783 350 10,433 0 0 0 0 0 0<br />

Donated 3,552 0 0 2,648 0 904 0 0 0<br />

Total 31 March 20<strong>13</strong> 114,917 32,469 59,365 3,301 4,106 9,014 0 6,609 53<br />

Net Book Value (A - B) 114,917 32,469 62,0<strong>13</strong> 653 4,106 9,014 0 6,609 53<br />

Depreciation at 1 April <strong>2012</strong> 38,017 762 11,544 874 0 14,359 18 8,193 2,267<br />

Prior Period Adjustments* (<strong>13</strong>,180) (762) (11,544) (874) 0 0 0 0 0<br />

Provided During the Year 7,108 0 3,326 163 0 2,340 0 1,269 10<br />

Impairments 36 0 36 0 0 0 0 0 0<br />

Reclassifications (1,494) 0 0 0 0 202 0 (1,696) 0<br />

Disposals (8,795) 0 0 0 0 (6,558) 0 0 (2,237)<br />

Depreciation at 31 March 20<strong>13</strong> (B) 21,692 0 3,362 163 0 10,343 18 7,766 40<br />

Additions - purchased 6,321 0 499 0 3,928 1,415 0 479 0<br />

Additions - Leased 2,256 0 0 0 0 1,183 0 1,073 0<br />

Additions - donated 194 0 0 0 0 194 0 0 0<br />

Impairments (16) 0 0 0 0 (16) 0 0 0<br />

Reclassifications (3,933) 0 719 0 (1,978) 269 0 (2,943) 0<br />

Revaluations 420 420 0 0 0 0 0 0 0<br />

Disposals (9,241) 0 0 0 0 (7,004) 0 0 (2,237)<br />

Cost or valuation at 31 March 20<strong>13</strong> (A) <strong>13</strong>6,609 32,469 65,375 816 4,106 19,357 18 14,375 93<br />

Cost or valuation at 1 April <strong>2012</strong> 153,788 32,811 75,701 1,690 2,156 23,316 18 15,766 2,330<br />

Prior Period Adjustment* (<strong>13</strong>,180) (762) (11,544) (874) 0 0 0 0 0<br />

.<br />

12.1 Property, plant <strong>and</strong> equipment Total L<strong>and</strong> Buildings Dwellings Assets under Plant <strong>and</strong> Transport Information Furniture &<br />

excluding<br />

construction machinery equipment technology fittings<br />

dwellings<br />

31 March 20<strong>13</strong> £000 £000 £000 £000 £000 £000 £000 £000 £000<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

142 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

12.1 Property, plant <strong>and</strong> equipment<br />

Total L<strong>and</strong> Buildings Dwellings Assets under Plant <strong>and</strong> Transport Information Furniture &<br />

Continuation<br />

excluding<br />

construction machinery equipment technology fittings<br />

dwellings<br />

<strong>and</strong> POA<br />

31 March <strong>2012</strong> £000 £000 £000 £000 £000 £000 £000 £000 £000<br />

Cost or valuation at 1 April 2011 145,932 34,595 69,573 1,238 602 22,243 18 15,333 2,330<br />

Additions purchased 5,425 0 1,763 0 2,156 1,073 0 433 0<br />

Additions donated 1,281 0 1,281 0 0 0 0 0 0<br />

Reclassifications 0 (1,558) 2,160 0 (602) 0 0 0 0<br />

Reclassified as held for sale 0 0 0 0 0 0 0 0 0<br />

Revaluation/indexation gains 6,212 1,519 4,241 452 0 0 0 0 0<br />

Impairments (5,062) (1,745) (3,317) 0 0 0 0 0 0<br />

Reversal of impairments 0 0 0 0 0 0 0 0 0<br />

At 31 March <strong>2012</strong> 153,788 32,811 75,701 1,690 2,156 23,316 18 15,766 2,330<br />

Depreciation at 1 April 2011 26,338 - 5,111 4<strong>13</strong> 0 12,103 18 6,445 2,248<br />

Impairments 4,197 762 3,343 92 0 0 0 0 0<br />

Charged during the year 7,482 - 3,090 369 0 2,256 0 1,748 19<br />

Depreciation at 31 March <strong>2012</strong> 38,017 762 11,544 874 0 14,359 18 8,193 2,267<br />

Net Book Value (A - B) 115,771 32,049 64,157 816 2,156 8,957 0 7,573 63<br />

Net book value<br />

Ownership Analysed as follows:-<br />

Owned 98,063 31,699 50,789 815 2,156 7,343 0 5,198 63<br />

Finance leased 1,301 - - 0 0 1,301 0 0 0<br />

LIFT 11,043 350 10,693 0 0 0 0 0 0<br />

Donated 2,989 - 2,675 1 0 3<strong>13</strong> 0 0 0<br />

Total 31 March <strong>2012</strong> 1<strong>13</strong>,396 32,049 64,157 816 2,156 8,957 0 5,198 63<br />

Protected Assets 70,169 17,276 52,893 0 0 0 0 0 0<br />

Unprotected Assets 45,602 14,773 11,264 816 2,156 8,957 0 7,573 63<br />

Total 31 March <strong>2012</strong> 115,771 32,049 64,157 816 2,156 8,957 0 7,573 63<br />

Page 31<br />

<strong>Annual</strong> accounts<br />

143


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

12.2 Revaluation reserve balance for property, plant & equipment<br />

L<strong>and</strong> Buildings Dwellings Plant <strong>and</strong> machinery Furniture &<br />

Total<br />

excluding<br />

fittings<br />

dwellings<br />

£000 £000 £000 £000 £000 £000<br />

At 1 April <strong>2012</strong> 12,800 9,683 772 152 29 23,436<br />

Depreciation Adjustment 0 (543) (154) (44) (9) (750)<br />

Impairment 0 0 0 (16) 0 (16)<br />

Revaluation 420 0 0 0 0 420<br />

At 31 March 20<strong>13</strong> <strong>13</strong>,220 9,140 618 92 20 23,090<br />

L<strong>and</strong> Buildings Dwellings Plant <strong>and</strong> machinery Furniture &<br />

Total<br />

excluding<br />

fittings<br />

dwellings<br />

£000 £000 £000 £000 £000 £000<br />

At 1 April 2011 <strong>13</strong>,026 9,287 640 271 38 23,262<br />

Depreciation Adjustment 0 (529) (319) (119) (9) (976)<br />

Impairment (1,745) (3,316) (1) 0 0 (5,062)<br />

Revaluation 1,519 4,241 452 0 0 6,212<br />

At 31 March <strong>2012</strong> 12,800 9,683 772 152 29 23,436<br />

Page 32<br />

144 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

<strong>13</strong> Economic lives of fixed assets Min life Max life<br />

Years<br />

Years<br />

Buildings exc Dwellings<br />

5 50<br />

Dwellings 5 5<br />

Plant <strong>and</strong> Machinery 2 15<br />

Transport Equipment 0 0<br />

Information Technology 1 15<br />

Furniture <strong>and</strong> Fittings 5 15<br />

Intangible assets (Software licenses) 5 15<br />

14 Investment Property 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

At Fair Value<br />

Balance at Beginning of Period <strong>13</strong>,124 10,777<br />

Net gain/(loss) from Fair Value Adjustments 1,692 2,347<br />

Balance at End of Period 14,816 <strong>13</strong>,124<br />

Income from Investment Properties 1,399 1,172<br />

Expenses of Investment Properties (895) (818)<br />

Surplus 504 354<br />

15 Impairments 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Loss on L<strong>and</strong> 0<br />

762<br />

Loss on Plant <strong>and</strong> Equipment 0<br />

3,343<br />

Loss on Building 36<br />

92<br />

Total 36 4,197<br />

16 Capital Commitments 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Property, plant <strong>and</strong> equipment 366 0<br />

Intangible Assets 21 0<br />

Total 387 0<br />

Contracted capital commitments at 31 March not otherwise<br />

included in these financial statements:<br />

<strong>Annual</strong> accounts<br />

145<br />

Page 33


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

17 Inventory Movement - <strong>2012</strong>/<strong>13</strong> Total Drugs Consumables Energy Other<br />

£000 £000 £000 £000 £000<br />

Carrying Value at 1st April 2,916 1,084 1,705 10 117<br />

Additions 24,148 11,498 12,440 7 203<br />

Inventories recognised as expenses (24,022) (11,387) (12,435) (7) (193)<br />

Carrying Value at 31st March 20<strong>13</strong> 3,042 1,195 1,710 10 127<br />

17 Inventory Movement - 2011/12 Total Drugs Consumables Energy Other<br />

£000 £000 £000 £000 £000<br />

Carrying Value at 1st April 2,994 1,159 1,714 9 112<br />

Additions 23,977 10,828 12,967 6 176<br />

Inventories recognised as expenses (24,055) (10,903) (12,976) (5) (171)<br />

Carrying Value at 31st March <strong>2012</strong> 2,916 1,084 1,705 10 117<br />

146 <strong>Annual</strong> accounts<br />

Page 34


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

18.1 Trade <strong>and</strong> other receivables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Current<br />

<strong>NHS</strong> receivables - - revenue 10,140 7,015<br />

<strong>NHS</strong> receivables - - accrued income 1,302 2,834<br />

<strong>NHS</strong> provision for credit notes (2,143) (1,328)<br />

<strong>NHS</strong> PDC Dividend Receivable 65 0<br />

Sub Total <strong>NHS</strong> 9,364 8,521<br />

Prepayments 1,526 1,706<br />

VAT receivable 392 326<br />

Other receivables 3,237 5,035<br />

Provision for impaired receivables (1,200) (1,079)<br />

Total current trade <strong>and</strong> other receivables <strong>13</strong>,319 14,509<br />

Non-Current<br />

Other receivables 1,473 1,344<br />

Total non-current trade <strong>and</strong> other receivables 1,473 1,344<br />

18.2 Provision for impairment of receivables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

At 1 April 1,079 1,170<br />

Increase/Reduction in in provision) 523 333<br />

Amounts Utilised (403) (426)<br />

Amounts Reversed 1 2<br />

At end of Period 1,200 1,079<br />

18.3.1 Ageing of impaired receivables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

0 - - 30 days 209 311<br />

30 - - 60 days 4 11<br />

60 - - 90 days 6 10<br />

90 - - 180 days 114 63<br />

over 180 days 867 684<br />

Total 1,200 1,079<br />

18.3.2 Ageing of non-Impaired receivables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

past their due date £000 £000<br />

0 - - 30 days 2,257 567<br />

30 - - 60 days 671 2,998<br />

60 - - 90 days 517 233<br />

90 - - 180 days 592 649<br />

over 180 days 3,147 3,075<br />

Total 7,184 7,522<br />

19 Cash <strong>and</strong> cash equivalents 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Balance at at 1 April 1,897 500<br />

Net increase in in year 2,009 1,397<br />

Balance at at end of Period 3,906 1,897<br />

Made up of<br />

Cash with Government banking services 3,667 1,887<br />

Commercial banks <strong>and</strong> cash in in h<strong>and</strong> 239 10<br />

Cash <strong>and</strong> cash equivalents as in in statement of financial position 3,906 1,897<br />

Cash <strong>and</strong> cash equivalents as in in statement of cash flows 3,906 1,897<br />

Page 35<br />

<strong>Annual</strong> accounts<br />

147


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

20 Trade <strong>and</strong> other payables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

20 Trade <strong>and</strong> other payables 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

£000 £000<br />

Current<br />

Current<br />

Receipts in advance 1,111 142<br />

Receipts in advance 1,111 142<br />

<strong>NHS</strong> payables revenue 2,506 1,525<br />

<strong>NHS</strong> payables - revenue 2,506 1,525<br />

Amounts due to other related parties revenue 1,633 1,442<br />

Amounts due to other related parties - revenue 1,633 1,442<br />

Other trade payables capital 584 563<br />

Other trade payables - capital 584 563<br />

Other trade payables revenue 7,768 8,527<br />

Other trade payables - revenue 7,768 8,527<br />

Social Security costs 2,802 2,802<br />

Social Security costs 2,802 2,802<br />

Other payables 380 42<br />

Other payables 380 42<br />

<strong>NHS</strong> PDC Dividend Receivable 61<br />

<strong>NHS</strong> PDC Dividend Receivable 0 61<br />

Accruals 3,662 3,244<br />

Accruals 3,662 3,244<br />

Total Trade <strong>and</strong> Other payables 20,446 18,348<br />

Total Trade <strong>and</strong> Other payables 20,446 18,348<br />

21.1 Borrowings 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

21.1 Borrowings 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

£000 £000<br />

Current<br />

Current<br />

Loans from Department of Health 390 390<br />

Loans from Department of Health 390 390<br />

Obligations under finance leases 705 705<br />

Obligations under finance leases 705 705<br />

Obligations under LIFT contracts 258 256<br />

Obligations under LIFT contracts 258 256<br />

Total current borrowings 1,353 1,351<br />

Total current borrowings 1,353 1,351<br />

Non-current<br />

Non-current<br />

Loans from Department of Health 7,075 7,465<br />

Loans from Department of Health 7,075 7,465<br />

Obligations under finance leases 1,990 585<br />

Obligations under finance leases 1,990 585<br />

Obligations under LIFT contracts 12,877 <strong>13</strong>,<strong>13</strong>6<br />

Obligations under LIFT contracts 12,877 <strong>13</strong>,<strong>13</strong>6<br />

Total non current borrowings 21,942 21,186<br />

Total non current borrowings 21,942 21,186<br />

The <strong>Trust</strong> is party to two Department of Health loans relating to capital investment as follows:<br />

The <strong>Trust</strong> is party to two Department of Health loans relating to capital investment as follows:<br />

The <strong>Trust</strong> is party to two Department of Health loans relating to capital investment as follows:<br />

• Loan 1 received 15th December 2009 for £4.0m. Repayments commenced on 15th March 2010 <strong>and</strong> will continue<br />

Loan until received 15th September 15th December 2034. 2009 The loan for £4.0m. carries Repayments a fixed interest commenced rate at on 4.11%. 15th March 2010 <strong>and</strong> will<br />

- Loan 1 received 15th December 2009 for £4.0m. Repayments commenced on 15th March 2010 <strong>and</strong> will<br />

continue until 15th September 2034. The loan carries fixed interest rate at 4.11%.<br />

• continue Loan until 2 received 15th September 15th September 2034. The 2010 loan for carries £4.6m. a fixed Repayments interest rate commenced at 4.11%. on 15th March 2011 <strong>and</strong> will continue<br />

until 15th September 2030.The loan carries a fixed interest rate at 3.25%.<br />

Loan received 15th September 2010 for £4.6m. Repayments commenced on 15th March 2011 <strong>and</strong> will<br />

- Loan 2 received 15th September 2010 for £4.6m. Repayments commenced on 15th March 2011 <strong>and</strong> will<br />

continue until 15th September 2030. The loan carries fixed interest rate at 3.25%.<br />

continue until 15th September 2030. The loan carries a fixed interest rate at 3.25%.<br />

21.2 Loans Payments Scheduled 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

21.2 Loans Payments Scheduled 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

£000 £000<br />

to Year 658 674<br />

0 to 1 Year 658 674<br />

to years 644 658<br />

1 to 2 years 644 658<br />

Years 1,849 1,891<br />

2 - 5 Years 1,849 1,891<br />

More Than Years 7,045 7,647<br />

More Than 5 Years 7,045 7,647<br />

Total Future Gross Loan Commitments 10,196 10,870<br />

Total Future Gross Loan Commitments 10,196 10,870<br />

Less Interest Element (2,731) (3,015)<br />

Less Interest Element (2,731) (3,015)<br />

Total Future Net Loan Commitments 7,465 7,855<br />

Total Future Net Loan Commitments 7,465 7,855<br />

148 <strong>Annual</strong> accounts<br />

Page 36<br />

Page 36


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

22 Finance lease obligations<br />

lease arrangements relate to a number of equipment leases which vary in length from three<br />

The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

to seven years.<br />

22 Finance lease obligations<br />

Minimum lease Minimum lease<br />

payments payments<br />

The lease arrangements relate to a number of equipment leases<br />

31<br />

which<br />

March<br />

vary<br />

20<strong>13</strong><br />

in length<br />

31<br />

from<br />

March<br />

three<br />

<strong>2012</strong><br />

to seven years.<br />

Amounts payable under finance leases £000 £000<br />

Minimum lease Minimum lease<br />

Gross lease liabilities<br />

payments payments<br />

Within one year 814 782<br />

Between one <strong>and</strong> five years 31 March 2,226 20<strong>13</strong> 31 March <strong>2012</strong> 611<br />

Future Amounts Finance payable Charges under finance leases (345) £000 (103) £000<br />

Present value of minimum lease payments 2,695 1,290<br />

Gross lease liabilities<br />

Net Within lease one Liabilities year<br />

Within Between one one year <strong>and</strong> five years<br />

814<br />

2,226 705<br />

782<br />

705 611<br />

Between Future Finance one <strong>and</strong> Charges five years (345) 1,990 (103) 585<br />

Present The LIFT value agreement of minimum is for a lease 25 year payments period which commenced in December 2,695<br />

2008. The scheme 1,290<br />

is<br />

for the provision of clinical accommodation on the Mount Vernon <strong>Hospital</strong> site which comprises<br />

Net<br />

23 four lease<br />

<strong>NHS</strong> surgical Liabilities<br />

Local theatres Improvement <strong>and</strong> outpatient Finance suites. <strong>Trust</strong> The (LIFT) lease contract payment (inclusive of capital <strong>and</strong> services)<br />

Within is £1,557k one per year annum (before RPI indexing).Under IFRIC 12, the asset is treated 705 as an asset of the 705<br />

Between <strong>Trust</strong>; the one substance <strong>and</strong> five of years the contract is that the <strong>Trust</strong> has a finance lease <strong>and</strong> 1,990 payments comprise 585<br />

23.1 two LIFT scheme on-Statement of Financial Position<br />

The LIFT<br />

elements:<br />

agreement<br />

imputed<br />

is for<br />

finance<br />

a 25 year<br />

lease<br />

period<br />

charges<br />

which<br />

<strong>and</strong><br />

commenced<br />

service charges.<br />

in December<br />

There are 2,695 2008.<br />

no guarantees,<br />

The scheme 1,290 is<br />

obligations<br />

for The the LIFT provision agreement or other<br />

of is clinical<br />

rights for a associated 25 accommodation year period with which the<br />

on<br />

scheme.<br />

the commenced Mount Vernon in December <strong>Hospital</strong> 2008. site The which scheme comprises<br />

for the provision of clinical<br />

accommodation on the Mount Vernon <strong>Hospital</strong> site which comprises four surgical theatres <strong>and</strong> outpatient suites. The<br />

23 four <strong>NHS</strong> surgical Local theatres Improvement <strong>and</strong> outpatient Finance suites. <strong>Trust</strong> The (LIFT) lease contract payment (inclusive of capital <strong>and</strong> services)<br />

Total is lease £1,557k payment obligations per annum (inclusive for on-statement (before of capital RPI indexing).Under <strong>and</strong> of financial services) is position £1,557k IFRIC LIFT 12, per the contracts annum asset (before is due: treated RPI indexing). as an asset Under of the IFRIC 12, the asset is<br />

<strong>Trust</strong>; treated the as substance asset of of the the <strong>Trust</strong>; contract the substance is that the of <strong>Trust</strong> the contract has a finance is that lease the <strong>Trust</strong> <strong>and</strong> has payments a finance comprise lease <strong>and</strong> payments comprise<br />

23.1 two elements: LIFT scheme imputed on-Statement finance lease of charges Financial<br />

<strong>and</strong> <strong>and</strong> Position service charges. 31 There There March are are 20<strong>13</strong> no no guarantees, 31 March obligations <strong>2012</strong> or other rights<br />

LIFT obligations associated Payments with or other Scheduled scheme. rights associated with the scheme.<br />

£000 £000<br />

Not later than one year 1,160 1,198<br />

Later Total than obligations one year, for not on-statement later than of five financial years position LIFT contracts due: 4,481 4,559<br />

Later than five years 22,300 23,383<br />

Sub total Gross Payments 31 March 27,941 20<strong>13</strong> 31 March 29,140 <strong>2012</strong><br />

LIFT Payments Scheduled £000 £000<br />

Less: Not later interest than element one year (14,806) 1,160 (15,748) 1,198<br />

Later than one year, not later than five years 4,481 4,559<br />

Total Later Future than five Net years LIFT Liabilities <strong>13</strong>,<strong>13</strong>5 22,300 <strong>13</strong>,392 23,383<br />

Sub total Gross Payments 27,941 29,140<br />

23.2 The <strong>Trust</strong> Charges is committed to expenditure to the following service charge payments over the life<br />

Less: of the interest LIFT scheme:- element (14,806) (15,748)<br />

Total Future Net LIFT Liabilities 31 March <strong>13</strong>,<strong>13</strong>5 20<strong>13</strong> 31 March <strong>13</strong>,392 <strong>2012</strong><br />

LIFT Expenditure £000 £000<br />

Not The 23.2 later <strong>Trust</strong> Charges than is committed to one expenditure<br />

yearto the following service charge payments over the life 397 357<br />

Later of the than LIFT one scheme:-<br />

The <strong>Trust</strong> is committed year, not to later the following than five service years charge payments over the life 1,747 of the LIFT scheme:- 1,669<br />

Later than five years 7,031 7,506<br />

Total 31 March 9,175 20<strong>13</strong> 31 March 9,532 <strong>2012</strong><br />

LIFT Expenditure £000 £000<br />

Not later than one year 397 357<br />

Later than one year, not later than five years 1,747 1,669<br />

Later than five years 7,031 7,506<br />

Total 9,175 9,532<br />

<strong>Annual</strong> accounts<br />

149


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

24 Related party transactions<br />

During the year none of the <strong>Trust</strong> board members or members of the key management staff, or parties related to any of<br />

them, has undertaken any material transactions with The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong>.<br />

The United Kingdom Government is regarded as a related party to the extent that it controls the Department of Health <strong>and</strong><br />

National Health Organisations through legislation <strong>and</strong> funding by the taxpayer. During the year The <strong>Hillingdon</strong> <strong>Hospital</strong>s<br />

<strong>NHS</strong> Foundation <strong>Trust</strong> has had a significant number of material transactions with the Department, <strong>and</strong> with other <strong>NHS</strong><br />

entities as well as directly with the UK Government. These transactions are itemised below subject to a minimum of £100k for<br />

transactions <strong>and</strong> £50k for balances for the year to 31st March 20<strong>13</strong>. These limits are in accordance with the Agreement of<br />

balances exercise for Whole Government <strong>Accounts</strong>.<br />

24.1 Balances<br />

Current<br />

Receivables as at<br />

31 March 20<strong>13</strong><br />

Current<br />

Receivables as at<br />

31 March <strong>2012</strong><br />

Current Payables<br />

as at 31 March<br />

20<strong>13</strong><br />

Current<br />

Payables as at<br />

31 March <strong>2012</strong><br />

Entities £000s £000s £000s £000s<br />

Central And North West London MH <strong>NHS</strong> Foundation <strong>Trust</strong> 749 572 343 67<br />

Chelsea And Westminster <strong>Hospital</strong> <strong>NHS</strong> Foundation <strong>Trust</strong> 70 91 52 7<br />

Royal Brompton And Harefield <strong>NHS</strong> Foundation <strong>Trust</strong><br />

<strong>13</strong>9 103 67 149<br />

East And North Hertfordshire <strong>NHS</strong> <strong>Trust</strong> 2,839 1,745 624 197<br />

Imperial College Healthcare <strong>NHS</strong> <strong>Trust</strong> 78 46 223 391<br />

North West London <strong>Hospital</strong>s <strong>NHS</strong> <strong>Trust</strong> 23 112 64 32<br />

Royal Free Hampstead <strong>NHS</strong> <strong>Trust</strong> 37 239 154 110<br />

London Strategic Health Authority 22 181<br />

Barnet PCT 79 27<br />

Buckinghamshire PCT 77 61<br />

Croydon PCT 28 66 502<br />

Ealing PCT 474 1,420 10<br />

Hammersmith And Fulham PCT 2 82<br />

Hampshire PCT 142<br />

Harrow PCT 317 166<br />

Hertfordshire PCT 382 253<br />

<strong>Hillingdon</strong> PCT<br />

3,264 3,311 3 7<br />

Hounslow PCT 670 148<br />

Surrey PCT<br />

<strong>NHS</strong> Blood <strong>and</strong> Transplant (excluding Bio Products Laboratory)<br />

<strong>NHS</strong> Business Services Authority (incl <strong>NHS</strong> Supply Chain)<br />

110 72<br />

160<br />

685<br />

Bexley <strong>NHS</strong> Care <strong>Trust</strong> PCT 4 1 63<br />

Greenwich Teaching PCT 9 91 24<br />

Islington PCT 55<br />

Other <strong>NHS</strong> 704 1,037 181 189<br />

Total <strong>NHS</strong> 10,140 9,849 2,506 1,907<br />

Charitable Funds 0 <strong>13</strong>1 0 0<br />

Central <strong>and</strong> Local Government 392 326 4,435 4,244<br />

Total 10,532 10,306 6,941 6,151<br />

150 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

24.2Transactions<br />

Revenue Year to 31<br />

March 20<strong>13</strong><br />

Revenue Year to<br />

31 March <strong>2012</strong><br />

Expenditure Year to Expenditure Year to<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Entities £000s £000s £000s £000s<br />

Central And North West London MH <strong>NHS</strong> Foundation <strong>Trust</strong> 1,352 222 654 659<br />

Chelsea And Westminster <strong>Hospital</strong> <strong>NHS</strong> Foundation <strong>Trust</strong> 1<strong>13</strong> 170 7 1<br />

Kings College <strong>Hospital</strong> <strong>NHS</strong> Foundation <strong>Trust</strong><br />

Moorfields Eye <strong>Hospital</strong> <strong>NHS</strong> Foundation <strong>Trust</strong><br />

205 210<br />

90<br />

Royal Brompton And Harefield <strong>NHS</strong> Foundation <strong>Trust</strong><br />

169 126 195 120<br />

Royal Free London <strong>NHS</strong> Foundation <strong>Trust</strong> 276 206<br />

University College London <strong>NHS</strong> Foundation <strong>Trust</strong> <strong>13</strong>8 84<br />

East And North Hertfordshire <strong>NHS</strong> <strong>Trust</strong> 6,462 6,577 1,075 451<br />

Imperial College Healthcare <strong>NHS</strong> <strong>Trust</strong> 5 784 636<br />

North West London <strong>Hospital</strong>s <strong>NHS</strong> <strong>Trust</strong> 549 576 402 20<br />

Royal Free Hampstead <strong>NHS</strong> <strong>Trust</strong> 309 121<br />

West Hertfordshire <strong>Hospital</strong>s <strong>NHS</strong> <strong>Trust</strong> 108 1<strong>13</strong> 79<br />

London Strategic Health Authority 6,975 7,058<br />

Barnet PCT 189 251<br />

Bedfordshire PCT 159 124<br />

Brent Teaching PCT 552 527<br />

Buckinghamshire PCT 102<br />

Croydon PCT 5,069 4,976<br />

Ealing PCT 12,914 12,365 10<br />

Hammersmith And Fulham PCT 370 495<br />

Hampshire PCT 4,465 3,900 1<br />

Harrow PCT 4,965 4,339<br />

Hertfordshire PCT 4,985 4,553<br />

<strong>Hillingdon</strong> PCT<br />

<strong>13</strong>1,997 128,391 0<br />

Hounslow PCT 2,647 1,773<br />

Kensington <strong>and</strong> Chelsea PCT 146<br />

Leicestershire <strong>and</strong> Rutl<strong>and</strong> PCT 125<br />

Luton Teaching PCT 123 104<br />

Redbridge PCT<br />

104<br />

South East Essex PCT 506 514<br />

Surrey PCT 446 434<br />

West Sussex 101<br />

Westminster PCT 111 1,388 1<br />

<strong>NHS</strong> Blood <strong>and</strong> Transplant (excluding Bio Products Laboratory)<br />

<strong>NHS</strong> Business Services Authority (incl <strong>NHS</strong> Supply Chain)<br />

1,207 1,485<br />

3,720<br />

<strong>NHS</strong> Litigation Authority 5,286 4,684<br />

Department of Health 189<br />

Other <strong>NHS</strong> 2,737 5,365 825 560<br />

Total <strong>NHS</strong> 188,904 184,757 10,984 12,932<br />

Central <strong>and</strong> Local Government 0 0 21,147 19,784<br />

Total 188,904 184,757 32,<strong>13</strong>1 32,716<br />

<strong>NHS</strong> Business Agency is no longer included in related<br />

<strong>NHS</strong> party Business transactions. Agency It is now longer classified included as a in related party transations. It is now classidied as a commercial company.<br />

commercial company.<br />

Page 39<br />

<strong>Annual</strong> accounts<br />

151


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

25 Provisions Current Non-current<br />

31 March 20<strong>13</strong> 31 March 20<strong>13</strong><br />

£000 £000<br />

Pensions relating to other staff 165 1,948<br />

Total 165 1,948<br />

Current<br />

Non-current<br />

31 March <strong>2012</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Pensions relating to other staff 162 1,930<br />

Total 162 1,930<br />

Analysis of Movements 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

At start of period 2,092 2,120<br />

Arising during the year 123 87<br />

Utilised during the year- accruals (42) (40)<br />

Utilised during the year- cash (123) (122)<br />

Unwinding of discount 63 47<br />

At end of period 2,1<strong>13</strong> 2,092<br />

Expected timing of cash flows:<br />

Within one year 165 162<br />

Between one <strong>and</strong> five years 660 648<br />

After five years 1,288 1,282<br />

Total 2,1<strong>13</strong> 2,092<br />

Provisions are liabilities that are of uncertain timing or amounts which the <strong>Trust</strong> expects to be<br />

settled by a transfer of economic benefits. The provision for staff pensions has been calculated using<br />

information supplied by <strong>NHS</strong> Business Service Authority Pensions Division.<br />

£29,487k is included in the provisions of the <strong>NHS</strong> Litigation Authority at 31st March 20<strong>13</strong> in respect<br />

of clinical negligence liabilities of the <strong>Trust</strong>. (£25,482k 31st March <strong>2012</strong>).<br />

152 <strong>Annual</strong> accounts


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

26 Contingent liabilities 31 March 20<strong>13</strong>31 March <strong>2012</strong><br />

£000 £000<br />

Contingent liabilities 46 16<br />

Total 46 16<br />

The <strong>Trust</strong>'s contingent liabilities include £40k relating to employee work injuries <strong>and</strong> £6k relating to public<br />

slips or falls. Further liabilities relate to the excess payable on claims made against the Liabilities to Third<br />

parties Scheme which is a non-clinical risk pooling scheme operated by the <strong>NHS</strong> Litigation Authority.<br />

27 Financial instruments 31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Book Value Fair Value Book Value Fair Value<br />

27.1 Financial Assets £000 £000 £000 £000<br />

<strong>NHS</strong> Receivables 10,140 10,140 9,849 9,849<br />

Non <strong>NHS</strong> Receivables 518 518 1,663 1,663<br />

Other Investments 14,816 14,816 <strong>13</strong>,124 <strong>13</strong>,124<br />

Cash <strong>and</strong> cash equivalents (at bank <strong>and</strong> in h<strong>and</strong>) 3,906 3,906 1,897 1,897<br />

Total at end of period<br />

29,380 0 29,380 26,533 26,533<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Book Value Fair Value Book Value Fair Value<br />

27.2 Financial Liabilities £000 £000 £000 £000<br />

Borrowings excluding Finance lease <strong>and</strong> LIFT liabilities 7,465 7,465 7,855 7,855<br />

Obligations under finance leases 2,695 2,695 1,290 1,290<br />

Obligations under LIFT contract <strong>13</strong>,<strong>13</strong>5 <strong>13</strong>,<strong>13</strong>5 <strong>13</strong>,392 <strong>13</strong>,392<br />

<strong>NHS</strong> Trade <strong>and</strong> Other payables excluding non financial assets 2,506 2,506 1,874 1,874<br />

Non-<strong>NHS</strong> Trade <strong>and</strong> Other payables excluding non financial assets 12,394 12,394 12,088 12,088<br />

Provisions Under Contract 2,1<strong>13</strong> 2,1<strong>13</strong> 2,092 2,092<br />

Total at end of period 40,308 40,308 38,591 38,591<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

27.2 Maturity of Financial Liabilities £000 £000<br />

In one year or less 15,576 15,475<br />

In more than one year but not more than two years 1,307 1,081<br />

In more than two years but not more than five years 4,539 1,571<br />

In more than five years 18,886 20,464<br />

Total 40,308 38,591<br />

<strong>Annual</strong> accounts<br />

153


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

28. 28 Financial Risk Risk Rating Rating<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

Metric Criteria Actual Rating Weighting Rating Weighting<br />

EBITDA Margin Underlying Performance 5.1% 3 25% 3 25%<br />

EBITDA, % achieved Achievement of Plan 88.4% 4 10% 3 10%<br />

Return on investment Financial Efficiency -1.4% 2 20% 2 20%<br />

I&E surplus margin Financial Efficiency -0.9% 2 20% 2 20%<br />

Liquid ratio Liquidity days 17.7 3 25% 3 25%<br />

Weighted Average Weighting 2.70 100% 2.60 100%<br />

Financial Risk Rating 3 3<br />

Financial Risk Rating boundaries:<br />

Weighting 5 4 3 2 1<br />

EBITDA Margin 25% 11.0% 9.0% 5.0% 1.0%


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

29 Prudential borrowing limit<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

£000 £000<br />

Total long term borrowing limit set by Monitor per Terms of<br />

Authorisation<br />

23,700 37,100<br />

Working Capital Factilty Facility limit set by by Monitor<br />

<strong>13</strong>,800 <strong>13</strong>,800<br />

Total Prudential Borrowing Limit 37,500 50,900<br />

Borrowing (as defined in the Prudential Borrowing Code) at 1 April 22,537 23,889<br />

Net actual borrowing/(repayment) in year 758 (1,352)<br />

Long term borrowing at 31 March 23,295 22,537<br />

The <strong>NHS</strong> foundation trust is required to comply <strong>and</strong> remain within a prudential borrowing limit. This is<br />

The made <strong>NHS</strong> up Foundation of two elements:- <strong>Trust</strong> is required to comply <strong>and</strong> remain within a prudential borrowing limit. This is<br />

made up of two elements:<br />

1) The maximum cumulative amount of long-term borrowing. This<br />

1. is set The by maximum reference cumulative to the four amount ratio tests of long-term set out in the borrowing. Prudential This Borrowing is set by reference Code for to <strong>NHS</strong> the foundation four ratio<br />

trusts.<br />

tests<br />

The<br />

set<br />

financial<br />

out in the<br />

risk<br />

Prudential<br />

rating set<br />

Borrowing<br />

under Monitor's<br />

Code for<br />

Compliance<br />

<strong>NHS</strong> foundation<br />

Framework<br />

trusts.<br />

determines<br />

The financial<br />

one<br />

risk<br />

of<br />

rating<br />

the ratios<br />

set<br />

<strong>and</strong> therefore can impact on the long term borrowing limit; <strong>and</strong><br />

under Monitor’s Compliance Framework determines one of the ratios <strong>and</strong> therefore can impact on the<br />

2) The amount of any working capital facility<br />

long term borrowing limit; <strong>and</strong><br />

approved by Monitor.<br />

Further information on the<br />

2. Prudential The amount Borrowing of any Code working for <strong>NHS</strong> capital foundation facility approved trusts <strong>and</strong> by Compliance Monitor. Framework can be found on<br />

Further Monitor's information website. on the Prudential Borrowing Code for <strong>NHS</strong> foundation trusts <strong>and</strong> Compliance<br />

Framework can be found on Monitor’s website.<br />

<strong>Annual</strong> accounts<br />

155


The <strong>Hillingdon</strong> <strong>Hospital</strong>s <strong>NHS</strong> Foundation <strong>Trust</strong> - <strong>Annual</strong> <strong>Accounts</strong> <strong>2012</strong>-<strong>13</strong><br />

30 Third 30 Third party party assets assets<br />

The <strong>Trust</strong> held £3,432 cash <strong>and</strong> cash equivalents at 31 March 20<strong>13</strong> (£1,823 at 31 March <strong>2012</strong>) which relates to monies held by the<br />

<strong>NHS</strong> <strong>Trust</strong> on behalf of patients. This has been excluded from the cash <strong>and</strong> cash equivalents figure reported in the accounts.<br />

31 March 20<strong>13</strong> 31 March <strong>2012</strong><br />

31 Losses 31 Losses <strong>and</strong> <strong>and</strong> Special Special Payments Payments<br />

Cases Value Cases Value<br />

£000 £000<br />

Losses of cash:<br />

Theft/Fraud 1 1 0 0<br />

Overpayment of salaries, wages,fees <strong>and</strong> allowances 3 9 4 1<br />

Bad debts <strong>and</strong> claims ab<strong>and</strong>oned<br />

Private patients 18 61 3 1<br />

Overseas overseas visitors 168 338 157 353<br />

Other 0 0 2 2<br />

Totals 190 409 0 166 357<br />

Amounts Recovered 1 1 1 2<br />

The amounts reported in this note were incurred as actual costs for the year to date <strong>and</strong> do not contain any accrued costs. These<br />

sums have been reported to <strong>and</strong> approved by the Audit Committee of the <strong>Trust</strong>.<br />

156 <strong>Annual</strong> accounts


Languages/ Alternative Formats<br />

<strong>Annual</strong> accounts<br />

157

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!